,aeid,acid,assay_component_endpoint_name,export_ready,internal_ready,assay_component_endpoint_desc,assay_function_type,normalized_data_type,burst_assay,key_positive_control,signal_direction,intended_target_type,intended_target_type_sub,intended_target_family,intended_target_family_sub,fit_all,cell_viability_assay,data_usability,n_chemicals,n_chemicals_no_chid,aid,assay_component_name,assay_component_desc,assay_component_target_desc,parameter_readout_type,assay_design_type,assay_design_type_sub,biological_process_target,detection_technology_type,detection_technology_type_sub,detection_technology,key_assay_reagent_type,key_assay_reagent,technological_target_type,technological_target_type_sub,asid,assay_name,assay_desc,timepoint_hr,organism_id,organism,tissue,cell_format,cell_free_component_source,cell_short_name,cell_growth_mode,assay_footprint,assay_format_type,assay_format_type_sub,content_readout_type,dilution_solvent,dilution_solvent_percent_max,fate,n_valid_hitcall_c,n_hitcall_c_hit,n_hitcall_c_nohit
10,22,11,APR_HepG2_StressKinase_1hr,1,1,"Data from the assay component APR_HepG2_StressKinase_1hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_StressKinase_1hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is stress response.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,cell cycle,stress response,0,0,1,310,0,2,APR_HepG2_StressKinase_1hr,"APR_HepG2_StressKinase_1hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_1hr assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",anti-phospho-c-jun antibody is used to tag and quantify the level of phosphorylated jun proto-oncogene protein. Changes in the signals are indicative of protein expression changes as a cellular response to stress in the system [GeneSymbol:JUN | GeneID:3725 | Uniprot_SwissProt_Accession:P05412].,single,enzyme reporter,enzyme activity,oxidative phosphorylation,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,anti-phospho-c-jun antibody,protein,protein-specified,2,APR_HepG2_1hr,"APR_HepG2_1hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 1 hour after chemical dosing in a 384-well plate.",1.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,297.0,12.0,285.0
11,24,12,APR_HepG2_CellCycleArrest_24hr,1,1,"Data from the assay component APR_HepG2_CellCycleArrest_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellCycleArrest_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,cell cycle,arrest,0,0,1,1067,40,3,APR_HepG2_CellCycleArrest_24hr,"APR_HepG2_CellCycleArrest_24hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",Hoechst-33342 dye is used as a stain for DNA to understand morphology in the system.,single,morphology reporter,cell phenotype,cell cycle,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,Hoechst-33342 dye,dna,dna-unspecified,2,APR_HepG2_24hr,"APR_HepG2_24hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,964.0,62.0,902.0
12,26,13,APR_HepG2_CellLoss_24hr,1,1,"Data from the assay component APR_HepG2_CellLoss_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellLoss_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log2_fold_induction,0,Camptothecin;Anisomycin;Paclitaxel;CCCP,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1067,40,3,APR_HepG2_CellLoss_24hr,"APR_HepG2_CellLoss_24hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell number, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",Hoechst-33342 dye is used as a stain for DNA to understand viability in the system.,single,viability reporter,cell number,cell death,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,Hoechst-33342 dye,dna,dna-unspecified,2,APR_HepG2_24hr,"APR_HepG2_24hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,986.0,220.0,766.0
13,28,14,APR_HepG2_MicrotubuleCSK_24hr,1,1,"Data from the assay component APR_HepG2_MicrotubuleCSK_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,cellular,cellular,cell morphology,cell conformation,0,0,1,1067,20,3,APR_HepG2_MicrotubuleCSK_24hr,"APR_HepG2_MicrotubuleCSK_24hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of protein conformation, a form of conformation reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.","anti-a-tubulin antibody is used to tag and quantify the level of tubulin, alpha 1a protein. Changes in the signals are indicative of protein expression changes as a cellular response to stress in the system [GeneSymbol:TUBA1A | GeneID:7846 | Uniprot_SwissProt_Accession:Q71U36].",single,conformation reporter,protein conformation,protein stabilization,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,anti-a-tubulin antibody,protein,protein-specified,2,APR_HepG2_24hr,"APR_HepG2_24hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,977.0,24.0,953.0
14,30,15,APR_HepG2_MitoMass_24hr,1,1,"Data from the assay component APR_HepG2_MitoMass_24hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMass_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,1067,20,3,APR_HepG2_MitoMass_24hr,"APR_HepG2_MitoMass_24hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",MitoTracker Red is used as a stain for the morphology of the mitochondria.,single,morphology reporter,cell phenotype,cell cycle,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,MitoTracker Red,cellular,mitochondria,2,APR_HepG2_24hr,"APR_HepG2_24hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,972.0,29.0,943.0
15,32,16,APR_HepG2_MitoMembPot_24hr,1,1,"Data from the assay component APR_HepG2_MitoMembPot_24hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMembPot_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,1067,20,3,APR_HepG2_MitoMembPot_24hr,"APR_HepG2_MitoMembPot_24hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",MitoTracker Red is used as a stain for the membrane potential of the mitochondria.,single,membrane potential reporter,dye binding,mitochondrial depolarization,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,MitoTracker Red,cellular,mitochondria,2,APR_HepG2_24hr,"APR_HepG2_24hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,957.0,42.0,915.0
16,34,17,APR_HepG2_MitoticArrest_24hr,1,1,"Data from the assay component APR_HepG2_MitoticArrest_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MitoticArrest_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,pathway,pathway-specified,cell cycle,arrest,0,0,1,1067,20,3,APR_HepG2_MitoticArrest_24hr,"APR_HepG2_MitoticArrest_24hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.","anti-phospho-histone-H3 antibody is used to tag and quantify the level of phosphorylated H3 histone, family 3A protein. Changes in the signals are indicative of protein expression changes as a cellular response to stress in the system [GeneSymbol:H3F3A | GeneID:3020 | Uniprot_SwissProt_Accession:P84243].",single,morphology reporter,cell phenotype,cell cycle,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,anti-phospho-histone-H3 antibody,protein,protein-specified,2,APR_HepG2_24hr,"APR_HepG2_24hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,967.0,39.0,928.0
17,36,18,APR_HepG2_NuclearSize_24hr,1,1,"Data from the assay component APR_HepG2_NuclearSize_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_NuclearSize_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the nuclear-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,nucleus,cell morphology,organelle conformation,0,0,1,1067,40,3,APR_HepG2_NuclearSize_24hr,"APR_HepG2_NuclearSize_24hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",Hoechst-33342 dye is used as a stain for DNA to understand morphology in the system.,single,morphology reporter,cell phenotype,cell cycle,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,Hoechst-33342 dye,dna,dna-unspecified,2,APR_HepG2_24hr,"APR_HepG2_24hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,1027.0,11.0,1016.0
18,38,19,APR_HepG2_P-H2AX_24hr,1,1,"Data from the assay component APR_HepG2_P-H2AX_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_P-H2AX_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is cellular response to DNA damage stimulus.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,dna binding,cellular response to DNA damage stimulus,0,0,1,1067,20,3,APR_HepG2_P-H2AX_24hr,"APR_HepG2_P-H2AX_24hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of dna content, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.","Anti-phospho-histone-H2AX antibody is used to tag and quantify the level of phosphorylated H2A histone family, member X protein. Changes in the signals are indicative of protein expression changes as a cellular response to stress in the system [GeneSymbol:H2AFX | GeneID:3014 | Uniprot_SwissProt_Accession:P16104].",single,viability reporter,dna content,oxidative phosphorylation,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,anti-phospho-histone-H2AX antibody,protein,protein-specified,2,APR_HepG2_24hr,"APR_HepG2_24hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,937.0,45.0,892.0
19,40,20,APR_HepG2_p53Act_24hr,1,1,"Data from the assay component APR_HepG2_p53Act_24hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_p53Act_24hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,1067,20,3,APR_HepG2_p53Act_24hr,"APR_HepG2_p53Act_24hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_24hr assay. It is designed to make measurements of dna content, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",anti-p53 antibody is used to tag and quantify the level of tumor protein p53 protein. Changes in the signals are indicative of protein expression changes as a cellular response to stress in the system [GeneSymbol:TP53 | GeneID:7157 | Uniprot_SwissProt_Accession:P04637].,single,viability reporter,dna content,cell death,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,anti-p53 antibody,protein,protein-specified,2,APR_HepG2_24hr,"APR_HepG2_24hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,959.0,34.0,925.0
21,44,22,APR_HepG2_CellCycleArrest_72hr,1,1,"Data from the assay component APR_HepG2_CellCycleArrest_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellCycleArrest_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,cell cycle,arrest,0,0,1,1067,40,4,APR_HepG2_CellCycleArrest_72hr,"APR_HepG2_CellCycleArrest_72hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",Hoechst-33342 dye is used as a stain for DNA to understand morphology in the system.,single,morphology reporter,cell phenotype,cell cycle,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,Hoechst-33342 dye,dna,dna-unspecified,2,APR_HepG2_72hr,"APR_HepG2_72hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 72 hours after chemical dosing in a 384-well plate.",72.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,934.0,46.0,888.0
22,46,23,APR_HepG2_CellLoss_72hr,1,1,"Data from the assay component APR_HepG2_CellLoss_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_CellLoss_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of all nuclear dna for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log2_fold_induction,0,Camptothecin;Anisomycin;Paclitaxel;CCCP,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1067,40,4,APR_HepG2_CellLoss_72hr,"APR_HepG2_CellLoss_72hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell number, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",Hoechst-33342 dye is used as a stain for DNA to understand viability in the system.,single,viability reporter,cell number,cell death,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,Hoechst-33342 dye,dna,dna-unspecified,2,APR_HepG2_72hr,"APR_HepG2_72hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 72 hours after chemical dosing in a 384-well plate.",72.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,944.0,316.0,628.0
23,48,24,APR_HepG2_MicrotubuleCSK_72hr,1,1,"Data from the assay component APR_HepG2_MicrotubuleCSK_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MicrotubuleCSK_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of conformation reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,cellular,cellular,cell morphology,cell conformation,0,0,1,1052,20,4,APR_HepG2_MicrotubuleCSK_72hr,"APR_HepG2_MicrotubuleCSK_72hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of protein conformation, a form of conformation reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.","anti-a-tubulin antibody is used to tag and quantify the level of tubulin, alpha 1a protein. Changes in the signals are indicative of protein expression changes as a cellular response to stress in the system [GeneSymbol:TUBA1A | GeneID:7846 | Uniprot_SwissProt_Accession:Q71U36].",single,conformation reporter,protein conformation,protein stabilization,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,anti-a-tubulin antibody,protein,protein-specified,2,APR_HepG2_72hr,"APR_HepG2_72hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 72 hours after chemical dosing in a 384-well plate.",72.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,941.0,24.0,917.0
24,50,25,APR_HepG2_MitoMass_72hr,1,1,"Data from the assay component APR_HepG2_MitoMass_72hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMass_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,1052,20,4,APR_HepG2_MitoMass_72hr,"APR_HepG2_MitoMass_72hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",MitoTracker Red is used as a stain for the morphology of the mitochondria.,single,morphology reporter,cell phenotype,cell cycle,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,MitoTracker Red,cellular,mitochondria,2,APR_HepG2_72hr,"APR_HepG2_72hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 72 hours after chemical dosing in a 384-well plate.",72.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,949.0,26.0,923.0
25,52,26,APR_HepG2_MitoMembPot_72hr,1,1,"Data from the assay component APR_HepG2_MitoMembPot_72hr was analyzed into 1 assay endpoint. This assay endpoint, APR_HepG2_MitoMembPot_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of membrane potential reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,1052,20,4,APR_HepG2_MitoMembPot_72hr,"APR_HepG2_MitoMembPot_72hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",MitoTracker Red is used as a stain for the membrane potential of the mitochondria.,single,membrane potential reporter,dye binding,mitochondrial depolarization,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,MitoTracker Red,cellular,mitochondria,2,APR_HepG2_72hr,"APR_HepG2_72hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 72 hours after chemical dosing in a 384-well plate.",72.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,969.0,26.0,943.0
26,54,27,APR_HepG2_MitoticArrest_72hr,1,1,"Data from the assay component APR_HepG2_MitoticArrest_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_MitoticArrest_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is arrest.",signaling,log2_fold_induction,0,Paclitaxel;CCCP,bidirectional,pathway,pathway-specified,cell cycle,arrest,0,0,1,1052,20,4,APR_HepG2_MitoticArrest_72hr,"APR_HepG2_MitoticArrest_72hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of cell phenotype, a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.","anti-phospho-histone-H3 antibody is used to tag and quantify the level of phosphorylated H3 histone, family 3A protein. Changes in the signals are indicative of protein expression changes as a cellular response to stress in the system [GeneSymbol:H3F3A | GeneID:3020 | Uniprot_SwissProt_Accession:P84243].",single,morphology reporter,cell phenotype,cell cycle,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,anti-phospho-histone-H3 antibody,protein,protein-specified,2,APR_HepG2_72hr,"APR_HepG2_72hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 72 hours after chemical dosing in a 384-well plate.",72.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,920.0,44.0,876.0
28,58,29,APR_HepG2_P-H2AX_72hr,1,1,"Data from the assay component APR_HepG2_P-H2AX_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_P-H2AX_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is cellular response to DNA damage stimulus.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,dna binding,cellular response to DNA damage stimulus,0,0,1,1067,20,4,APR_HepG2_P-H2AX_72hr,"APR_HepG2_P-H2AX_72hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of dna content, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.","Anti-phospho-histone-H2AX antibody is used to tag and quantify the level of phosphorylated H2A histone family, member X protein. Changes in the signals are indicative of protein expression changes as a cellular response to stress in the system [GeneSymbol:H2AFX | GeneID:3014 | Uniprot_SwissProt_Accession:P16104].",single,viability reporter,dna content,oxidative phosphorylation,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,anti-phospho-histone-H2AX antibody,protein,protein-specified,2,APR_HepG2_72hr,"APR_HepG2_72hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 72 hours after chemical dosing in a 384-well plate.",72.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,930.0,41.0,889.0
29,60,30,APR_HepG2_p53Act_72hr,1,1,"Data from the assay component APR_HepG2_p53Act_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_p53Act_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene TP53. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,1067,20,4,APR_HepG2_p53Act_72hr,"APR_HepG2_p53Act_72hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of dna content, a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",anti-p53 antibody is used to tag and quantify the level of tumor protein p53 protein. Changes in the signals are indicative of protein expression changes as a cellular response to stress in the system [GeneSymbol:TP53 | GeneID:7157 | Uniprot_SwissProt_Accession:P04637].,single,viability reporter,dna content,cell death,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,anti-p53 antibody,protein,protein-specified,2,APR_HepG2_72hr,"APR_HepG2_72hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 72 hours after chemical dosing in a 384-well plate.",72.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,941.0,35.0,906.0
30,62,31,APR_HepG2_StressKinase_72hr,1,1,"Data from the assay component APR_HepG2_StressKinase_72hr was analyzed into 1 assay endpoint. 
This assay endpoint, APR_HepG2_StressKinase_72hr, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of enzyme reporter, measures of protein for gain or loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene . 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is stress response.",signaling,log2_fold_induction,0,Camptothecin;Anisomycin,bidirectional,pathway,pathway-specified,cell cycle,stress response,0,0,1,1067,20,4,APR_HepG2_StressKinase_72hr,"APR_HepG2_StressKinase_72hr is one of 10 assay component(s) measured or calculated from the APR_HepG2_72hr assay. It is designed to make measurements of enzyme activity, a form of enzyme reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology.",anti-phospho-c-jun antibody is used to tag and quantify the level of phosphorylated jun proto-oncogene protein. Changes in the signals are indicative of protein expression changes as a cellular response to stress in the system [GeneSymbol:JUN | GeneID:3725 | Uniprot_SwissProt_Accession:P05412].,single,enzyme reporter,enzyme activity,oxidative phosphorylation,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,anti-phospho-c-jun antibody,protein,protein-specified,2,APR_HepG2_72hr,"APR_HepG2_72hr is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 72 hours after chemical dosing in a 384-well plate.",72.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,997.0,14.0,983.0
31,63,32,ATG_Ahr_CIS,1,1,"Data from the assay component ATG_Ahr_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Ahr_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain or loss-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AHR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.",reporter gene,log2_fold_induction,0,6-formylindolo carbazole,bidirectional,protein,transcription factor,dna binding,basic helix-loop-helix protein,0,0,1,4040,2703,5,ATG_Ahr_CIS,"ATG_Ahr_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element AhRE, which is responsive to the endogenous human aryl hydrocarbon receptor [GeneSymbol:AHR | GeneID:196 | Uniprot_SwissProt_Accession:P35869].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,AhRE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3679.0,469.0,3210.0
32,64,33,ATG_AP_1_CIS,1,1,"Data from the assay component ATG_AP_1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_AP_1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOS and JUN. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,4040,2703,5,ATG_AP_1_CIS,"ATG_AP_1_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene AP-1, which is responsive to the endogenous human FBJ murine osteosarcoma viral oncogene homolog and jun proto-oncogene [GeneSymbol:FOS & JUN | GeneID:2353 & 3725 | Uniprot_SwissProt_Accession:P01100 & P05412].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,AP-1 RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3635.0,298.0,3337.0
33,65,34,ATG_AP_2_CIS,1,1,"Data from the assay component ATG_AP_2_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_AP_2_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TFAP2A and TFAP2B and TFAP2D. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-turn-helix leucine zipper.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,basic helix-turn-helix leucine zipper,0,0,1,4040,2702,5,ATG_AP_2_CIS,"ATG_AP_2_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene AP-2, which is responsive to the endogenous human transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) and transcription factor AP-2 beta (activating enhancer binding protein 2 beta) and transcription factor AP-2 delta (activating enhancer binding protein 2 delta) [GeneSymbol:TFAP2A & TFAP2B & TFAP2D | GeneID:7020 & 7021 & 83741 | Uniprot_SwissProt_Accession:P05549 & Q92481 & Q7Z6R9].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,AP-2 RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3857.0,13.0,3844.0
34,66,35,ATG_BRE_CIS,1,1,"Data from the assay component ATG_BRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_BRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SMAD1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is Smad protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,Smad protein,0,0,1,4040,2703,5,ATG_BRE_CIS,"ATG_BRE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element BRE, which is responsive to the endogenous human SMAD family member 1 [GeneSymbol:SMAD1 | GeneID:4086 | Uniprot_SwissProt_Accession:Q15797].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,BRE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3734.0,168.0,3566.0
35,67,36,ATG_C_EBP_CIS,1,1,"Data from the assay component ATG_C_EBP_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_C_EBP_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CEBPB. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,4040,2703,5,ATG_C_EBP_CIS,"ATG_C_EBP_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene C/EBP, which is responsive to the endogenous human CCAAT/enhancer binding protein (C/EBP), beta [GeneSymbol:CEBPB | GeneID:1051 | Uniprot_SwissProt_Accession:P17676].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,C/EBP RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3806.0,95.0,3711.0
36,68,37,ATG_CMV_CIS,1,1,"Data from the assay component ATG_CMV_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_CMV_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2702,5,ATG_CMV_CIS,"ATG_CMV_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene CMV, which is used as an internal marker.",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,CMV RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3710.0,270.0,3440.0
37,69,38,ATG_CRE_CIS,1,1,"Data from the assay component ATG_CRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_CRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene CREB3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,Forskolin,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,4040,2703,5,ATG_CRE_CIS,"ATG_CRE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element CRE, which is responsive to the endogenous human cAMP responsive element binding protein 3 [GeneSymbol:CREB3 | GeneID:10488 | Uniprot_SwissProt_Accession:O43889].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,CRE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3792.0,146.0,3646.0
38,70,39,ATG_DR4_LXR_CIS,1,1,"Data from the assay component ATG_DR4_LXR_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_DR4_LXR_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H2 and NR1H3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2703,5,ATG_DR4_LXR_CIS,"ATG_DR4_LXR_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element LXRE, which is responsive to the endogenous human nuclear receptor subfamily 1, group H, member 2 and nuclear receptor subfamily 1, group H, member 3 [GeneSymbol:NR1H2 & NR1H3 | GeneID:7376 & 10062 | Uniprot_SwissProt_Accession:P55055 & Q13133].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,LXRE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3635.0,23.0,3612.0
39,71,40,ATG_DR5_RAR_CIS,1,1,"Data from the assay component ATG_DR5_RAR_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_DR5_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARA and RARB and RARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,9-cis-Retinoic acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2703,5,ATG_DR5_RAR_CIS,"ATG_DR5_RAR_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element RARE, which is responsive to the endogenous human retinoic acid receptor, alpha and retinoic acid receptor, beta and retinoic acid receptor, gamma [GeneSymbol:RARA & RARB & RARG | GeneID:5914 & 5915 & 5916 | Uniprot_SwissProt_Accession:P10276 & P10826 & P13631].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,RARE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3763.0,139.0,3624.0
40,72,41,ATG_E_Box_CIS,1,1,"Data from the assay component ATG_E_Box_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_E_Box_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene USF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,basic helix-loop-helix protein,0,0,1,4040,2703,5,ATG_E_Box_CIS,"ATG_E_Box_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene Ebox, which is responsive to the endogenous human upstream transcription factor 1 [GeneSymbol:USF1 | GeneID:7391 | Uniprot_SwissProt_Accession:P22415].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,Ebox RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3778.0,25.0,3753.0
41,73,42,ATG_E2F_CIS,1,1,"Data from the assay component ATG_E2F_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_E2F_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene E2F1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is E2F transcription factor.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,E2F transcription factor,0,0,1,4040,2703,5,ATG_E2F_CIS,"ATG_E2F_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene E2F, which is responsive to the endogenous human E2F transcription factor 1 [GeneSymbol:E2F1 | GeneID:1869 | Uniprot_SwissProt_Accession:Q01094].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,E2F RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3874.0,12.0,3862.0
42,74,43,ATG_EGR_CIS,1,1,"Data from the assay component ATG_EGR_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_EGR_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene EGR1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,zinc finger,0,0,1,4040,2703,5,ATG_EGR_CIS,"ATG_EGR_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene EGR, which is responsive to the endogenous human early growth response 1 [GeneSymbol:EGR1 | GeneID:1958 | Uniprot_SwissProt_Accession:P18146].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,EGR RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3747.0,219.0,3528.0
43,75,44,ATG_ERE_CIS,1,1,"Data from the assay component ATG_ERE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ERE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,17b-Estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2703,5,ATG_ERE_CIS,"ATG_ERE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element ERE, which is responsive to the endogenous human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,ERE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3661.0,615.0,3046.0
45,77,46,ATG_FoxA2_CIS,1,1,"Data from the assay component ATG_FoxA2_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_FoxA2_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOXA2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,forkhead box protein,0,0,1,4040,2703,5,ATG_FoxA2_CIS,"ATG_FoxA2_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene FoxA, which is responsive to the endogenous human forkhead box A2 [GeneSymbol:FOXA2 | GeneID:3170 | Uniprot_SwissProt_Accession:Q9Y261].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,FoxA RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3902.0,30.0,3872.0
46,78,47,ATG_FoxO_CIS,1,1,"Data from the assay component ATG_FoxO_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_FoxO_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene FOXO1 and FOXO3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,forkhead box protein,0,0,1,4040,2702,5,ATG_FoxO_CIS,"ATG_FoxO_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene FoxO, which is responsive to the endogenous human forkhead box O1 and forkhead box O3 [GeneSymbol:FOXO1 & FOXO3 | GeneID:2308 & 2309 | Uniprot_SwissProt_Accession:Q12778 & O43524].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,FoxO RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3843.0,10.0,3833.0
48,80,49,ATG_GLI_CIS,1,1,"Data from the assay component ATG_GLI_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GLI_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene GLI1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,zinc finger,0,0,1,4040,2703,5,ATG_GLI_CIS,"ATG_GLI_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene GLI, which is responsive to the endogenous human GLI family zinc finger 1 [GeneSymbol:GLI1 | GeneID:2735 | Uniprot_SwissProt_Accession:P08151].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GLI RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3853.0,51.0,3802.0
49,81,50,ATG_GRE_CIS,1,1,"Data from the assay component ATG_GRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,Dexamethasone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2703,5,ATG_GRE_CIS,"ATG_GRE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element GRE, which is responsive to the endogenous human nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) [GeneSymbol:NR3C1 | GeneID:2908 | Uniprot_SwissProt_Accession:P04150].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GRE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3850.0,13.0,3837.0
50,82,51,ATG_HIF1a_CIS,1,1,"Data from the assay component ATG_HIF1a_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HIF1a_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HIF1A. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,basic helix-loop-helix protein,0,0,1,4040,2703,5,ATG_HIF1a_CIS,"ATG_HIF1a_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene HIF1a, which is responsive to the endogenous human hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) [GeneSymbol:HIF1A | GeneID:3091 | Uniprot_SwissProt_Accession:Q16665].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,HIF1a RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3675.0,179.0,3496.0
51,83,52,ATG_HNF6_CIS,1,1,"Data from the assay component ATG_HNF6_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HNF6_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ONECUT1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is homeobox protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,homeobox protein,0,0,1,4040,2703,5,ATG_HNF6_CIS,"ATG_HNF6_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene HNF6, which is responsive to the endogenous human one cut homeobox 1 [GeneSymbol:ONECUT1 | GeneID:3175 | Uniprot_SwissProt_Accession:Q9UBC0].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,HNF6 RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3848.0,14.0,3834.0
52,84,53,ATG_HSE_CIS,1,1,"Data from the assay component ATG_HSE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HSE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HSF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is heat shock protein.",reporter gene,log2_fold_induction,0,Geldanamycin,gain,protein,transcription factor,dna binding,heat shock protein,0,0,1,4040,2703,5,ATG_HSE_CIS,"ATG_HSE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene HSE, which is responsive to the endogenous human heat shock transcription factor 1 [GeneSymbol:HSF1 | GeneID:3297 | Uniprot_SwissProt_Accession:Q00613].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,HSE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3702.0,119.0,3583.0
53,85,54,ATG_IR1_CIS,1,1,"Data from the assay component ATG_IR1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_IR1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H4. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2702,5,ATG_IR1_CIS,"ATG_IR1_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene IR1, which is responsive to the endogenous human nuclear receptor subfamily 1, group H, member 4 [GeneSymbol:NR1H4 | GeneID:9971 | Uniprot_SwissProt_Accession:Q96RI1].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,IR1 RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3772.0,57.0,3715.0
59,91,60,ATG_MRE_CIS,1,1,"Data from the assay component ATG_MRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_MRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MTF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,zinc finger,0,0,1,4040,2703,5,ATG_MRE_CIS,"ATG_MRE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element MRE, which is responsive to the endogenous human metal-regulatory transcription factor 1 [GeneSymbol:MTF1 | GeneID:4520 | Uniprot_SwissProt_Accession:Q14872].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,MRE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3630.0,336.0,3294.0
61,93,62,ATG_Myc_CIS,1,1,"Data from the assay component ATG_Myc_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Myc_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene MYC. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,basic helix-loop-helix leucine zipper,0,0,1,4040,2686,5,ATG_Myc_CIS,"ATG_Myc_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene Myc, which is responsive to the endogenous human v-myc avian myelocytomatosis viral oncogene homolog [GeneSymbol:MYC | GeneID:4609 | Uniprot_SwissProt_Accession:P01106].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,Myc RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3820.0,46.0,3774.0
62,94,63,ATG_NF_kB_CIS,1,1,"Data from the assay component ATG_NF_kB_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NF_kB_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFKB1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is NF-kappa B.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,NF-kappa B,0,0,1,4040,2703,5,ATG_NF_kB_CIS,"ATG_NF_kB_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene NF-kB, which is responsive to the endogenous human nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 [GeneSymbol:NFKB1 | GeneID:4790 | Uniprot_SwissProt_Accession:P19838].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,NF-kB RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3774.0,46.0,3728.0
63,95,64,ATG_NFI_CIS,1,1,"Data from the assay component ATG_NFI_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NFI_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFIA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is nuclear factor I.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,nuclear factor I,0,0,1,4040,2703,5,ATG_NFI_CIS,"ATG_NFI_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene NFI, which is responsive to the endogenous human nuclear factor I/A [GeneSymbol:NFIA | GeneID:4774 | Uniprot_SwissProt_Accession:Q12857].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,NFI RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3814.0,84.0,3730.0
64,96,65,ATG_NRF1_CIS,1,1,"Data from the assay component ATG_NRF1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NRF1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NRF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is nuclear respiratory factors.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,nuclear respiratory factors,0,0,1,4040,2703,5,ATG_NRF1_CIS,"ATG_NRF1_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene NRF1, which is responsive to the endogenous human nuclear respiratory factor 1 [GeneSymbol:NRF1 | GeneID:4899 | Uniprot_SwissProt_Accession:Q16656].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,NRF1 RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3854.0,33.0,3821.0
65,97,66,ATG_NRF2_ARE_CIS,1,1,"Data from the assay component ATG_NRF2_ARE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NRF2_ARE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NFE2L2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,4040,2703,5,ATG_NRF2_ARE_CIS,"ATG_NRF2_ARE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element ARE, which is responsive to the endogenous human nuclear factor, erythroid 2-like 2 [GeneSymbol:NFE2L2 | GeneID:4780 | Uniprot_SwissProt_Accession:Q16236].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,ARE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3473.0,845.0,2628.0
66,98,67,ATG_Oct_MLP_CIS,1,1,"Data from the assay component ATG_Oct_MLP_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Oct_MLP_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene POU2F1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is POU domain protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,POU domain protein,0,0,1,4040,2703,5,ATG_Oct_MLP_CIS,"ATG_Oct_MLP_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene Oct, which is responsive to the endogenous human POU class 2 homeobox 1 [GeneSymbol:POU2F1 | GeneID:5451 | Uniprot_SwissProt_Accession:P14859].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,Oct RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3666.0,256.0,3410.0
67,99,68,ATG_p53_CIS,1,1,"Data from the assay component ATG_p53_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_p53_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TP53. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,tumor suppressor,0,0,1,4040,2703,5,ATG_p53_CIS,"ATG_p53_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene p53, which is responsive to the endogenous human tumor protein p53 [GeneSymbol:TP53 | GeneID:7157 | Uniprot_SwissProt_Accession:P04637].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,p53 RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3760.0,29.0,3731.0
68,100,69,ATG_Pax6_CIS,1,1,"Data from the assay component ATG_Pax6_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Pax6_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PAX6. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is paired box protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,paired box protein,0,0,1,4040,2703,5,ATG_Pax6_CIS,"ATG_Pax6_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene Pax, which is responsive to the endogenous human paired box 6 [GeneSymbol:PAX6 | GeneID:5080 | Uniprot_SwissProt_Accession:P26367].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,Pax RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3756.0,198.0,3558.0
69,101,70,ATG_PBREM_CIS,1,1,"Data from the assay component ATG_PBREM_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PBREM_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2702,5,ATG_PBREM_CIS,"ATG_PBREM_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene PBREM, which is responsive to the endogenous human nuclear receptor subfamily 1, group I, member 3 [GeneSymbol:NR1I3 | GeneID:9970 | Uniprot_SwissProt_Accession:Q14994].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,PBREM RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3780.0,217.0,3563.0
70,102,71,ATG_PPRE_CIS,1,1,"Data from the assay component ATG_PPRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARA and PPARD and PPARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Rosiglitazone,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2703,5,ATG_PPRE_CIS,"ATG_PPRE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element PPRE, which is responsive to the endogenous human peroxisome proliferator-activated receptor alpha and peroxisome proliferator-activated receptor delta and peroxisome proliferator-activated receptor gamma [GeneSymbol:PPARA & PPARD & PPARG | GeneID:5465 & 5467 & 5468 | Uniprot_SwissProt_Accession:Q07869 & Q03181 & P37231].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,PPRE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3724.0,324.0,3400.0
71,103,72,ATG_PXRE_CIS,1,1,"Data from the assay component ATG_PXRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PXRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Rifampicin,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2727,5,ATG_PXRE_CIS,"ATG_PXRE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element PXRE, which is responsive to the endogenous human nuclear receptor subfamily 1, group I, member 2 [GeneSymbol:NR1I2 | GeneID:8856 | Uniprot_SwissProt_Accession:O75469].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,PXRE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3268.0,1260.0,2008.0
72,104,73,ATG_RORE_CIS,1,1,"Data from the assay component ATG_RORE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RORE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORA and RORB and RORC. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,4040,2703,5,ATG_RORE_CIS,"ATG_RORE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element RORE, which is responsive to the endogenous human RAR-related orphan receptor A and RAR-related orphan receptor B and RAR-related orphan receptor C [GeneSymbol:RORA & RORB & RORC | GeneID:6095 & 6096 & 6097 | Uniprot_SwissProt_Accession:P35398 & Q92753 & P51449].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,RORE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3821.0,215.0,3606.0
73,105,74,ATG_Sox_CIS,1,1,"Data from the assay component ATG_Sox_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Sox_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SOX1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is HMG box protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,HMG box protein,0,0,1,4040,2702,5,ATG_Sox_CIS,"ATG_Sox_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene SOX, which is responsive to the endogenous human SRY (sex determining region Y)-box 1 [GeneSymbol:SOX1 | GeneID:6656 | Uniprot_SwissProt_Accession:O00570].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,SOX RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3822.0,72.0,3750.0
74,106,75,ATG_Sp1_CIS,1,1,"Data from the assay component ATG_Sp1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Sp1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SP1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,zinc finger,0,0,1,4040,2702,5,ATG_Sp1_CIS,"ATG_Sp1_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene Sp1, which is responsive to the endogenous human Sp1 transcription factor [GeneSymbol:SP1 | GeneID:6667 | Uniprot_SwissProt_Accession:P08047].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,Sp1 RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3784.0,132.0,3652.0
75,107,76,ATG_SREBP_CIS,1,1,"Data from the assay component ATG_SREBP_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_SREBP_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene SREBF1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,basic helix-loop-helix leucine zipper,0,0,1,4040,2703,5,ATG_SREBP_CIS,"ATG_SREBP_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene SREBP, which is responsive to the endogenous human sterol regulatory element binding transcription factor 1 [GeneSymbol:SREBF1 | GeneID:6720 | Uniprot_SwissProt_Accession:P36956].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,SREBP RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3695.0,238.0,3457.0
76,108,77,ATG_STAT3_CIS,1,1,"Data from the assay component ATG_STAT3_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_STAT3_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene STAT3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is stat protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,stat protein,0,0,1,4040,2703,5,ATG_STAT3_CIS,"ATG_STAT3_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene STAT, which is responsive to the endogenous human signal transducer and activator of transcription 3 (acute-phase response factor) [GeneSymbol:STAT3 | GeneID:6774 | Uniprot_SwissProt_Accession:P40763].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,STAT RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3884.0,11.0,3873.0
77,109,78,ATG_TA_CIS,1,1,"Data from the assay component ATG_TA_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_TA_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2703,5,ATG_TA_CIS,"ATG_TA_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene TA, which is used as a basal promoter.",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,TA RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3855.0,90.0,3765.0
78,110,79,ATG_TAL_CIS,1,1,"Data from the assay component ATG_TAL_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_TAL_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the background control at the transcription factor-level as they relate to the gene . 

Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is internal marker.",background control,log2_fold_induction,0,,gain,protein,transcription factor,background measurement,internal marker,0,0,1,4040,2703,5,ATG_TAL_CIS,"ATG_TAL_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene TAL, which is used as a basal promoter.",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,TAL RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3896.0,47.0,3849.0
79,111,80,ATG_TCF_b_cat_CIS,1,1,"Data from the assay component ATG_TCF_b_cat_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_TCF_b_cat_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TCF7 and TCF7L2 and LEF1 and TCF7L1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is HMG box protein.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,HMG box protein,0,0,1,4040,2703,5,ATG_TCF_b_cat_CIS,"ATG_TCF_b_cat_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene TCF/b-cat, which is responsive to the endogenous human transcription factor 7 (T-cell specific, HMG-box) and transcription factor 7-like 2 (T-cell specific, HMG-box) and lymphoid enhancer-binding factor 1 and transcription factor 7-like 1 (T-cell specific, HMG-box) [GeneSymbol:TCF7 & TCF7L2 & LEF1 & TCF7L1 | GeneID:6932 & 6934 & 51176 & 83439 | Uniprot_SwissProt_Accession:P36402 & Q9NQB0 & Q9UJU2 & Q9HCS4].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,TCF/b-cat RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3742.0,12.0,3730.0
80,112,81,ATG_TGFb_CIS,1,1,"Data from the assay component ATG_TGFb_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_TGFb_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TGFB1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,growth factor,transforming growth factor beta,0,0,1,4040,2703,5,ATG_TGFb_CIS,"ATG_TGFb_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene TGF, which is responsive to the endogenous human transforming growth factor, beta 1 [GeneSymbol:TGFB1 | GeneID:7040 | Uniprot_SwissProt_Accession:P01137].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,TGF RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3823.0,62.0,3761.0
81,113,82,ATG_VDRE_CIS,1,1,"Data from the assay component ATG_VDRE_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_VDRE_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene VDR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2703,5,ATG_VDRE_CIS,"ATG_VDRE_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene response element VDRE, which is responsive to the endogenous human vitamin D (1,25- dihydroxyvitamin D3) receptor [GeneSymbol:VDR | GeneID:7421 | Uniprot_SwissProt_Accession:P11473].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,VDRE RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3653.0,619.0,3034.0
82,114,83,ATG_Xbp1_CIS,1,1,"Data from the assay component ATG_Xbp1_CIS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_Xbp1_CIS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene XBP1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,4040,2703,5,ATG_Xbp1_CIS,"ATG_Xbp1_CIS is one of 52 assay component(s) measured or calculated from the ATG_CIS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the cis-acting reporter gene Xbp1, which is responsive to the endogenous human X-box binding protein 1 [GeneSymbol:XBP1 | GeneID:7494 | Uniprot_SwissProt_Accession:P17861].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,Xbp1 RTU,rna,mRNA,3,ATG_CIS,"ATG_CIS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3730.0,184.0,3546.0
83,115,84,ATG_AR_TRANS,1,1,"Data from the assay component ATG_AR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_AR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,6a-Fluorotestosterone,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2681,6,ATG_AR_TRANS,"ATG_AR_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-AR, also known as human androgen receptor [GeneSymbol:AR | GeneID:367 | Uniprot_SwissProt_Accession:P10275].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-AR RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3965.0,19.0,3946.0
84,116,85,ATG_CAR_TRANS,1,1,"Data from the assay component ATG_CAR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_CAR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_CAR_TRANS,"ATG_CAR_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-CAR, also known as human nuclear receptor subfamily 1, group I, member 3 [GeneSymbol:NR1I3 | GeneID:9970 | Uniprot_SwissProt_Accession:Q14994].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-CAR RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3914.0,14.0,3900.0
85,117,86,ATG_ERa_TRANS,1,1,"Data from the assay component ATG_ERa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ERa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESR1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,17b-Estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2692,6,ATG_ERa_TRANS,"ATG_ERa_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-ERa, also known as human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-ERa RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3734.0,532.0,3202.0
87,119,88,ATG_ERRg_TRANS,1,1,"Data from the assay component ATG_ERRg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_ERRg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ESRRG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2692,6,ATG_ERRg_TRANS,"ATG_ERRg_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-ERRg, also known as human estrogen-related receptor gamma [GeneSymbol:ESRRG | GeneID:2104 | Uniprot_SwissProt_Accession:P62508].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-ERRg RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3979.0,11.0,3968.0
88,120,89,ATG_FXR_TRANS,1,1,"Data from the assay component ATG_FXR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_FXR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H4. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,CDCA,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_FXR_TRANS,"ATG_FXR_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-FXR, also known as human nuclear receptor subfamily 1, group H, member 4 [GeneSymbol:NR1H4 | GeneID:9971 | Uniprot_SwissProt_Accession:Q96RI1].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-FXR RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3914.0,42.0,3872.0
90,122,91,ATG_GR_TRANS,1,1,"Data from the assay component ATG_GR_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_GR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR3C1. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,4040,2692,6,ATG_GR_TRANS,"ATG_GR_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-GR, also known as human nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) [GeneSymbol:NR3C1 | GeneID:2908 | Uniprot_SwissProt_Accession:P04150].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-GR RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3947.0,39.0,3908.0
91,123,92,ATG_HNF4a_TRANS,1,1,"Data from the assay component ATG_HNF4a_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_HNF4a_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene HNF4A. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,4040,2692,6,ATG_HNF4a_TRANS,"ATG_HNF4a_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-HNF4a, also known as human hepatocyte nuclear factor 4, alpha [GeneSymbol:HNF4A | GeneID:3172 | Uniprot_SwissProt_Accession:P41235].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-HNF4a RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3943.0,23.0,3920.0
93,125,94,ATG_LXRa_TRANS,1,1,"Data from the assay component ATG_LXRa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_LXRa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,T0901317,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_LXRa_TRANS,"ATG_LXRa_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-LXRa, also known as human nuclear receptor subfamily 1, group H, member 3 [GeneSymbol:NR1H3 | GeneID:10062 | Uniprot_SwissProt_Accession:Q13133].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-LXRa RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3908.0,40.0,3868.0
94,126,95,ATG_LXRb_TRANS,1,1,"Data from the assay component ATG_LXRb_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_LXRb_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1H2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,T0901317,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_LXRb_TRANS,"ATG_LXRb_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-LXRb, also known as human nuclear receptor subfamily 1, group H, member 2 [GeneSymbol:NR1H2 | GeneID:7376 | Uniprot_SwissProt_Accession:P55055].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-LXRb RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3917.0,23.0,3894.0
99,131,100,ATG_NURR1_TRANS,1,1,"Data from the assay component ATG_NURR1_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_NURR1_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR4A2. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,4040,2692,6,ATG_NURR1_TRANS,"ATG_NURR1_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-NURR1, also known as human nuclear receptor subfamily 4, group A, member 2 [GeneSymbol:NR4A2 | GeneID:4929 | Uniprot_SwissProt_Accession:P43354].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-NURR1 RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3891.0,129.0,3762.0
100,132,101,ATG_PPARa_TRANS,1,1,"Data from the assay component ATG_PPARa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPARa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,GW0742,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_PPARa_TRANS,"ATG_PPARa_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-PPARa, also known as human peroxisome proliferator-activated receptor alpha [GeneSymbol:PPARA | GeneID:5465 | Uniprot_SwissProt_Accession:Q07869].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-PPARa RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3884.0,153.0,3731.0
101,133,102,ATG_PPARd_TRANS,1,1,"Data from the assay component ATG_PPARd_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPARd_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARD. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,GW7647,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2677,6,ATG_PPARd_TRANS,"ATG_PPARd_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-PPARd, also known as human peroxisome proliferator-activated receptor delta [GeneSymbol:PPARD | GeneID:5467 | Uniprot_SwissProt_Accession:Q03181].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-PPARd RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3957.0,29.0,3928.0
102,134,103,ATG_PPARg_TRANS,1,1,"Data from the assay component ATG_PPARg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_PPARg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Rosiglitazone,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_PPARg_TRANS,"ATG_PPARg_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-PPARg, also known as human peroxisome proliferator-activated receptor gamma [GeneSymbol:PPARG | GeneID:5468 | Uniprot_SwissProt_Accession:P37231].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-PPARg RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3655.0,679.0,2976.0
103,135,104,ATG_PXR_TRANS,1,1,"Data from the assay component ATG_PXR_TRANS was analyzed into 1 assay endpoint. This assay endpoint, ATG_PXR_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene NR1I2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,T0901317,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2712,6,ATG_PXR_TRANS,"ATG_PXR_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-PXR, also known as human nuclear receptor subfamily 1, group I, member 2 [GeneSymbol:NR1I2 | GeneID:8856 | Uniprot_SwissProt_Accession:O75469].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-PXR RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3604.0,674.0,2930.0
104,136,105,ATG_RARa_TRANS,1,1,"Data from the assay component ATG_RARa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RARa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Retinoic Acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_RARa_TRANS,"ATG_RARa_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-RARa, also known as human retinoic acid receptor, alpha [GeneSymbol:RARA | GeneID:5914 | Uniprot_SwissProt_Accession:P10276].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-RARa RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3805.0,34.0,3771.0
106,138,107,ATG_RARg_TRANS,1,1,"Data from the assay component ATG_RARg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RARg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RARG. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,Retinoic Acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_RARg_TRANS,"ATG_RARg_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-RARg, also known as human retinoic acid receptor, gamma [GeneSymbol:RARG | GeneID:5916 | Uniprot_SwissProt_Accession:P13631].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-RARg RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3908.0,25.0,3883.0
108,140,109,ATG_RORg_TRANS,1,1,"Data from the assay component ATG_RORg_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RORg_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RORC. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,orphan,0,0,1,4040,2692,6,ATG_RORg_TRANS,"ATG_RORg_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-RORg, also known as human RAR-related orphan receptor C [GeneSymbol:RORC | GeneID:6097 | Uniprot_SwissProt_Accession:P51449].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-RORg RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3969.0,10.0,3959.0
109,141,110,ATG_RXRa_TRANS,1,1,"Data from the assay component ATG_RXRa_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_RXRa_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,9-cis-Retinoic acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_RXRa_TRANS,"ATG_RXRa_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-RXRa, also known as human retinoid X receptor, alpha [GeneSymbol:RXRA | GeneID:6256 | Uniprot_SwissProt_Accession:P19793].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-RXRa RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3924.0,50.0,3874.0
110,142,111,ATG_RXRb_TRANS,1,1,"Data from the assay component ATG_RXRb_TRANS was analyzed into 1 assay endpoint. This assay endpoint, ATG_RXRb_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene RXRB. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,9-cis-Retinoic acid,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_RXRb_TRANS,"ATG_RXRb_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-RXRb, also known as human retinoid X receptor, beta [GeneSymbol:RXRB | GeneID:6257 | Uniprot_SwissProt_Accession:P28702].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-RXRb RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3747.0,327.0,3420.0
111,143,112,ATG_THRa1_TRANS,1,1,"Data from the assay component ATG_THRa1_TRANS was analyzed into 1 assay endpoint. 

This assay endpoint, ATG_THRa1_TRANS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene THRA. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,T3,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,4040,2692,6,ATG_THRa1_TRANS,"ATG_THRa1_TRANS is one of 30 assay component(s) measured or calculated from the ATG_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the transfected trans-acting reporter gene and exogenous transcription factor GAL4-THRa, also known as human thyroid hormone receptor, alpha [GeneSymbol:THRA | GeneID:7067 | Uniprot_SwissProt_Accession:P10827].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,GAL4-THRa RTU,rna,mRNA,3,ATG_TRANS,"ATG_TRANS is a cell-based, multiplexed-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,3922.0,60.0,3862.0
113,146,114,BSK_3C_Eselectin,1,1,"Data from the assay component BSK_3C_Eselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_Eselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,selectins,0,0,1,1705,0,7,BSK_3C_Eselectin,BSK_3C_Eselectin is an assay component measured in the BSK_3C assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.,E-selectin antibody is used to tag and quantify the level of selectin E protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:SELE | GeneID:6401 | Uniprot_SwissProt_Accession:P16581].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,E-selectin antibody,protein,protein-specified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1572.0,116.0,1456.0
114,148,115,BSK_3C_HLADR,1,1,"Data from the assay component BSK_3C_HLADR was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_HLADR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is MHC Class II.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,MHC Class II,0,0,1,1705,0,7,BSK_3C_HLADR,BSK_3C_HLADR is an assay component measured in the BSK_3C assay. It measures HLA-DR antibody related to regulation of gene expression using ELISA technology.,"HLA-DR antibody is used to tag and quantify the level of major histocompatibility complex, class II, DR alpha protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:HLA-DRA | GeneID:3122 | Uniprot_SwissProt_Accession:P01903].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,HLA-DR antibody,protein,protein-specified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1522.0,172.0,1350.0
115,150,116,BSK_3C_ICAM1,1,1,"Data from the assay component BSK_3C_ICAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_ICAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene ICAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0,7,BSK_3C_ICAM1,BSK_3C_ICAM1 is an assay component measured in the BSK_3C assay. It measures ICAM-1 antibody related to regulation of gene expression using ELISA technology.,ICAM-1 antibody is used to tag and quantify the level of intercellular adhesion molecule 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:ICAM1 | GeneID:3383 | Uniprot_SwissProt_Accession:P05362].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,ICAM-1 antibody,protein,protein-specified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1643.0,52.0,1591.0
116,152,117,BSK_3C_IL8,1,1,"Data from the assay component BSK_3C_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0,7,BSK_3C_IL8,BSK_3C_IL8 is an assay component measured in the BSK_3C assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.,IL-8 antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 8 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:CXCL8 | GeneID:3576 | Uniprot_SwissProt_Accession:P10145].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-8 antibody,protein,protein-specified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1564.0,108.0,1456.0
117,154,118,BSK_3C_MCP1,1,1,"Data from the assay component BSK_3C_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,7,BSK_3C_MCP1,BSK_3C_MCP1 is an assay component measured in the BSK_3C assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.,MCP-1 antibody is used to tag and quantify the level of chemokine (C-C motif) ligand 2 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:CCL2 | GeneID:6347 | Uniprot_SwissProt_Accession:P13500].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MCP-1 antibody,protein,protein-specified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1569.0,111.0,1458.0
118,156,119,BSK_3C_MIG,1,1,"Data from the assay component BSK_3C_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,7,BSK_3C_MIG,BSK_3C_MIG is an assay component measured in the BSK_3C assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.,MIG antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 9 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:CXCL9 | GeneID:4283 | Uniprot_SwissProt_Accession:Q07325].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MIG antibody,protein,protein-specified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1658.0,49.0,1609.0
119,158,120,BSK_3C_Proliferation,1,1,"Data from the assay component BSK_3C_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_3C_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1705,0,7,BSK_3C_Proliferation,BSK_3C_Proliferation is an assay component measured in the BSK_3C assay. It measures 0.1% sulforhodamine related to cell proliferation using Sulforhodamine staining technology.,Proliferation in the 3C system is a measure of endothelial cell profliferation which is important to the process of wound healing and angiogensis.,single,viability reporter,protein content,cell proliferation,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1508.0,440.0,1068.0
120,160,121,BSK_3C_SRB,1,1,"Data from the assay component BSK_3C_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0,7,BSK_3C_SRB,BSK_3C_SRB is an assay component measured in the BSK_3C assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,"SRB in the 3C system is a measure of the total protein content of venular endothelial cells.  Cell viability of adherent cells is measured by Sulforhodamine B (SRB) staining, a method that determines cell density by measuring total protein content of test wells.",single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1529.0,132.0,1397.0
121,162,122,BSK_3C_Thrombomodulin,1,1,"Data from the assay component BSK_3C_Thrombomodulin was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_Thrombomodulin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,gpcr,rhodopsin-like receptor,0,0,1,1705,0,7,BSK_3C_Thrombomodulin,BSK_3C_Thrombomodulin is an assay component measured in the BSK_3C assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.,Thrombomodulin antibody is used to tag and quantify the level of thrombomodulin protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:THBD | GeneID:7056 | Uniprot_SwissProt_Accession:P07204].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Thrombomodulin antibody,protein,protein-specified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1624.0,50.0,1574.0
122,164,123,BSK_3C_TissueFactor,1,1,"Data from the assay component BSK_3C_TissueFactor was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_TissueFactor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is coagulation factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,coagulation factor,0,0,1,1705,0,7,BSK_3C_TissueFactor,BSK_3C_TissueFactor is an assay component measured in the BSK_3C assay. It measures Tissue Factor antibody related to regulation of gene expression using ELISA technology.,"Tissue Factor antibody is used to tag and quantify the level of coagulation factor III (thromboplastin, tissue factor) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:F3 | GeneID:2152 | Uniprot_SwissProt_Accession:P13726].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Tissue Factor antibody,protein,protein-specified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1583.0,130.0,1453.0
123,166,124,BSK_3C_uPAR,1,1,"Data from the assay component BSK_3CAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_3CAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator,0,0,1,1705,0,7,BSK_3C_uPAR,BSK_3CAR is an assay component measured in the BSK_3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.,"uPAR antibody is used to tag and quantify the level of plasminogen activator, urokinase receptor protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:PLAUR | GeneID:5329 | Uniprot_SwissProt_Accession:Q03405].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,uPAR antibody,protein,protein-specified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1553.0,124.0,1429.0
124,168,125,BSK_3C_VCAM1,1,1,"Data from the assay component BSK_3C_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0,7,BSK_3C_VCAM1,BSK_3C_VCAM1 is an assay component measured in the BSK_3C assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.,VCAM-1 antibody is used to tag and quantify the level of vascular cell adhesion molecule 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:VCAM1 | GeneID:7412 | Uniprot_SwissProt_Accession:P19320].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,VCAM-1 antibody,protein,protein-specified,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1582.0,86.0,1496.0
125,170,126,BSK_3C_Vis,1,1,"Data from the assay component BSK_3C_Vis was analyzed into 1 assay endpoint. This assay endpoint, BSK_3C_Vis, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand changes in the background control. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a background control function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",background control,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell morphology,cell conformation,0,0,1,1484,0,7,BSK_3C_Vis,BSK_3C_Vis is an assay component measured in the BSK_3C assay. It measures NA related to cell morphology using light microscopy technology.,Visual microscropy is used to quantify changes to the morphology of the cells.,single,morphology reporter,cell phenotype,cell morphology,Microscopy,Optical microscopy: Fluorescence microscopy,light microscopy,,,cellular,cellular,4,BSK_3C,"BSK_3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1312.0,124.0,1188.0
126,172,127,BSK_4H_Eotaxin3,1,1,"Data from the assay component BSK_4H_Eotaxin3 was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_Eotaxin3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL26. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,8,BSK_4H_Eotaxin3,BSK_4H_Eotaxin3 is an assay component measured in the BSK_4H assay. It measures Eotaxin-3 antibody related to regulation of gene expression using ELISA technology.,Eotaxin-3 antibody is used to tag and quantify the level of chemokine (C-C motif) ligand 26 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from histamine and IL4 [GeneSymbol:CCL26 | GeneID:10344 | Uniprot_SwissProt_Accession:Q9Y258].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Eotaxin-3 antibody,protein,protein-specified,4,BSK_4H,"BSK_4H is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1532.0,310.0,1222.0
127,174,128,BSK_4H_MCP1,1,1,"Data from the assay component BSK_4H_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,8,BSK_4H_MCP1,BSK_4H_MCP1 is an assay component measured in the BSK_4H assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.,MCP-1 antibody is used to tag and quantify the level of chemokine (C-C motif) ligand 2 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from histamine and IL4 [GeneSymbol:CCL2 | GeneID:6347 | Uniprot_SwissProt_Accession:P13500].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MCP-1 antibody,protein,protein-specified,4,BSK_4H,"BSK_4H is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1600.0,318.0,1282.0
128,176,129,BSK_4H_Pselectin,1,1,"Data from the assay component BSK_4H_Pselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_Pselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELP. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,selectins,0,0,1,1705,0,8,BSK_4H_Pselectin,BSK_4H_Pselectin is an assay component measured in the BSK_4H assay. It measures P-Selectin antibody related to regulation of gene expression using ELISA technology.,"P-Selectin antibody is used to tag and quantify the level of selectin P (granule membrane protein 140kDa, antigen CD62) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from histamine and IL4 [GeneSymbol:SELP | GeneID:6403 | Uniprot_SwissProt_Accession:P16109].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,P-Selectin antibody,protein,protein-specified,4,BSK_4H,"BSK_4H is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1568.0,306.0,1262.0
129,178,130,BSK_4H_SRB,1,1,"Data from the assay component BSK_4H_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0,8,BSK_4H_SRB,BSK_4H_SRB is an assay component measured in the BSK_4H assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,"SRB in the 4H system is a measure of the total protein content of venular endothelial cells.  Cell viability of adherent cells is measured by Sulforhodamine B (SRB) staining, a method that determines cell density by measuring total protein content of test wells.",single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_4H,"BSK_4H is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1555.0,260.0,1295.0
130,180,131,BSK_4H_uPAR,1,1,"Data from the assay component BSK_4HAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_4HAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator,0,0,1,1705,0,8,BSK_4H_uPAR,BSK_4HAR is an assay component measured in the BSK_4H assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.,"uPAR antibody is used to tag and quantify the level of plasminogen activator, urokinase receptor protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from histamine and IL4 [GeneSymbol:PLAUR | GeneID:5329 | Uniprot_SwissProt_Accession:Q03405].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,uPAR antibody,protein,protein-specified,4,BSK_4H,"BSK_4H is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1588.0,259.0,1329.0
131,182,132,BSK_4H_VCAM1,1,1,"Data from the assay component BSK_4H_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0,8,BSK_4H_VCAM1,BSK_4H_VCAM1 is an assay component measured in the BSK_4H assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.,VCAM-1 antibody is used to tag and quantify the level of vascular cell adhesion molecule 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from histamine and IL4 [GeneSymbol:VCAM1 | GeneID:7412 | Uniprot_SwissProt_Accession:P19320].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,VCAM-1 antibody,protein,protein-specified,4,BSK_4H,"BSK_4H is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1568.0,308.0,1260.0
132,184,133,BSK_4H_VEGFRII,1,1,"Data from the assay component BSK_4H_VEGFRII was analyzed into 1 assay endpoint. This assay endpoint, BSK_4H_VEGFRII, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene KDR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,1705,0,8,BSK_4H_VEGFRII,BSK_4H_VEGFRII is an assay component measured in the BSK_4H assay. It measures VEGFRII antibody related to regulation of gene expression using ELISA technology.,VEGFRII antibody is used to tag and quantify the level of kinase insert domain receptor (a type III receptor tyrosine kinase) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from histamine and IL4 [GeneSymbol:KDR | GeneID:3791 | Uniprot_SwissProt_Accession:P35968].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,VEGFRII antibody,protein,protein-specified,4,BSK_4H,"BSK_4H is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,umbilical vein endothelium,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1629.0,158.0,1471.0
133,186,134,BSK_BE3C_HLADR,1,1,"Data from the assay component BSK_BE3C_HLADR was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_HLADR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is MHC Class II.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,MHC Class II,0,0,1,1705,0,9,BSK_BE3C_HLADR,BSK_BE3C_HLADR is an assay component measured in the BSK_BE3C assay. It measures HLA-DR antibody related to regulation of gene expression using ELISA technology.,"HLA-DR antibody is used to tag and quantify the level of major histocompatibility complex, class II, DR alpha protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:HLA-DRA | GeneID:3122 | Uniprot_SwissProt_Accession:P01903].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,HLA-DR antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1548.0,277.0,1271.0
134,188,135,BSK_BE3C_IL1a,1,1,"Data from the assay component BSK_BE3C_IL1a was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_IL1a, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0,9,BSK_BE3C_IL1a,BSK_BE3C_IL1a is an assay component measured in the BSK_BE3C assay. It measures IL-1a antibody related to regulation of gene expression using ELISA technology.,"IL-1a antibody is used to tag and quantify the level of interleukin 1, alpha protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:IL1A | GeneID:3552 | Uniprot_SwissProt_Accession:P01583].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-1a antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1595.0,203.0,1392.0
135,190,136,BSK_BE3C_IP10,1,1,"Data from the assay component BSK_BE3C_IP10 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_IP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,9,BSK_BE3C_IP10,BSK_BE3C_IP10 is an assay component measured in the BSK_BE3C assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.,IP-10 antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 10 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:CXCL10 | GeneID:3627 | Uniprot_SwissProt_Accession:P02778].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IP-10 antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1558.0,264.0,1294.0
136,192,137,BSK_BE3C_MIG,1,1,"Data from the assay component BSK_BE3C_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,9,BSK_BE3C_MIG,BSK_BE3C_MIG is an assay component measured in the BSK_BE3C assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.,MIG antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 9 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:CXCL9 | GeneID:4283 | Uniprot_SwissProt_Accession:Q07325].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MIG antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1644.0,124.0,1520.0
137,194,138,BSK_BE3C_MMP1,1,1,"Data from the assay component BSK_BE3C_MMP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_MMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,1705,0,9,BSK_BE3C_MMP1,BSK_BE3C_MMP1 is an assay component measured in the BSK_BE3C assay. It measures MMP-1 antibody related to regulation of gene expression using ELISA technology.,MMP-1 antibody is used to tag and quantify the level of matrix metallopeptidase 1 (interstitial collagenase) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:MMP1 | GeneID:4312 | Uniprot_SwissProt_Accession:P03956].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MMP-1 antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1590.0,237.0,1353.0
138,196,139,BSK_BE3C_PAI1,1,1,"Data from the assay component BSK_BE3C_PAI1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_PAI1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SERPINE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator inhibitor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,1705,0,9,BSK_BE3C_PAI1,BSK_BE3C_PAI1 is an assay component measured in the BSK_BE3C assay. It measures PAI-1 antibody related to regulation of gene expression using ELISA technology.,"PAI-1 antibody is used to tag and quantify the level of serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:SERPINE1 | GeneID:5054 | Uniprot_SwissProt_Accession:P05121].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,PAI-1 antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1565.0,200.0,1365.0
139,198,140,BSK_BE3C_SRB,1,1,"Data from the assay component BSK_BE3C_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0,9,BSK_BE3C_SRB,BSK_BE3C_SRB is an assay component measured in the BSK_BE3C assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,"SRB in the BE3C system is a measure of the total protein content of bronchial epithelial cells.  Cell viability of adherent cells is measured by Sulforhodamine B (SRB) staining, a method that determines cell density by measuring total protein content of test wells.",single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1634.0,144.0,1490.0
140,200,141,BSK_BE3C_TGFb1,1,1,"Data from the assay component BSK_BE3C_TGFb1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_TGFb1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TGFB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,growth factor,transforming growth factor beta,0,0,1,1484,0,9,BSK_BE3C_TGFb1,BSK_BE3C_TGFb1 is an assay component measured in the BSK_BE3C assay. It measures TGF-b1 antibody related to regulation of gene expression using ELISA technology.,"TGF-b1 antibody is used to tag and quantify the level of transforming growth factor, beta 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:TGFB1 | GeneID:7040 | Uniprot_SwissProt_Accession:P01137].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,TGF-b1 antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1406.0,142.0,1264.0
141,202,142,BSK_BE3C_tPA,1,1,"Data from the assay component BSK_BE3C_tPA was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3C_tPA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAT. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine protease.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,serine protease,0,0,1,1705,0,9,BSK_BE3C_tPA,BSK_BE3C_tPA is an assay component measured in the BSK_BE3C assay. It measures tPA antibody related to regulation of gene expression using ELISA technology.,"tPA antibody is used to tag and quantify the level of plasminogen activator, tissue protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:PLAT | GeneID:5327 | Uniprot_SwissProt_Accession:P00750].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,tPA antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1608.0,208.0,1400.0
142,204,143,BSK_BE3C_uPA,1,1,"Data from the assay component BSK_BE3CA was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3CA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAU. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine protease.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,serine protease,0,0,1,1705,0,9,BSK_BE3C_uPA,BSK_BE3CA is an assay component measured in the BSK_BE3C assay. It measures uPA antibody related to regulation of gene expression using ELISA technology.,"uPA antibody is used to tag and quantify the level of plasminogen activator, urokinase protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:PLAU | GeneID:5328 | Uniprot_SwissProt_Accession:P00749].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,uPA antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1576.0,173.0,1403.0
143,206,144,BSK_BE3C_uPAR,1,1,"Data from the assay component BSK_BE3CAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_BE3CAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator,0,0,1,1705,0,9,BSK_BE3C_uPAR,BSK_BE3CAR is an assay component measured in the BSK_BE3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.,"uPAR antibody is used to tag and quantify the level of plasminogen activator, urokinase receptor protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:PLAUR | GeneID:5329 | Uniprot_SwissProt_Accession:Q03405].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,uPAR antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1594.0,160.0,1434.0
144,208,145,BSK_CASM3C_HLADR,1,1,"Data from the assay component BSK_CASM3C_HLADR was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_HLADR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene HLA-DRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is MHC Class II.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,MHC Class II,0,0,1,1705,0,10,BSK_CASM3C_HLADR,BSK_CASM3C_HLADR is an assay component measured in the BSK_CASM3C assay. It measures HLA-DR antibody related to regulation of gene expression using ELISA technology.,"HLA-DR antibody is used to tag and quantify the level of major histocompatibility complex, class II, DR alpha protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:HLA-DRA | GeneID:3122 | Uniprot_SwissProt_Accession:P01903].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,HLA-DR antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1600.0,104.0,1496.0
145,210,146,BSK_CASM3C_IL6,1,1,"Data from the assay component BSK_CASM3C_IL6 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_IL6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL6. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0,10,BSK_CASM3C_IL6,BSK_CASM3C_IL6 is an assay component measured in the BSK_CASM3C assay. It measures IL-6 antibody related to regulation of gene expression using ELISA technology.,IL-6 antibody is used to tag and quantify the level of interleukin 6 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:IL6 | GeneID:3569 | Uniprot_SwissProt_Accession:P05231].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-6 antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1603.0,78.0,1525.0
146,212,147,BSK_CASM3C_IL8,1,1,"Data from the assay component BSK_CASM3C_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0,10,BSK_CASM3C_IL8,BSK_CASM3C_IL8 is an assay component measured in the BSK_CASM3C assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.,IL-8 antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 8 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:CXCL8 | GeneID:3576 | Uniprot_SwissProt_Accession:P10145].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-8 antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1640.0,41.0,1599.0
147,214,148,BSK_CASM3C_LDLR,1,1,"Data from the assay component BSK_CASM3C_LDLR was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_LDLR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene LDLR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the misc protein intended target family, where the subfamily is LDL receptor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,misc protein,LDL receptor,0,0,1,1705,0,10,BSK_CASM3C_LDLR,BSK_CASM3C_LDLR is an assay component measured in the BSK_CASM3C assay. It measures LDLR antibody related to regulation of gene expression using ELISA technology.,LDLR antibody is used to tag and quantify the level of low density lipoprotein receptor protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:LDLR | GeneID:3949 | Uniprot_SwissProt_Accession:P01130].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,LDLR antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1615.0,82.0,1533.0
148,216,149,BSK_CASM3C_MCP1,1,1,"Data from the assay component BSK_CASM3C_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,10,BSK_CASM3C_MCP1,BSK_CASM3C_MCP1 is an assay component measured in the BSK_CASM3C assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.,MCP-1 antibody is used to tag and quantify the level of chemokine (C-C motif) ligand 2 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:CCL2 | GeneID:6347 | Uniprot_SwissProt_Accession:P13500].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MCP-1 antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1586.0,69.0,1517.0
149,218,150,BSK_CASM3C_MCSF,1,1,"Data from the assay component BSK_CASM3C_MCSF was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_MCSF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is colony stimulating factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,colony stimulating factor,0,0,1,1705,0,10,BSK_CASM3C_MCSF,BSK_CASM3C_MCSF is an assay component measured in the BSK_CASM3C assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.,M-CSF antibody is used to tag and quantify the level of colony stimulating factor 1 (macrophage) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:CSF1 | GeneID:1435 | Uniprot_SwissProt_Accession:P09603].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,M-CSF antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1588.0,83.0,1505.0
150,220,151,BSK_CASM3C_MIG,1,1,"Data from the assay component BSK_CASM3C_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,10,BSK_CASM3C_MIG,BSK_CASM3C_MIG is an assay component measured in the BSK_CASM3C assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.,MIG antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 9 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:CXCL9 | GeneID:4283 | Uniprot_SwissProt_Accession:Q07325].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MIG antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1661.0,44.0,1617.0
151,222,152,BSK_CASM3C_Proliferation,1,1,"Data from the assay component BSK_CASM3C_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_CASM3C_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1705,0,10,BSK_CASM3C_Proliferation,BSK_CASM3C_Proliferation is an assay component measured in the BSK_CASM3C assay. It measures 0.1% sulforhodamine related to cell proliferation using Sulforhodamine staining technology.,Proliferation in the CASM3C system is a measure of coronary artery smooth muscle cell proliferation which is important to the process of vasacular biology and restenosis.,single,viability reporter,protein content,cell proliferation,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1533.0,315.0,1218.0
152,224,153,BSK_CASM3C_SAA,1,1,"Data from the assay component BSK_CASM3C_SAA was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_SAA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SAA1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is apolipoproteins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,apolipoproteins,0,0,1,1705,0,10,BSK_CASM3C_SAA,BSK_CASM3C_SAA is an assay component measured in the BSK_CASM3C assay. It measures SAA antibody related to regulation of gene expression using ELISA technology.,Serum Amyloid A (SAA) is a member of the apolipoprotein family that is an acute phase reactant.  SAA is categorized as an inflammation-related activity in the CASM3C system modeling Th1 vascular smooth muscle inflammation. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:SAA1 | GeneID:6288 | Uniprot_SwissProt_Accession:P0DJI8].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,SAA antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1600.0,68.0,1532.0
153,226,154,BSK_CASM3C_SRB,1,1,"Data from the assay component BSK_CASM3C_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0,10,BSK_CASM3C_SRB,BSK_CASM3C_SRB is an assay component measured in the BSK_CASM3C assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,"SRB in the CASM3C system is a measure of the total protein content of coronary artery smooth muscle cells.  Cell viability of adherent cells is measured by Sulforhodamine B (SRB) staining, a method that determines cell density by measuring total protein content of test wells.",single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1620.0,63.0,1557.0
154,228,155,BSK_CASM3C_Thrombomodulin,1,1,"Data from the assay component BSK_CASM3C_Thrombomodulin was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_Thrombomodulin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene THBD. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,gpcr,rhodopsin-like receptor,0,0,1,1705,0,10,BSK_CASM3C_Thrombomodulin,BSK_CASM3C_Thrombomodulin is an assay component measured in the BSK_CASM3C assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.,Thrombomodulin antibody is used to tag and quantify the level of thrombomodulin protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:THBD | GeneID:7056 | Uniprot_SwissProt_Accession:P07204].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Thrombomodulin antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1587.0,131.0,1456.0
155,230,156,BSK_CASM3C_TissueFactor,1,1,"Data from the assay component BSK_CASM3C_TissueFactor was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_TissueFactor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is coagulation factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,coagulation factor,0,0,1,1705,0,10,BSK_CASM3C_TissueFactor,BSK_CASM3C_TissueFactor is an assay component measured in the BSK_CASM3C assay. It measures Tissue Factor antibody related to regulation of gene expression using ELISA technology.,"Tissue Factor antibody is used to tag and quantify the level of coagulation factor III (thromboplastin, tissue factor) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:F3 | GeneID:2152 | Uniprot_SwissProt_Accession:P13726].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Tissue Factor antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1606.0,76.0,1530.0
156,232,157,BSK_CASM3C_uPAR,1,1,"Data from the assay component BSK_CASM3CAR was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3CAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAUR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator,0,0,1,1705,0,10,BSK_CASM3C_uPAR,BSK_CASM3CAR is an assay component measured in the BSK_CASM3C assay. It measures uPAR antibody related to regulation of gene expression using ELISA technology.,"uPAR antibody is used to tag and quantify the level of plasminogen activator, urokinase receptor protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:PLAUR | GeneID:5329 | Uniprot_SwissProt_Accession:Q03405].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,uPAR antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1585.0,73.0,1512.0
157,234,158,BSK_CASM3C_VCAM1,1,1,"Data from the assay component BSK_CASM3C_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_CASM3C_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0,10,BSK_CASM3C_VCAM1,BSK_CASM3C_VCAM1 is an assay component measured in the BSK_CASM3C assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.,VCAM-1 antibody is used to tag and quantify the level of vascular cell adhesion molecule 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines [GeneSymbol:VCAM1 | GeneID:7412 | Uniprot_SwissProt_Accession:P19320].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,VCAM-1 antibody,protein,protein-specified,4,BSK_CASM3C,"BSK_CASM3C is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and coronary artery smooth muscle cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell,,coronary artery smooth muscle cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1588.0,119.0,1469.0
158,236,159,BSK_hDFCGF_CollagenIII,1,1,"Data from the assay component BSK_hDFCGF_CollagenIII was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_CollagenIII, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene COL3A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is collagen.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,collagen,0,0,1,1705,0,11,BSK_hDFCGF_CollagenIII,BSK_hDFCGF_CollagenIII is an assay component measured in the BSK_hDFCGF assay. It measures Collagen antibody related to regulation of gene expression using ELISA technology.,"Collagen antibody is used to tag and quantify the level of collagen, type III, alpha 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and growth factors [GeneSymbol:COL3A1 | GeneID:1281 | Uniprot_SwissProt_Accession:P02461].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Collagen antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1552.0,145.0,1407.0
159,238,160,BSK_hDFCGF_EGFR,1,1,"Data from the assay component BSK_hDFCGF_EGFR was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_EGFR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene EGFR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is receptor tyrosine kinase.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,1705,0,11,BSK_hDFCGF_EGFR,BSK_hDFCGF_EGFR is an assay component measured in the BSK_hDFCGF assay. It measures EGFR antibody related to regulation of gene expression using ELISA technology.,EGFR antibody is used to tag and quantify the level of epidermal growth factor receptor protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and growth factors [GeneSymbol:EGFR | GeneID:1956 | Uniprot_SwissProt_Accession:P00533].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,EGFR antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1619.0,42.0,1577.0
160,240,161,BSK_hDFCGF_IL8,1,1,"Data from the assay component BSK_hDFCGF_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0,11,BSK_hDFCGF_IL8,BSK_hDFCGF_IL8 is an assay component measured in the BSK_hDFCGF assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.,IL-8 antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 8 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and growth factors [GeneSymbol:CXCL8 | GeneID:3576 | Uniprot_SwissProt_Accession:P10145].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-8 antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1618.0,49.0,1569.0
161,242,162,BSK_hDFCGF_IP10,1,1,"Data from the assay component BSK_hDFCGF_IP10 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_IP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,11,BSK_hDFCGF_IP10,BSK_hDFCGF_IP10 is an assay component measured in the BSK_hDFCGF assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.,IP-10 antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 10 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and growth factors [GeneSymbol:CXCL10 | GeneID:3627 | Uniprot_SwissProt_Accession:P02778].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IP-10 antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1518.0,154.0,1364.0
162,244,163,BSK_hDFCGF_MCSF,1,1,"Data from the assay component BSK_hDFCGF_MCSF was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_MCSF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is colony stimulating factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,colony stimulating factor,0,0,1,1705,0,11,BSK_hDFCGF_MCSF,BSK_hDFCGF_MCSF is an assay component measured in the BSK_hDFCGF assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.,M-CSF antibody is used to tag and quantify the level of colony stimulating factor 1 (macrophage) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and growth factors [GeneSymbol:CSF1 | GeneID:1435 | Uniprot_SwissProt_Accession:P09603].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,M-CSF antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1528.0,126.0,1402.0
163,246,164,BSK_hDFCGF_MIG,1,1,"Data from the assay component BSK_hDFCGF_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,11,BSK_hDFCGF_MIG,BSK_hDFCGF_MIG is an assay component measured in the BSK_hDFCGF assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.,MIG antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 9 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and growth factors [GeneSymbol:CXCL9 | GeneID:4283 | Uniprot_SwissProt_Accession:Q07325].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MIG antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1587.0,96.0,1491.0
164,248,165,BSK_hDFCGF_MMP1,1,1,"Data from the assay component BSK_hDFCGF_MMP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_MMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,1705,0,11,BSK_hDFCGF_MMP1,BSK_hDFCGF_MMP1 is an assay component measured in the BSK_hDFCGF assay. It measures MMP-1 antibody related to regulation of gene expression using ELISA technology.,MMP-1 antibody is used to tag and quantify the level of matrix metallopeptidase 1 (interstitial collagenase) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and growth factors [GeneSymbol:MMP1 | GeneID:4312 | Uniprot_SwissProt_Accession:P03956].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MMP-1 antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1573.0,111.0,1462.0
165,250,166,BSK_hDFCGF_PAI1,1,1,"Data from the assay component BSK_hDFCGF_PAI1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_PAI1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SERPINE1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is plasmogen activator inhibitor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,1705,0,11,BSK_hDFCGF_PAI1,BSK_hDFCGF_PAI1 is an assay component measured in the BSK_hDFCGF assay. It measures PAI-1 antibody related to regulation of gene expression using ELISA technology.,"PAI-1 antibody is used to tag and quantify the level of serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and growth factors [GeneSymbol:SERPINE1 | GeneID:5054 | Uniprot_SwissProt_Accession:P05121].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,PAI-1 antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1567.0,122.0,1445.0
166,252,167,BSK_hDFCGF_Proliferation,1,1,"Data from the assay component BSK_hDFCGF_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_hDFCGF_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1705,0,11,BSK_hDFCGF_Proliferation,BSK_hDFCGF_Proliferation is an assay component measured in the BSK_hDFCGF assay. It measures 0.1% sulforhodamine related to cell proliferation using Sulforhodamine staining technology.,0.1% sulforhodamine is used to tag and quantify the total protein levels in the system. Changes to these absorbance signals can be indicative of the viability in the system when conditioned to simulate proinflammation from cytokines and growth factors.,single,viability reporter,protein content,cell proliferation,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1488.0,463.0,1025.0
167,254,168,BSK_hDFCGF_SRB,1,1,"Data from the assay component BSK_hDFCGF_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0,11,BSK_hDFCGF_SRB,BSK_hDFCGF_SRB is an assay component measured in the BSK_hDFCGF assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,0.1% sulforhodamine is used to tag and quantify the total protein levels in the system. Changes to these absorbance signals can be indicative of the viability in the system when conditioned to simulate proinflammation from cytokines and growth factors.,single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1581.0,98.0,1483.0
168,256,169,BSK_hDFCGF_TIMP1,1,1,"Data from the assay component BSK_hDFCGF_TIMP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_TIMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TIMP1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease inhibitor intended target family, where the subfamily is metalloproteinase inhibitor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease inhibitor,metalloproteinase inhibitor,0,0,1,1705,0,11,BSK_hDFCGF_TIMP1,BSK_hDFCGF_TIMP1 is an assay component measured in the BSK_hDFCGF assay. It measures TIMP-1 antibody related to regulation of gene expression using ELISA technology.,TIMP-1 antibody is used to tag and quantify the level of TIMP metallopeptidase inhibitor 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and growth factors [GeneSymbol:TIMP1 | GeneID:7076 | Uniprot_SwissProt_Accession:P01033].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,TIMP-1 antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1615.0,88.0,1527.0
169,258,170,BSK_hDFCGF_VCAM1,1,1,"Data from the assay component BSK_hDFCGF_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_hDFCGF_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0,11,BSK_hDFCGF_VCAM1,BSK_hDFCGF_VCAM1 is an assay component measured in the BSK_hDFCGF assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.,VCAM-1 antibody is used to tag and quantify the level of vascular cell adhesion molecule 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and growth factors [GeneSymbol:VCAM1 | GeneID:7412 | Uniprot_SwissProt_Accession:P19320].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,VCAM-1 antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1566.0,146.0,1420.0
170,260,171,BSK_KF3CT_ICAM1,1,1,"Data from the assay component BSK_KF3CT_ICAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_ICAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene ICAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0,12,BSK_KF3CT_ICAM1,BSK_KF3CT_ICAM1 is an assay component measured in the BSK_KF3CT assay. It measures ICAM-1 antibody related to regulation of gene expression using ELISA technology.,ICAM-1 antibody is used to tag and quantify the level of intercellular adhesion molecule 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and TGFb [GeneSymbol:ICAM1 | GeneID:3383 | Uniprot_SwissProt_Accession:P05362].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,ICAM-1 antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1621.0,165.0,1456.0
171,262,172,BSK_KF3CT_IL1a,1,1,"Data from the assay component BSK_KF3CT_IL1a was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_IL1a, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0,12,BSK_KF3CT_IL1a,BSK_KF3CT_IL1a is an assay component measured in the BSK_KF3CT assay. It measures IL-1a antibody related to regulation of gene expression using ELISA technology.,"IL-1a antibody is used to tag and quantify the level of interleukin 1, alpha protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and TGFb [GeneSymbol:IL1A | GeneID:3552 | Uniprot_SwissProt_Accession:P01583].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-1a antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1576.0,209.0,1367.0
172,264,173,BSK_KF3CT_IP10,1,1,"Data from the assay component BSK_KF3CT_IP10 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_IP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL10. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,12,BSK_KF3CT_IP10,BSK_KF3CT_IP10 is an assay component measured in the BSK_KF3CT assay. It measures IP-10 antibody related to regulation of gene expression using ELISA technology.,IP-10 antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 10 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and TGFb [GeneSymbol:CXCL10 | GeneID:3627 | Uniprot_SwissProt_Accession:P02778].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IP-10 antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1548.0,208.0,1340.0
173,266,174,BSK_KF3CT_MCP1,1,1,"Data from the assay component BSK_KF3CT_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,12,BSK_KF3CT_MCP1,BSK_KF3CT_MCP1 is an assay component measured in the BSK_KF3CT assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.,MCP-1 antibody is used to tag and quantify the level of chemokine (C-C motif) ligand 2 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and TGFb [GeneSymbol:CCL2 | GeneID:6347 | Uniprot_SwissProt_Accession:P13500].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MCP-1 antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1601.0,206.0,1395.0
174,268,175,BSK_KF3CT_MMP9,1,1,"Data from the assay component BSK_KF3CT_MMP9 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_MMP9, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene MMP9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,1705,0,12,BSK_KF3CT_MMP9,BSK_KF3CT_MMP9 is an assay component measured in the BSK_KF3CT assay. It measures MMP-9 antibody related to regulation of gene expression using ELISA technology.,"MMP-9 antibody is used to tag and quantify the level of matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and TGFb [GeneSymbol:MMP9 | GeneID:4318 | Uniprot_SwissProt_Accession:P14780].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MMP-9 antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1563.0,283.0,1280.0
175,270,176,BSK_KF3CT_SRB,1,1,"Data from the assay component BSK_KF3CT_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0,12,BSK_KF3CT_SRB,BSK_KF3CT_SRB is an assay component measured in the BSK_KF3CT assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,0.1% sulforhodamine is used to tag and quantify the total protein levels in the system. Changes to these absorbance signals can be indicative of the viability in the system when conditioned to simulate proinflammation from cytokines and TGFb.,single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1626.0,155.0,1471.0
176,272,177,BSK_KF3CT_TGFb1,1,1,"Data from the assay component BSK_KF3CT_TGFb1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_TGFb1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TGFB1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,growth factor,transforming growth factor beta,0,0,1,1484,0,12,BSK_KF3CT_TGFb1,BSK_KF3CT_TGFb1 is an assay component measured in the BSK_KF3CT assay. It measures TGF-b1 antibody related to regulation of gene expression using ELISA technology.,"TGF-b1 antibody is used to tag and quantify the level of transforming growth factor, beta 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and TGFb [GeneSymbol:TGFB1 | GeneID:7040 | Uniprot_SwissProt_Accession:P01137].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,TGF-b1 antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1384.0,189.0,1195.0
177,274,178,BSK_KF3CT_TIMP2,1,1,"Data from the assay component BSK_KF3CT_TIMP2 was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CT_TIMP2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TIMP2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease inhibitor intended target family, where the subfamily is metalloproteinase inhibitor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease inhibitor,metalloproteinase inhibitor,0,0,1,1705,0,12,BSK_KF3CT_TIMP2,BSK_KF3CT_TIMP2 is an assay component measured in the BSK_KF3CT assay. It measures TIMP-2 antibody related to regulation of gene expression using ELISA technology.,TIMP-2 antibody is used to tag and quantify the level of TIMP metallopeptidase inhibitor 2 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and TGFb [GeneSymbol:TIMP2 | GeneID:7077 | Uniprot_SwissProt_Accession:Q96MC4].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,TIMP-2 antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1592.0,241.0,1351.0
178,276,179,BSK_KF3CT_uPA,1,1,"Data from the assay component BSK_KF3CTA was analyzed into 1 assay endpoint. This assay endpoint, BSK_KF3CTA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PLAU. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is serine protease.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,serine protease,0,0,1,1705,0,12,BSK_KF3CT_uPA,BSK_KF3CTA is an assay component measured in the BSK_KF3CT assay. It measures uPA antibody related to regulation of gene expression using ELISA technology.,"uPA antibody is used to tag and quantify the level of plasminogen activator, urokinase protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from cytokines and TGFb [GeneSymbol:PLAU | GeneID:5328 | Uniprot_SwissProt_Accession:P00749].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,uPA antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1603.0,194.0,1409.0
179,278,180,BSK_LPS_CD40,1,1,"Data from the assay component BSK_LPS_CD40 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_CD40, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD40. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,1705,0,13,BSK_LPS_CD40,BSK_LPS_CD40 is an assay component measured in the BSK_LPS assay. It measures CD40 antibody related to regulation of gene expression using ELISA technology.,"CD40 antibody is used to tag and quantify the level of CD40 molecule, TNF receptor superfamily member 5 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator [GeneSymbol:CD40 | GeneID:958 | Uniprot_SwissProt_Accession:P25942].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,CD40 antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1578.0,327.0,1251.0
180,280,181,BSK_LPS_Eselectin,1,1,"Data from the assay component BSK_LPS_Eselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_Eselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,selectins,0,0,1,1705,0,13,BSK_LPS_Eselectin,BSK_LPS_Eselectin is an assay component measured in the BSK_LPS assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.,E-selectin antibody is used to tag and quantify the level of selectin E protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator [GeneSymbol:SELE | GeneID:6401 | Uniprot_SwissProt_Accession:P16581].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,E-selectin antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1575.0,206.0,1369.0
181,282,182,BSK_LPS_IL1a,1,1,"Data from the assay component BSK_LPS_IL1a was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_IL1a, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene IL1A. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0,13,BSK_LPS_IL1a,BSK_LPS_IL1a is an assay component measured in the BSK_LPS assay. It measures IL-a antibody related to regulation of gene expression using ELISA technology.,"IL-a antibody is used to tag and quantify the level of interleukin 1, alpha protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator [GeneSymbol:IL1A | GeneID:3552 | Uniprot_SwissProt_Accession:P01583].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-a antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1588.0,240.0,1348.0
182,284,183,BSK_LPS_IL8,1,1,"Data from the assay component BSK_LPS_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0,13,BSK_LPS_IL8,BSK_LPS_IL8 is an assay component measured in the BSK_LPS assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.,IL-8 antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 8 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator [GeneSymbol:CXCL8 | GeneID:3576 | Uniprot_SwissProt_Accession:P10145].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-8 antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1580.0,242.0,1338.0
183,286,184,BSK_LPS_MCP1,1,1,"Data from the assay component BSK_LPS_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,13,BSK_LPS_MCP1,BSK_LPS_MCP1 is an assay component measured in the BSK_LPS assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.,MCP-1 antibody is used to tag and quantify the level of chemokine (C-C motif) ligand 2 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator [GeneSymbol:CCL2 | GeneID:6347 | Uniprot_SwissProt_Accession:P13500].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MCP-1 antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1551.0,208.0,1343.0
184,288,185,BSK_LPS_MCSF,1,1,"Data from the assay component BSK_LPS_MCSF was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_MCSF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CSF1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is colony stimulating factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,colony stimulating factor,0,0,1,1705,0,13,BSK_LPS_MCSF,BSK_LPS_MCSF is an assay component measured in the BSK_LPS assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.,M-CSF antibody is used to tag and quantify the level of colony stimulating factor 1 (macrophage) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator [GeneSymbol:CSF1 | GeneID:1435 | Uniprot_SwissProt_Accession:P09603].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,M-CSF antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1581.0,290.0,1291.0
185,290,186,BSK_LPS_PGE2,1,1,"Data from the assay component BSK_LPS_PGE2 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_PGE2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene PTGER2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is rhodopsin-like receptor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,gpcr,rhodopsin-like receptor,0,0,1,1705,0,13,BSK_LPS_PGE2,BSK_LPS_PGE2 is an assay component measured in the BSK_LPS assay. It measures PGE2 antibody related to regulation of gene expression using ELISA technology.,"PGE2 antibody is used to tag and quantify the level of prostaglandin E receptor 2 (subtype EP2), 53kDa protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator [GeneSymbol:PTGER2 | GeneID:5732 | Uniprot_SwissProt_Accession:P43116].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,PGE2 antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1559.0,276.0,1283.0
186,292,187,BSK_LPS_SRB,1,1,"Data from the assay component BSK_LPS_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0,13,BSK_LPS_SRB,BSK_LPS_SRB is an assay component measured in the BSK_LPS assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,0.1% sulforhodamine is used to tag and quantify the total protein levels in the system. Changes to these absorbance signals can be indicative of the viability in the system when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator.,single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1576.0,257.0,1319.0
187,294,188,BSK_LPS_TissueFactor,1,1,"Data from the assay component BSK_LPS_TissueFactor was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_TissueFactor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene F3. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is coagulation factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,coagulation factor,0,0,1,1705,0,13,BSK_LPS_TissueFactor,BSK_LPS_TissueFactor is an assay component measured in the BSK_LPS assay. It measures CD142 Tissue Factor antibody related to regulation of gene expression using ELISA technology.,"CD142 Tissue Factor antibody is used to tag and quantify the level of coagulation factor III (thromboplastin, tissue factor) protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator [GeneSymbol:F3 | GeneID:2152 | Uniprot_SwissProt_Accession:P13726].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,CD142 Tissue Factor antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1594.0,207.0,1387.0
188,296,189,BSK_LPS_TNFa,1,1,"Data from the assay component BSK_LPS_TNFa was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_TNFa, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene TNF. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,1705,0,13,BSK_LPS_TNFa,BSK_LPS_TNFa is an assay component measured in the BSK_LPS assay. It measures TNF-a antibody related to regulation of gene expression using ELISA technology.,TNF-a antibody is used to tag and quantify the level of tumor necrosis factor protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator [GeneSymbol:TNF | GeneID:7124 | Uniprot_SwissProt_Accession:P01375].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,TNF-a antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1531.0,252.0,1279.0
189,298,190,BSK_LPS_VCAM1,1,1,"Data from the assay component BSK_LPS_VCAM1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_LPS_VCAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene VCAM1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1705,0,13,BSK_LPS_VCAM1,BSK_LPS_VCAM1 is an assay component measured in the BSK_LPS assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.,VCAM-1 antibody is used to tag and quantify the level of vascular cell adhesion molecule 1 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from Toll-like receptor (TLR4) activator [GeneSymbol:VCAM1 | GeneID:7412 | Uniprot_SwissProt_Accession:P19320].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,VCAM-1 antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1552.0,302.0,1250.0
190,300,191,BSK_SAg_CD38,1,1,"Data from the assay component BSK_SAg_CD38 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_CD38, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD38. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is other cytokine.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,other cytokine,0,0,1,1705,0,14,BSK_SAg_CD38,"BSK_SAg_CD38 is one of 10 assay component(s) measured or calculated from the BSK_SAg assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with fluorescence intensity signals by Enzyme-linked immunosorbent assay technology.",CD38 antibody is used to tag and quantify the level of CD38 molecule protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from T-cell Receptor (TCR) activation [GeneSymbol:CD38 | GeneID:952 | Uniprot_SwissProt_Accession:P28907].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,CD38 antibody,protein,protein-specified,4,BSK_SAg,"BSK_SAg is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1545.0,163.0,1382.0
191,302,192,BSK_SAg_CD40,1,1,"Data from the assay component BSK_SAg_CD40 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_CD40, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD40. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,1705,0,14,BSK_SAg_CD40,"BSK_SAg_CD40 is one of 10 assay component(s) measured or calculated from the BSK_SAg assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with fluorescence intensity signals by Enzyme-linked immunosorbent assay technology.","CD40 antibody is used to tag and quantify the level of CD40 molecule, TNF receptor superfamily member 5 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from T-cell Receptor (TCR) activation [GeneSymbol:CD40 | GeneID:958 | Uniprot_SwissProt_Accession:P25942].",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,CD40 antibody,protein,protein-specified,4,BSK_SAg,"BSK_SAg is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1557.0,192.0,1365.0
192,304,193,BSK_SAg_CD69,1,1,"Data from the assay component BSK_SAg_CD69 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_CD69, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CD69. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is inflammatory factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,1705,0,14,BSK_SAg_CD69,"BSK_SAg_CD69 is one of 10 assay component(s) measured or calculated from the BSK_SAg assay. It is designed to make measurements of enzyme-linked immunosorbent assay, a form of binding reporter, as detected with fluorescence intensity signals by Enzyme-linked immunosorbent assay technology.",CD69 antibody is used to tag and quantify the level of CD69 molecule protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from T-cell Receptor (TCR) activation [GeneSymbol:CD69 | GeneID:969 | Uniprot_SwissProt_Accession:Q07108].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,CD69 antibody,protein,protein-specified,4,BSK_SAg,"BSK_SAg is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1562.0,169.0,1393.0
193,306,194,BSK_SAg_Eselectin,1,1,"Data from the assay component BSK_SAg_Eselectin was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_Eselectin, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene SELE. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is selectins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,selectins,0,0,1,1705,0,14,BSK_SAg_Eselectin,BSK_SAg_Eselectin is an assay component measured in the BSK_SAg assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.,E-selectin antibody is used to tag and quantify the level of selectin E protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from T-cell Receptor (TCR) activation [GeneSymbol:SELE | GeneID:6401 | Uniprot_SwissProt_Accession:P16581].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,E-selectin antibody,protein,protein-specified,4,BSK_SAg,"BSK_SAg is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1513.0,195.0,1318.0
194,308,195,BSK_SAg_IL8,1,1,"Data from the assay component BSK_SAg_IL8 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_IL8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL8. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,1705,0,14,BSK_SAg_IL8,BSK_SAg_IL8 is an assay component measured in the BSK_SAg assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.,IL-8 antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 8 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from T-cell Receptor (TCR) activation [GeneSymbol:CXCL8 | GeneID:3576 | Uniprot_SwissProt_Accession:P10145].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-8 antibody,protein,protein-specified,4,BSK_SAg,"BSK_SAg is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1544.0,149.0,1395.0
195,310,196,BSK_SAg_MCP1,1,1,"Data from the assay component BSK_SAg_MCP1 was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_MCP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CCL2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,14,BSK_SAg_MCP1,BSK_SAg_MCP1 is an assay component measured in the BSK_SAg assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.,MCP-1 antibody is used to tag and quantify the level of chemokine (C-C motif) ligand 2 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from T-cell Receptor (TCR) activation [GeneSymbol:CCL2 | GeneID:6347 | Uniprot_SwissProt_Accession:P13500].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MCP-1 antibody,protein,protein-specified,4,BSK_SAg,"BSK_SAg is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1568.0,116.0,1452.0
196,312,197,BSK_SAg_MIG,1,1,"Data from the assay component BSK_SAg_MIG was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_MIG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, gain or loss-of-signal activity can be used to understand changes in the signaling as they relate to the gene CXCL9. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is chemotactic factor.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,1705,0,14,BSK_SAg_MIG,BSK_SAg_MIG is an assay component measured in the BSK_SAg assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.,MIG antibody is used to tag and quantify the level of chemokine (C-X-C motif) ligand 9 protein. Changes in the signals are indicative of protein expression changes when conditioned to simulate proinflammation from T-cell Receptor (TCR) activation [GeneSymbol:CXCL9 | GeneID:4283 | Uniprot_SwissProt_Accession:Q07325].,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MIG antibody,protein,protein-specified,4,BSK_SAg,"BSK_SAg is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1616.0,46.0,1570.0
198,316,199,BSK_SAg_Proliferation,1,1,"Data from the assay component BSK_SAg_Proliferation was analyzed into 1 assay endpoint. 
This assay endpoint, BSK_SAg_Proliferation, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, measures of total protein for gain or loss-of-signal activity can be used to understand the viability at the cellular-level. 
Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves a viability function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,1705,0,14,BSK_SAg_Proliferation,"BSK_SAg_Proliferation is an assay component in the BSK_SAg assay. It measures protein content, a form of viability reporter, as detected with absorbance signals by Sulforhodamine staining technology. ",0.1% sulforhodamine is used to tag and quantify the total protein levels in the system. Changes to these absorbance signals can be indicative of the viability in the system when conditioned to simulate proinflammation from T-cell Receptor (TCR) activation.,single,viability reporter,protein content,cell proliferation,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_SAg,"BSK_SAg is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1504.0,393.0,1111.0
199,318,200,BSK_SAg_SRB,1,1,"Data from the assay component BSK_SAg_SRB was analyzed into 1 assay endpoint. This assay endpoint, BSK_SAg_SRB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. 
Using a type of viability reporter, gain or loss-of-signal activity can be used to understand changes in the signaling. 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is cell conformation.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,1705,0,14,BSK_SAg_SRB,"BSK_SAg_SRB is an assay component measured in the BSK_SAg assay. It measures protein content, a form of viability reporter, as detected with absorbance signals by Sulforhodamine staining technology.",0.1% sulforhodamine is used to tag and quantify the total protein levels in the system. Changes to these absorbance signals can be indicative of the viability in the system when conditioned to simulate proinflammation from T-cell Receptor (TCR) activation.,single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_SAg,"BSK_SAg is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,1576.0,128.0,1448.0
475,739,476,OT_AR_ARELUC_AG_1440,1,1,"Data from the assay component OT_AR_ARELUC_AG_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARELUC_AG_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,6-alpha-Fluorotestosterone,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5168,290,OT_AR_ARELUC_AG_1440,"OT_AR_ARELUC_AG_1440 is one of one assay component(s) measured or calculated from the OT_AR_ARELUC_AG_1440 assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by Luciferase technology.",Changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [D-luciferin] are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human androgen receptor [GeneSymbol:AR | GeneID:367 | Uniprot_SwissProt_Accession:P10275].,single,inducible reporter,luciferase induction,regulation of gene expression,Luminescence,Bioluminescence,Luciferase,substrate,D-luciferin,protein,receptor,6,OT_AR_ARELUC_AG_1440,"OT_AR_ARELUC_AG_1440 is a cell-based, single-readout assay that uses CHO-K1, a chinese hamster ovary cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,10029.0,chinese hamster,ovary,cell line,,CHO-K1,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,1794.0,55.0,1739.0
476,740,477,OT_AR_ARSRC1_0480,1,1,"Data from the assay component OT_AR_ARSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARSRC1_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,"4,5-alpha-Dihydrotestosterone",gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472,291,OT_AR_ARSRC1_0480,"OT_AR_ARSRC1_0480 is one of one assay component(s) measured or calculated from the OT_AR_ARSRC1_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.","Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human androgen receptor and SRC proto-oncogene, non-receptor tyrosine kinase [GeneSymbol:AR & SRC | GeneID:367 & 6714 | Uniprot_SwissProt_Accession:P10275 & P12931].",single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_AR_ARSRC1_0480,"OT_AR_ARSRC1_0480 is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 8 hours after chemical dosing in a 384-well plate.",8.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1718.0,133.0,1585.0
477,741,478,OT_AR_ARSRC1_0960,1,1,"Data from the assay component OT_AR_ARSRC1_0960 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_AR_ARSRC1_0960, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene AR. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,"4,5-alpha-Dihydrotestosterone",gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472,292,OT_AR_ARSRC1_0960,"OT_AR_ARSRC1_0960 is one of one assay component(s) measured or calculated from the OT_AR_ARSRC1_0960 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.","Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human androgen receptor and SRC proto-oncogene, non-receptor tyrosine kinase [GeneSymbol:AR & SRC | GeneID:367 & 6714 | Uniprot_SwissProt_Accession:P10275 & P12931].",single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_AR_ARSRC1_0960,"OT_AR_ARSRC1_0960 is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 16 hours after chemical dosing in a 384-well plate.",16.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1668.0,174.0,1494.0
478,742,479,OT_ER_ERaERa_0480,1,1,"Data from the assay component OT_ER_ERaERa_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERa_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472,293,OT_ER_ERaERa_0480,"OT_ER_ERaERa_0480 is one of one assay component(s) measured or calculated from the OT_ER_ERaERa_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.",Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].,single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_ER_ERaERa_0480,"OT_ER_ERaERa_0480  is a cell-based assay that uses HEK293T, a human kidney cell line, with measurements taken at 8 hours after chemical dosing in a 384-well plate.",8.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1787.0,61.0,1726.0
479,743,480,OT_ER_ERaERa_1440,1,1,"Data from the assay component OT_ER_ERaERa_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERa_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472,294,OT_ER_ERaERa_1440,"OT_ER_ERaERa_1440 is one of one assay component(s) measured or calculated from the OT_ER_ERaERa_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.",Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].,single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_ER_ERaERa_1440,"OT_ER_ERaERa_1440  is a cell-based assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1784.0,65.0,1719.0
480,744,481,OT_ER_ERaERb_0480,1,1,"Data from the assay component OT_ER_ERaERb_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERb_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1 and ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472,295,OT_ER_ERaERb_0480,"OT_ER_ERaERb_0480 is one of one assay component(s) measured or calculated from the OT_ER_ERaERb_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.",Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human estrogen receptor 1 and estrogen receptor 2 (ER beta) [GeneSymbol:ESR1 & ESR2 | GeneID:2099 & 2100 | Uniprot_SwissProt_Accession:P03372 & Q92731].,single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_ER_ERaERb_0480,"OT_ER_ERaERb_0480  is a cell-based assay that uses HEK293T, a human kidney cell line, with measurements taken at 8 hours after chemical dosing in a 384-well plate.",8.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1755.0,100.0,1655.0
481,745,482,OT_ER_ERaERb_1440,1,1,"Data from the assay component OT_ER_ERaERb_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERaERb_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR1 and ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472,296,OT_ER_ERaERb_1440,"OT_ER_ERaERb_1440 is one of one assay component(s) measured or calculated from the OT_ER_ERaERb_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.",Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human estrogen receptor 1 and estrogen receptor 2 (ER beta) [GeneSymbol:ESR1 & ESR2 | GeneID:2099 & 2100 | Uniprot_SwissProt_Accession:P03372 & Q92731].,single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_ER_ERaERb_1440,"OT_ER_ERaERb_1440  is a cell-based assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1698.0,107.0,1591.0
482,746,483,OT_ER_ERbERb_0480,1,1,"Data from the assay component OT_ER_ERbERb_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERbERb_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472,297,OT_ER_ERbERb_0480,"OT_ER_ERbERb_0480 is one of one assay component(s) measured or calculated from the OT_ER_ERbERb_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.",Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human estrogen receptor 2 (ER beta) [GeneSymbol:ESR2 | GeneID:2100 | Uniprot_SwissProt_Accession:Q92731].,single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_ER_ERbERb_0480,"OT_ER_ERbERb_0480  is a cell-based assay that uses HEK293T, a human kidney cell line, with measurements taken at 8 hours after chemical dosing in a 384-well plate.",8.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1754.0,87.0,1667.0
483,747,484,OT_ER_ERbERb_1440,1,1,"Data from the assay component OT_ER_ERbERb_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ER_ERbERb_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene ESR2. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",binding,percent_activity,0,17b-Estradiol,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472,298,OT_ER_ERbERb_1440,"OT_ER_ERbERb_1440 is one of one assay component(s) measured or calculated from the OT_ER_ERbERb_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.",Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human estrogen receptor 2 (ER beta) [GeneSymbol:ESR2 | GeneID:2100 | Uniprot_SwissProt_Accession:Q92731].,single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_ER_ERbERb_1440,"OT_ER_ERbERb_1440  is a cell-based assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1756.0,102.0,1654.0
484,750,487,OT_ERa_GFPERaERE_0120,1,1,"Data from the assay component OT_ERa_GFPERaERE_0120 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ERa_EREGFP_0120, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,(Z)-4-Hydroxytamoxifen,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472,301,OT_ERa_GFPERaERE_0120,"OT_ERa_GFPERaERE_0120 is one of one assay component(s) measured or calculated from the OT_ERa_GFPERaERE_0120 assay. It is designed to make measurements of fluorescent protein induction, a form of inducible reporter, as detected with optical microscopy: fluorescence microscopy signals by Microscopy technology.",Changes to optical microscopy: fluorescence microscopy signals produced from the fluorescent protein induction are indicative of a change in the receptor function and kinetics for the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].,single,inducible reporter,fluorescent protein induction,regulation of gene expression,Microscopy,Optical microscopy: Fluorescence microscopy,Microscopy,,,protein,receptor,6,OT_ERa_GFPERaERE_0120,"OT_ERa_GFPERaERE_0120 is a cell-based, single-readout assay that uses HeLa, a human cervix cell line, with measurements taken at 2 hours after chemical dosing in a 384-well plate.",2.0,9606.0,human,cervix,cell line,,HeLa,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,1791.0,96.0,1695.0
485,751,488,OT_ERa_GFPERaERE_0480,1,1,"Data from the assay component OT_ERa_GFPERaERE_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_ERa_EREGFP_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ESR1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,(Z)-4-Hydroxytamoxifen,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1858,5472,302,OT_ERa_GFPERaERE_0480,"OT_ERa_GFPERaERE_0480 is one of one assay component(s) measured or calculated from the OT_ERa_GFPERaERE_0480 assay. It is designed to make measurements of fluorescent protein induction, a form of inducible reporter, as detected with optical microscopy: fluorescence microscopy signals by Microscopy technology.",Changes to optical microscopy: fluorescence microscopy signals produced from the fluorescent protein induction are indicative of a change in the receptor function and kinetics for the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].,single,inducible reporter,fluorescent protein induction,regulation of gene expression,Microscopy,Optical microscopy: Fluorescence microscopy,Microscopy,,,protein,receptor,6,OT_ERa_GFPERaERE_0480,"OT_ERa_GFPERaERE_0480 is a cell-based, single-readout assay that uses HeLa, a human cervix cell line, with measurements taken at 8 hours after chemical dosing in a 384-well plate.",8.0,9606.0,human,cervix,cell line,,HeLa,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,1778.0,90.0,1688.0
486,753,490,OT_FXR_FXRSRC1_0480,1,1,"Data from the assay component OT_FXR_FXRSRC1_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_FXR_FXRSRC1_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,GW4064,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,1858,5472,304,OT_FXR_FXRSRC1_0480,"OT_FXR_FXRSRC1_0480 is one of one assay component(s) measured or calculated from the OT_FXR_FXRSRC1_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.","Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human SRC proto-oncogene, non-receptor tyrosine kinase and nuclear receptor subfamily 1, group H, member 4 [GeneSymbol:SRC & NR1H4 | GeneID:6714 & 9971 | Uniprot_SwissProt_Accession:P12931 & Q96RI1].",single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_FXR_FXRSRC1_0480,"OT_FXR_FXRSRC1_0480  is a cell-based assay that uses HEK293T, a human kidney cell line, with measurements taken at 8 hours after chemical dosing in a 384-well plate.",8.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1638.0,146.0,1492.0
487,754,491,OT_FXR_FXRSRC1_1440,1,1,"Data from the assay component OT_FXR_FXRSRC1_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_FXR_FXRSRC1_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene NR1H4. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,GW4064,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,1858,5472,305,OT_FXR_FXRSRC1_1440,"OT_FXR_FXRSRC1_1440 is one of one assay component(s) measured or calculated from the OT_FXR_FXRSRC1_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.","Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human SRC proto-oncogene, non-receptor tyrosine kinase and nuclear receptor subfamily 1, group H, member 4 [GeneSymbol:SRC & NR1H4 | GeneID:6714 & 9971 | Uniprot_SwissProt_Accession:P12931 & Q96RI1].",single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_FXR_FXRSRC1_1440,"OT_FXR_FXRSRC1_1440  is a cell-based assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1631.0,128.0,1503.0
488,755,492,OT_NURR1_NURR1RXRa_0480,1,1,"Data from the assay component OT_NURR1_NURR1RXRa_0480 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_NURR1_NURR1RXRa_0480, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene RXRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,Isoproterenol;Fenoterol,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,1861,8100,306,OT_NURR1_NURR1RXRa_0480,"OT_NURR1_NURR1RXRa_0480 is one of one assay component(s) measured or calculated from the OT_NURR1_NURR1RXRa_0480 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.","Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human nuclear receptor subfamily 4, group A, member 2 and retinoid X receptor, alpha [GeneSymbol:NR4A2 & RXRA | GeneID:4929 & 6256 | Uniprot_SwissProt_Accession:P43354 & P19793].",single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_NURR1_NURR1RXRa_0480,"OT_NURR1_NURR1RXRa_0480  is a cell-based assay that uses HEK293T, a human kidney cell line, with measurements taken at 8 hours after chemical dosing in a 384-well plate.",8.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1765.0,114.0,1651.0
489,756,493,OT_NURR1_NURR1RXRa_1440,1,1,"Data from the assay component OT_NURR1_NURR1RXRa_1440 was analyzed into 1 assay endpoint. 
This assay endpoint, OT_NURR1_NURR1RXRa_1440, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as they relate to the gene RXRA. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",binding,percent_activity,0,Isoproterenol;Fenoterol,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,1861,8100,307,OT_NURR1_NURR1RXRa_1440,"OT_NURR1_NURR1RXRa_1440 is one of one assay component(s) measured or calculated from the OT_NURR1_NURR1RXRa_1440 assay. It is designed to make measurements of protein fragment complementation, a form of binding reporter, as detected with fluorescence intensity signals by Protein-fragment Complementation technology.","Changes to fluorescence intensity signals produced from the protein fragment complementation are indicative of a change in the receptor function and kinetics for the human nuclear receptor subfamily 4, group A, member 2 and retinoid X receptor, alpha [GeneSymbol:NR4A2 & RXRA | GeneID:4929 & 6256 | Uniprot_SwissProt_Accession:P43354 & P19793].",single,binding reporter,protein fragment complementation assay,protein stabilization,Fluorescence,Fluorescence intensity,Protein-fragment Complementation,,,protein,receptor,6,OT_NURR1_NURR1RXRa_1440,"OT_NURR1_NURR1RXRa_1440  is a cell-based assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 384-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,protein complex format,single,DMSO,0.5,Selected assays,1757.0,100.0,1657.0
494,761,498,TOX21_AR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_AR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,R1881,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,91904,310,TOX21_AR_BLA_Agonist_ratio,TOX21_AR_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity. ,"TOX21_AR_BLA_Agonist_ratio was designed to  target nuclear receptor activity at the protein (receptor) level, specifically mapping to AR gene(s) using a positive control of R1881 ",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_AR_BLA_Agonist,"TOX21_AR_BLA_Agonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,7655.0,182.0,7473.0
495,762,499,TOX21_AR_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_AR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,Cyproterone acetate,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,92032,311,TOX21_AR_BLA_Antagonist_ratio,TOX21_AR_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_AR_BLA_Antagonist_ratio was designed to  target nuclear receptor activity at the protein (receptor) level, specifically mapping to AR gene(s) using a positive control of Cyproterone acetate ",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_AR_BLA_Antagonist,"TOX21_AR_BLA_Antagonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,7317.0,513.0,6804.0
497,764,501,TOX21_AR_LUC_MDAKB2_Agonist,1,1,"Data from the assay component TOX21_AR_LUC_MDAKB2_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",agonist,percent_activity,0,R1881,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,92160,312,TOX21_AR_LUC_MDAKB2_Agonist,"TOX21_AR_LUC_MDAKB2_Agonist is one of one assay component(s) measured or calculated from the TOX21_AR_LUC_MDAkb2_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.",Changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo] are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human androgen receptor [GeneSymbol:AR | GeneID:367 | Uniprot_SwissProt_Accession:P10275].,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_AR_LUC_MDAKB2_Agonist,"TOX21_AR_LUC_MDAKB2_Agonist is a cell-based, single-readout assay that uses MDA-kb2, a human breast cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,breast,cell line,,MDA-kb2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,8157.0,234.0,7923.0
498,765,502,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881,1,1,"Data from the assay component TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",antagonist,percent_activity,0,Nilutamide,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,91506,313,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881,"TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881 is one of one assay component(s) measured or calculated from the TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881 assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.","Androgen receptor (AR) is an important member of the nuclear receptor family. Its signaling plays a critical role in AR-dependent prostate cancer and other androgen related diseases. Considerable attention has been given in the past decades to develop methods to study and screen for the environmental chemicals that have the potential to interfere with metabolic homeostasis, reproduction, developmental and behavioral functions. Therefore AR binding assay for screening androgen antagonists can be used to identify potential endocrine disruptors. Changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo] are indicative of changes in transcriptional gene expression due to antagonist activity regulated by the human androgen receptor [GeneSymbol:AR | GeneID:367 | Uniprot_SwissProt_Accession:P10275].",single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881,"TOX21_AR_LUC_MDAKB2_Antagonist_10nM_R1881 is a cell-based, single-readout assay that uses MDA-kb2, a human breast cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate. This is an secondary assay to TOX21_AR_LUC_MDAKB2_Agonist for antagonist specificity. ",24.0,9606.0,human,breast,cell line,,MDA-kb2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,7567.0,382.0,7185.0
500,767,504,TOX21_Aromatase_Inhibition,1,1,"Data from the assay component TOX21_Aromatase_Inhibition was analyzed into 1 assay endpoint. This assay endpoint, TOX21_Aromatase_Inhibition, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP19A1. 
Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is steroidogenesis-related.",inducer,percent_activity,0,Letrozole,loss,protein,enzyme,cyp,steroidogenesis-related,0,0,1,8306,72640,314,TOX21_Aromatase_Inhibition,"TOX21_Aromatase_Inhibition is one of one assay component(s) measured or calculated from the TOX21_Aromatase_Inhibition assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.","Changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo] are indicative of changes in transcriptional gene expression due to modulation of the human cytochrome P450, family 19, subfamily A, polypeptide 1 [GeneSymbol:CYP19A1 | GeneID:1588 | Uniprot_SwissProt_Accession:P11511].",single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,enzyme,7,TOX21_Aromatase_Inhibition,"TOX21_Aromatase_Inhibition is a cell-based, single-readout assay that uses MCF-7, a human breast cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,breast,cell line,,MCF7,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,7533.0,398.0,7135.0
514,781,518,TOX21_ELG1_LUC_Agonist,1,1,"Data from the assay component TOX21_ELG1_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ELG1_LUC_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ATAD5.  Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the hydrolase intended target family, where the subfamily is atpase.",agonist,percent_activity,0,5-Fluorouridine,gain,protein,enzyme,hydrolase,atpase,0,0,1,8305,92160,317,TOX21_ELG1_LUC_Agonist,"TOX21_ELG1_LUC_Agonist is one of one assay component(s) measured or calculated from the TOX21_ELG1_LUC_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.","Changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo] are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human ATPase family, AAA domain containing 5 [GeneSymbol:ATAD5 | GeneID:79915 | Uniprot_SwissProt_Accession:Q96QE3].",single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,enzyme,7,TOX21_ELG1_LUC_Agonist,"TOX21_ELG1_LUC_Agonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,8189.0,42.0,8147.0
518,785,522,TOX21_ERa_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_ERa_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,17b-Estradiol,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,92160,318,TOX21_ERa_BLA_Agonist_ratio,TOX21_ERa_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity.,"TOX21_ERa_BLA_Agonist_ratio was designed to target nuclear receptor activity at the protein (receptor) level, specifically mapping to ESR1 gene(s) using a positive control of 17b-estradiol",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_ERa_BLA_Agonist,"TOX21_ERa_BLA_Agonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,8089.0,215.0,7874.0
519,786,523,TOX21_ERa_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_ERa_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,4-hydroxytamoxifen,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,92032,319,TOX21_ERa_BLA_Antagonist_ratio,TOX21_ERa_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_ERa_BLA_Antagonist_ratio was designed to target nuclear receptor activity at the protein (receptor) level, specifically mapping to ESR1 gene(s) using a positive control of 4-hydroxytamoxifen",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_ERa_BLA_Antagonist,"TOX21_ERa_BLA_Antagonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,7389.0,479.0,6910.0
521,788,525,TOX21_ERa_LUC_VM7_Agonist,1,1,"Data from the assay component TOX21_ERa_LUC_VM7_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_LUC_VM7_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1.  Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",agonist,percent_activity,0,17b-Estradiol,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,91634,320,TOX21_ERa_LUC_VM7_Agonist,"TOX21_ERa_LUC_VM7_Agonist is one of one assay component(s) measured or calculated from the TOX21_ERa_LUC_VM7_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.",TOX21_ERa_LUC_VM7_Agonist was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_ERa_LUC_VM7_Agonist,"TOX21_ERa_LUC_VM7_Agonist is a cell-based, single-readout assay that uses VM7, a human breast tissue cell line, with measurements taken at 22 hours after chemical dosing in a 1536-well plate.",22.0,9606.0,human,breast,cell line,,VM7,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,7131.0,470.0,6661.0
522,789,526,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2,1,1,"Data from the assay component TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",antagonist,percent_activity,0,4-hydroxytamoxifen,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,91534,321,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2,"TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2 is one of one assay component(s) measured or calculated from the TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2 assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.",Changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo] are indicative of changes in transcriptional gene expression due to antagonist activity regulated by the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372] using a positive control of 4-hydroxytamoxifen,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2,"TOX21_ERa_LUC_VM7_Antagonist_0.5nM_E2 is a cell-based, single-readout assay that uses VM7, a human breast tissue cell line, with measurements taken at 22 hours after chemical dosing in a 1536-well plate. This is a secondary assay for specificity to TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2.",22.0,9606.0,human,breast,cell line,,VM7,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,7538.0,381.0,7157.0
526,793,530,TOX21_GR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_GR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,Dexamethasone,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,92032,322,TOX21_GR_BLA_Agonist_ratio,TOX21_GR_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) substrate used as the measure of target activity.,"TOX21_GR_BLA_Agonist_ratio was designed to target nuclear receptor (non-steroidal) activity at the protein (receptor) level, specifically mapping to NR3C1 gene(s) using a positive control of Dexamethasone",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_GR_BLA_Agonist,"TOX21_GR_BLA_Agonist is a cell-based, single-readout assay that uses HeLa, a human cervix cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,cervix,cell line,,HeLa,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,7976.0,195.0,7781.0
527,794,531,TOX21_GR_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_GR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_GR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand gene activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",antagonist,percent_activity,0,Mifeprostone,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,8306,91534,323,TOX21_GR_BLA_Antagonist_ratio,TOX21_GR_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_GR_BLA_Antagonist_ratio was designed to target nuclear receptor activity at the protein (receptor) level, specifically mapping to NR3C1 gene(s) using a positive control of Mifepristone",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_GR_BLA_Antagonist,"TOX21_GR_BLA_Antagonist is a cell-based, single-readout assay that uses HeLa, a human cervix cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,cervix,cell line,,HeLa,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,7533.0,283.0,7250.0
534,802,539,TOX21_PPARg_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_PPARg_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,Rosiglitazone,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,8306,92160,325,TOX21_PPARg_BLA_Agonist_ratio,TOX21_PPARg_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity..,"TOX21_PPARg_BLA_Agonist_ratio was designed to target nuclear receptor (non-steroidal) activity at the protein (receptor) level, specifically mapping to PPARG gene(s) using a positive control of Rosiglitazone",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_PPARg_BLA_Agonist,"TOX21_PPARg_BLA_Agonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,7934.0,78.0,7856.0
535,803,540,TOX21_TR_LUC_GH3_Agonist,1,1,"Data from the assay component TOX21_TR_LUC_GH3_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_LUC_GH3_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA and THRB. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,percent_activity,0,0.092 uM T3,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,8306,92160,326,TOX21_TR_LUC_GH3_Agonist,"TOX21_TR_LUC_GH3_Agonist is one of one assay component(s) measured or calculated from the TOX21_TR_LUC_GH3_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.","Changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo] are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human thyroid hormone receptor, alpha and thyroid hormone receptor, beta [GeneSymbol:THRA & THRB | GeneID:7067 & 7068 | Uniprot_SwissProt_Accession:P10827 & P10828]. Thyroid receptor (TR), a nuclear hormone receptor, plays an important role in development, proliferation, differentiation, metabolism, brain function, and cardiovascular system. TR-interacting compounds have been shown to disrupt thyroid homeostasis.",single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_TR_LUC_GH3_Agonist,"TOX21_TR_LUC_GH3_Agonist is a cell-based, single-readout assay that uses GH3, a rat pituitary gland cell line, with measurements taken at 28 hours after chemical dosing in a 1536-well plate.",28.0,10116.0,rat,pituitary gland,cell line,,GH3,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,8292.0,15.0,8277.0
536,804,541,TOX21_TR_LUC_GH3_Antagonist,1,1,"Data from the assay component TOX21_TR_LUC_GH3_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_LUC_GH3_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRA and THRB. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",antagonist,percent_activity,0,1 nM T3,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,8306,91776,327,TOX21_TR_LUC_GH3_Antagonist,"TOX21_TR_LUC_GH3_Antagonist is one of one assay component(s) measured or calculated from the TOX21_TR_LUC_GH3_Antagonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.","Changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo] are indicative of changes in transcriptional gene expression due to antagonist activity regulated by the human thyroid hormone receptor, alpha and thyroid hormone receptor, beta [GeneSymbol:THRA & THRB | GeneID:7067 & 7068 | Uniprot_SwissProt_Accession:P10827 & P10828]. Thyroid receptor (TR), a nuclear hormone receptor, plays an important role in development, proliferation, differentiation, metabolism, brain function, and cardiovascular system. TR-interacting compounds have been shown to disrupt thyroid homeostasis.",single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_TR_LUC_GH3_Antagonist,"TOX21_TR_LUC_GH3_Antagonist is a cell-based, single-readout assay that uses GH3, a rat pituitary gland cell line, with measurements taken at 28 hours after chemical dosing in a 1536-well plate.",28.0,10116.0,rat,pituitary gland,cell line,,GH3,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,7008.0,669.0,6339.0
538,806,543,TOX21_AhR_LUC_Agonist,1,1,"Data from the assay component TOX21_AhR_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AhR_LUC_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AHR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic helix-loop-helix protein.",agonist,percent_activity,0,Omeprazole,gain,protein,receptor,dna binding,basic helix-loop-helix protein,0,0,1,8306,92160,328,TOX21_AhR_LUC_Agonist,"TOX21_AhR_LUC_Agonist is one of one assay component(s) measured or calculated from the TOX21_AhR_LUC_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CALUX luciferase quantitation technology.",Changes to bioluminescence signals produced from the luciferase induction are indicative of agonist activity regulated by the receptor function and kinetics for the human aryl hydrocarbon receptor [GeneSymbol:AHR | GeneID:196 | Uniprot_SwissProt_Accession:P35869].,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CALUX luciferase quantitation,substrate,One-Glo,protein,receptor,7,TOX21_AhR_LUC_Agonist,"TOX21_AhR_LUC_Agonist is a cell-based, single-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,7727.0,175.0,7552.0
540,891,586,CEETOX_H295R_11DCORT,1,1,"Data from the assay component CEETOX_H295R_11DCORT was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_11DCORT, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 11-Deoxycortisol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,11-Deoxycortisol,steroid hormone,glucocorticoids,0,0,1,577,1083,370,CEETOX_H295R_11DCORT,"CEETOX_H295R_11DCORT is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,11-Deoxycortisol,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,540.0,149.0,391.0
541,893,587,CEETOX_H295R_OHPREG,1,1,"Data from the assay component CEETOX_H295R_OHPREG was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_OHPREG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxypregnenolone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,17alpha-hydroxypregnenolone,steroid hormone,progestagens,0,0,1,577,1084,370,CEETOX_H295R_OHPREG,"CEETOX_H295R_OHPREG is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,17alpha-hydroxypregnenolone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,533.0,121.0,412.0
542,895,588,CEETOX_H295R_OHPROG,1,1,"Data from the assay component CEETOX_H295R_OHPROG was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_OHPROG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxyprogesterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,17alpha-hydroxyprogesterone,steroid hormone,progestagens,0,0,1,577,1083,370,CEETOX_H295R_OHPROG,"CEETOX_H295R_OHPROG is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,17alpha-hydroxyprogesterone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,545.0,208.0,337.0
543,897,589,CEETOX_H295R_ANDR,1,1,"Data from the assay component CEETOX_H295R_ANDR was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ANDR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Androstenedione in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Androstenedione,steroid hormone,androgens,0,0,1,577,1083,370,CEETOX_H295R_ANDR,"CEETOX_H295R_ANDR is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,Androstenedione,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,545.0,142.0,403.0
544,899,590,CEETOX_H295R_CORTIC,1,1,"Data from the assay component CEETOX_H295R_CORTIC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_CORTIC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Corticosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Corticosterone,steroid hormone,glucocorticoids,0,0,1,577,1083,370,CEETOX_H295R_CORTIC,"CEETOX_H295R_CORTIC is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,Corticosterone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,535.0,84.0,451.0
545,901,591,CEETOX_H295R_CORTISOL,1,1,"Data from the assay component CEETOX_H295R_CORTISOL was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_CORTISOL, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Cortisol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Cortisol,steroid hormone,glucocorticoids,0,0,1,577,1084,370,CEETOX_H295R_CORTISOL,"CEETOX_H295R_CORTISOL is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,Cortisol,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,559.0,104.0,455.0
546,905,593,CEETOX_H295R_DOC,1,1,"Data from the assay component CEETOX_H295R_DOC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_DOC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  11-Deoxycorticosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,11-Deoxycorticosterone,steroid hormone,glucocorticoids,0,0,1,577,1083,370,CEETOX_H295R_DOC,"CEETOX_H295R_DOC is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,11-Deoxycorticosterone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,544.0,157.0,387.0
547,907,594,CEETOX_H295R_ESTRADIOL,1,1,"Data from the assay component CEETOX_H295R_ESTRADIOL was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ESTRADIOL, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estradiol in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Estradiol,steroid hormone,estrogens,0,0,1,577,1079,370,CEETOX_H295R_ESTRADIOL,"CEETOX_H295R_ESTRADIOL is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,Estradiol,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,549.0,61.0,488.0
548,909,595,CEETOX_H295R_ESTRONE,1,1,"Data from the assay component CEETOX_H295R_ESTRONE was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ESTRONE, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estrone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Estrone,steroid hormone,estrogens,0,0,1,577,1078,370,CEETOX_H295R_ESTRONE,"CEETOX_H295R_ESTRONE is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,Estrone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,553.0,79.0,474.0
549,913,597,CEETOX_H295R_PROG,1,1,"Data from the assay component CEETOX_H295R_PROG was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_PROG, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Progesterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Progesterone,steroid hormone,progestagens,0,0,1,577,1084,370,CEETOX_H295R_PROG,"CEETOX_H295R_PROG is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,Progesterone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,536.0,187.0,349.0
550,915,598,CEETOX_H295R_TESTO,1,1,"Data from the assay component CEETOX_H295R_TESTO was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_TESTO, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Testosterone in H295R cell line at 48hr of chemical exposure. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens.",detection of steroid hormone,log2_fold_induction,0,Prochloraz;Forskolin,bidirectional,molecular messenger,Testosterone,steroid hormone,androgens,0,0,1,577,1084,370,CEETOX_H295R_TESTO,"CEETOX_H295R_TESTO is one of 23 assay component(s) measured or calculated from the CEETOX_H295R assay. It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology.",,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,Spectrophotometry,Absorbance,HPLC-MS-MS,inducer,,molecular messenger,Testosterone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,549.0,122.0,427.0
551,916,599,LTEA_HepaRG_ABCB1,1,1,"Data from the assay component LTEA_HepaRG_ABCB1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCB1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,ABC transporter,0,0,1,1061,3722,371,LTEA_HepaRG_ABCB1,LTEA_HepaRG_ABCB1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis/NR mediated transport.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,853.0,147.0,706.0
552,918,600,LTEA_HepaRG_ABCB11,1,1,"Data from the assay component LTEA_HepaRG_ABCB11 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCB11, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,ABC transporter,0,0,1,1061,3086,371,LTEA_HepaRG_ABCB11,LTEA_HepaRG_ABCB11  is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis/NR mediated transport.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,907.0,202.0,705.0
553,920,601,LTEA_HepaRG_ABCC2,1,1,"Data from the assay component LTEA_HepaRG_ABCC2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCC2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,ABC transporter,0,0,1,1061,3862,371,LTEA_HepaRG_ABCC2,LTEA_HepaRG_ABCC2 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis/NR mediated transport.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,914.0,127.0,787.0
554,922,602,LTEA_HepaRG_ABCC3,1,1,"Data from the assay component LTEA_HepaRG_ABCC3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCC3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,ABC transporter,0,0,1,1061,3963,371,LTEA_HepaRG_ABCC3,LTEA_HepaRG_ABCC3 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated transport.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,963.0,43.0,920.0
555,924,603,LTEA_HepaRG_ABCG2,1,1,"Data from the assay component LTEA_HepaRG_ABCG2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ABCG2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,ABC transporter,0,0,1,1061,3281,371,LTEA_HepaRG_ABCG2,LTEA_HepaRG_ABCG2 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis/NR mediated transport.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,910.0,137.0,773.0
556,926,604,LTEA_HepaRG_ACLY,1,1,"Data from the assay component LTEA_HepaRG_ACLY was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ACLY, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is steatosis.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,lyase,steatosis,0,0,1,1061,3959,371,LTEA_HepaRG_ACLY,LTEA_HepaRG_ACLY is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,878.0,68.0,810.0
557,928,605,LTEA_HepaRG_ACOX1,1,1,"Data from the assay component LTEA_HepaRG_ACOX1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ACOX1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidase intended target family, where the subfamily is steatosis.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,oxidase,steatosis,0,0,1,1061,3870,371,LTEA_HepaRG_ACOX1,LTEA_HepaRG_ACOX1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,858.0,93.0,765.0
558,930,606,LTEA_HepaRG_ADK,1,1,"Data from the assay component LTEA_HepaRG_ADK was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ADK, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is steatosis.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,kinase,steatosis,0,0,1,1061,3635,371,LTEA_HepaRG_ADK,LTEA_HepaRG_ADK is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,900.0,52.0,848.0
559,932,607,LTEA_HepaRG_AFP,1,1,"Data from the assay component LTEA_HepaRG_AFP was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_AFP, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the background measurement intended target family, where the subfamily is assay control.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,background measurement,assay control,0,0,1,1061,3164,371,LTEA_HepaRG_AFP,LTEA_HepaRG_AFP is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Undifferentiated hepatocyte.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,891.0,213.0,678.0
560,934,608,LTEA_HepaRG_ALPP,1,1,"Data from the assay component LTEA_HepaRG_ALPP was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ALPP, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,phosphatase,"Cell proliferation, survival, death",0,0,1,1061,3324,371,LTEA_HepaRG_ALPP,"LTEA_HepaRG_ALPP is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,909.0,116.0,793.0
561,936,609,LTEA_HepaRG_APOA5,1,1,"Data from the assay component LTEA_HepaRG_APOA5 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_APOA5, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the apolipoprotein intended target family, where the subfamily is Steatosis.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,apolipoprotein,Steatosis,0,0,1,1061,3123,371,LTEA_HepaRG_APOA5,LTEA_HepaRG_APOA5 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,913.0,124.0,789.0
563,940,611,LTEA_HepaRG_BAX,1,1,"Data from the assay component LTEA_HepaRG_BAX was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BAX, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3935,371,LTEA_HepaRG_BAX,"LTEA_HepaRG_BAX is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,968.0,55.0,913.0
564,942,612,LTEA_HepaRG_BCL2,1,1,"Data from the assay component LTEA_HepaRG_BCL2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BCL2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3199,371,LTEA_HepaRG_BCL2,"LTEA_HepaRG_BCL2 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,963.0,76.0,887.0
565,944,613,LTEA_HepaRG_BCL2L11,1,1,"Data from the assay component LTEA_HepaRG_BCL2L11 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BCL2L11, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3828,371,LTEA_HepaRG_BCL2L11,"LTEA_HepaRG_BCL2L11 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,945.0,52.0,893.0
566,946,614,LTEA_HepaRG_BID,1,1,"Data from the assay component LTEA_HepaRG_BID was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_BID, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3534,371,LTEA_HepaRG_BID,"LTEA_HepaRG_BID is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,911.0,50.0,861.0
567,948,615,LTEA_HepaRG_CASP3,1,1,"Data from the assay component LTEA_HepaRG_CASP3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CASP3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease,cysteine protease,0,0,1,1061,3784,371,LTEA_HepaRG_CASP3,"LTEA_HepaRG_CASP3 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,906.0,41.0,865.0
568,950,616,LTEA_HepaRG_CASP8,1,1,"Data from the assay component LTEA_HepaRG_CASP8 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CASP8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is cysteine protease.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease,cysteine protease,0,0,1,1061,3638,371,LTEA_HepaRG_CASP8,"LTEA_HepaRG_CASP8 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,933.0,43.0,890.0
569,952,617,LTEA_HepaRG_CAT,1,1,"Data from the assay component LTEA_HepaRG_CAT was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CAT, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the catalase intended target family, where the subfamily is oxidative stress.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,catalase,oxidative stress,0,0,1,1061,4004,371,LTEA_HepaRG_CAT,LTEA_HepaRG_CAT is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Oxidative Stress.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,905.0,105.0,800.0
570,954,618,LTEA_HepaRG_CCND1,1,1,"Data from the assay component LTEA_HepaRG_CCND1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CCND1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3913,371,LTEA_HepaRG_CCND1,"LTEA_HepaRG_CCND1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,924.0,63.0,861.0
571,956,619,LTEA_HepaRG_CCND2,1,1,"Data from the assay component LTEA_HepaRG_CCND2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CCND2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,878,1743,371,LTEA_HepaRG_CCND2,"LTEA_HepaRG_CCND2 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,817.0,18.0,799.0
572,958,620,LTEA_HepaRG_CDKN1A,1,1,"Data from the assay component LTEA_HepaRG_CDKN1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CDKN1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3988,371,LTEA_HepaRG_CDKN1A,"LTEA_HepaRG_CDKN1A is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,922.0,51.0,871.0
573,960,621,LTEA_HepaRG_CFLAR,1,1,"Data from the assay component LTEA_HepaRG_CFLAR was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CFLAR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,"Cell proliferation, survival, death",0,0,1,1061,3836,371,LTEA_HepaRG_CFLAR,"LTEA_HepaRG_CFLAR is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,908.0,55.0,853.0
574,962,622,LTEA_HepaRG_CYP1A1,1,1,"Data from the assay component LTEA_HepaRG_CYP1A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP1A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3293,371,LTEA_HepaRG_CYP1A1,LTEA_HepaRG_CYP1A1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,849.0,529.0,320.0
575,964,623,LTEA_HepaRG_CYP1A2,1,1,"Data from the assay component LTEA_HepaRG_CYP1A2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP1A2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,2769,371,LTEA_HepaRG_CYP1A2,LTEA_HepaRG_CYP1A2 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,872.0,325.0,547.0
576,966,624,LTEA_HepaRG_CYP24A1,1,1,"Data from the assay component LTEA_HepaRG_CYP24A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP24A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1059,1940,371,LTEA_HepaRG_CYP24A1,LTEA_HepaRG_CYP24A1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,983.0,15.0,968.0
577,968,625,LTEA_HepaRG_CYP2B6,1,1,"Data from the assay component LTEA_HepaRG_CYP2B6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2B6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3181,371,LTEA_HepaRG_CYP2B6,LTEA_HepaRG_CYP2B6 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,851.0,372.0,479.0
578,970,626,LTEA_HepaRG_CYP2C19,1,1,"Data from the assay component LTEA_HepaRG_CYP2C19 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2C19, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3245,371,LTEA_HepaRG_CYP2C19,LTEA_HepaRG_CYP2C19 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,897.0,224.0,673.0
579,972,627,LTEA_HepaRG_CYP2C8,1,1,"Data from the assay component LTEA_HepaRG_CYP2C8 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2C8, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3069,371,LTEA_HepaRG_CYP2C8,LTEA_HepaRG_CYP2C8 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,907.0,134.0,773.0
580,974,628,LTEA_HepaRG_CYP2C9,1,1,"Data from the assay component LTEA_HepaRG_CYP2C9 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2C9, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3617,371,LTEA_HepaRG_CYP2C9,LTEA_HepaRG_CYP2C9 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,937.0,91.0,846.0
581,976,629,LTEA_HepaRG_CYP2E1,1,1,"Data from the assay component LTEA_HepaRG_CYP2E1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP2E1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3623,371,LTEA_HepaRG_CYP2E1,LTEA_HepaRG_CYP2E1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,834.0,308.0,526.0
582,978,630,LTEA_HepaRG_CYP3A4,1,1,"Data from the assay component LTEA_HepaRG_CYP3A4 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP3A4, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3714,371,LTEA_HepaRG_CYP3A4,LTEA_HepaRG_CYP3A4 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,887.0,230.0,657.0
583,980,631,LTEA_HepaRG_CYP3A5,1,1,"Data from the assay component LTEA_HepaRG_CYP3A5 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP3A5, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3701,371,LTEA_HepaRG_CYP3A5,LTEA_HepaRG_CYP3A5 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,919.0,69.0,850.0
584,982,632,LTEA_HepaRG_CYP3A7,1,1,"Data from the assay component LTEA_HepaRG_CYP3A7 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP3A7, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3172,371,LTEA_HepaRG_CYP3A7,LTEA_HepaRG_CYP3A7 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism/Undifferentiated hepatocyte.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,881.0,189.0,692.0
585,984,633,LTEA_HepaRG_CYP4A11,1,1,"Data from the assay component LTEA_HepaRG_CYP4A11 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP4A11, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3415,371,LTEA_HepaRG_CYP4A11,LTEA_HepaRG_CYP4A11 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,904.0,216.0,688.0
586,986,634,LTEA_HepaRG_CYP4A22,1,1,"Data from the assay component LTEA_HepaRG_CYP4A22 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP4A22, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,2858,371,LTEA_HepaRG_CYP4A22,LTEA_HepaRG_CYP4A22 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,902.0,192.0,710.0
587,988,635,LTEA_HepaRG_CYP7A1,1,1,"Data from the assay component LTEA_HepaRG_CYP7A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_CYP7A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,1061,3341,371,LTEA_HepaRG_CYP7A1,LTEA_HepaRG_CYP7A1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,864.0,185.0,679.0
588,990,636,LTEA_HepaRG_DDIT3,1,1,"Data from the assay component LTEA_HepaRG_DDIT3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_DDIT3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic leucine zipper,0,0,1,1061,3853,371,LTEA_HepaRG_DDIT3,LTEA_HepaRG_DDIT3 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Oxidative Stress.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,926.0,92.0,834.0
589,992,637,LTEA_HepaRG_EGF,1,1,"Data from the assay component LTEA_HepaRG_EGF was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_EGF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is EGF-like domain.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,EGF-like domain,0,0,1,1061,3204,371,LTEA_HepaRG_EGF,"LTEA_HepaRG_EGF is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,959.0,64.0,895.0
590,994,638,LTEA_HepaRG_EGR1,1,1,"Data from the assay component LTEA_HepaRG_EGR1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_EGR1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is zinc finger.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,zinc finger,0,0,1,1061,3922,371,LTEA_HepaRG_EGR1,"LTEA_HepaRG_EGR1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,963.0,53.0,910.0
591,996,639,LTEA_HepaRG_EZR,1,1,"Data from the assay component LTEA_HepaRG_EZR was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_EZR, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the membrane protein intended target family, where the subfamily is Cellular remodeling.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,membrane protein,Cellular remodeling,0,0,1,1061,3860,371,LTEA_HepaRG_EZR,LTEA_HepaRG_EZR is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cellular remodeling.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,882.0,35.0,847.0
592,998,640,LTEA_HepaRG_FABP1,1,1,"Data from the assay component LTEA_HepaRG_FABP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FABP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is fatty acid carrier protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,fatty acid carrier protein,0,0,1,1061,4024,371,LTEA_HepaRG_FABP1,LTEA_HepaRG_FABP1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,851.0,199.0,652.0
593,1000,641,LTEA_HepaRG_FAS,1,1,"Data from the assay component LTEA_HepaRG_FAS was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FAS, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine receptor intended target family, where the subfamily is TNF receptor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cytokine receptor,TNF receptor,0,0,1,1061,3756,371,LTEA_HepaRG_FAS,"LTEA_HepaRG_FAS is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,932.0,49.0,883.0
594,1002,642,LTEA_HepaRG_FASN,1,1,"Data from the assay component LTEA_HepaRG_FASN was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FASN, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is fatty acid synthase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,lyase,fatty acid synthase,0,0,1,1061,4083,371,LTEA_HepaRG_FASN,LTEA_HepaRG_FASN is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,919.0,137.0,782.0
595,1004,643,LTEA_HepaRG_FMO3,1,1,"Data from the assay component LTEA_HepaRG_FMO3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FMO3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is dioxygenase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,oxidoreductase,dioxygenase,0,0,1,1061,3763,371,LTEA_HepaRG_FMO3,LTEA_HepaRG_FMO3 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,901.0,131.0,770.0
596,1006,644,LTEA_HepaRG_FOXO1,1,1,"Data from the assay component LTEA_HepaRG_FOXO1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FOXO1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,forkhead box protein,0,0,1,1061,3696,371,LTEA_HepaRG_FOXO1,"LTEA_HepaRG_FOXO1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,961.0,45.0,916.0
597,1008,645,LTEA_HepaRG_FOXO3,1,1,"Data from the assay component LTEA_HepaRG_FOXO3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_FOXO3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is forkhead box protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,forkhead box protein,0,0,1,1061,3922,371,LTEA_HepaRG_FOXO3,"LTEA_HepaRG_FOXO3 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,902.0,62.0,840.0
598,1010,646,LTEA_HepaRG_GADD45A,1,1,"Data from the assay component LTEA_HepaRG_GADD45A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GADD45A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is Oxidative Stress.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell cycle,Oxidative Stress,0,0,1,1061,3689,371,LTEA_HepaRG_GADD45A,LTEA_HepaRG_GADD45A is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Oxidative Stress.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,927.0,80.0,847.0
599,1012,647,LTEA_HepaRG_GADD45B,1,1,"Data from the assay component LTEA_HepaRG_GADD45B was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GADD45B, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mutagenicity response intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,mutagenicity response,"Cell proliferation, survival, death",0,0,1,1061,3898,371,LTEA_HepaRG_GADD45B,"LTEA_HepaRG_GADD45B is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,932.0,57.0,875.0
600,1014,648,LTEA_HepaRG_GADD45G,1,1,"Data from the assay component LTEA_HepaRG_GADD45G was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GADD45G, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mutagenicity response intended target family, where the subfamily is Cell proliferation, survival, death.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,mutagenicity response,"Cell proliferation, survival, death",0,0,1,1061,3831,371,LTEA_HepaRG_GADD45G,"LTEA_HepaRG_GADD45G is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,927.0,88.0,839.0
601,1016,649,LTEA_HepaRG_GCLC,1,1,"Data from the assay component LTEA_HepaRG_GCLC was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GCLC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ligase intended target family, where the subfamily is C-N ligase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,ligase,C-N ligase,0,0,1,1061,3869,371,LTEA_HepaRG_GCLC,LTEA_HepaRG_GCLC is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Oxidative Stress.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,887.0,55.0,832.0
602,1018,650,LTEA_HepaRG_GCLM,1,1,"Data from the assay component LTEA_HepaRG_GCLM was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GCLM, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ligase intended target family, where the subfamily is C-N ligase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,ligase,C-N ligase,0,0,1,1061,3872,371,LTEA_HepaRG_GCLM,"LTEA_HepaRG_GCLM is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,927.0,57.0,870.0
603,1026,654,LTEA_HepaRG_GSTA2,1,1,"Data from the assay component LTEA_HepaRG_GSTA2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GSTA2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is alkyl and aryl transferase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transferase,alkyl and aryl transferase,0,0,1,1061,3553,371,LTEA_HepaRG_GSTA2,LTEA_HepaRG_GSTA2 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Oxidative Stress.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,917.0,129.0,788.0
604,1028,655,LTEA_HepaRG_GSTM3,1,1,"Data from the assay component LTEA_HepaRG_GSTM3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_GSTM3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is alkyl and aryl transferase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transferase,alkyl and aryl transferase,0,0,1,1061,3275,371,LTEA_HepaRG_GSTM3,LTEA_HepaRG_GSTM3 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Oxidative Stress.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,974.0,34.0,940.0
605,1030,656,LTEA_HepaRG_HGF,1,1,"Data from the assay component LTEA_HepaRG_HGF was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HGF, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is hepatocyte growth factor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,hepatocyte growth factor,0,0,1,1061,3167,371,LTEA_HepaRG_HGF,"LTEA_HepaRG_HGF is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,964.0,33.0,931.0
606,1032,657,LTEA_HepaRG_HIF1A,1,1,"Data from the assay component LTEA_HepaRG_HIF1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HIF1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic helix-loop-helix protein,0,0,1,1061,3988,371,LTEA_HepaRG_HIF1A,"LTEA_HepaRG_HIF1A is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,896.0,32.0,864.0
607,1034,658,LTEA_HepaRG_HMGCS2,1,1,"Data from the assay component LTEA_HepaRG_HMGCS2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HMGCS2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the lyase intended target family, where the subfamily is HMG-CoA synthase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,lyase,HMG-CoA synthase,0,0,1,1061,3616,371,LTEA_HepaRG_HMGCS2,LTEA_HepaRG_HMGCS2 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,890.0,158.0,732.0
608,1036,659,LTEA_HepaRG_HSPA1A,1,1,"Data from the assay component LTEA_HepaRG_HSPA1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_HSPA1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is heat shock protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,heat shock protein,0,0,1,1061,3942,371,LTEA_HepaRG_HSPA1A,LTEA_HepaRG_HSPA1A is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Oxidative Stress.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,899.0,69.0,830.0
609,1038,660,LTEA_HepaRG_ICAM1,1,1,"Data from the assay component LTEA_HepaRG_ICAM1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_ICAM1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell adhesion molecules intended target family, where the subfamily is Immunoglobulin CAM.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cell adhesion molecules,Immunoglobulin CAM,0,0,1,1061,3760,371,LTEA_HepaRG_ICAM1,LTEA_HepaRG_ICAM1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Fibrosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,962.0,41.0,921.0
610,1040,661,LTEA_HepaRG_IGF1,1,1,"Data from the assay component LTEA_HepaRG_IGF1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IGF1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is insulin-like.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,insulin-like,0,0,1,1061,3232,371,LTEA_HepaRG_IGF1,"LTEA_HepaRG_IGF1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,906.0,188.0,718.0
611,1042,662,LTEA_HepaRG_IGFBP1,1,1,"Data from the assay component LTEA_HepaRG_IGFBP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IGFBP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is hormone carrier protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,hormone carrier protein,0,0,1,1061,3887,371,LTEA_HepaRG_IGFBP1,"LTEA_HepaRG_IGFBP1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,936.0,102.0,834.0
612,1044,663,LTEA_HepaRG_IL6,1,1,"Data from the assay component LTEA_HepaRG_IL6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IL6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine intended target family, where the subfamily is interleukins.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cytokine,interleukins,0,0,1,1061,3820,371,LTEA_HepaRG_IL6,LTEA_HepaRG_IL6 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Inflammation.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,963.0,50.0,913.0
613,1046,664,LTEA_HepaRG_IL6R,1,1,"Data from the assay component LTEA_HepaRG_IL6R was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_IL6R, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine receptor intended target family, where the subfamily is JAK-STAT cytokine receptor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cytokine receptor,JAK-STAT cytokine receptor,0,0,1,1061,3748,371,LTEA_HepaRG_IL6R,LTEA_HepaRG_IL6R is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Inflammation.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,927.0,64.0,863.0
614,1048,665,LTEA_HepaRG_JUN,1,1,"Data from the assay component LTEA_HepaRG_JUN was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_JUN, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic leucine zipper,0,0,1,1061,3739,371,LTEA_HepaRG_JUN,"LTEA_HepaRG_JUN is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,955.0,31.0,924.0
615,1050,666,LTEA_HepaRG_KCNK1,1,1,"Data from the assay component LTEA_HepaRG_KCNK1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_KCNK1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the ion channel intended target family, where the subfamily is potassium channel.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,ion channel,potassium channel,0,0,1,1061,3156,371,LTEA_HepaRG_KCNK1,LTEA_HepaRG_KCNK1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Hyperplasia.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,953.0,32.0,921.0
616,1052,667,LTEA_HepaRG_KRT19,1,1,"Data from the assay component LTEA_HepaRG_KRT19 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_KRT19, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the filaments intended target family, where the subfamily is keratin.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,filaments,keratin,0,0,1,1061,4033,371,LTEA_HepaRG_KRT19,"LTEA_HepaRG_KRT19 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,926.0,141.0,785.0
617,1054,668,LTEA_HepaRG_LIPC,1,1,"Data from the assay component LTEA_HepaRG_LIPC was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_LIPC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is lipase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,esterase,lipase,0,0,1,1061,3159,371,LTEA_HepaRG_LIPC,LTEA_HepaRG_LIPC is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,950.0,123.0,827.0
618,1056,669,LTEA_HepaRG_LPL,1,1,"Data from the assay component LTEA_HepaRG_LPL was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_LPL, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the esterase intended target family, where the subfamily is lipase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,esterase,lipase,0,0,1,1061,3819,371,LTEA_HepaRG_LPL,LTEA_HepaRG_LPL is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,871.0,118.0,753.0
619,1058,670,LTEA_HepaRG_MIR122,1,1,"Data from the assay component LTEA_HepaRG_MIR122 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MIR122, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the microrna intended target family, where the subfamily is post-transcriptional regulation.",reporter gene,log2_fold_induction,0,,bidirectional,rna,miRNA,microrna,post-transcriptional regulation,0,0,1,1061,2865,371,LTEA_HepaRG_MIR122,LTEA_HepaRG_MIR122 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of MicroRNA.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,953.0,92.0,861.0
620,1060,671,LTEA_HepaRG_MMP10,1,1,"Data from the assay component LTEA_HepaRG_MMP10 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MMP10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease,matrix metalloproteinase,0,0,1,1061,3209,371,LTEA_HepaRG_MMP10,LTEA_HepaRG_MMP10 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Fibrosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,961.0,42.0,919.0
621,1062,672,LTEA_HepaRG_MMP3,1,1,"Data from the assay component LTEA_HepaRG_MMP3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MMP3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease intended target family, where the subfamily is matrix metalloproteinase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease,matrix metalloproteinase,0,0,1,1061,3383,371,LTEA_HepaRG_MMP3,LTEA_HepaRG_MMP3 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Fibrosis.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,935.0,76.0,859.0
622,1064,673,LTEA_HepaRG_MYC,1,1,"Data from the assay component LTEA_HepaRG_MYC was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_MYC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic helix-loop-helix leucine zipper.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic helix-loop-helix leucine zipper,0,0,1,1061,3727,371,LTEA_HepaRG_MYC,"LTEA_HepaRG_MYC is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,928.0,94.0,834.0
623,1066,674,LTEA_HepaRG_NFE2L2,1,1,"Data from the assay component LTEA_HepaRG_NFE2L2 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_NFE2L2, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic leucine zipper,0,0,1,1061,3529,371,LTEA_HepaRG_NFE2L2,LTEA_HepaRG_NFE2L2 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Inflammation/injury.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,867.0,74.0,793.0
624,1068,675,LTEA_HepaRG_NFKB1,1,1,"Data from the assay component LTEA_HepaRG_NFKB1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_NFKB1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is NF-kappa B.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,NF-kappa B,0,0,1,1061,3692,371,LTEA_HepaRG_NFKB1,"LTEA_HepaRG_NFKB1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,866.0,40.0,826.0
625,1070,676,LTEA_HepaRG_NQO1,1,1,"Data from the assay component LTEA_HepaRG_NQO1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_NQO1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is quinone-acceptor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,oxidoreductase,quinone-acceptor,0,0,1,1061,3345,371,LTEA_HepaRG_NQO1,LTEA_HepaRG_NQO1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Diseases associated with NQO1 includeTardive DyskinesiaandChildhood Leukemia..,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,967.0,39.0,928.0
626,1072,677,LTEA_HepaRG_PDK4,1,1,"Data from the assay component LTEA_HepaRG_PDK4 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PDK4, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the kinase intended target family, where the subfamily is serine/threonine kinase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,kinase,serine/threonine kinase,0,0,1,1061,3526,371,LTEA_HepaRG_PDK4,"LTEA_HepaRG_PDK4 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Diseases associated with PDK4 includePlatelet Glycoprotein Iv DeficiencyandDiabetes Mellitus, Noninsulin-Dependent..",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,877.0,157.0,720.0
627,1074,678,LTEA_HepaRG_PEG10,1,1,"Data from the assay component LTEA_HepaRG_PEG10 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PEG10, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,xenobiotic metabolism,0,0,1,1061,4029,371,LTEA_HepaRG_PEG10,"LTEA_HepaRG_PEG10 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,922.0,180.0,742.0
628,1076,679,LTEA_HepaRG_PPP2R4,1,1,"Data from the assay component LTEA_HepaRG_PPP2R4 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PPP2R4, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is serine/threonine phosphatase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,phosphatase,serine/threonine phosphatase,0,0,1,1061,3908,371,LTEA_HepaRG_PPP2R4,"LTEA_HepaRG_PPP2R4 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,936.0,39.0,897.0
629,1078,680,LTEA_HepaRG_PTEN,1,1,"Data from the assay component LTEA_HepaRG_PTEN was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_PTEN, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the phosphatase intended target family, where the subfamily is dual-specific phosphatase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,phosphatase,dual-specific phosphatase,0,0,1,1061,3715,371,LTEA_HepaRG_PTEN,"LTEA_HepaRG_PTEN is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,917.0,37.0,880.0
630,1080,681,LTEA_HepaRG_SDHB,1,1,"Data from the assay component LTEA_HepaRG_SDHB was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SDHB, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the oxidoreductase intended target family, where the subfamily is ubiquinone.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,oxidoreductase,ubiquinone,0,0,1,1061,3987,371,LTEA_HepaRG_SDHB,"LTEA_HepaRG_SDHB is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,930.0,44.0,886.0
631,1082,682,LTEA_HepaRG_SLC22A1,1,1,"Data from the assay component LTEA_HepaRG_SLC22A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLC22A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is organic cation transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,organic cation transporter,0,0,1,1061,3277,371,LTEA_HepaRG_SLC22A1,LTEA_HepaRG_SLC22A1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated transport.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,908.0,177.0,731.0
632,1084,683,LTEA_HepaRG_SLCO1B1,1,1,"Data from the assay component LTEA_HepaRG_SLCO1B1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLCO1B1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is organic anion transporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,organic anion transporter,0,0,1,1061,3305,371,LTEA_HepaRG_SLCO1B1,LTEA_HepaRG_SLCO1B1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated transport.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,927.0,114.0,813.0
633,1086,684,LTEA_HepaRG_STAT3,1,1,"Data from the assay component LTEA_HepaRG_STAT3 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_STAT3, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is stat protein.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,stat protein,0,0,1,1061,3965,371,LTEA_HepaRG_STAT3,"LTEA_HepaRG_STAT3 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,844.0,56.0,788.0
634,1088,685,LTEA_HepaRG_SULT2A1,1,1,"Data from the assay component LTEA_HepaRG_SULT2A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SULT2A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is sulfotransferase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transferase,sulfotransferase,0,0,1,1061,3753,371,LTEA_HepaRG_SULT2A1,LTEA_HepaRG_SULT2A1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated transport.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,893.0,104.0,789.0
635,1090,686,LTEA_HepaRG_TGFA,1,1,"Data from the assay component LTEA_HepaRG_TGFA was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TGFA, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is EGF-like domain.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,EGF-like domain,0,0,1,1061,3637,371,LTEA_HepaRG_TGFA,"LTEA_HepaRG_TGFA is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,972.0,64.0,908.0
636,1092,687,LTEA_HepaRG_TGFB1,1,1,"Data from the assay component LTEA_HepaRG_TGFB1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TGFB1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is transforming growth factor beta.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,transforming growth factor beta,0,0,1,1061,3916,371,LTEA_HepaRG_TGFB1,"LTEA_HepaRG_TGFB1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,959.0,61.0,898.0
637,1094,688,LTEA_HepaRG_THRSP,1,1,"Data from the assay component LTEA_HepaRG_THRSP was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_THRSP, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor intended target family, where the subfamily is NR mediated metabolism.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,growth factor,NR mediated metabolism,0,0,1,1061,3138,371,LTEA_HepaRG_THRSP,LTEA_HepaRG_THRSP is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,930.0,167.0,763.0
638,1096,689,LTEA_HepaRG_TIMP1,1,1,"Data from the assay component LTEA_HepaRG_TIMP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TIMP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the protease inhibitor intended target family, where the subfamily is metalloproteinase inhibitor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,protease inhibitor,metalloproteinase inhibitor,0,0,1,1061,4114,371,LTEA_HepaRG_TIMP1,"LTEA_HepaRG_TIMP1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,946.0,26.0,920.0
639,1098,690,LTEA_HepaRG_TNFRSF1A,1,1,"Data from the assay component LTEA_HepaRG_TNFRSF1A was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TNFRSF1A, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cytokine receptor intended target family, where the subfamily is TNF receptor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,cytokine receptor,TNF receptor,0,0,1,1061,3418,371,LTEA_HepaRG_TNFRSF1A,"LTEA_HepaRG_TNFRSF1A is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Cell proliferation, survival, death.",Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,896.0,55.0,841.0
640,1100,691,LTEA_HepaRG_TP53,1,1,"Data from the assay component LTEA_HepaRG_TP53 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_TP53, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is tumor suppressor.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,tumor suppressor,0,0,1,1061,3734,371,LTEA_HepaRG_TP53,LTEA_HepaRG_TP53 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Oxidative Stress.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,907.0,73.0,834.0
641,1102,692,LTEA_HepaRG_UGT1A1,1,1,"Data from the assay component LTEA_HepaRG_UGT1A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_UGT1A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is glucuronosyltransferase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transferase,glucuronosyltransferase,0,0,1,1061,3562,371,LTEA_HepaRG_UGT1A1,LTEA_HepaRG_UGT1A1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Steatosis/NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,859.0,259.0,600.0
642,1104,693,LTEA_HepaRG_UGT1A6,1,1,"Data from the assay component LTEA_HepaRG_UGT1A6 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_UGT1A6, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where the subfamily is glucuronosyltransferase.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transferase,glucuronosyltransferase,0,0,1,1061,3593,371,LTEA_HepaRG_UGT1A6,LTEA_HepaRG_UGT1A6 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated metabolism.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,919.0,73.0,846.0
643,1106,694,LTEA_HepaRG_XBP1,1,1,"Data from the assay component LTEA_HepaRG_XBP1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_XBP1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,dna binding,basic leucine zipper,0,0,1,1061,3451,371,LTEA_HepaRG_XBP1,LTEA_HepaRG_XBP1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of Diseases associated with XBP1 includeMajor Affective Disorder 7andBipolar Disorde.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,935.0,58.0,877.0
646,1110,697,TOX21_ARE_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_ARE_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_ARE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFE2L2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic leucine zipper.",ratio,percent_activity,0,Beta-Naphthoflavone,gain,pathway,pathway-specified,dna binding,basic leucine zipper,0,0,1,7522,68362,372,TOX21_ARE_BLA_Agonist_ratio,TOX21_ARE_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_ARE_BLA_Agonist_ratio was designed to  target transcription factor activity, specifically mapping to NFE2L2 gene(s) using a positive control of Beta-Naphthoflavone",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_ARE_BLA_Agonist,"TOX21_ARE_BLA_Agonist is a cell-based, single-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,6283.0,457.0,5826.0
649,1113,700,TOX21_HSE_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_HSE_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_HSE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HSF1.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is heat shock protein.",ratio,percent_activity,0,17-AAG,gain,pathway,pathway-specified,dna binding,heat shock protein,0,0,1,7522,68490,373,TOX21_HSE_BLA_Agonist_ratio,TOX21_HSE_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene  substrate used as the measure of target activity,"TOX21_HSE_BLA_Agonist_ratio was designed to target transcription factor activity, specifically mapping to HSF1 gene(s) using a positive control of 17-AAG",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_HSE_BLA_Agonist,"TOX21_HSE_BLA_Agonist is a cell-based, single-readout assay that uses HeLa, a human cervix cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,cervix,cell line,,HeLa,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7104.0,116.0,6988.0
652,1116,703,TOX21_p53_BLA_p1_ratio,1,1,"Data from the assay component TOX21_p53_BLA_p1_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p1_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.",ratio,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,8306,103890,374,TOX21_p53_BLA_p1_ratio,TOX21_p53_BLA_p1_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_p53_BLA_p1_ratio was designed to target transcription factor activity, specifically mapping to TP53 gene(s) using a positive control of Mitomycin C",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_p53_BLA_p1,"TOX21_p53_BLA_p1 is a cell-based, single-readout assay that uses HCT116, a human intestinal cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,intestinal,cell line,,HCT116,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7799.0,153.0,7646.0
655,1119,706,TOX21_FXR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_FXR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_FXR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,Chenodeoxycholic acid,gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,7522,68490,375,TOX21_FXR_BLA_Agonist_ratio,TOX21_FXR_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_FXR_BLA_Agonist_ratio was designed to target nuclear receptor activity at the protein (receptor) level, specifically mapping to NR1H4 gene(s) using a positive control of Chenodeoxycholic acid",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_FXR_BLA_Agonist,"TOX21_FXR_BLA_Agonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7354.0,22.0,7332.0
656,1120,707,TOX21_FXR_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_FXR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_FXR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR1H4. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,Guggulsterone,loss,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,7522,62602,376,TOX21_FXR_BLA_Antagonist_ratio,TOX21_FXR_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_FXR_BLA_Antagonist_ratio was designed to target nuclear receptor activity at the protein (receptor) level, specifically mapping to NR1H4 gene(s) using a positive control of Guggulsterone",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_FXR_BLA_Antagonist,"TOX21_FXR_BLA_Antagonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,6780.0,330.0,6450.0
660,1124,711,TOX21_PPARd_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_PPARd_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,"L-165,041",gain,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,7522,68490,377,TOX21_PPARd_BLA_Agonist_ratio,TOX21_PPARd_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_PPARD_BLA_Agonist_ratio was designed to target nuclear receptor  activity at the protein (receptor) level, specifically mapping to PPARD gene(s) using a positive control of L-165,041",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_PPARd_BLA_Agonist,"TOX21_PPARd_BLA_Agonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7279.0,25.0,7254.0
661,1125,712,TOX21_PPARd_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_PPARd_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARd_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARD. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,MK886,loss,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,7522,68490,378,TOX21_PPARd_BLA_Antagonist_ratio,TOX21_PPARd_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_PPARD_BLA_Antagonist_ratio was designed to target nuclear receptor  activity at the protein (receptor) level, specifically mapping to PPARD gene(s) using a positive control of MK886",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_PPARd_BLA_Antagonist,"TOX21_PPARd_BLA_Antagonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7116.0,146.0,6970.0
663,1127,714,TOX21_PPARg_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_PPARg_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PPARg_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene PPARG. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,GW9662,loss,pathway,pathway-specified,nuclear receptor,non-steroidal,0,0,1,7522,68362,379,TOX21_PPARg_BLA_Antagonist_ratio,TOX21_PPARg_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_PPARg_BLA_Antagonist_ratio was designed to target nuclear receptor  activity at the protein (receptor) level, specifically mapping to PPARG gene(s) using a positive control of GW9662",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_PPARg_BLA_Antagonist,"TOX21_PPARg_BLA_Antagonist is a cell-based, single-readout assay that uses HEK293, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,6955.0,256.0,6699.0
667,1131,718,TOX21_VDR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_VDR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,Calcitriol,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,7522,72202,380,TOX21_VDR_BLA_Agonist_ratio,TOX21_VDR_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_VDR_BLA_Agonist_ratio was designed to measure cleaved reporter gene substrate to target nuclear receptor  activity at the protein (receptor) level, specifically mapping to NR1I1 gene(s) using a positive control of Calcitriol",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_VDR_BLA_Agonist,"TOX21_VDR_BLA_Agonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7111.0,15.0,7096.0
668,1132,719,TOX21_VDR_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_VDR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_VDR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP24A1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,"1alpha,25-Dihydroxy vitamin D3",loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,7522,68490,381,TOX21_VDR_BLA_Antagonist_ratio,TOX21_VDR_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene reporter gene substrate used as the measure of target activity.,"TOX21_VDR_BLA_Antagonist_ratio was designed to target nuclear receptor  activity at the protein (receptor) level, specifically mapping to NR1I1 gene(s) using a positive control of Tetraoctyl ammonium bromide",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_VDR_BLA_Antagonist,"TOX21_VDR_BLA_Antagonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7233.0,128.0,7105.0
670,1134,721,TOX21_DT40,1,1,"Data from the assay component TOX21_DT40 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_DT40, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint.",viability,percent_activity,0,Tetraoctyl ammonium bromide,loss,pathway,pathway-specified,cell cycle,DNA repair,0,0,1,8306,91634,382,TOX21_DT40,TOX21_DT40 is an assay readout measuring cellular ATP content as a determinant of cell viability using CellTiter-Glo Luciferase-coupled ATP quantitation,TOX21_DT40 assay was designed to target cell cycle (cytotoxicity) activity at the cellular (cellular) level in isogenic wildtype cells using a positive control of tetraoctylammonium bromide. Results from the wild-type cells can be compared to TOX21_DT40_100 (aeid 2130) and TOX21_DT40_657 (aeid 2131) isogenic cell line assays which contain DNA repair enzyme deletions to detect DNA-damaging agents,single,viability reporter,ATP content,cell proliferation,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,CellTiter-Glo,chemical,ATP,7,TOX21_DT40,"TOX21_DT40 is a cell-based, single-readout assay that uses DT40, a chicken lymphoblast cell line, with measurements taken at 40 hours after chemical dosing in a 1536-well plate.",40.0,9031.0,chicken,lymphoblast,cell line,,DT40,suspension,microplate: 1536-well plate,cell-based,cell-based format,multiplexed,DMSO,0.0,Selected assays,6845.0,1391.0,5454.0
671,1136,722,LTEA_HepaRG_LDH_cytotoxicity,1,1,"Data from the assay component LTEA_HepaRG_LDH_cytotoxicity was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_LDH_cytotoxicity, was analyzed in the positive fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for loss-of-signal activity can be used to understand cell death. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is proliferation.",viability,percent_activity,0,,loss,cellular,cellular,cell cycle,proliferation,0,0,1,1061,3360,371,LTEA_HepaRG_LDH_cytotoxicity,LTEA_HepaRG_LDH_cytotoxicity is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of cell viability / cytotoxicity.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,viability reporter,dehydrogenase activity determination,cell death,Spectrophotometry,Absorbance,Enzyme activity,substrate,,protein,enzyme,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,1022.0,159.0,863.0
694,1317,892,TOX21_p53_BLA_p2_ratio,1,1,"Data from the assay component TOX21_p53_BLA_p2_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p2_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.",ratio,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,8306,30464,402,TOX21_p53_BLA_p2_ratio,TOX21_p53_BLA_p2_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_p53_BLA_p2_ratio was designed to target transcription factor activity, specifically mapping to TP53 gene(s) using a positive control of Mitomycin C",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_p53_BLA_p2,"TOX21_p53_BLA_p2 is a cell-based, single-readout assay that uses HCT116, a human intestinal cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,intestinal,cell line,,HCT116,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7603.0,129.0,7474.0
698,1321,896,TOX21_p53_BLA_p3_ratio,1,1,"Data from the assay component TOX21_p53_BLA_p3_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_p53_BLA_p3_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter,  gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.",ratio,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,8306,30720,403,TOX21_p53_BLA_p3_ratio,TOX21_p53_BLA_p3_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_p53_BLA_p3_ratio was designed to target transcription factor activity, specifically mapping to TP53 gene(s) using a positive control of Mitomycin C",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_p53_BLA_p3,"TOX21_p53_BLA_p3 is a cell-based, single-readout assay that uses HCT116, a human intestinal cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,intestinal,cell line,,HCT116,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7685.0,101.0,7584.0
702,1325,900,TOX21_p53_BLA_p4_ratio,1,1,"Data from the assay component TOX21_p53_BLA_p4_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p4_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.",ratio,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,8306,30720,404,TOX21_p53_BLA_p4_ratio,TOX21_p53_BLA_p4_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1)reporter gene substrate used as the measure of target activity.,"TOX21_p53_BLA_p4_ratio was designed to target transcription factor activity, specifically mapping to TP53 gene(s) using a positive control of Mitomycin C",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_p53_BLA_p4,"TOX21_p53_BLA_p4 is a cell-based, single-readout assay that uses HCT116, a human intestinal cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,intestinal,cell line,,HCT116,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7606.0,76.0,7530.0
706,1329,904,TOX21_p53_BLA_p5_ratio,1,1,"Data from the assay component TOX21_p53_BLA_p5_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_p53_BLA_p5_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TP53. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity.  To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is tumor suppressor.",ratio,percent_activity,0,Mitomycin C;Nutlin3,gain,pathway,pathway-specified,dna binding,tumor suppressor,0,0,1,8306,30720,405,TOX21_p53_BLA_p5_ratio,TOX21_p53_BLA_p5_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_p53_BLA_p5_ratio was designed to target transcription factor activity, specifically mapping to TP53 gene(s) using a positive control of Mitomycin C",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_p53_BLA_p5,"TOX21_p53_BLA_p5 is a cell-based, single-readout assay that uses HCT116, a human intestinal cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,intestinal,cell line,,HCT116,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7642.0,96.0,7546.0
711,1342,909,TOX21_ESRE_BLA_ratio,1,1,"Data from the assay component TOX21_ESRE_BLA_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ESRE_BLA_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene ATF6.  Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is basic leucine zipper.",ratio,percent_activity,0,17-AAG,gain,pathway,pathway-specified,dna binding,basic leucine zipper,0,0,1,7522,68490,406,TOX21_ESRE_BLA_ratio,TOX21_ESRE_BLA_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_ESRE_BLA_ratio was designed to target transcription factor activity, specifically mapping to ATF6 gene(s) using a positive control of 17-AAG",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_ESRE_BLA,"TOX21_ESRE_BLA is a cell-based, single-readout assay that uses HeLa, a human cervix cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,cervix,cell line,,HeLa,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7262.0,31.0,7231.0
715,1346,913,TOX21_NFkB_BLA_agonist_ratio,1,1,"Data from the assay component TOX21_NFkB_BLA_Agonist_ratio was analyzed into 1 assay endpoint.  This assay endpoint, TOX21_NFkB_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NFKB1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA binding intended target family, where the subfamily is NF-kappa B.",ratio,percent_activity,0,TNFa,gain,pathway,pathway-specified,dna binding,NF-kappa B,0,0,1,7522,68362,407,TOX21_NFkB_BLA_agonist_ratio,TOX21_NFkB_BLA_Agonist_ratio is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"TOX21_NFkB_BLA_Agonist_ratio was designed to target transcription factor activity, specifically mapping to NFKB1 gene(s) using a positive control of TNFa",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_NFkB_BLA_Agonist,"TOX21_NFkB_BLA_Agonist is a cell-based, single-readout assay that uses ME-180, a human cervix cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,cervix,cell line,,ME-180,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7452.0,19.0,7433.0
741,1372,939,Tanguay_ZF_120hpf_MORT,1,1,"Data from the assay component Tanguay_ZF_120hpf_MORT was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_MORT, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2156,409,Tanguay_ZF_120hpf_MORT,Tanguay_ZF_120hpf_Mort  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_Mort assay. It is designed to make measurements of mortality as detected with brightfield microscopy of developing zebrafish embryos.,Mortality is measured by light microscopic examination of developing zebrafish embryos.,multiple,viability reporter,embryonic mortality,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,embryonic mortality,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1002.0,53.0,949.0
742,1373,940,Tanguay_ZF_120hpf_YSE,1,1,"Data from the assay component Tanguay_ZF_120hpf_YSE was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_YSE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_YSE,Tanguay_ZF_120hpf_YSE  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_YSE assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,extraembryonic membrane development,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1018.0,79.0,939.0
743,1374,941,Tanguay_ZF_120hpf_AXIS,1,1,"Data from the assay component Tanguay_ZF_120hpf_AXIS was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_AXIS, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_AXIS,Tanguay_ZF_120hpf_AXIS  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_AXIS assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,body axis morphogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1026.0,81.0,945.0
744,1375,942,Tanguay_ZF_120hpf_EYE,1,1,"Data from the assay component Tanguay_ZF_120hpf_EYE was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_EYE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_EYE,Tanguay_ZF_120hpf_EYE  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_EYE assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,embryonic eye development,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1030.0,54.0,976.0
745,1376,943,Tanguay_ZF_120hpf_SNOU,1,1,"Data from the assay component Tanguay_ZF_120hpf_SNOU was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_SNOU, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_SNOU,Tanguay_ZF_120hpf_SNOU  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_SNOU assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,embryonic snout morphogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1017.0,69.0,948.0
746,1377,944,Tanguay_ZF_120hpf_JAW,1,1,"Data from the assay component Tanguay_ZF_120hpf_JAW was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_JAW, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_JAW,Tanguay_ZF_120hpf_JAW  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_JAW assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,embryonic jaw development,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1011.0,62.0,949.0
747,1378,945,Tanguay_ZF_120hpf_OTIC,1,1,"Data from the assay component Tanguay_ZF_120hpf_OTIC was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_OTIC, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_OTIC,Tanguay_ZF_120hpf_OTIC  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_OTIC assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,otic vesicle morphogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1045.0,30.0,1015.0
748,1379,946,Tanguay_ZF_120hpf_PE,1,1,"Data from the assay component Tanguay_ZF_120hpf_PE was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_PE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_PE,Tanguay_ZF_120hpf_PE  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_PE assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,embryonic morphogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1008.0,68.0,940.0
749,1380,947,Tanguay_ZF_120hpf_BRAI,1,1,"Data from the assay component Tanguay_ZF_120hpf_BRAI was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_BRAI, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_BRAI,Tanguay_ZF_120hpf_BRAI  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_BRAI assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,brain morphogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1040.0,47.0,993.0
750,1381,948,Tanguay_ZF_120hpf_SOMI,1,1,"Data from the assay component Tanguay_ZF_120hpf_SOMI was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_SOMI, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_SOMI,Tanguay_ZF_120hpf_SOMI  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_SOMI assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,somitogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1045.0,24.0,1021.0
751,1382,949,Tanguay_ZF_120hpf_PFIN,1,1,"Data from the assay component Tanguay_ZF_120hpf_PFIN was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_PFIN, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_PFIN,Tanguay_ZF_120hpf_PFIN  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_PFIN assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,pectoral fin morphogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1042.0,36.0,1006.0
752,1383,950,Tanguay_ZF_120hpf_CFIN,1,1,"Data from the assay component Tanguay_ZF_120hpf_CFIN was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_CFIN, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_CFIN,Tanguay_ZF_120hpf_CFIN  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_CFIN assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,caudal fin morphogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1035.0,31.0,1004.0
753,1384,951,Tanguay_ZF_120hpf_PIG,1,1,"Data from the assay component Tanguay_ZF_120hpf_PIG was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_PIG, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_PIG,Tanguay_ZF_120hpf_PIG  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_PIG assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,embryonic pigmentation,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1044.0,33.0,1011.0
754,1385,952,Tanguay_ZF_120hpf_CIRC,1,1,"Data from the assay component Tanguay_ZF_120hpf_CIRC was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_CIRC, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_CIRC,Tanguay_ZF_120hpf_CIRC  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_CIRC assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,angiogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1048.0,11.0,1037.0
755,1386,953,Tanguay_ZF_120hpf_TRUN,1,1,"Data from the assay component Tanguay_ZF_120hpf_TRUN was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_TRUN, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_TRUN,Tanguay_ZF_120hpf_TRUN  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_TRUN assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,embryonic morphogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1033.0,39.0,994.0
756,1387,954,Tanguay_ZF_120hpf_SWIM,1,1,"Data from the assay component Tanguay_ZF_120hpf_SWIM was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_SWIM, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_SWIM,Tanguay_ZF_120hpf_SWIM  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_SWIM assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,swim bladder morphogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1043.0,20.0,1023.0
757,1388,955,Tanguay_ZF_120hpf_NC,1,1,"Data from the assay component Tanguay_ZF_120hpf_NC was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_NC, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_NC,Tanguay_ZF_120hpf_NC  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_NC assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,embryonic notochord morphogenesis,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1054.0,12.0,1042.0
758,1389,956,Tanguay_ZF_120hpf_TR,1,1,"Data from the assay component Tanguay_ZF_120hpf_TR was analyzed into 1 assay endpoints. This assay endpoint, Tanguay_ZF_120hpf_TR, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defects as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the MALFORMATION intended target family, where the subfamily is TOTAL.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,,0,0,1,1061,2154,409,Tanguay_ZF_120hpf_TR,Tanguay_ZF_120hpf_TR  is one of one assay component(s) measured or calculated from the Tanguay_ZF_120hpf_TR assay. It is designed to make measurements of morphology as detected with brightfield microscopy of developing zebrafish embryos.,Morphology is measured by light microscopic examination of developing zebrafish embryos.,multiple,morphology reporter,anatomical entity,regulation of morphogenesis,Microscopy,Optical microscopy,light microscopy,,,embryonic development,embryonic functional response,13,Tanguay_ZF_120hpf,"Tanguay_ZF_120hpf is a whole embryo, multiplexed endpoint assay using zebrafish larvae exposed for 120 hr",120.0,7955.0,zebrafish,ova,whole embryo,,dechorionated zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.7,Selected assays,1029.0,54.0,975.0
761,1394,959,LTEA_HepaRG_SLC10A1,1,1,"Data from the assay component LTEA_HepaRG_SLC10A1 was analyzed into 1 endpoint. This assay endpoint, LTEA_HepaRG_SLC10A1, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, measures of mRNA induction for gain or loss-of-signal activity can be used to understand regulation of transcription factor activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is sodium/bile acid cotransporter.",reporter gene,log2_fold_induction,0,,bidirectional,rna,mRNA,transporter,sodium/bile acid cotransporter,0,0,1,97,326,371,LTEA_HepaRG_SLC10A1,LTEA_HepaRG_SLC10A1 is one of 102 assay component(s) measured in the LTEA HepaRG cell culture assay. It is a marker of NR mediated transport.,Metabolically-competent HepaRG cell cultures were exposed to a chemical for 48 hours before cytotoxicty (LDH) and alterations in transcription were assessed.,single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Fluidigm qRT-PCR,,,rna,mRNA,9,LTEA_HepaRG,"LTEA_HepaRG is a cell based, multiplexed-readout assay that uses HepaRG, a human liver cell line, with measurements taken at 48 hours after chemical dosing on a 96-well plate.",48.0,9606.0,human,liver,cell line,,HepaRG,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.5,Selected assays,82.0,30.0,52.0
764,1507,962,CCTE_Padilla_ZF_144hpf_TERATOSCORE,1,1,"Data from the assay component CCTE_Padilla_ZF_144hpf_TERATOSCORE was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Padilla_ZF_144hpf_TERATOSCORE, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphological reporter, gain-of-signal activity can be used to understand changes in  developmental defect  as they relate to the whole embryo. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the malformation intended target family, where the subfamily is total.",developmental defect,percent_activity,0,,gain,organism,malformation,malformation,total,0,0,1,723,3581,410,CCTE_Padilla_ZF_144hpf_TERATOSCORE,CCTE_Padilla_ZF_144hpf_TERATOSCORE is one of one assay component(s) measured or calculated from the CCTE_Padilla_ZF_144hpf assay. It is designed to make measurements of developmental malformations and mortality as detected with brightfield microscopy.,"Individual embryos were examined daily for malformations, failure to hatch and mortality. Results were scored by customized rubric and a composite score derived.",multiple,morphology reporter,embryo development,regulation of development,Microscopy,Optical microscopy,light microscopy,,,embryonic development,physical feature,12,CCTE_Padilla_ZF_144hpf,Zebrafish embryos were exposed to chemicals starting 6 hr post-fertilization for 5 days in 96-well plates. Developing larvae were examined microscopically daily for malformation and mortality. ,144.0,7955.0,zebrafish,ova,whole embryo,,zebrafish embryo,suspension,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.4,Selected assays,517.0,298.0,219.0
771,1615,842,CLD_CYP1A1_6hr,1,1,"Data from the assay component CLD_CYP1A1_6hr was analyzed at the endpoint, CLD_CYP1A1_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,337,399,CLD_CYP1A1_6hr,"CLD_CYP1A1_6hr is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP1A1 qNPA probes,rna,mRNA,11,CLD_6hr,"CLD_6hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 6 hours after chemical dosing in a 96-well plate.",6.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,251.0,91.0,160.0
772,1616,843,CLD_CYP1A2_6hr,1,1,"Data from the assay component CLD_CYP1A2_6hr was analyzed at the endpoint, CLD_CYP1A2_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,337,399,CLD_CYP1A2_6hr,"CLD_CYP1A2_6hr is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP1A2 qNPA probes,rna,mRNA,11,CLD_6hr,"CLD_6hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 6 hours after chemical dosing in a 96-well plate.",6.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,276.0,54.0,222.0
773,1617,844,CLD_CYP2B6_6hr,1,1,"Data from the assay component CLD_CYP2B6_6hr was analyzed at the endpoint, CLD_CYP2B6_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,337,399,CLD_CYP2B6_6hr,"CLD_CYP2B6_6hr is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP2B6 qNPA probes,rna,mRNA,11,CLD_6hr,"CLD_6hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 6 hours after chemical dosing in a 96-well plate.",6.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,262.0,128.0,134.0
776,1620,847,CLD_CYP3A4_6hr,1,1,"Data from the assay component CLD_CYP3A4_6hr was analyzed at the endpoint, CLD_CYP3A4_6hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,300,399,CLD_CYP3A4_6hr,"CLD_CYP3A4_6hr is one of 16 assay component(s) measured or calculated from the CLD_6hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP3A4 qNPA probes,rna,mRNA,11,CLD_6hr,"CLD_6hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 6 hours after chemical dosing in a 96-well plate.",6.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,268.0,47.0,221.0
783,1627,854,CLD_ABCB1_24hr,1,1,"Data from the assay component CLD_ABCB1_24hr was analyzed at the endpoint, CLD_ABCB1_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCB1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,345,400,CLD_ABCB1_24hr,"CLD_ABCB1_24hr is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,ABCB1 qNPA probes,rna,mRNA,11,CLD_24hr,"CLD_24hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,296.0,11.0,285.0
787,1631,858,CLD_CYP1A1_24hr,1,1,"Data from the assay component CLD_CYP1A1_24hr was analyzed at the endpoint, CLD_CYP1A1_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,309,400,CLD_CYP1A1_24hr,"CLD_CYP1A1_24hr is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP1A1 qNPA probes,rna,mRNA,11,CLD_24hr,"CLD_24hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,251.0,108.0,143.0
788,1632,859,CLD_CYP1A2_24hr,1,1,"Data from the assay component CLD_CYP1A2_24hr was analyzed at the endpoint, CLD_CYP1A2_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,345,400,CLD_CYP1A2_24hr,"CLD_CYP1A2_24hr is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP1A2 qNPA probes,rna,mRNA,11,CLD_24hr,"CLD_24hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,256.0,101.0,155.0
789,1633,860,CLD_CYP2B6_24hr,1,1,"Data from the assay component CLD_CYP2B6_24hr was analyzed at the endpoint, CLD_CYP2B6_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,342,400,CLD_CYP2B6_24hr,"CLD_CYP2B6_24hr is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP2B6 qNPA probes,rna,mRNA,11,CLD_24hr,"CLD_24hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,259.0,117.0,142.0
792,1636,863,CLD_CYP3A4_24hr,1,1,"Data from the assay component CLD_CYP3A4_24hr was analyzed at the endpoint, CLD_CYP3A4_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,289,400,CLD_CYP3A4_24hr,"CLD_CYP3A4_24hr is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP3A4 qNPA probes,rna,mRNA,11,CLD_24hr,"CLD_24hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,259.0,113.0,146.0
797,1641,868,CLD_SULT2A_24hr,1,1,"Data from the assay component CLD_SULT2A_24hr was analyzed at the endpoint, CLD_SULT2A_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SULT2A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is sulfotransferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,sulfotransferase,0,0,1,310,343,400,CLD_SULT2A_24hr,"CLD_SULT2A_24hr is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,SULT2A1 qNPA probes,rna,mRNA,11,CLD_24hr,"CLD_24hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,285.0,22.0,263.0
798,1642,869,CLD_UGT1A1_24hr,1,1,"Data from the assay component CLD_UGT1A1_24hr was analyzed at the endpoint, CLD_UGT1A1_24hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene UGT1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is glucuronosyltransferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,glucuronosyltransferase,0,0,1,310,345,400,CLD_UGT1A1_24hr,"CLD_UGT1A1_24hr is one of 16 assay component(s) measured or calculated from the CLD_24hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,UGT1A1 qNPA probes,rna,mRNA,11,CLD_24hr,"CLD_24hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,280.0,26.0,254.0
799,1643,870,CLD_ABCB1_48hr,1,1,"Data from the assay component CLD_ABCB1_48hr was analyzed at the endpoint, CLD_ABCB1_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCB1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,349,401,CLD_ABCB1_48hr,"CLD_ABCB1_48hr is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,ABCB1 qNPA probes,rna,mRNA,11,CLD_48hr,"CLD_48hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,304.0,12.0,292.0
801,1645,872,CLD_ABCG2_48hr,1,1,"Data from the assay component CLD_ABCG2_48hr was analyzed at the endpoint, CLD_ABCG2_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ABCG2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where subfamily is ABC transporter.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transporter,ABC transporter,0,0,1,310,349,401,CLD_ABCG2_48hr,"CLD_ABCG2_48hr is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,ABCG2 qNPA probes,rna,mRNA,11,CLD_48hr,"CLD_48hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,297.0,12.0,285.0
803,1647,874,CLD_CYP1A1_48hr,1,1,"Data from the assay component CLD_CYP1A1_48hr was analyzed at the endpoint, CLD_CYP1A1_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,303,401,CLD_CYP1A1_48hr,"CLD_CYP1A1_48hr is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP1A1 qNPA probes,rna,mRNA,11,CLD_48hr,"CLD_48hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,263.0,98.0,165.0
804,1648,875,CLD_CYP1A2_48hr,1,1,"Data from the assay component CLD_CYP1A2_48hr was analyzed at the endpoint, CLD_CYP1A2_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP1A2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,317,401,CLD_CYP1A2_48hr,"CLD_CYP1A2_48hr is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP1A2 qNPA probes,rna,mRNA,11,CLD_48hr,"CLD_48hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,267.0,111.0,156.0
805,1649,876,CLD_CYP2B6_48hr,1,1,"Data from the assay component CLD_CYP2B6_48hr was analyzed at the endpoint, CLD_CYP2B6_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP2B6. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,342,401,CLD_CYP2B6_48hr,"CLD_CYP2B6_48hr is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP2B6 qNPA probes,rna,mRNA,11,CLD_48hr,"CLD_48hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,259.0,113.0,146.0
808,1652,879,CLD_CYP3A4_48hr,1,1,"Data from the assay component CLD_CYP3A4_48hr was analyzed at the endpoint, CLD_CYP3A4_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene CYP3A4. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cyp intended target family, where subfamily is xenobiotic metabolism.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,cyp,xenobiotic metabolism,0,0,1,310,225,401,CLD_CYP3A4_48hr,"CLD_CYP3A4_48hr is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,CYP3A4 qNPA probes,rna,mRNA,11,CLD_48hr,"CLD_48hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,253.0,116.0,137.0
810,1654,881,CLD_GSTA2_48hr,1,1,"Data from the assay component CLD_GSTA2_48hr was analyzed at the endpoint, CLD_GSTA2_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GSTA2. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is alkyl and aryl transferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,alkyl and aryl transferase,0,0,1,310,343,401,CLD_GSTA2_48hr,"CLD_GSTA2_48hr is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,GSTA2 qNPA probes,rna,mRNA,11,CLD_48hr,"CLD_48hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,291.0,18.0,273.0
813,1657,884,CLD_SULT2A_48hr,1,1,"Data from the assay component CLD_SULT2A_48hr was analyzed at the endpoint, CLD_SULT2A_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene SULT2A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is sulfotransferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,sulfotransferase,0,0,1,310,349,401,CLD_SULT2A_48hr,"CLD_SULT2A_48hr is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,SULT2A1 qNPA probes,rna,mRNA,11,CLD_48hr,"CLD_48hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,281.0,22.0,259.0
814,1658,885,CLD_UGT1A1_48hr,1,1,"Data from the assay component CLD_UGT1A1_48hr was analyzed at the endpoint, CLD_UGT1A1_48hr, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene UGT1A1. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transferase intended target family, where subfamily is glucuronosyltransferase.",reporter gene,log2_fold_induction,0,,gain,rna,mRNA,transferase,glucuronosyltransferase,0,0,1,310,349,401,CLD_UGT1A1_48hr,"CLD_UGT1A1_48hr is one of 16 assay component(s) measured or calculated from the CLD_48hr assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with chemiluminescence signals by Quantitative Nuclease Protection Assay (qNPA) technology.",,single,inducible reporter,mRNA induction,,Luminescence,Chemiluminescence,Quantitative Nuclease Protection Assay (qNPA),coupled substrate,UGT1A1 qNPA probes,rna,mRNA,11,CLD_48hr,"CLD_48hr is a cell-based, multiplexed-readout assay that uses hepatocyte, a human liver primary cell, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,liver,primary cell,,hepatocyte,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,284.0,38.0,246.0
815,1659,1013,TOX21_RAR_LUC_Agonist,1,1,"Data from the assay component TOX21_RAR_LUC_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RAR_LUC_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RARA. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",agonist,percent_activity,0,Retinol,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,7522,68362,425,TOX21_RAR_LUC_Agonist,"TOX21_RAR_LUC_Agonist is one of one assay component(s) measured or calculated from the TOX21_RAR_LUC_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology",TOX21_RAR_LUC_Agonist was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human retinoic acid receptor alpha  [GeneSymbol:RARA],single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_RAR_LUC_Agonist,"TOX21_RAR_LUC_Agonist is a cell-based, single-readout assay that uses C3H10T1/2, a mouse sarcoma cell line, with measurements taken at 6 hours after chemical dosing in a 1536-well plate.",6.0,10090.0,mouse,embryo,cell line,,C3H10T1/2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7234.0,87.0,7147.0
817,1661,1015,TOX21_RORg_LUC_CHO_Antagonist,1,1,"Data from the assay component TOX21_RORg_LUC_CHO_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RORg_LUC_CHO_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1F3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",antagonist,percent_activity,0,TO-901317,loss,protein,receptor,nuclear receptor,orphan,0,0,1,7872,52522,426,TOX21_RORg_LUC_CHO_Antagonist,"TOX21_RORg_LUC_CHO_Antagonist is one of one assay component(s) measured or calculated from the TOX21_RORg_LUC_CHO_Antagonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology",TOX21_RORg_LUC_CHO_Antagonist was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human retinoid-related orphan receptor gamma  [GeneSymbol:NR1F3],single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_RORg_LUC_CHO_Antagonist,"TOX21_RORg_LUC_CHO_Antagonist is a cell-based, single-readout assay that uses CHO-K1, a chinese hamster ovary cell line, with measurements taken at 17 hours after chemical dosing in a 1536-well plate.",17.0,10029.0,chinese hamster,ovary,cell line,,CHO-K1,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,7300.0,405.0,6895.0
820,1682,1027,STM_H9_CystineISnorm_perc,1,1,"Data from the assay component STM_H9_CystineISnorm_perc was analyzed at the assay endpoint STM_H9_CystineISnorm_perc in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand relative metabolite change.",relative metabolite change,log2_fold_induction,0,Methotrexate,bidirectional,protein,secretome metabolite,metabolite,Cystine,0,0,1,380,3509,428,STM_H9_CystineISnorm_perc,STM_H9_CystineISnorm_perc is one of 10 components calculated in the STM_H9_secretome assay. It measures the integrated area of the endogenous cystine normalized to the spiked-in isotopically labeled standard and to the median value of the 0.1% DMSO neutral control treatment  using UPLC-HRMS technology.,Changes in cystine utilization relative to the neutral control.,single,biochemical reporter,metabolite detection,metabolism,Mass spectrometry,integrated area of the endogenous cystine normalized to the spiked-in isotopically labeled standard normalized the median value of the 0.1% DMSO neutral control treatment ,UPLC-HRMS,substrate,cystine/C13Cystine/DMSO,metabolite,cystine/C13Cystine,14,STM_H9_secretome,"STM_H9_secretome utilizes undifferentiated H9 cells to measure relative changes in two metabolites, ornithine (ORN) and cystine (CYSS) in the secretome, targeting a critical drop in the ORN/CYSS ratio as a biomarker for developmental toxicity.",72.0,9606.0,human,,cell-based,H9 embryonic stem cell line,hESC,monolayer,microplate: 96-well plate,cell-based,cell-based format,metabolomic,DMSO,0.1,Selected assays,300.0,94.0,206.0
821,1688,1030,STM_H9_OrnithineISnorm_perc,1,1,"Data from the assay component STM_H9_OrnithineISnorm_perc was analyzed at the assay endpoint STM_H9_OrnithineISnorm_perc in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand relative metabolite change.",relative metabolite change,log2_fold_induction,0,Methotrexate,bidirectional,protein,secretome metabolite,metabolite,Ornithine,0,0,1,380,2919,428,STM_H9_OrnithineISnorm_perc,STM_H9_OrnithineISnorm is one of 10 components calculated in the STM_H9_secretome assay. It measures the integrated area of the endogenous ornithine normalized to the spiked-in isotopically labeled standard and to the median value of the 0.1% DMSO neutral control treatment using UPLC-HRMS technology.,Changes in ornithine release relative to the neutral control. ,single,biochemical reporter,metabolite detection,metabolism,Mass spectrometry,integrated area of the endogenous ornithine normalized to the spiked-in isotopically labeled standard normalized the median value of the 0.1% DMSO neutral control treatment ,UPLC-HRMS,substrate,Ornithine/C13Ornithine/DMSO,metabolite,ornithine/C13Ornithine,14,STM_H9_secretome,"STM_H9_secretome utilizes undifferentiated H9 cells to measure relative changes in two metabolites, ornithine (ORN) and cystine (CYSS) in the secretome, targeting a critical drop in the ORN/CYSS ratio as a biomarker for developmental toxicity.",72.0,9606.0,human,,cell-based,H9 embryonic stem cell line,hESC,monolayer,microplate: 96-well plate,cell-based,cell-based format,metabolomic,DMSO,0.1,Selected assays,288.0,93.0,195.0
822,1690,1031,STM_H9_OrnCyssISnorm_ratio,1,1,"Data from the assay component STM_H9_OrnCyssISnorm_ratio was analyzed at the assay endpoint STM_H9_OrnCyssISnorm_ratio in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand relative metabolite change.",relative metabolite change,log2_fold_induction,0,Methotrexate,bidirectional,protein,secretome metabolite,metabolite,Ornithine/Cystine,0,0,1,429,2942,428,STM_H9_OrnCyssISnorm_ratio,STM_H9_OrnCyssISnorm_ratio is one of 10 components calculated in the STM_H9_secretome assay. It is the ratio value of OrnISnorm_perc to CyssISnorm_perc.,"Change in the ratio value of Orn release to Cyss utilization, indicative of the targeted biomarker of the assay. ",single,ratiometric,metabolite ratio,metabolism,Mass spectrometry,Orn:Cyss ratio calculated from DMSO-normalized values ,UPLC-HRMS,ratio,ornithine/cystine,metabolite,ornithine/cystine,14,STM_H9_secretome,"STM_H9_secretome utilizes undifferentiated H9 cells to measure relative changes in two metabolites, ornithine (ORN) and cystine (CYSS) in the secretome, targeting a critical drop in the ORN/CYSS ratio as a biomarker for developmental toxicity.",72.0,9606.0,human,,cell-based,H9 embryonic stem cell line,hESC,monolayer,microplate: 96-well plate,cell-based,cell-based format,metabolomic,DMSO,0.1,Selected assays,373.0,177.0,196.0
851,1816,1120,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881,1,1,"Data from the assay component TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity.  Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",antagonist,percent_activity,0,Nilutamide,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52102,441,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881,"TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881 is one of one assay component(s) measured or calculated from the TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals following addition of luciferin substrate and ATP.","Androgen receptor (AR) is an important member of the nuclear receptor family. Its signaling plays a critical role in AR-dependent prostate cancer and other androgen related diseases. Considerable attention has been given in the past decades to develop methods to study and screen for the environmental chemicals that have the potential to interfere with metabolic homeostasis, reproduction, developmental and behavioral functions. Changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo] are indicative of changes in transcriptional gene expression due to antagonist activity regulated by the human androgen receptor [GeneSymbol:AR | GeneID:367 | Uniprot_SwissProt_Accession:P10275].",single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881,"TOX21_AR_LUC_MDAKB2_Antagonist_0.5nM_R1881 is a cell-based, single-readout assay that uses MDA-kb2, a human breast cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate. ",24.0,9606.0,human,breast,cell line,,MDA-kb2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,6983.0,731.0,6252.0
855,1820,1124,TOX21_RXR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_RXR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RXR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where subfamily is NF-kappa B.",ratio,percent_activity,0,9-cis-Retinoic acid,gain,pathway,pathway-specified,dna binding,NF-kappa B,0,0,1,7872,52248,442,TOX21_RXR_BLA_Agonist_ratio,TOX21_RXR_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity. ,"TOX21_RXR_BLA_Agonist_ratio was designed to target nuclear receptor  activity at the protein (receptor) level, specifically mapping to RXRA gene(s) using a positive control of 9-cis-Retinoic acid",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_RXR_BLA_Agonist,"TOX21_RXR_BLA_Agonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,6699.0,147.0,6552.0
857,1822,1126,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide,1,1,"Data from the assay component TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",agonist,percent_activity,0,R1881,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52650,443,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide,"TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide is one of one assay component(s) measured or calculated from the TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signal following addition of luciferin substrate and ATP.",TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo] in the presence of an AR agonist. Changes are indicative of  transcriptional gene expression that may not be due to direct regulation by the human androgen receptor [GeneSymbol: NR3C4 | GeneID: NR3C4 | Uniprot_SwissProt_Accession:].,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide,"TOX21_AR_LUC_MDAKB2_Agonist_3uM_Nilutamide is a cell-based, single-readout assay that uses MDA-kb2, a human breast cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate. This is an secondary assay to TOX21_AR_LUC_MDAKB2_Agonist for agonist specificity. This particular screening for measuring luciferase reporter gene activity using MDA-kb2 cells against Tox21 10K library compounds is a confirmation study on agonist mode screening in the presence of AR-antagonist compound (Nilutamide) at 3.0uM final concentration. ",24.0,9606.0,human,breast,cell line,,MDA-kb2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7770.0,131.0,7639.0
862,1827,1131,ArunA_Migration_hNP,1,1,"Data from the assay component ArunA_Migration_hNP was analyzed at the endpoint, ArunA_Migration_hNP, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of distribution reporter, loss-of-signal activity can be used to understand the cell migration. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is migration.",developmental,log2_fold_induction,0,cytochalasin D,loss,cellular,migration,neurodevelopment,migration,0,0,1,59,401,447,ArunA_Migration_hNP,"ArunA_Migration_hNP is an assay component measured from the ArunA_Migration_hNP assay. It is designed to make measurements of  cell migration, a form of distribution reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology. ",Changes in fluorescence intensity related to Ki-67 expression is indicative of the cell migration.,single,distribution reporter,cell migration,neurovascular unit NVU development (neurogenic outcomes),Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,Calcein-AM,protein,Ki-67,16,ArunA_Migration_hNP,"ArunA_Migration_hNP is a cell-based, single-readout assay that uses human H9-derived neuroprogenitor stem cells (hNP1). Measurements were taken 72 hours after chemical dosing in a 96-well plate.",72.0,9606.0,human,H9-derived neuroprogenitor stem cells,cell line,,hNP1,adherent,microplate: 96-well plate,cell-based,cell-based format,single,DMSO,0.1,Selected assays,55.0,15.0,40.0
864,1831,1133,ArunA_NOG_NucleusCount,1,1,"Data from the assay component ArunA_NOG_NucleusCount was analyzed at the endpoint, ArunA_NOG_NucleusCount, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neurite outgrowth.",developmental,log2_fold_induction,0,,loss,cellular,nucleus,cell cycle,cell count,0,0,1,59,240,449,ArunA_NOG_NucleusCount,"ArunA_NOG_NucleusCount is an assay component measured from the ArunA_NOG assay. It is designed to make measurements of  viability related to the number of neurons, using a form of viability reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology. ","Changes in fluorescence intensity related to the number of Hoechst 33,258 labelled nuceli is indicative of the viability of the system.",single,morphology reporter,cell viability,neurovascular unit NVU development (neurogenic outcomes),Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,Hoechst-33258 dye,cellular,labelled nuclei,16,ArunA_NOG,"ArunA_NOG (Neurite Outgrowth) is a cell-based, image-based assay that uses human H9-derived embryonic differentiated neurons (hNN). Measurements were taken 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,H9-derived embryonic differentiated neurons,cell line,,hNN,adherent,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.1,Selected assays,52.0,11.0,41.0
867,1838,1136,ArunA_NOG_BranchPointsPerNeurite,1,1,"Data from the assay component ArunA_NOG_BranchPointsPerNeurite was analyzed at the endpoint, ArunA_NOG_BranchPointsPerNeurite, with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neurite outgrowth.",developmental,log2_fold_induction,0,,gain,cellular,morphology,neurodevelopment,neurite outgrowth,0,0,1,59,240,449,ArunA_NOG_BranchPointsPerNeurite,"ArunA_NOG_BranchPointsPerNeurite is an assay component measured from the ArunA_NOG assay. It is designed to make measurements of  neurite outgrowth related to branch points per neurite, using a form of morphology reporter, as detected with fluorescence intensity signals by HCS Fluorescent Imaging technology. ",Changes in fluorescence intensity related to bIII-tubulin/DyLight1 488 antibody labelling is indicative of the neurite outgrowth.,multiple,morphology reporter,neurite outgrowth,neurovascular unit NVU development (neurogenic outcomes),Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,antibody,bIII-tubulin/DyLight1 488 antibody,cellular,branch points per neurite,16,ArunA_NOG,"ArunA_NOG (Neurite Outgrowth) is a cell-based, image-based assay that uses human H9-derived embryonic differentiated neurons (hNN). Measurements were taken 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,H9-derived embryonic differentiated neurons,cell line,,hNN,adherent,microplate: 96-well plate,cell-based,cell-based format,image-based,DMSO,0.1,Selected assays,57.0,10.0,47.0
868,1839,1137,TOX21_RAR_LUC_Antagonist,1,1,"Data from the assay component TOX21_RAR_LUC_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_RAR_LUC_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RARA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where subfamily is non-steroidal.",antagonist,percent_activity,0,ER50891,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,7872,52650,450,TOX21_RAR_LUC_Antagonist,"TOX21_RAR_LUC_Antagonist is one of one assay component(s) measured or calculated from the TOX21_RAR_LUC_Antagonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology",TOX21_RAR_LUC_Antagonist was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human retinoic acid receptor alpha  [GeneSymbol:RARA],single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_RAR_LUC_Antagonist,"TOX21_RAR_LUC_Antagonist is a cell-based, single-readout assay that uses C3H10T1/2, a mouse sarcoma cell line, with measurements taken at 6 hours after chemical dosing in a 1536-well plate.",6.0,10090.0,mouse,embryo,cell line,,C3H10T1/2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.0,Selected assays,6828.0,421.0,6407.0
872,1843,1141,TOX21_H2AX_HTRF_CHO_Agonist_ratio,1,1,"Data from the assay component TOX21_H2AX_HTRF_CHO_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_H2AX_HTRF_CHO_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene H2AFX. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is histone.",ratio,percent_activity,0,Etoposide,gain,pathway,pathway-specified,dna binding,histone H2A,0,0,1,7872,52650,451,TOX21_H2AX_HTRF_CHO_Agonist_ratio,TOX21_H2AX_HTRF_CHO_Agonist_ratio is an assay readout measuring protein phosphorylation and designed using homogenous time resolved fluorescence between two labled antibodies. The signal is derived from the  the ratio of acceptor (d2)-conjugated antibody emission (ch2) to donor (Europium-cryptate)-conjugated antibody emission (ch1) used as the measure of target activity. ,"TOX21_H2AX_HTRF_CHO_Agonist_ratio  was designed to target protein phosphorylation, specifically mapping to H2AFX gene(s) using a positive control of Etoposide",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Homogeneous Time Resolved Fluorescence,substrate,CCF4-AM,protein,receptor,7,TOX21_H2AX_HTRF_CHO_Agonist,"TOX21_H2AX_HTRF_CHO_Agonist is a cell-based, single-readout assay that uses CHO-K1, a chinese hamster ovary cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,10029.0,chinese hamster,ovary,cell line,,CHO-K1,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7529.0,172.0,7357.0
875,1846,1144,TOX21_AP1_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_AP1_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_AP1_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene JUN|FOS|JUN. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is basic leucine zipper.",ratio,percent_activity,0,EGF,gain,protein,transcription factor,dna binding,basic leucine zipper,0,0,1,7872,52650,452,TOX21_AP1_BLA_Agonist_ratio,TOX21_AP1_BLA_Agonist_ratio is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity. ,"TOX21_AP1_BLA_Agonist_ratio was designed to target transcription factor activity, specifically mapping to JUN gene(s) using a positive control of EGF",multiple,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_AP1_BLA_Agonist,"TOX21_AP1_BLA_Agonist is a cell-based, single-readout assay that uses ME-180, a human cervix cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,cervix,cell line,,ME-180,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7158.0,294.0,6864.0
880,1854,534,TOX21_MMP_ratio,1,1,"Data from the assay component TOX21_MMP_ratio was analyzed into 1 assay endpoint. The assay endpoin, TOX21_MMP_ratio, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of membrane potential reporter, gain-of-signal activity can be used to understand changes in the signaling. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell morphology intended target family, where the subfamily is organelle conformation.",signaling,percent_activity,0,FCCP,gain,cellular,mitochondria,cell morphology,organelle conformation,0,0,1,8305,91022,324,TOX21_MMP_ratio,"TOX21_MMP_ratio is one of 2 assay component(s) measured or calculated from the TOX21_MMP assay. It is designed to make measurements of dye binding, a form of membrane potential reporter, as detected with fluorescence intensity signals by homogenous mitochondrial membrane potential assay technology.",Mito-MPS is used as a stain for the membrane potential of the mitochondria.,multiple,membrane potential reporter,dye binding,mitochondrial depolarization,Fluorescence,Fluorescence intensity,homogenous mitochondrial membrane potential assay,stain,Mito-MPS,cellular,mitochondria,7,TOX21_MMP,"TOX21_MMP (Mitochondrial Membrane Potential) is a cell-based, single-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,7444.0,71.0,7373.0
881,1855,1829,ACEA_AR_agonist_80hr,1,1,"Data from the assay component ACEA_AR_agonist_80hr was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 
Using a type of growth reporter, measures of the cells for gain-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the geneAR 
Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. 
To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",signaling,percent_activity,0,testosterone,gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1831,16305,533,ACEA_AR_agonist_80hr,"ACEA_AR_agonist_80hr is one of two assay component(s) measured or calculated from the ACEA_AR assay. It is designed to make measurements of real-time cell-growth kinetics, a form of growth reporter, as detected with electrical impedance signals by Real-Time Cell Electrode Sensor (RT-CES) technology.",Electrical impedance is used to quantify changes to the growth of the cells where increase impedance is positively correlated with increased cell growth,single,growth reporter,real-time cell-growth kinetics,cell proliferation,Label Free Technology,Electrical Sensor: Impedance,RT-CES,,,cellular,cellular,1,ACEA_AR_agonist,"ACEA_AR_agonist is a cell-based, single-readout assay that uses 22Rv1, a human prostate cancer cell line, with measurements taken at 80 hours after chemical dosing in a 96-well or 384-well plate.",80.0,9606.0,human,prostate,cell line,,22Rv1,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,1742.0,35.0,1707.0
882,1856,1830,ACEA_AR_antagonist_80hr,1,1,"Data from the assay component ACEA_AR_antagonist_80hr was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of growth reporter, measures of the cells for loss-of-signal activity can be used to understand the signaling at the pathway-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a signaling function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",signaling,log2_fold_induction,0,,loss,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1836,16476,534,ACEA_AR_antagonist_80hr,"ACEA_AR_antagonist_80hr is one of two assay component(s) measured or calculated from the ACEA_AR assay. It is designed to make measurements of real-time cell-growth kinetics, a form of growth reporter, as detected with electrical impedance signals by Real-Time Cell Electrode Sensor (RT-CES) technology.",Electrical impedance is used to quantify changes to the growth of the cells where increase impedance is positively correlated with increased cell growth,single,growth reporter,real-time cell-growth kinetics,cell proliferation,Label Free Technology,Electrical Sensor: Impedance,RT-CES,,,cellular,cellular,1,ACEA_AR_antagonist,"ACEA_AR_antagonist is a cell-based, single-readout assay that uses 22Rv1, a human prostate cancer cell line, with measurements taken at 80 hours after chemical dosing in a 96-well or 384-well plate.",80.0,9606.0,human,prostate,cell line,,22Rv1,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,1573.0,142.0,1431.0
884,1858,1114,STM_H9_NormalizedViability,1,1,"Data from the assay component STM_H9_Viability was analyzed at the assay endpoint STM_H9_Viability_Norm in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand viability.",viability,percent_activity,0,,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,429,3951,437,STM_H9_NormalizedViability,STM_H9_NormalizedViability is a component calculated in the STM_H9_viability assay. It measures cell viability using  background corrected relative fluorescence units (RFU) value from the CellTiterFluor Assay normalized to the value of the 0.1% DMSO neutral control treatment (by 96-well plate),Changes in fluorescence are indicative of changes in cell viability. ,single,viability reporter,cell viability,cell viability,Fluorescence,fluorescent signal proportional to the number of living cells,CellTiter-FluorTM,substrate,fluorescent signal,cellular,living cells,14,STM_H9_viability,STM_H9_viability utilizes undifferentiated H9 cells to measure cell viability.,72.0,9606.0,human,,cell-based,H9 embryonic stem cell line,hESC,monolayer,microplate: 96-well plate,cell-based,cell-based format,metabolomic,DMSO,0.1,Selected assays,427.0,138.0,289.0
890,1923,1861,ATG_frER1_XSP1,1,1,"The assay endpoint ATG_frER1_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48,569,ATG_frER1_XSP1,"ATG_frER1_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the frog estrogen receptor. [GeneSymbol:esr1.L | GeneID: 398734 | Uniprot_SwissProt_Accession:Q6W5G7].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-frER1 RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,80.0,32.0,48.0
891,1925,1862,ATG_zfER1_XSP1,1,1,"The assay endpoint ATG_zfER1_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48,569,ATG_zfER1_XSP1,"ATG_zfER1_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the zebrafish estrogen receptor. [GeneSymbol:esr1 | GeneID: 259252| Uniprot_SwissProt_Accession:P57717].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-zfER1 RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,76.0,16.0,60.0
892,1927,1863,ATG_zfER2a_XSP1,1,1,"The assay endpoint ATG_zfER2a_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48,569,ATG_zfER2a_XSP1,"ATG_zfER2a_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the zebrafish estrogen receptor. [GeneSymbol:esr2a | GeneID: 317734| Uniprot_SwissProt_Accession:Q7ZU32].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-zfER2a RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,76.0,21.0,55.0
893,1929,1864,ATG_zfER2b_XSP1,1,1,"The assay endpoint ATG_zfER2b_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48,569,ATG_zfER2b_XSP1,"ATG_zfER2b_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the zebrafish estrogen receptor. [GeneSymbol:esr2b | GeneID: 317733| Uniprot_SwissProt_Accession:Q5PR29].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-zfER2b RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,66.0,47.0,19.0
894,1931,1865,ATG_frER2_XSP1,1,1,"The assay endpoint ATG_frER2_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48,569,ATG_frER2_XSP1,"ATG_frER2_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the frog estrogen receptor. [GeneSymbol:esr2.L | GeneID: 100174814| Uniprot_SwissProt_Accession:A0A1L8FA50].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-frER2 RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,67.0,41.0,26.0
895,1933,1866,ATG_chERa_XSP1,1,1,"The assay endpoint ATG_chERa_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48,569,ATG_chERa_XSP1,"ATG_chERa_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the chicken estrogen receptor. [GeneSymbol:ESR1 | GeneID: 396099| Uniprot_SwissProt_Accession:P06212].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-chERa RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,81.0,37.0,44.0
896,1935,1867,ATG_hERa_XSP1,1,1,"The assay endpoint ATG_hERa_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48,569,ATG_hERa_XSP1,"ATG_hERa_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the human estrogen receptor. [GeneSymbol:ESR1 | GeneID: 2099| Uniprot_SwissProt_Accession:P03372].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-ERa RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,74.0,35.0,39.0
897,1937,1868,ATG_trERa_XSP1,1,1,"The assay endpoint ATG_trERa_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48,569,ATG_trERa_XSP1,"ATG_trERa_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the turtle estrogen receptor. [GeneSymbol:ESR1 | GeneID: 101933533| Uniprot_SwissProt_Accession:B6E1V9].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-trERa RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,68.0,41.0,27.0
898,1939,1869,ATG_hERb_XSP1,1,1,"The assay endpoint ATG_hERb_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,99,48,569,ATG_hERb_XSP1,"ATG_hERb_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the human estrogen receptor. [GeneSymbol:ESR2 | GeneID: 2100| Uniprot_SwissProt_Accession:Q92731].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-ERb RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,81.0,25.0,56.0
904,1951,1875,ATG_hPPARg_XSP1,1,1,"The assay endpoint ATG_hPPARg_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48,569,ATG_hPPARg_XSP1,"ATG_hPPARg_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element PPARg, which is responsive to the human peroxisome proliferator activated receptor gamma. [GeneSymbol:PPARG | GeneID: 5468| Uniprot_SwissProt_Accession:P37231].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-PPARg RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,77.0,30.0,47.0
905,1953,1876,ATG_mPPARg_XSP1,1,1,"The assay endpoint ATG_mPPARg_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48,569,ATG_mPPARg_XSP1,"ATG_mPPARg_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element PPARg, which is responsive to the mouse peroxisome proliferator activated receptor gamma. [GeneSymbol:Pparg | GeneID: 19016| Uniprot_SwissProt_Accession:P37238].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-mPPARg RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,84.0,44.0,40.0
906,1955,1877,ATG_zfPPARg_XSP1,1,1,"The assay endpoint ATG_zfPPARg_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48,569,ATG_zfPPARg_XSP1,"ATG_zfPPARg_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element PPARg, which is responsive to the zebrafish peroxisome proliferator activated receptor gamma. [GeneSymbol: pparg | GeneID: 557037| Uniprot_SwissProt_Accession:A6XMH6].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-zfPPARg RTU,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,87.0,10.0,77.0
907,1957,1878,ATG_mPXR_XSP1,1,1,"The assay endpoint ATG_mPXR_XSP1 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PXR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,99,48,569,ATG_mPXR_XSP1,"ATG_mPXR_XSP1 is one of 29 assay components measured or calculated from the ATG_XSP1_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element PXR, which is responsive to the mouse pregnane X receptor. [GeneSymbol: NR1IA | GeneID: 8856| Uniprot_SwissProt_Accession:O75469].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,,rna,mRNA,3,ATG_XSP1_multi-species_TRANS,"ATG_XSP1_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp1 included 3 nM 6-alpha-fluorotestosterone to partially stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,78.0,40.0,38.0
916,1975,1887,ATG_trERa_XSP2,1,1,"The assay endpoint ATG_trERa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_trERa_XSP2,"ATG_trERa_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the turtle estrogen receptor. [GeneSymbol:ESR1 | GeneID: 101933533| Uniprot_SwissProt_Accession:B6E1V9].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-trERa RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,162.0,81.0,81.0
917,1977,1888,ATG_hERb_XSP2,1,1,"The assay endpoint ATG_hERb_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_hERb_XSP2,"ATG_hERb_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the human estrogen receptor. [GeneSymbol:ESR2 | GeneID: 2100| Uniprot_SwissProt_Accession:Q92731].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-ER-b RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,174.0,60.0,114.0
918,1979,1889,ATG_trAR_XSP2,1,1,"The assay endpoint ATG_trAR_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_trAR_XSP2,"ATG_trAR_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element AR, which is responsive to the turtle androgen receptor. [GeneSymbol:AR | GeneID:101947425 | Uniprot_SwissProt_Accession:NA].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-trAR RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,167.0,12.0,155.0
920,1983,1891,ATG_zfER1_XSP2,1,1,"The assay endpoint ATG_zfER1_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_zfER1_XSP2,"ATG_zfER1_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the zebrafish estrogen receptor. [GeneSymbol:esr1 | GeneID: 259252| Uniprot_SwissProt_Accession:P57717].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-zfER1 RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,172.0,50.0,122.0
921,1985,1892,ATG_chERa_XSP2,1,1,"The assay endpoint ATG_chERa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_chERa_XSP2,"ATG_chERa_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the chicken estrogen receptor. [GeneSymbol:ESR1 | GeneID: 396099| Uniprot_SwissProt_Accession:P06212].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-chERa RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,162.0,93.0,69.0
922,1987,1893,ATG_zfER2a_XSP2,1,1,"The assay endpoint ATG_zfER2a_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_zfER2a_XSP2,"ATG_zfER2a_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the zebrafish estrogen receptor. [GeneSymbol:esr2a | GeneID: 317734| Uniprot_SwissProt_Accession:Q7ZU32].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-zfER2a RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,172.0,68.0,104.0
924,1991,1895,ATG_chAR_XSP2,1,1,"The assay endpoint ATG_chAR_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene AR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_chAR_XSP2,"ATG_chAR_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element AR, which is responsive to the chicken androgen receptor. [GeneSymbol:ar | GeneID:422165| Uniprot_SwissProt_Accession:Q2ACE0].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-chAR RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,163.0,17.0,146.0
925,1993,1896,ATG_frER1_XSP2,1,1,"The assay endpoint ATG_frER1_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_frER1_XSP2,"ATG_frER1_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the frog estrogen receptor. [GeneSymbol:esr1.L | GeneID: 398734 | Uniprot_SwissProt_Accession:Q6W5G7].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-frER1 RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,172.0,74.0,98.0
928,1999,1899,ATG_zfER2b_XSP2,1,1,"The assay endpoint ATG_zfER2b_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_zfER2b_XSP2,"ATG_zfER2b_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the zebrafish estrogen receptor. [GeneSymbol:esr2b | GeneID: 317733| Uniprot_SwissProt_Accession:Q5PR29].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-zfER2b RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,147.0,109.0,38.0
929,2001,1900,ATG_hERa_XSP2,1,1,"The assay endpoint ATG_hERa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_hERa_XSP2,"ATG_hERa_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the human estrogen receptor. [GeneSymbol:ESR1 | GeneID: 2099| Uniprot_SwissProt_Accession:P03372].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-ERa RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,163.0,110.0,53.0
932,2007,1903,ATG_frER2_XSP2,1,1,"The assay endpoint ATG_frER2_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene ER. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,192,150,571,ATG_frER2_XSP2,"ATG_frER2_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element ER, which is responsive to the frog estrogen receptor. [GeneSymbol:esr2.L | GeneID: 100174814| Uniprot_SwissProt_Accession:A0A1L8FA50].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-frER2 RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,160.0,85.0,75.0
933,2009,1904,ATG_mPPARg_XSP2,1,1,"The assay endpoint ATG_mPPARg_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150,571,ATG_mPPARg_XSP2,"ATG_mPPARg_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element PPARg, which is responsive to the mouse peroxisome proliferator activated receptor gamma. [GeneSymbol:Pparg | GeneID: 19016| Uniprot_SwissProt_Accession:P37238].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-mPPARg RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,165.0,94.0,71.0
934,2011,1905,ATG_zfPPARg_XSP2,1,1,"The assay endpoint ATG_zfPPARg_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150,571,ATG_zfPPARg_XSP2,"ATG_zfPPARg_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element PPARg, which is responsive to the zebrafish peroxisome proliferator activated receptor gamma. [GeneSymbol: pparg | GeneID: 557037| Uniprot_SwissProt_Accession:A6XMH6].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-zfPPARg RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,180.0,18.0,162.0
935,2013,1906,ATG_hPPARg_XSP2,1,1,"The assay endpoint ATG_hPPARg_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PPARg. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150,571,ATG_hPPARg_XSP2,"ATG_hPPARg_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element PPARg, which is responsive to the human peroxisome proliferator activated receptor gamma. [GeneSymbol:PPARG | GeneID: 5468| Uniprot_SwissProt_Accession:P37231].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-PPARg RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,169.0,91.0,78.0
936,2015,1907,ATG_mPXR_XSP2,1,1,"The assay endpoint ATG_mPXR_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene PXR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150,571,ATG_mPXR_XSP2,"ATG_mPXR_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element PXR, which is responsive to the mouse pregnane X receptor. [GeneSymbol: NR1IA | GeneID: 8856| Uniprot_SwissProt_Accession:O75469].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,161.0,82.0,79.0
937,2017,1908,ATG_trTRa_XSP2,1,1,"The assay endpoint ATG_trTRa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150,571,ATG_trTRa_XSP2,"ATG_trTRa_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element TRa, which is responsive to the turtle thyroid hormone receptor, alpha. [GeneSymbol: THRA | GeneID: 101949057| Uniprot_SwissProt_Accession: NA].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-trTRa RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,172.0,18.0,154.0
938,2019,1909,ATG_zfTRa_XSP2,1,1,"The assay endpoint ATG_zfTRa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150,571,ATG_zfTRa_XSP2,"ATG_zfTRa_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element TRa, which is responsive to the zebrafish thyroid hormone receptor, alpha a. [GeneSymbol: thraa | GeneID: 30670| Uniprot_SwissProt_Accession: Q98867].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-zfTRa RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,180.0,16.0,164.0
939,2021,1910,ATG_zfTRb_XSP2,1,1,"The assay endpoint ATG_zfTRb_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150,571,ATG_zfTRb_XSP2,"ATG_zfTRb_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element TRa, which is responsive to the zebrafish thyroid hormone receptor, beta. [GeneSymbol: thrb | GeneID: 30607| Uniprot_SwissProt_Accession: Q9PVE4].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-zfTRb RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,177.0,14.0,163.0
941,2025,1912,ATG_frTRa_XSP2,1,1,"The assay endpoint ATG_frTRa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150,571,ATG_frTRa_XSP2,"ATG_frTRa_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element TRa, which is responsive to the frog thyroid hormone receptor, alpha L homeolog. [GeneSymbol: thra.L | GeneID: 397942| Uniprot_SwissProt_Accession: P15204].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-frTRa RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,171.0,24.0,147.0
942,2027,1913,ATG_hTRa_XSP2,1,1,"The assay endpoint ATG_hTRa_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,150,571,ATG_hTRa_XSP2,"ATG_hTRa_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element TRa, which is responsive to the human thyroid hormone receptor, alpha. [GeneSymbol: THRA | GeneID: 7067| Uniprot_SwissProt_Accession: P10827].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-THRa RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,177.0,12.0,165.0
943,2029,1914,ATG_hTRb_XSP2,1,1,"The assay endpoint ATG_hTRb_XSP2 was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. 

Using a type of inducible reporter, measures of mRNA for gain-of-signal activity can be used to understand the reporter gene at the transcription factor-level as they relate to the gene TR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay  endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",reporter gene,log2_fold_induction,0,,gain,protein,transcription factor,nuclear receptor,non-steroidal,0,0,1,192,149,571,ATG_hTRb_XSP2,"ATG_hTRb_XSP2 is one of 29 assay components measured or calculated from the ATG_XSP2_multi-species_TRANS assay. It is designed to make measurements of mRNA induction, a form of inducible reporter, as detected with fluorescence intensity signals by Reverse transcription polymerase chain reaction (RT-PCR) and Capillary electrophoresis technology.","Changes to fluorescence intensity signals are indicative of inducible changes in transcription factor activity. This is quantified by the level of mRNA reporter sequence unique to the trans-acting reporter gene response element TRa, which is responsive to the human thyroid hormone receptor, beta. [GeneSymbol: THRB | GeneID: 7068| Uniprot_SwissProt_Accession: P10828].",single,inducible reporter,mRNA induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,RT-PCR and Capillary electrophoresis,inducer,gal4-THR-b RTU,rna,mRNA,3,ATG_XSP2_multi-species_TRANS,"ATG_XSP2_multi-species_TRANS is a cell-based, multiplexed assay created by modifying the existing Attagene TRANS-FACTORIAL system to include a panel of nuclear receptors from some or all the following species:  human (Homo sapiens), mouse (Mus musculus), frog (Xenopus laevis), zebrafish (Danio rerio), chicken (Gallus gallus), and turtle (Chrysemys picta). The ECOTOX-FACTORIAL format uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate. Xsp2 included 3 nM 6-alpha-fluorotestosterone and 1.5 nM norgestrel to stimulate the androgen receptor.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,multiplexed,DMSO,1.0,Selected assays,175.0,14.0,161.0
944,2031,1915,ATG_XTT_Cytotoxicity_XSP2,1,1,"Data from the assay component ATG_XTT_Cytotoxicity_XSP2 was analyzed into 1 assay endpoint. This assay endpoint, ATG_XTT_Cytotoxicity_XSP2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cell cycle intended target family, where the subfamily is cytotoxicity.",viability,log2_fold_induction,0,,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,90,0,572,ATG_XTT_Cytotoxicity_XSP2,"ATG_XTT_Cytotoxicity_XSP2 is an assay component measured from the ATG_XSP2_XTT_Cytotoxicity_multi-species assay. It is designed to make measurements of cell number, a form of viability reporter, as detected with fluorescence intensity signals by XTT cytotoxicity assay technology.",Changes to fluorescence intensity signals produced from an enzymatic reaction involving the key substrate [XTT reagent] are correlated to the viability of the mitochondria in the system.,single,viability reporter,cell number,cell death,Fluorescence,Fluorescence Intensity,XTT cytotoxicity assay,substrate,XTT reagent,cellular,mitochondria,3,ATG_XSP2_XTT_Cytotoxicity_multi-species,"ATG_XSP2_XTT_Cytotoxicity_multi-species is a cell-based, single-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 24-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 24-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,89.0,12.0,77.0
945,2037,1919,CPHEA_Stoker_NIS_Inhibition_RAIU,1,1,"Data from the assay component CPHEA_Stoker_NIS_Inhibition_RAIU was analyzed at the endpoint, CPHEA_Stoker_NIS_Inhibition_RAIU, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Measures of radioactive substrate uptake for loss-of-signal activity can be used to understand the effects on transporter function at the pathway level as they relate to the sodium-iodide symporter, gene SLC5A5. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transporter intended target family, where the subfamily is sodium-iodide symporter (NIS).",transporter,percent_activity,0,NaClO4,loss,protein,protein-specified,transporter,sodium-iodide symporter (NIS),0,0,1,642,8207,574,CPHEA_Stoker_NIS_Inhibition_RAIU,"CPHEA_Stoker_NIS_Inhibition_RAIU is one of 2 assay components measured from the CPHEA_Stoker_NIS assay. It is designed to make measurements of radioactive substrate uptake to understand transporter function, as detected with 125-i signals by MicroBeta radioactivity plate reader technology.",The sodium iodide symporter (NIS) is a transmembrane glycoprotein that mediates iodide uptake into the thyroid gland as the initial step of thyroid hormone biosynthesis. Inhibition of iodide uptake through the thyroid NIS can result in decreased thyroid hormone biosynthesis. The radioactive iodide uptake (RAIU) assay can be used to detect thyroid disrupting chemicals that inhibit the human sodium iodide symporter (NIS).,single,transporter function,radioactive substrate uptake,regulation of transporter activity,radiometry,radiodetection,MicroBeta radioactivity plate reader,substrate,125-I,cellular,substrate uptake,21,CPHEA_Stoker_NIS,"CPHEA_Stoker_NIS is a cell-based, single-readout assay that uses hNIS-HEK293T-EPA, a novel human kidney cell line expressing human NIS, with measurements taken at 2 hours after chemical dosing in a 96-well plate. This radioactive iodide uptake (RAIU) assay is used to identify inhibitors of NIS-mediated iodide uptake. A parallel cytoxicity assay (Cell Titer Glo, Promega) was also run in the same cell line.",2.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 96-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,460.0,29.0,431.0
948,2040,1922,TOX21_TSHR_HTRF_Agonist_ratio,1,1,"Data from the assay component TOX21_TSHR_HTRF_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.",ratio,percent_activity,0,TSH,gain,protein,receptor,gpcr,thyrotropin-releasing hormone receptor,0,0,1,7872,52650,575,TOX21_TSHR_HTRF_Agonist_ratio,"TOX21_TSHR_HTRF_Agonist_ratio is one of one assay component(s) measured or calculated from the TOX21_TSHR_HTRF_Agonist assay. It is designed to make measurements of TSHR agonism, with cAMP as an indicator of TSHR activation.","TOX21_TSHR_HTRF_Agonist_ratio was designed to target  receptor activation through increased cAMP generation, specifically mapping to TSHR gene(s) using a positive control of TSH.",single,inducible reporter,cAMP measurement,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Homogeneous Time Resolved Fluorescence,substrate,d2-labeled cAMP,protein,receptor,7,TOX21_TSHR_Agonist,"Tox21_TSHR_Agonist  is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 0.5 hours after chemical dosing in a 1536-well plate.",0.5,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7523.0,215.0,7308.0
951,2043,1925,TOX21_TSHR_HTRF_Antagonist_ratio,1,1,"Data from the assay component TOX21_TSHR_HTRF_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this one serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.",ratio,percent_activity,0,no TSH stimulation,loss,protein,receptor,gpcr,thyrotropin-releasing hormone receptor,0,0,1,7872,52650,576,TOX21_TSHR_HTRF_Antagonist_ratio,"TOX21_TSHR_HTRF_Antagonist_ratio is one of one assay component(s) measured or calculated from the TOX21_TSHR_Antagonist assay. It is designed to make measurements of TSHR antagonism, with cAMP as an indicator of TSHR activation.","TOX21_TSHR_HTRF_Antagonist_ratio was designed to target  receptor inhibition through decreased cAMP generation, specifically mapping to TSHR gene(s) using a positive control of no TSH stimulation",single,inducible reporter,cAMP measurement,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Homogeneous Time Resolved Fluorescence,substrate,d2-labeled cAMP,protein,receptor,7,TOX21_TSHR_Antagonist,"Tox21_TSHR_Antagonist  is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 0.5 hours after chemical dosing in a 1536-well plate.",0.5,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7617.0,67.0,7550.0
954,2046,1928,TOX21_TSHR_wt_Agonist_HTRF_ratio,1,1,"Data from the assay component TOX21_TSHR_HTRF_wt_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TSHR_HTRF_wt_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TSHR. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.",ratio,percent_activity,0,Forskolin,gain,pathway,pathway-specified,gpcr,thyrotropin-releasing hormone receptor,0,0,1,7872,52522,577,TOX21_TSHR_wt_Agonist_HTRF_ratio,TOX21_TSHR_wt_Agonist_HTRF_ratio is one of one assay component(s) measured or calculated from the TOX21_TSHR_wt assay. It is designed to indicate background cAMP activity.,TOX21_TSHR_wt_HTRF_ratio was designed to target  background cAMP generation in cells lacking TSHR,single,inducible reporter,cAMP measurement,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,Homogeneous Time Resolved Fluorescence,substrate,d2-labeled cAMP,protein,receptor,7,TOX21_TSHR_wt,"Tox21_TSHR_wt  is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 0.5 hours after chemical dosing in a 1536-well plate.",0.5,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7805.0,24.0,7781.0
955,2047,1929,TOX21_CAR_Agonist,1,1,"Data from the assay component TOX21_CAR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_CAR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1I3. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",agonist,percent_activity,0,CITCO,gain,protein,receptor,nuclear receptor,xenobiotic,0,0,1,7872,52650,578,TOX21_CAR_Agonist,"TOX21_CAR_Agonist is one of one assay component(s) measured or calculated from the TOX21_CAR_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.",TOX21_CAR_Agonist assay  was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human constitutive androstane receptor (CAR) [GeneSymbol:NR1I3],single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_CAR_Agonist,"TOX21_CAR_Agonist is a cell-based, single-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7323.0,351.0,6972.0
957,2049,1931,TOX21_CAR_Antagonist,1,1,"Data from the assay component TOX21_CAR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_CAR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR1I3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",antagonist,percent_activity,0,PK11195,loss,protein,receptor,nuclear receptor,xenobiotic,0,0,1,7872,52102,579,TOX21_CAR_Antagonist,"TOX21_CAR_Antagonist is one of one assay component(s) measured or calculated from the TOX21_CAR_Antagonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.",TOX21_CAR_Antagonist assay  was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to antagonist activity regulated by the human constitutive androstane receptor (CAR)  [GeneSymbol:NR1I3] stimulated with CITCO,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_CAR_Antagonist,"TOX21_CAR_Antagonist is a cell-based, single-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,6688.0,189.0,6499.0
959,2053,1935,TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2,1,1,"Data from the assay component TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",antagonist,percent_activity,0,4-hydroxytamoxifen,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52650,580,TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2,"TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2 is one of one assay component(s) measured or calculated from the TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2 assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.",Changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo] are indicative of changes in transcriptional gene expression due to antagonist activity regulated by the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2,"TOX21_ERa_LUC_VM7_Antagonist_0.1nM_E2 is a cell-based, single-readout assay that uses VM7, a human breast tissue cell line, with measurements taken at 48 hours after chemical dosing in a 1536-well plate.",22.0,9606.0,human,breast,cell line,,VM7,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7132.0,453.0,6679.0
961,2055,1937,TOX21_ERR_Agonist,1,1,"Data from the assay component TOX21_ERR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",agonist,percent_activity,0,Genistein,gain,protein,receptor,nuclear receptor,orphan,0,0,1,7872,52650,581,TOX21_ERR_Agonist,"TOX21_ERR_Agonist is one of one assay component(s) measured or calculated from the TOX21_ERR_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.",TOX21_ERR_Agonist was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human estrogen-related receptor alpha [GeneSymbol:ESRRA | GeneID:2101|.,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,enzyme,7,TOX21_ERR,"TOX21_ERR is a cell-based, single-readout assay that uses ERR-HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,ERR-HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,6804.0,91.0,6713.0
962,2057,1939,TOX21_ERR_Antagonist,1,1,"Data from the assay component TOX21_ERR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family.",antagonist,percent_activity,0,XCT790,loss,protein,receptor,nuclear receptor,orphan,0,0,1,7872,52650,581,TOX21_ERR_Antagonist,"TOX21_ERR_Agonist is one of one assay component(s) measured or calculated from the TOX21_ERR_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.",TOX21_ERR_Agonist was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human estrogen-related receptor alpha [GeneSymbol:ESRRA | GeneID:2101|.,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,enzyme,7,TOX21_ERR,"TOX21_ERR is a cell-based, single-readout assay that uses ERR-HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,ERR-HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,6816.0,723.0,6093.0
965,2061,1943,TOX21_HDAC_Inhibition,1,1,"Data from the assay component TOX21_HDAC_Inhibition was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HDAC_Inhibition, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HDAC1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function.",reporter gene,percent_activity,0,Trichostatin A,loss,pathway,pathway-specified,hydrolase,,0,0,1,7872,52650,582,TOX21_HDAC_Inhibition,TOX21_HDAC_Inhibition is one of one assay component(s) measured or calculated from the TOX21_HDAC_Inhibition assay. It is designed to make measurements of HDAC activity as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.,TOX21_HDAC_Inhibition was designed to target enzymatic activity specifically mapping to HDAC1 gene(s) using a positive control of Trichostatin A,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,enzyme,7,TOX21_HDAC_Inhibition,"TOX21_HDAC_Inhibition is a cell-based, single-readout assay that uses HCT-116, a human colon cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,colon,cell line,,HCT116,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7580.0,226.0,7354.0
969,2065,1947,TOX21_HRE_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_HRE_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_HRE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene HIF1A. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the dna binding intended target family, where the subfamily is hypoxia-response element.",ratio,percent_activity,0,Cobalt(II)chloride hexahydrate,gain,pathway,pathway-specified,dna binding,hypoxia-response element,0,0,1,7872,56490,583,TOX21_HRE_BLA_Agonist_ratio,TOX21_HRE_BLA_Agonist_ratio is an assay readout measuring reporter gene via transcription factor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity. ,"TOX21_HRE_BLA_Agonist_ratio was designed to target transcription factor activity, specifically mapping to HIF1A gene(s) using a positive control of Cobalt(II)chloride hexahydrate",single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_HRE_BLA_Agonist,"TOX21_HRE_BLA_Agonist is a cell-based, single-readout assay that uses ME-180, a human cervix cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,cervix,cell line,,ME-180,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7646.0,74.0,7572.0
972,2068,1950,TOX21_PGC_ERR_Agonist,1,1,"Data from the assay component TOX21_PGC_ERR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PGC_ERR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",agonist,percent_activity,0,Genistein,gain,protein,receptor,nuclear receptor,orphan,0,0,1,7872,52650,585,TOX21_PGC_ERR_Agonist,"TOX21_PGC_ERR_Agonist is one of one assay component(s) measured or calculated from the TOX21_PGC_ERR_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology",TOX21_PGC_ERR_Agonist was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human estrogen-related receptor alpha  [GeneSymbol:ESRRA | GeneID:2101| in the presence of PGC1a expression,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_PGC_ERR,"TOX21_PGC_ERR is a cell-based, single-readout assay that uses PGC/ERR HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,PGC/ERR HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7368.0,95.0,7273.0
973,2070,1952,TOX21_PGC_ERR_Antagonist,1,1,"Data from the assay component TOX21_PGC_ERR_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PGC_ERR_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESRRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is orphan.",antagonist,percent_activity,0,XCT790,loss,protein,receptor,nuclear receptor,orphan,0,0,1,7872,52650,585,TOX21_PGC_ERR_Antagonist,"TOX21_PGC_ERR_Antagonist is one of one assay component(s) measured or calculated from the TOX21_PGC_ERR_Agonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology",TOX21_PGC_ERR_Agonist was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human estrogen-related receptor alpha [GeneSymbol:ESRRA | GeneID:2101|in the presence of PGC1a expression,single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_PGC_ERR,"TOX21_PGC_ERR is a cell-based, single-readout assay that uses PGC/ERR HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,PGC/ERR HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,6710.0,286.0,6424.0
1000,2108,1990,TOX21_SHH_3T3_GLI3_Antagonist,1,1,"Data from the assay component TOX21_SHH_3T3_GLI3_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SHH_3T3_GLI3_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene GLI3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function.",antagonist,percent_activity,0,Cyclopamine,loss,pathway,pathway-specified,dna binding,zinc finger,0,0,1,7872,52650,589,TOX21_SHH_3T3_GLI3_Antagonist,"TOX21_SHH_3T3_GLI3_Antagonist is one of one assay component(s) measured or calculated from the TOX21_SHH_3T3_GLI3_Antagonist assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.","TOX21_SHH_3T3_GLI3_Antagonist was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to antagonism  of Gli3 activation using conditioned medium, part of the sonic hedgehog (Shh) pathway",single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_SHH_3T3_GLI3_Antagonist,"TOX21_SHH_3T3_GLI3_Antagonist is a cell-based, single-readout assay that uses NIH/3T3, a mouse embryo cell line, with measurements taken at 24 hours after chemical dosing in a 1536 well.",24.0,10090.0,mouse,embryo,cell line,,NIH/3T3,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7071.0,617.0,6454.0
1005,2115,2001,TOX21_ERb_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_ERb_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERb_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,17b-Estradiol,gain,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52394,593,TOX21_ERb_BLA_Agonist_ratio,TOX21_ERb_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity. ,"TOX21_ERb_BLA_Agonist_ch2 was designed to target nuclear receptor activity at the protein (receptor) level, specifically mapping to ESR2 gene(s) using a positive control of 17b-estradiol",single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_ERb_BLA_Agonist,"TOX21_ERb_BLA_Agonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,7788.0,61.0,7727.0
1009,2119,1997,TOX21_ERb_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_ERb_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_ERb_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene ESR2. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,4-hydroxytamoxifen,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52650,592,TOX21_ERb_BLA_Antagonist_ratio,TOX21_ERb_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity. ,"TOX21_ERb_BLA_Antagonist_ratio was designed to target nuclear receptor activity at the protein (receptor) level, specifically mapping to ESR2 gene(s) using a positive control of 4-hydroxytamoxifen",single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_ERb_BLA_Antagonist,"TOX21_ERb_BLA_Antagonist is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate.",24.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,1.0,Selected assays,6891.0,509.0,6382.0
1013,2123,2005,TOX21_PR_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_PR_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,promegestone (R5020),gain,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52522,594,TOX21_PR_BLA_Agonist_ratio,TOX21_PR_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"Progesterone receptor (PR), a nuclear hormone receptor, plays an important role in development, metabolic homeostasis and reproduction. It is activated by the steroid hormone progesterone. Endocrine disrupting chemicals (EDCs) and their interactions with steroid hormone receptors like PR causes disruption of normal endocrine function. ",single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_PR_BLA_Agonist,"TOX21_PR_BLA_Agonist is a cell-based, single-readout assay that uses transfected HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate. To identify the compounds that stimulate PR signaling, a PR-UAS-bla GripTite cell line i.e. PR-UAS-bla HEK293T (Invitrogen, Carlsbad, CA, USA) containing a beta-lactamase reporter gene under the control of an UAS response element was used to screen Tox21 10K compound library. The cytotoxicity of the Tox21 compound library against the PR-bla cell line was tested in parallel by measuring the cell viability using CellTiter-Glo assay in the same wells.",24.0,9606.0,human,kidney,cell line,,PR-UAS-bla-HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.1,Selected assays,7723.0,116.0,7607.0
1017,2127,2009,TOX21_PR_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_PR_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity an be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,RU486,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,7872,52102,595,TOX21_PR_BLA_Antagonist_ratio,TOX21_PR_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"Progesterone receptor (PR), a nuclear hormone receptor, plays an important role in development, metabolic homeostasis and reproduction. It is activated by the steroid hormone progesterone. Endocrine disrupting chemicals (EDCs) and their interactions with steroid hormone receptors like PR causes disruption of normal endocrine function. ",single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_PR_BLA_Antagonist,"TOX21_PR_BLA_Antagonist is a cell-based, single-readout assay that uses transfected HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate. To identify the compounds that stimulate PR signaling, a PR-UAS-bla GripTite cell line i.e. PR-UAS-bla HEK293T (Invitrogen, Carlsbad, CA, USA) containing a beta-lactamase reporter gene under the control of an UAS response element was used to screen Tox21 10K compound library. The cytotoxicity of the Tox21 compound library against the PR-bla cell line was tested in parallel by measuring the cell viability using CellTiter-Glo assay in the same wells. ",24.0,9606.0,human,kidney,cell line,,PR-UAS-bla-HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.1,Selected assays,6876.0,865.0,6011.0
1019,2130,2012,TOX21_DT40_100,1,1,"Data from the assay component TOX21_DT40_100 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_DT40_100, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the viability as they relate to the gene Ku70 - Rad54 (-/-). Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA repair family.",viability,percent_activity,0,Tetraoctyl ammonium bromide,loss,pathway,pathway-specified,cell cycle,DNA repair,0,0,1,8306,92160,382,TOX21_DT40_100,TOX21_DT40_100 is an assay readout measuring cellular ATP content as a determinant of cell viability using CellTiter-Glo Luciferase-coupled ATP quantitation,"TOX21_DT40_100 assay was designed to target cell cycle (cytotoxicity) activity at the cellular (cellular) level, specifically mapping to Ku70 and Rad54 gene(s) using a positive control of tetraoctylammonium bromide. The DT40_100 cells have Ku70 and Rad54 gene deletions (-/-) which are involved in reparing chromosomal breaks. Results should be compared to the isogenic wild-type cells (DT40; aeid 1124 ) and Rev3(-/-) (DT40_657; aeid 2131) to evaluate potential DNA-damaging agents",single,viability reporter,ATP content,regulation of DNA repair,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,CellTiter-Glo,chemical,ATP,7,TOX21_DT40,"TOX21_DT40 is a cell-based, single-readout assay that uses DT40, a chicken lymphoblast cell line, with measurements taken at 40 hours after chemical dosing in a 1536-well plate.",40.0,9031.0,chicken,lymphoblast,cell line,,DT40,suspension,microplate: 1536-well plate,cell-based,cell-based format,multiplexed,DMSO,0.0,Selected assays,6871.0,1551.0,5320.0
1020,2131,2013,TOX21_DT40_657,1,1,"Data from the assay component TOX21_DT40_657 was analyzed into 1 assay endpoint. This assay endpoint, TOX21_DT40_657, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene Rev3. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the DNA repair family.",viability,percent_activity,0,Tetraoctyl ammonium bromide,loss,pathway,pathway-specified,cell cycle,DNA repair,0,0,1,8306,92032,382,TOX21_DT40_657,TOX21_DT40_657 is an assay readout measuring cellular ATP content as a determinant of cell viability using CellTiter-Glo Luciferase-coupled ATP quantitation,"TOX21_DT40_657 assay was designed to target cell cycle (cytotoxicity) activity at the cellular (cellular) level, specifically mapping to Rev3 gene(s) using a positive control of tetraoctylammonium bromide. The DT40_657 cells have Rev3 gene deletions (-/-) which is involved in DNA repair. Results should be compared to the isogenic wild-type cells (DT40; aeid 1124 ) and Ku70/Rad54 (DT40_100; aeid 2130) to evaluate potential DNA-damaging agents. ",single,viability reporter,ATP content,regulation of DNA repair,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,CellTiter-Glo,chemical,ATP,7,TOX21_DT40,"TOX21_DT40 is a cell-based, single-readout assay that uses DT40, a chicken lymphoblast cell line, with measurements taken at 40 hours after chemical dosing in a 1536-well plate.",40.0,9031.0,chicken,lymphoblast,cell line,,DT40,suspension,microplate: 1536-well plate,cell-based,cell-based format,multiplexed,DMSO,0.0,Selected assays,6768.0,1281.0,5487.0
1021,2143,2023,CEETOX_H295R_11DCORT_noMTC,1,1,"Data from the assay component CEETOX_H295R_11DCORT_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_11DCORT_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 11-Deoxycortisol in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,11-Deoxycortisol,steroid hormone,glucocorticoids,0,0,1,85,132,370,CEETOX_H295R_11DCORT_noMTC,"one of 12 assay component(s) measured or calculated from the CEETOX_H295R assay (11 hormones and 1 viability assay). It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology. The concentrations for these components have not been pre-filtered for the maximum tolerated concentration (MTC) based on the MTT assay (_noMTC).",steroid hormone biosynthesis,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,HPLC-MS-MS,HPLC-MS-MS,HPLC-MS-MS,pre-stimulation,forskolin,molecular messenger,11-Deoxycortisol,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,83.0,21.0,62.0
1022,2145,2024,CEETOX_H295R_OHPREG_noMTC,1,1,"Data from the assay component CEETOX_H295R_OHPREG_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_OHPREG_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxypregnenolone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,17alpha-hydroxypregnenolone,steroid hormone,progestagens,0,0,1,85,132,370,CEETOX_H295R_OHPREG_noMTC,"one of 12 assay component(s) measured or calculated from the CEETOX_H295R assay (11 hormones and 1 viability assay). It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology. The concentrations for these components have not been pre-filtered for the maximum tolerated concentration (MTC) based on the MTT assay (_noMTC).",steroid hormone biosynthesis,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,HPLC-MS-MS,HPLC-MS-MS,HPLC-MS-MS,pre-stimulation,forskolin,molecular messenger,17alpha-hydroxypregnenolone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,80.0,13.0,67.0
1023,2147,2025,CEETOX_H295R_OHPROG_noMTC,1,1,"Data from the assay component CEETOX_H295R_OHPROG_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_OHPROG_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of 17alpha-hydroxyprogesterone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,17alpha-hydroxyprogesterone,steroid hormone,progestagens,0,0,1,85,132,370,CEETOX_H295R_OHPROG_noMTC,"one of 12 assay component(s) measured or calculated from the CEETOX_H295R assay (11 hormones and 1 viability assay). It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology. The concentrations for these components have not been pre-filtered for the maximum tolerated concentration (MTC) based on the MTT assay (_noMTC).",steroid hormone biosynthesis,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,HPLC-MS-MS,HPLC-MS-MS,HPLC-MS-MS,pre-stimulation,forskolin,molecular messenger,17alpha-hydroxyprogesterone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,81.0,25.0,56.0
1024,2149,2026,CEETOX_H295R_ANDR_noMTC,1,1,"Data from the assay component CEETOX_H295R_ANDR_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ANDR_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Androstenedione in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Androstenedione,steroid hormone,androgens,0,0,1,85,132,370,CEETOX_H295R_ANDR_noMTC,"one of 12 assay component(s) measured or calculated from the CEETOX_H295R assay (11 hormones and 1 viability assay). It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology. The concentrations for these components have not been pre-filtered for the maximum tolerated concentration (MTC) based on the MTT assay (_noMTC).",steroid hormone biosynthesis,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,HPLC-MS-MS,HPLC-MS-MS,HPLC-MS-MS,pre-stimulation,forskolin,molecular messenger,Androstenedione,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,84.0,17.0,67.0
1025,2151,2027,CEETOX_H295R_CORTIC_noMTC,1,1,"Data from the assay component CEETOX_H295R_CORTIC_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_CORTIC_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Corticosterone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Corticosterone,steroid hormone,glucocorticoids,0,0,1,85,132,370,CEETOX_H295R_CORTIC_noMTC,"one of 12 assay component(s) measured or calculated from the CEETOX_H295R assay (11 hormones and 1 viability assay). It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology. The concentrations for these components have not been pre-filtered for the maximum tolerated concentration (MTC) based on the MTT assay (_noMTC).",steroid hormone biosynthesis,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,HPLC-MS-MS,HPLC-MS-MS,HPLC-MS-MS,pre-stimulation,forskolin,molecular messenger,Corticosterone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,81.0,17.0,64.0
1026,2153,2028,CEETOX_H295R_CORTISOL_noMTC,1,1,"Data from the assay component CEETOX_H295R_CORTISOL_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_CORTISOL_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of Cortisol in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Cortisol ,steroid hormone,glucocorticoids,0,0,1,85,132,370,CEETOX_H295R_CORTISOL_noMTC,"one of 12 assay component(s) measured or calculated from the CEETOX_H295R assay (11 hormones and 1 viability assay). It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology. The concentrations for these components have not been pre-filtered for the maximum tolerated concentration (MTC) based on the MTT assay (_noMTC).",steroid hormone biosynthesis,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,HPLC-MS-MS,HPLC-MS-MS,HPLC-MS-MS,pre-stimulation,forskolin,molecular messenger,Cortisol ,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,82.0,19.0,63.0
1027,2157,2030,CEETOX_H295R_DOC_noMTC,1,1,"Data from the assay component CEETOX_H295R_DOC_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_DOC_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  11-Deoxycorticosterone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is glucocorticoids.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,11-Deoxycorticosterone,steroid hormone,glucocorticoids,0,0,1,85,132,370,CEETOX_H295R_DOC_noMTC,"one of 12 assay component(s) measured or calculated from the CEETOX_H295R assay (11 hormones and 1 viability assay). It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology. The concentrations for these components have not been pre-filtered for the maximum tolerated concentration (MTC) based on the MTT assay (_noMTC).",steroid hormone biosynthesis,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,HPLC-MS-MS,HPLC-MS-MS,HPLC-MS-MS,pre-stimulation,forskolin,molecular messenger,11-Deoxycorticosterone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,79.0,17.0,62.0
1028,2159,2031,CEETOX_H295R_ESTRADIOL_noMTC,1,1,"Data from the assay component CEETOX_H295R_ESTRADIOL_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_ESTRADIOL_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Estradiol in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is estrogens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Estradiol,steroid hormone,estrogens,0,0,1,85,132,370,CEETOX_H295R_ESTRADIOL_noMTC,"one of 12 assay component(s) measured or calculated from the CEETOX_H295R assay (11 hormones and 1 viability assay). It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology. The concentrations for these components have not been pre-filtered for the maximum tolerated concentration (MTC) based on the MTT assay (_noMTC).",steroid hormone biosynthesis,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,HPLC-MS-MS,HPLC-MS-MS,HPLC-MS-MS,pre-stimulation,forskolin,molecular messenger,Estradiol,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,83.0,10.0,73.0
1030,2165,2034,CEETOX_H295R_PROG_noMTC,1,1,"Data from the assay component CEETOX_H295R_PROG_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_PROG_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Progesterone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is progestagens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Progesterone,steroid hormone,progestagens,0,0,1,85,132,370,CEETOX_H295R_PROG_noMTC,"one of 12 assay component(s) measured or calculated from the CEETOX_H295R assay (11 hormones and 1 viability assay). It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology. The concentrations for these components have not been pre-filtered for the maximum tolerated concentration (MTC) based on the MTT assay (_noMTC).",steroid hormone biosynthesis,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,HPLC-MS-MS,HPLC-MS-MS,HPLC-MS-MS,pre-stimulation,forskolin,molecular messenger,Progesterone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,79.0,18.0,61.0
1031,2167,2035,CEETOX_H295R_TESTO_noMTC,1,1,"Data from the assay component CEETOX_H295R_TESTO_noMTC was analyzed into 1 assay endpoint. This assay endpoint, CEETOX_H295R_TESTO_noMTC, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity using HPLC-MS-MS was used to understand synthesis of  Testosterone in H295R cell line at 48hr of chemical exposure, without filtering concentrations for maximum tolerated concentration (MTC). To generalize the intended target to other relatable targets, this assay endpoint is annotated to the steroid hormone intended target family, where the subfamily is androgens.",detection of steroid hormone,log2_fold_induction,0,prochloraz; forskolin,bidirectional,molecular messenger,Testosterone,steroid hormone,androgens,0,0,1,85,132,370,CEETOX_H295R_TESTO_noMTC,"one of 12 assay component(s) measured or calculated from the CEETOX_H295R assay (11 hormones and 1 viability assay). It is designed to make measurements of hormone induction, a form of inducible reporter, as detected with absorbance signals by HPLC-MS-MS technology. The concentrations for these components have not been pre-filtered for the maximum tolerated concentration (MTC) based on the MTT assay (_noMTC).",steroid hormone biosynthesis,single,inducible reporter,hormone induction,regulation of steroid hormone biosynthetic process,HPLC-MS-MS,HPLC-MS-MS,HPLC-MS-MS,pre-stimulation,forskolin,molecular messenger,Testosterone,8,CEETOX_H295R,"CEETOX_H295R is a cell-based, multiplexed-readout assay that uses H295R, a human adrenal gland cell line, with measurements taken at 48 hours after chemical dosing in a 96-well plate.",48.0,9606.0,human,adrenal gland,cell line,,H295R,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,83.0,11.0,72.0
1039,2218,2279,TOX21_PR_BLA_Followup_Agonist_ratio,1,1,"Data from the assay component TOX21_PR_BLA_Followup_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Followup_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR3C3. 

Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves a reporter gene function. 

To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,promegestone (R5020),gain,protein,receptor,nuclear receptor,steroidal,0,0,1,231,480,642,TOX21_PR_BLA_Followup_Agonist_ratio,TOX21_PR_BLA_Followup_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"Progesterone receptor (PR), a nuclear hormone receptor, plays an important role in development, metabolic homeostasis and reproduction. It is activated by the steroid hormone progesterone. Endocrine disrupting chemicals (EDCs) and their interactions with steroid hormone receptors like PR causes disruption of normal endocrine function. ",single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_PR_BLA_Followup,"TOX21_PR_BLA_Followup is a secondary assay for specificity for the TOX21_PR_BLA_Agonist assay. To differentiate true PR agonists from cytotoxic substances, this follow up assay is multiplexed with a cell viability assay. The compounds were also tested for auto fluorescence that may interfere with the biological target readout resulting in potential false positives and/or negatives. To identify the compounds that stimulate PR signaling, a PR-UAS-bla GripTite cell line i.e. PR-UAS-bla HEK293T (Invitrogen, Carlsbad, CA, USA) containing a beta-lactamase reporter gene under the control of an UAS response element was used to screen Tox21 10K compound library. The cytotoxicity of the Tox21 compound library against the PR-bla cell line was tested in parallel by measuring the cell viability using CellTiter-Glo assay in the same wells. ",24.0,9606.0,human,kidney,cell line,,PR-UAS-bla-HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.1,Selected assays,207.0,22.0,185.0
1040,2219,2280,TOX21_PR_BLA_Followup_Antagonist_ratio,1,1,"Data from the assay component TOX21_PR_BLA_Followup_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_BLA_Followup_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, measures of receptor for gain-of-signal activity can be used to understand the reporter gene at the pathway-level as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",ratio,percent_activity,0,RU486,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,231,432,642,TOX21_PR_BLA_Followup_Antagonist_ratio,TOX21_PR_BLA_Followup_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"Progesterone receptor (PR), a nuclear hormone receptor, plays an important role in development, metabolic homeostasis and reproduction. It is activated by the steroid hormone progesterone. Endocrine disrupting chemicals (EDCs) and their interactions with steroid hormone receptors like PR causes disruption of normal endocrine function. ",single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_PR_BLA_Followup,"TOX21_PR_BLA_Followup is a secondary assay for specificity for the TOX21_PR_BLA_Agonist assay. To differentiate true PR agonists from cytotoxic substances, this follow up assay is multiplexed with a cell viability assay. The compounds were also tested for auto fluorescence that may interfere with the biological target readout resulting in potential false positives and/or negatives. To identify the compounds that stimulate PR signaling, a PR-UAS-bla GripTite cell line i.e. PR-UAS-bla HEK293T (Invitrogen, Carlsbad, CA, USA) containing a beta-lactamase reporter gene under the control of an UAS response element was used to screen Tox21 10K compound library. The cytotoxicity of the Tox21 compound library against the PR-bla cell line was tested in parallel by measuring the cell viability using CellTiter-Glo assay in the same wells. ",24.0,9606.0,human,kidney,cell line,,PR-UAS-bla-HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.1,Selected assays,151.0,62.0,89.0
1043,2222,2283,TOX21_PR_LUC_Followup_Agonist,1,1,"Data from the assay component TOX21_PR_LUC_Followup_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_LUC_Followup_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor target family, where the subfamily is steroidal.",agonist,percent_activity,0,promegestone (R5020),gain,protein,receptor,nuclear receptor,steroidal,0,0,1,231,480,643,TOX21_PR_LUC_Followup_Agonist,"TOX21_PR_LUC_Followup_Agonist is one of one assay component(s) measured or calculated from the TOX21_PR_LUC_Followup assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology",TOX21_PR_LUC_Agonist assay was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human Progesterone receptor (PR),single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_PR_LUC_Followup,"TOX21_PR_LUC_Followup is a secondary assay for specificity for the TOX21_PR_BLA_Agonist assay. To differentiate true PR agonists from cytotoxic substances, this follow up assay is multiplexed with a cell viability assay.",24.0,9606.0,human,kidney,cell line,,HEK293-PR-A,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,196.0,32.0,164.0
1044,2223,2284,TOX21_PR_LUC_Followup_Antagonist,1,1,"Data from the assay component TOX21_PR_LUC_Followup_Antagonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PR_LUC_Followup_Antagonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene NR3C3. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor target family, where the subfamily is steroidal.",antagonist,percent_activity,0,RU486,loss,protein,receptor,nuclear receptor,steroidal,0,0,1,231,432,643,TOX21_PR_LUC_Followup_Antagonist,"TOX21_PR_LUC_Followup_Antagonist is one of one assay component(s) measured or calculated from the TOX21_PR_LUC_Followup assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology",TOX21_PR_LUC_Antagonist assay was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [One-Glo]. Changes are indicative of changes in transcriptional gene expression due to antagonist activity regulated by the human Progesterone receptor (PR),single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_PR_LUC_Followup,"TOX21_PR_LUC_Followup is a secondary assay for specificity for the TOX21_PR_BLA_Agonist assay. To differentiate true PR agonists from cytotoxic substances, this follow up assay is multiplexed with a cell viability assay.",24.0,9606.0,human,kidney,cell line,,HEK293-PR-A,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,168.0,53.0,115.0
1061,2240,2301,TOX21_TRB_BLA_Antagonist_Followup_ratio,1,1,"Data from the assay component TOX21_TRB_BLA_Antagonist_Followup_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TRB_BLA_Antagonist_Followup_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene THRB. 

Furthermore, this assay endpoint can be referred to as a primary readout,  because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is non-steroidal.",ratio,percent_activity,0,T3,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,121,252,649,TOX21_TRB_BLA_Antagonist_Followup_ratio,TOX21_TRB_BLA_Antagonist_Followup_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"Thyroid receptor (TR), a nuclear hormone receptor, plays an important role in development, proliferation, differentiation, metabolism, brain function, and cardiovascular system. TR-interacting compounds have been shown to disrupt thyroid homeostasis.",single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_TRB_BLA_Antagonist_Followup,"The GeneBLAzer TRb-UAS-bla HEK293T assay kit for human TRb (ThermoFisherScientific  Catalog No. K1684) was used as a secondary assay for specificity (TRb-bla).This assay contained the ligand-binding domain (LBD) of the human TRb fused to the DNA-binding domain of GAL4 stably integrated in the GeneBLAzer UAS-bla HEK293Tcell line. The reporter gene, b-lactamase, is under the transcriptional control of a UAS that binds the GAL4 DNA-binding domain. A cell viability assay was run in parallel for these cells as well using the CellTiter-Glo viability assay kit.",1.0,9606.0,human,kidney,cell line,,TRb-UAS-bla-HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.1,Selected assays,105.0,20.0,85.0
1075,2257,2318,TOX21_TR_RXR_BLA_Antagonist_Followup_ratio,1,1,"Data from the assay component TOX21_TR_RXR_BLA_Antagonist_Followup_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_TR_RXR_BLA_Antagonist_Followup_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene RXRA. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where subfamily is non-steroidal.",ratio,percent_activity,0,1 nM T21_TR_RXR_BLA_Antagonist,loss,protein,receptor,nuclear receptor,non-steroidal,0,0,1,121,288,654,TOX21_TR_RXR_BLA_Antagonist_Followup_ratio,TOX21_TR_RXR_BLA_Antagonist_Followup_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,Activity at the RXR portion of the TR:RXR heterodimer is specifically screened to assess contribution in GH3-TRE-Luc signal in TOX21_TR_LUC_GH3 assays.,single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_TR_RXR_BLA_Antagonist_Followup,GeneBLAzer RXRa-UAS-bla HEK293T assay (RXRa-bla) (ThermoFisherScientific  Catalog No. K1697) was run in qHTS 1536 well format as a secondary assay for specificity of response in the TOX21_TR_GH3_LUC_Agonist assay.,16.0,9606.0,human,kidney,cell line,,RXRa-UAS-bla HEK 293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.1,Selected assays,116.0,12.0,104.0
1076,2258,2319,TOX21_TR_RXR_BLA_Antagonist_Followup_viability,1,1,"The assay component endpoint  TOX21_TR_RXR_BLA_Antagonist_Followup_viability was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,tetraoctylammonium bromide,loss,cellular,cellular,cell cycle,cytotoxicity,0,0,1,121,240,654,TOX21_TR_RXR_BLA_Antagonist_Followup_viability,TOX21_TR_RXR_BLA_Antagonist_Followup_viability is a component of the TOX21_TR_RXR_BLA_Antagonist_Followup assay. This component measures cell viability using the CellTiter-Glo Luciferase-coupled ATP quantitation.,Changes to bioluminescence signals produced from an enzymatic reaction catalyzed by luciferase between the key substrate [CellTiter-Glo] and the target cofactor [ATP] are correlated to the viability of the system.,single,viability reporter,ATP content,cell proliferation,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,CellTiter-Glo,chemical,ATP,7,TOX21_TR_RXR_BLA_Antagonist_Followup,GeneBLAzer RXRa-UAS-bla HEK293T assay (RXRa-bla) (ThermoFisherScientific  Catalog No. K1697) was run in qHTS 1536 well format as a secondary assay for specificity of response in the TOX21_TR_GH3_LUC_Agonist assay.,16.0,9606.0,human,kidney,cell line,,RXRa-UAS-bla HEK 293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,0.1,Selected assays,114.0,11.0,103.0
1101,2363,2370,TOX21_PXR_agonist,1,1,"Data from the assay component TOX21_PXR_Agonist was analyzed into 1 assay endpoint. This assay endpoint, TOX21_PXR_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to gene NR1I2. Furthermore, this assay endpoint can be referred to as a primary readout, because the performed assay has only produced 1 assay endpoint. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor target family, where the subfamily is non-steroidal.",agonist,percent_activity,0,46 uM rifampicin ,gain,protein,receptor,nuclear receptor,non-steroidal,0,0,1,7872,46890,670,TOX21_PXR_agonist,"TOX21_PXR_agonist is one of one assay component(s) measured or calculated from the TOX21_PXR  assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by CellTiter-Glo Luciferase-coupled ATP quantitation technology.","The human pregnane X receptor (hPXR) regulates the expression of several drug metabolizing enzymes and induction of these proteins is a major mechanism for developing drug resistance in cancer. One such key enzyme catalyzing the drug metabolism is cytochrome P450 3A4 (CYP3A4). Changes in CYP3A4 expression affect drug metabolism, thereby reducing the therapeutic efficacy and altering toxicological response to a drug and which finally causes adverse drug interaction.",single,inducible reporter,luciferase induction,regulation of transcription factor activity,Luminescence,Bioluminescence,CellTiter-Glo Luciferase-coupled ATP quantitation,substrate,One-Glo,protein,receptor,7,TOX21_PXR,"The TOX21_PXR is a cell-based, single-readout assay that uses HepG2, a human liver cell line, with measurements taken at 24 hours after chemical dosing on a microplate: 1536-well plate. To screen Tox21 libraries for compounds that activate hPXR-mediated CYP3A4 gene expression, PXR-Luc HepG2 cells were used. Cytotoxicity of the compounds was tested in parallel by measuring the cell viability using CellTiter-Fluor assay system in the same wells.",24.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,5951.0,488.0,5463.0
1102,2364,2371,TOX21_TRHR_HEK293_agonist,1,1,"TOX21_TRHR_HEK293_Agonist  used a type of biochemical reporter where gain-of-signal activity can be used to understand changes in the receptor activation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.",agonist,percent_activity,0,TRH,gain,protein,receptor,gpcr,thyrotropin-releasing hormone receptor,0,0,1,7872,43086,671,TOX21_TRHR_HEK293_agonist,"TOX21_TRHR_HEK293_Agonist is one of 2 assay components measured in the TOX21_TRHR_HEK293 assay. It is designed to make measurements of intracellular calcium, a form of biochemical reporter, as detected with Fluorescence intensity signals by FDSS 7000EX kinetic plate reader technology.","Thyrotropin-releasing hormone (TRH) receptor (TRHR) is a G-protein-coupled receptor which binds the tripeptide thyrotropin releasing hormone. TRHR is found in the brain and, when bound by TRH, acts (through phospholipase C) to increase intracellular inositol trisphosphate. It plays a crucial role in the anterior pituitary where it controls the synthesis and secretion of thyroid stimulating hormone and prolactin. Intracellular calcium is measured as an indicator of Gq-coupled human thyrotropin-releasing hormone receptor (TRHR) activation using fluorescent detection in a TRHR-Hek293 cell-based assay. Activation of this GPCR is indicated by increased intracellular calcium as measured in this cell-based fluorescent reporter assay.",single,biochemical reporter,intracellular calcium,receptor activation,Fluorescence,Fluorescence intensity,FDSS 7000EX kinetic plate reader,chemical,intracellular calcium,chemical,intracellular calcium,7,TOX21_TRHR_HEK293,"TOX21_TRHR_HEK293 assay is a cell-based assay, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate. It has the potential to screen G protein-coupled receptors. A compound/drug can either activate (agonist) or suppress (antagonist) GPCRs that can be monitored by levels of intracellular calcium. Using this assay, the Tox21 10K compound library was screened to identify potential TRHR agonists.",20.0,9606.0,human,kidney,cell line,,HEK293,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7690.0,75.0,7615.0
1103,2365,2372,TOX21_TRHR_HEK293_antagonist,1,1,"TOX21_TRHR_HEK293_Antagonist  used a type of biochemical reporter where loss-of-signal activity can be used to understand changes in the receptor activation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the gpcr intended target family, where the subfamily is thyrotropin-releasing hormone receptor.",antagonist,percent_activity,0,1 nM T293,loss,protein,receptor,gpcr,thyrotropin-releasing hormone receptor,0,0,1,7872,43086,671,TOX21_TRHR_HEK293_antagonist,"TOX21_TRHR_HEK293_Antagonist is one of 2 assay components measured in the TOX21_TRHR_HEK293 assay. It is designed to make measurements of intracellular calcium, a form of biochemical reporter, as detected with Fluorescence intensity signals by FDSS 7000EX kinetic plate reader technology.","Thyrotropin-releasing hormone (TRH) receptor (TRHR) is a G-protein-coupled receptor which binds the tripeptide thyrotropin releasing hormone. TRHR is found in the brain and, when bound by TRH, acts (through phospholipase C) to increase intracellular inositol trisphosphate. It plays a crucial role in the anterior pituitary where it controls the synthesis and secretion of thyroid stimulating hormone and prolactin. Inactivation of this GPCR is indicated by decreased intracellular calcium as measured in this cell-based fluorescent assay.",single,biochemical reporter,intracellular calcium,receptor activation,Fluorescence,Fluorescence intensity,FDSS 7000EX kinetic plate reader,chemical,intracellular calcium,chemical,intracellular calcium,7,TOX21_TRHR_HEK293,"TOX21_TRHR_HEK293 assay is a cell-based assay, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 24 hours after chemical dosing in a 1536-well plate. It has the potential to screen G protein-coupled receptors. A compound/drug can either activate (agonist) or suppress (antagonist) GPCRs that can be monitored by levels of intracellular calcium. Using this assay, the Tox21 10K compound library was screened to identify potential TRHR agonists.",20.0,9606.0,human,kidney,cell line,,HEK293,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7628.0,67.0,7561.0
1104,2366,2373,TOX21_CASP3_HEPG2,1,1,"The assay component endpoint  TOX21_CASP3_HEPG2 was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. The TOX21_CASP3_HEPG2 assay is a homogeneous, luminescent assay that measures caspase-3 activity following compound treatment as an indicator of induction of apoptosis. Gain-of-signal activity can be used to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to apoptosis, where the subfamily is caspase.",inducer,percent_activity,0,Staurosporine,gain,cellular,cellular,apoptosis,caspase,0,0,1,7872,46890,672,TOX21_CASP3_HEPG2,TOX21_CASP3_HEPG2 is a component of the TOX21_CASP3_HEPG2 assay. This component measures caspase activity using the Caspase-Glo 3/7 assay system.,"Apoptosis is a process of programmed cell death and plays a central role in the development of multicellular organisms. It is a highly regulated process and induces cell death by activating caspases, which are the members of cysteine aspartic acid-specific protease (caspase) family. Caspases involved in apoptosis are classified by their mechanism of action as initiator caspases (caspase-2, -8, -9 and -10) and executioner caspases (caspase-3, -6, and -7). Inhibition of apoptosis results in number of cancers, autoimmune diseases, inflammatory diseases and viral infection.",single,inducible reporter,caspase activity,apoptosis,Luminescence,Bioluminescence,Caspase-Glo 3/7,substrate,Caspase-Glo 3/7 reagent,chemical,ATP,7,TOX21_CASP3_HEPG2,"The TOX21_CASP3_HEPG2 is a cell-based, single-readout assay that uses HepG2, a human liver cell line, with measurements taken at 16 hours after chemical dosing on a microplate: 1536-well plate. To identify small molecule compounds that induce apoptosis, a homogeneous, luminescent Caspase-Glo 3/7 assay was used. HepG2 cells were used to screen Tox21 libraries for identifying caspase-3/7 activity inducers. Cytotoxicity of the compounds was tested in parallel by measuring the cell viability using CellTiter-Fluor assay system in the same wells.",16.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7584.0,65.0,7519.0
1106,2368,2375,TOX21_CASP3_CHO,1,1,"The assay component endpoint  TOX21_CASP3_CHO was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. The TOX21_CASP3_CHO assay is a homogeneous, luminescent assay that measures caspase-3 activity following chemical treatment as an indicator of induction of apoptosis. Gain-of-signal activity can be used to understand changes in apoptosis. To generalize the intended target to other relatable targets, this assay endpoint is annotated to apoptosis, where the subfamily is caspase.",inducer,percent_activity,0,Staurosporine,gain,cellular,cellular,apoptosis,caspase,0,0,1,7872,46890,678,TOX21_CASP3_CHO,TOX21_CASP3_CHO is a component of the TOX21_CASP3_CHO assay. This component measures caspase activity using the Caspase-Glo 3/7 assay system.,"Apoptosis is a process of programmed cell death and plays a central role in the development of multicellular organisms. It is a highly regulated process and induces cell death by activating caspases, which are the members of cysteine aspartic acid-specific protease (caspase) family. Caspases involved in apoptosis are classified by their mechanism of action as initiator caspases (caspase-2, -8, -9 and -10) and executioner caspases (caspase-3, -6, and -7). Inhibition of apoptosis results in number of cancers, autoimmune diseases, inflammatory diseases and viral infection.",single,inducible reporter,caspase activity,apoptosis,Luminescence,Bioluminescence,Caspase-Glo 3/7,substrate,Caspase-Glo 3/7 reagent,chemical ,ATP,7,TOX21_CASP3_CHO,"The TOX21_CASP3_CHO is a cell-based, single-readout assay that uses CHO-K1, a hamster ovary cell line, with measurements taken at 16 hours after chemical dosing on a microplate: 1536-well plate.  To identify small molecule compounds that induce apoptosis, a homogeneous, luminescent Caspase-Glo 3/7 assay was used. Wild type CHO-K1 cells were used to screen Tox21 libraries for identifying caspase-3/7 activity inducers. Cytotoxicity of the compounds was tested in parallel by measuring the cell viability using CellTiter-Fluor assay system in the same wells.",16.0,10029.0,chinese hamster,ovary,cell line,,CHO-K1,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7749.0,21.0,7728.0
1110,2372,2379,TOX21_SBE_BLA_Antagonist_ratio,1,1,"Data from the assay component TOX21_SBE_BLA_Antagonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SBE_BLA_Antagonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, loss-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TGFB1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor receptor intended target family, where subfamily is transforming growth factor beta.",ratio,percent_activity,0,,loss,protein,receptor,growth factor receptor,transforming growth factor beta,0,0,1,7872,46890,679,TOX21_SBE_BLA_Antagonist_ratio,TOX21_SBE_BLA_Antagonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"Transforming growth factor beta (TGF-beta) superfamily consists of a large number of structurally related dimeric proteins that act as hormones or local mediators in regulating a wide range of biological functions. This superfamily includes TGF-betas themselves, the bone morphogenetic proteins (BMPs) and the activins. These ligands induce oligomerization of serine/threonine receptor kinases and phosphorylate the cytoplasmic signaling molecules of Smad protein family.",single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_SBE_BLA_Antagonist,"The TOX21_SBE_BLA_Antagonist is a cell-based, single-readout assay that uses HEK293T , a human kidney cell line, with measurements taken at 5 hours after chemical dosing on a microplate: 1536-well plate. This cell line contains a beta-lactamase reporter gene under control of the Smad binding element (SBE) stably integrated into HEK 293T cells. Cytotoxicity of the compounds was tested in parallel by measuring the cell viability using CellTiter-Glo assay system in the same wells.",5.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7267.0,494.0,6773.0
1114,2376,2383,TOX21_SBE_BLA_Agonist_ratio,1,1,"Data from the assay component TOX21_SBE_BLA_Agonist_ratio was analyzed into 1 assay endpoint. This assay endpoint, TOX21_SBE_BLA_Agonist_ratio, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to the gene TGFB1. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints and this ratio serves a reporter gene function to understand target activity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the growth factor receptor intended target family, where subfamily is transforming growth factor beta.",ratio,percent_activity,0,TGFb,gain,protein,receptor,growth factor receptor,transforming growth factor beta,0,0,1,7872,46778,680,TOX21_SBE_BLA_Agonist_ratio,TOX21_SBE_BLA_Agonist_ratio is an assay readout measuring reporter gene via receptor activity and designed using inducible reporter (beta lactamase induction) detected with GAL4 b-lactamase reporter gene. The signal is derived from the ratio of cleaved (ch2) to uncleaved (ch1) reporter gene substrate used as the measure of target activity.,"Transforming growth factor beta (TGF-beta) superfamily consists of a large number of structurally related dimeric proteins that act as hormones or local mediators in regulating a wide range of biological functions. This superfamily includes TGF-betas themselves, the bone morphogenetic proteins (BMPs) and the activins. These ligands induce oligomerization of serine/threonine receptor kinases and phosphorylate the cytoplasmic signaling molecules of Smad protein family.",single,inducible reporter,beta lactamase induction,regulation of transcription factor activity,Fluorescence,Fluorescence intensity,GAL4 b-lactamase reporter gene,substrate,CCF4-AM,protein,receptor,7,TOX21_SBE_BLA_Agonist,"The TOX21_SBE_BLA_Agonist is a cell-based, single-readout assay that uses HEK293T , a human kidney cell line, with measurements taken at 5 hours after chemical dosing on a microplate: 1536-well plate. This cell line contains a beta-lactamase reporter gene under control of the Smad binding element (SBE) stably integrated into HEK 293T cells. Cytotoxicity of the compounds was tested in parallel by measuring the cell viability using CellTiter-Glo assay system in the same wells.",5.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 1536-well plate,cell-based,cell-based format,single,DMSO,,Selected assays,7769.0,15.0,7754.0
1116,2386,2393,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist,1,1,"Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist, was analyzed in the positive analysis fitting direction relative to DHT as the baseline of activity. 

Using a type of binding reporter, measures of receptor for loss-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.",binding,percent_activity,0,DMSO,loss,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1964,13769,681,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Antagonist is one of four assay components measured from the UPITT_AR_TIF2_PPIB assay. It is designed to make measurements of red fluorescence localized in the nucleolar region of the cell nucleus as detected with high-content fluorescent imaging.,Loss of DHT-induced red fluorescence in nucleolar region of the cell nucleus is consistent with antagonism of human androgen receptor activity [GeneSymbol: AR | GeneID: 367 |,single,binding reporter,protein-protein binding,receptor binding,Fluorescence,Optical microscopy: Fluorescence microscopy,HCS Fluorescent Imaging,,,protein,receptor binding,25,UPITT_AR_TIF2_PPIB,"UPITT_AR_TIF2_PPIB is a cell-based, high-content imaging assay that uses U2OS, a human osteosarcoma cell line, expressing a human androgen receptor fused to red fluorescent protein and the coactivator TIF2 fused to green fluorescent protein. ",3.0,9606.0,human,bone,cell line,,U2OS,,microplate: 384-well plate,cell-based,protein complex format,image-based,DMSO,0.5,Selected assays,1735.0,279.0,1456.0
1117,2387,2394,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist,1,1,"Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the baseline of activity. 

Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.",binding,percent_activity,0,dihydroxytestosterone (DHT),gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1964,13742,681,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Agonist is one of four assay components measured from the UPITT_AR_TIF2_PPIB assay. It is designed to make measurements of red fluorescence localized in the nucleolar region of the cell nucleus as detected with high-content fluorescent imaging.,Increased red fluorescence in nucleolar region of the cell nucleus is consistent with agonism of human androgen receptor activity [GeneSymbol: AR | GeneID: 367 |,single,binding reporter,protein-protein binding,receptor binding,Fluorescence,Optical microscopy: Fluorescence microscopy,HCS Fluorescent Imaging,,,protein,receptor binding,25,UPITT_AR_TIF2_PPIB,"UPITT_AR_TIF2_PPIB is a cell-based, high-content imaging assay that uses U2OS, a human osteosarcoma cell line, expressing a human androgen receptor fused to red fluorescent protein and the coactivator TIF2 fused to green fluorescent protein. ",3.0,9606.0,human,bone,cell line,,U2OS,,microplate: 384-well plate,cell-based,protein complex format,image-based,DMSO,0.5,Selected assays,1751.0,64.0,1687.0
1118,2390,2397,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist,1,1,"Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist, was analyzed in the positive analysis fitting direction relative to DHT as the baseline of activity. 

Using a type of binding reporter, measures of receptor for loss-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.",binding,percent_activity,0,DMSO,loss,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1964,13769,681,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Antagonist is one of four assay components measured from the UPITT_AR_TIF2_PPIB assay. It is designed to make measurements of the ratio of red fluorescence localized in the nucleolar region of the cell nucleus to red fluorescence localized in the cytoplasm as detected with high-content fluorescent imaging.,Decrease of the ratio of DHT-induced red fluorescence in nucleolar region of the cell nucleus to the red fluorescence localized in the cytoplasm is consistent with antagonism of human androgen receptor activity [GeneSymbol: AR | GeneID: 367 |,single,binding reporter,protein-protein binding,receptor binding,Fluorescence,Optical microscopy: Fluorescence microscopy,HCS Fluorescent Imaging,,,protein,receptor binding,25,UPITT_AR_TIF2_PPIB,"UPITT_AR_TIF2_PPIB is a cell-based, high-content imaging assay that uses U2OS, a human osteosarcoma cell line, expressing a human androgen receptor fused to red fluorescent protein and the coactivator TIF2 fused to green fluorescent protein. ",3.0,9606.0,human,bone,cell line,,U2OS,,microplate: 384-well plate,cell-based,protein complex format,image-based,DMSO,0.5,Selected assays,1843.0,131.0,1712.0
1119,2391,2398,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist,1,1,"Data from the assay component UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist was analyzed into 1 assay endpoint. 

This assay endpoint, UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist, was analyzed in the positive analysis fitting direction relative to DMSO as the baseline of activity. 

Using a type of binding reporter, measures of receptor for gain-of-signal activity can be used to understand the binding at the pathway-level as it relates to the gene AR.",binding,percent_activity,0,dihydroxytestosterone (DHT),gain,pathway,pathway-specified,nuclear receptor,steroidal,0,0,1,1964,13742,681,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist,UPITT_HCI_U2OS_AR_TIF2_Nucleoli_Cytoplasm_Ratio_Agonist is one of four assay components measured from the UPITT_AR_TIF2_PPIB assay. It is designed to make measurements of the ratio of red fluorescence localized in the nucleolar region of the cell nucleus to red fluorescence localized in the cytoplasm as detected with high-content fluorescent imaging.,Increased ratio of DHT-induced red fluorescence in nucleolar region of the cell nucleus to the red fluorescence localized in the cytoplasm is consistent with agonism of human androgen receptor activity [GeneSymbol: AR | GeneID: 367 |,single,binding reporter,protein-protein binding,receptor binding,Fluorescence,Optical microscopy: Fluorescence microscopy,HCS Fluorescent Imaging,,,protein,receptor binding,25,UPITT_AR_TIF2_PPIB,"UPITT_AR_TIF2_PPIB is a cell-based, high-content imaging assay that uses U2OS, a human osteosarcoma cell line, expressing a human androgen receptor fused to red fluorescent protein and the coactivator TIF2 fused to green fluorescent protein. ",3.0,9606.0,human,bone,cell line,,U2OS,,microplate: 384-well plate,cell-based,protein complex format,image-based,DMSO,0.5,Selected assays,1775.0,48.0,1727.0
1120,2442,2440,CCTE_Simmons_MITO_basal_resp_rate,1,1,"Data from the assay component CCTE_Simmons_MITO_basal_resp_rate was analyzed at the endpoint, CCTE_Simmons_MITO_basal_resp_rate_OCR, with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of respirometric reporter, measures of basal respiration for gain or loss-of-signal activity can be used to understand cellular oxygen consumption as it relates to cellular respiration. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mitochondria intended target family, where the subfamily is respiration.",cellular respiration,fold_induction,0,Fenpyroximate,bidirectional,cellular,cellular,mitochondria,respiration,0,0,1,265,539,682,CCTE_Simmons_MITO_basal_resp_rate,"CCTE_Simmons_MITO_basal_resp_rate is one of 4 assay components calculated from the CCTE_Simmons_MITO assay. It is designed to make measurements of basal respiration using a form of respirometric reporter, as detected with bioluminescence signals by Seahorse XF96 technology. ","Basal respiration rate is caculated from the oxygen consumption rates at T6 (36 min) following test compound injection, at 18 min elapsed exposure.",single,respirometric reporter,basal respiration,cellular oxygen consumption,Fluorescence,oxygen consumption rate,Seahorse XF96,fluorescent oxygen sensor,Seahorse assay cartridge,chemical,dissolved oxygen,17,CCTE_Simmons_MITO,"CCTE_Simmons_MITO is cell-based, respirometric assay using HepG2 cells and a Seahorse XF Analyzer to measure oxygen consumption rates over four temporal phases spanning a total of 72 minutes: pre-injection (pre-treatment), basal (following test compound injection), maximal (following FCCP uncoupler injection), and inhibited (following rotenone/antimycin A injection)",1.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 96-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,157.0,65.0,92.0
1121,2444,2441,CCTE_Simmons_MITO_max_resp_rate,1,1,"Data from the assay component CCTE_Simmons_MITO_max_resp_rate was analyzed at the endpoint, CCTE_Simmons_MITO_max_resp_rate_OCR, with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of respirometric reporter, measures of maximal respiration for gain or loss-of-signal activity can be used to understand cellular oxygen consumption as it relates to cellular respiration. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the mitochondria intended target family, where the subfamily is respiration.",cellular respiration,fold_induction,0,Fenpyroximate,bidirectional,cellular,cellular,mitochondria,respiration,0,0,1,265,539,682,CCTE_Simmons_MITO_max_resp_rate,"CCTE_Simmons_MITO_max_resp_rate is one of 4 assay components calculated from the CCTE_Simmons_MITO assay. It is designed to make measurements of maximal respiration using a form of respirometric reporter, as detected with bioluminescence signals by Seahorse XF96 technology. ","Maximal respiration is calculated as oxygen consumption rates at T9 (54 min)following test compound injection at T6 and FCCP (uncoupler reagent), at 36 min elapsed exposure.",single,respirometric reporter,maximal respiration,cellular oxygen consumption,Fluorescence,oxygen consumption rate,Seahorse XF96,fluorescent oxygen sensor,Seahorse assay cartridge,chemical,dissolved oxygen,17,CCTE_Simmons_MITO,"CCTE_Simmons_MITO is cell-based, respirometric assay using HepG2 cells and a Seahorse XF Analyzer to measure oxygen consumption rates over four temporal phases spanning a total of 72 minutes: pre-injection (pre-treatment), basal (following test compound injection), maximal (following FCCP uncoupler injection), and inhibited (following rotenone/antimycin A injection)",1.0,9606.0,human,liver,cell line,,HepG2,adherent,microplate: 96-well plate,cell-based,cell-based format,single,DMSO,0.5,Selected assays,183.0,70.0,113.0
1124,2451,2445,CCTE_Harrill_HTTr_Viability_MCF7,1,1,"The assay component endpoint CCTE_Harrill_HTTr_Viability_MCF7 was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain-of-signal activity can be used to evaluate membrane integrity using propidium iodide dye exclusion to understand changes in cytotoxicity. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cytotoxicity.",viability,percent_activity,0,1 nM N6,gain,cellular,cellular,cell cycle,cytotoxicity,0,0,1,2050,4576,665,CCTE_Harrill_HTTr_Viability_MCF7,One of seven assay components measured from the CCTE_Harrill_HTTr_Viability assay. This was part of a full screening experiment. This is a cell-based assay that evaluates cell viability in MCF-7 cells cultured in DMEM + 10% fetal bovine serum. High content imaging is used to evaluate membrane integrity using propidium iodide dye exclusion. Measurements are taken at 6 hours after chemical dosing in 384-well format.,propidium iodide is membrane impermeant and binds to DNA in dead/dying cells.,multiplexed,viability reporter,membrane impermeable stain for DNA,cell cycle,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,propidium iodide,cellular,nuclear DNA,17,CCTE_Harrill_HTTr_Viability,This is a cell-based assay that evaluates cell viability using high content imaging  to evaluate membrane integrity using propidium iodide dye exclusion in a 384 well format.,1.0,9606.0,human,breast,cell line,,MCF7,,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,,Selected assays,2009.0,21.0,1988.0
1126,2453,2444,CCTE_Harrill_HTTr_CellCount_MCF7,1,1,"The assay component endpoint CCTE_Harrill_HTTr_CellCount_MCF7 was analyzed with bidirectional fitting relation to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand changes in cell count. To generalize the intended target to other relatable targets, this assay endpoint is annotated to cell cycle, where the subfamily is cell count.",viability,percent_activity,0,1 nM N6,loss,cellular,cellular,cell cycle,cell count,0,0,1,2050,4576,683,CCTE_Harrill_HTTr_CellCount_MCF7,This is a cell-based assay that evaluates cell viability and cell growth in MCF-7 cells. This was part of a full screening experiment. High content imaging is used to count the number of Hoechst-labeled nuclei that are present in an assay well in 384-well format.,Count of Hoechst-labeled nuclei indicates live cell number,multiplexed,viability reporter,cell number,cell cycle,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain,Hoechst-33342 dye,cellular,nucleus,17,CCTE_Harrill_HTTr_CellCount,This is a cell-based assay that evaluates cell viability and cell growth using high content imaging to count the number of Hoechst-labeled nuclei that are present in an assay well in 384-well format.,1.0,9606.0,human,breast,cell line,,MCF7,,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,,Selected assays,2024.0,15.0,2009.0
1127,2454,2447,CCTE_Shafer_MEA_acute_spike_number,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_spike_number was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_spike_number, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,tetrodotoxin,bidirectional,extracellular,action potential,neuroactivity,neural network function: activity,0,0,1,509,1496,877,CCTE_Shafer_MEA_acute_spike_number,CCTE_Shafer_MEA_acute_spike_number is a component of the CCTE_Shafer_MEA_acute assay. It measures the total number of spikes (action potential firings) in a 40-minute recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The recordings before and after chemical treatment are used to calculate a percent change in the spike number in each well. ,The number of spikes is a measure of general activity in the network. Changes in electrical activity are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,399.0,128.0,271.0
1128,2456,2448,CCTE_Shafer_MEA_acute_firing_rate_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_firing_rate_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_firing_rate_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,tetrodotoxin,bidirectional,extracellular,action potential,neuroactivity,neural network function: activity,0,0,1,509,1496,877,CCTE_Shafer_MEA_acute_firing_rate_mean,CCTE_Shafer_MEA_acute_firing_rate_mean is a component of the CCTE_Shafer_MEA_acute assay. It measures the frequency number of spikes (action potential firings) as the total number of spikes divided by the length of the recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The firing rate is divided by the number of electrodes to report a well-mean value. The recordings before and after chemical treatment are used to calculate a percent change in the mean firing rate in each well.,The mean firing rate is a measure of general activity in the network. Changes in electrical activity are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,394.0,120.0,274.0
1129,2458,2449,CCTE_Shafer_MEA_acute_burst_number,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_burst_number was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_burst_number, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: activity,0,0,1,509,1496,877,CCTE_Shafer_MEA_acute_burst_number,CCTE_Shafer_MEA_acute_burst_number is a component of the CCTE_Shafer_MEA_acute assay. It measures the total number of single-electrode bursts (temporally-clustered groups of action potential firing) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The recordings before and after chemical treatment are used to calculate a percent change in the burst number in each well.,The number of bursts is a measure of general activity in the network. Changes in electrical activity are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,393.0,90.0,303.0
1130,2460,2450,CCTE_Shafer_MEA_acute_burst_duration_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_burst_duration_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_burst_duration_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: bursting activity,0,0,1,509,1226,877,CCTE_Shafer_MEA_acute_burst_duration_mean,CCTE_Shafer_MEA_acute_burst_duration_mean is a component of the CCTE_Shafer_MEA_acute assay. It measures the average time from the first spike (action potential firing) to the last spike in a single-electrode burst (temporally-clustered group of spikes) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The recordings before and after chemical treatment are used to calculate a percent change in the mean burst duration in each well.,The mean burst duration is a measure of bursting activity in a neural network. Changes in electrical activity are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,459.0,23.0,436.0
1131,2462,2451,CCTE_Shafer_MEA_acute_per_burst_spike_number_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_per_burst_spike_number_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_per_burst_spike_number_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: bursting activity,0,0,1,509,1226,877,CCTE_Shafer_MEA_acute_per_burst_spike_number_mean,CCTE_Shafer_MEA_acute_per_burst_spike_number_mean is a component of the CCTE_Shafer_MEA_acute assay. It measures the average number of spikes (action potential firings) in a single-electrode burst (temporally-clustered group of spikes) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The recordings before and after chemical treatment are used to calculate a percent change in the mean number of spikes per burst in each well.,The mean number of spikes in a burst is a measure of bursting activity in a neural network. Changes in electrical activity are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,442.0,68.0,374.0
1133,2466,2453,CCTE_Shafer_MEA_acute_burst_percentage_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_burst_percentage_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_burst_percentage_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: bursting activity,0,0,1,509,1327,877,CCTE_Shafer_MEA_acute_burst_percentage_mean,CCTE_Shafer_MEA_acute_burst_percentage_mean is a component of the CCTE_Shafer_MEA_acute assay. It measures the percentage of spikes (action potential firing) in a single-electrode burst (temporally-clustered groups of spikes) as the number of spikes in bursts divided by the total number of spikes during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The average of the burst percentages across electrodes is calculated to report a well-level value. The recordings before and after chemical treatment are used to calculate a percent change in the mean burst percentage in each well.,The mean percent of spikes in bursts is a measure of bursting activity in a neural network. Changes in electrical activity are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,380.0,111.0,269.0
1134,2468,2454,CCTE_Shafer_MEA_acute_burst_percentage_std,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_burst_percentage_std was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_burst_percentage_std, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: bursting activity,0,0,1,509,1274,877,CCTE_Shafer_MEA_acute_burst_percentage_std,CCTE_Shafer_MEA_acute_burst_percentage_std is a component of the CCTE_Shafer_MEA_acute assay. It measures the percentage of spikes (action potential firing) in a single-electrode burst (temporally-clustered groups of spikes) as the number of spikes in bursts divided by the total number of spikes during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The standard deviation of the burst percentages across electrodes is calculated to report a well-level value. The recordings before and after chemical treatment are used to calculate a percent change in the standard deviation of the burst percentage in each well.,The standard deviation of the percent of spikes in bursts is a measure of bursting activity in a neural network. Changes in electrical activity are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,382.0,39.0,343.0
1135,2470,2455,CCTE_Shafer_MEA_acute_per_network_burst_spike_number_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_per_network_burst_spike_number_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_per_network_burst_spike_number_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1239,877,CCTE_Shafer_MEA_acute_per_network_burst_spike_number_mean,CCTE_Shafer_MEA_acute_per_network_burst_spike_number_mean is a component of the CCTE_Shafer_MEA_acute assay. It measures the average number of spikes (action potential firings) in a network burst (temporally-clustered group of spikes across multiple electrodes) as the total number of spikes in a network burst divided by the number of network bursts during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The recordings before and after chemical treatment are used to calculate a percent change in the mean number of spikes in a network burst in each well.,Networks bursts occur as the result of network connectivity. Changes in the mean number of spikes in a network burst are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,398.0,47.0,351.0
1136,2472,2456,CCTE_Shafer_MEA_acute_per_network_burst_spike_number_std,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_burst_spike_number_std was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_burst_spike_number_std, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1219,877,CCTE_Shafer_MEA_acute_per_network_burst_spike_number_std,CCTE_Shafer_MEA_acute_per_network_burst_spike_number_std is a component of the CCTE_Shafer_MEA_acute assay. It measures the standard deviation of the number of spikes (action potential firings) in a network burst (temporally-clustered group of spikes across multiple electrodes) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The recordings before and after chemical treatment are used to calculate a percent change in the standard deviation of the number of spikes in network bursts in each well.,Networks bursts occur as the result of network connectivity. Changes in the standard deviation of the number of spikes in a network burst are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,409.0,67.0,342.0
1137,2474,2457,CCTE_Shafer_MEA_acute_per_network_burst_electrodes_number_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_per_network_burst_electrodes_number_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_per_network_burst_electrodes_number_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1239,877,CCTE_Shafer_MEA_acute_per_network_burst_electrodes_number_mean,CCTE_Shafer_MEA_acute_per_network_burst_electrodes_number_mean is a component of the CCTE_Shafer_MEA_acute assay. It measures the average number of electrodes with activity during a network burst (a temporally-clustered group of action potential firing across multiple electrodes) in a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The recordings before and after chemical treatment are used to calculate a percent change in the mean number of electrodes participating in network bursts in each well.,Networks bursts occur as the result of network connectivity. Changes in the average number of electrodes participating in a network burst are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,426.0,57.0,369.0
1138,2476,2458,CCTE_Shafer_MEA_acute_network_burst_percentage,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_network_burst_percentage was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_network_burst_percentage, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1239,877,CCTE_Shafer_MEA_acute_network_burst_percentage,CCTE_Shafer_MEA_acute_network_burst_percentage is a component of the CCTE_Shafer_MEA_acute assay. It measures the percent of spikes (action potential firings) in network bursts (temporally-clustered groups of spikes across multiple electrodes) as the number of spikes occuring in network bursts divided by the total number of spikes during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The recordings before and after chemical treatment are used to calculate a percent change in the network burst percentage in each well.,Networks bursts occur as the result of network connectivity. Changes in the percent of spikes in a network burst are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,377.0,83.0,294.0
1139,2478,2459,CCTE_Shafer_MEA_acute_cross_correlation_area,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_cross_correlation_area was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_cross_correlation_area, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1496,877,CCTE_Shafer_MEA_acute_cross_correlation_area,CCTE_Shafer_MEA_acute_cross_correlation_area is a component of the CCTE_Shafer_MEA_acute assay. It measures the area under the well-wide pooled inter-electrode cross-correlation of action potential firing (not normalized to auto-correlations) within a window centered around 0 for the phase lag during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The recordings before and after chemical treatment are used to calculate a percent change in the cross correlation area in each well.,The cross correlation area is a measure of the synchrony of a neural network. Changes in the synchrony are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,398.0,46.0,352.0
1140,2480,2460,CCTE_Shafer_MEA_acute_cross_correlation_HWHM,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_cross_correlation_HWHM was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_cross_correlation_HWHM, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1496,877,CCTE_Shafer_MEA_acute_cross_correlation_HWHM,CCTE_Shafer_MEA_acute_cross_correlation_HWHM is a component of the CCTE_Shafer_MEA_acute assay. It measures the distance along the x-axis (phase lag) from the left half maximum height to the center of the cross-correlogram of action potential firing during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. Smaller values indicate a narrower correlogram (greater synchrony). The recordings before and after chemical treatment are used to calculate a percent change in the half width at half maximum of the cross-correlogram in each well.,The half width at half maximum of the cross-correlogram is a measure of the synchrony of a neural network. Changes in the synchrony are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,404.0,106.0,298.0
1141,2482,2461,CCTE_Shafer_MEA_acute_synchrony_index,1,1,"Data from the assay component CCTE_Shafer_MEA_acute_synchrony_index was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_acute_synchrony_index, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neuroactivity,neural network function: network connectivity,0,0,1,509,1274,877,CCTE_Shafer_MEA_acute_synchrony_index,CCTE_Shafer_MEA_acute_synchrony_index is a component of the CCTE_Shafer_MEA_acute assay. It measures the synchrony of the neural network as a unitless measure between 0 (low synchrony) to 1 (high synchrony) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The recordings before and after chemical treatment are used to calculate a percent change in the synchrony index in each well.,The synchrony index is a measure of the synchrony of a neural network. Changes in the synchrony are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_acute,"CCTE_Shafer_MEA_acute assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_acute assay uses primary cultures of rat cortical neurons. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. Baseline 40-minute recordings are made on days post-plating 13 or 15, followed by a secondary 40-minute recording after chemical exposure.",0.666666666666667,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.2,Selected assays,380.0,110.0,270.0
1142,2484,2462,CCTE_Deisenroth_AIME_96WELL_LUC_Active,1,1,"CCTE_Deisenroth_AIME_96WELL_LUC_Active is a component of the CCTE_Deisenroth_AIME_96WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates reporter induction in metabolism positive mode. Using a type of inducible reporter in VM7Luc cells, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to xenobiotic metabolism and the gene ESR1. This assay endpoint, CCTE_Deisenroth_AIME_96WELL_LUC_Active, was analyzed in the positive analysis fitting direction relative to 17beta-estradiol as the positive control in the ERTA assay. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,17beta-estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,74,270,684,CCTE_Deisenroth_AIME_96WELL_LUC_Active,"CCTE_Deisenroth_AIME_96WELL_LUC_Active is one of four assay components measured or calculated from the CCTE_Deisenroth_AIME_96WELL assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by luciferase-coupled ATP quantitation technology.",CCTE_Deisenroth_AIME_96WELL_LUC_Active was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [Bright-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].,single,inducible reporter,mRNA induction,regulation of estrogen receptor activity,Luminescence,Luminescence intensity,multimode microplate reader,inducer,ERE linked luciferase reporter enzyme,rna,mRNA,17,CCTE_Deisenroth_AIME_96WELL,"CCTE_Deisenroth_AIME_96WELL (AIME metabolism assay) is a cell-based, single-readout assay that uses VM7Luc4E2, a human mammary gland/breast cell line, with measurements taken at 24 hour after chemical dosing in a 96-well plate.",24.0,9606.0,human,mammary gland/breast,cell line,,VM7Luc4E2,adherent,microplate: 96-well plate,cell-based,cell-based format,single,DMSO,0.2,Selected assays,54.0,15.0,39.0
1146,2488,2466,CCTE_Deisenroth_AIME_384WELL_LUC_Active,1,1,"CCTE_Deisenroth_AIME_384WELL_LUC_Active is a component of the CCTE_Deisenroth_AIME_384WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates reporter induction in metabolism positive mode. Using a type of inducible reporter in VM7Luc cells, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to xenobiotic metabolism and the gene ESR1. This assay endpoint, CCTE_Deisenroth_AIME_384WELL_LUC_Active, was analyzed in the positive analysis fitting direction relative to 17beta-estradiol as the positive control in the ERTA assay. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,17beta-estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,769,4495,685,CCTE_Deisenroth_AIME_384WELL_LUC_Active,"CCTE_Deisenroth_AIME_384WELL_LUC_Active is one of four assay components measured or calculated from the CCTE_Deisenroth_AIME_384WELL assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by luciferase-coupled ATP quantitation technology.",CCTE_Deisenroth_AIME_384WELL_LUC_Active was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [Bright-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].,single,inducible reporter,mRNA induction,regulation of estrogen receptor activity,Luminescense,Luminescence intensity,multimode microplate reader,inducer,ERE linked luciferase reporter enzyme,rna,mRNA,17,CCTE_Deisenroth_AIME_384WELL,"CCTE_Deisenroth_AIME_384WELL (AIME metabolism assay) is a cell-based, single-readout assay that uses VM7Luc4E2, a human mammary gland/breast cell line, with measurements taken at 24 hour after chemical dosing in a 384-well plate.",24.0,9606.0,human,mammary gland/breast,cell line,,VM7Luc4E2,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.2,Selected assays,716.0,45.0,671.0
1147,2489,2467,CCTE_Deisenroth_AIME_384WELL_CTox_Active,1,1,"CCTE_Deisenroth_AIME_384WELL_CTox_Active is a component of the CCTE_Deisenroth_AIME_384WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates cytotoxicity in metabolism positive mode. Using a type of flourescent probe in VM7Luc cells, loss-of-signal activity can be used to understand loss of viability. This assay endpoint, CCTE_Deisenroth_AIME_384WELL_CTox_Active, was analyzed with bidirectional fitting in the ERTA assay.",viability,log2_fold_induction,0,,loss,protein,protein-unspecified,protease,,0,0,1,769,3290,685,CCTE_Deisenroth_AIME_384WELL_CTox_Active,"CCTE_Deisenroth_AIME_384WELL_CTox_Active is one of four assay components measured or calculated from the CCTE_Deisenroth_AIME_384WELL assay. It is designed to make measurements of a protease substrate, a type of viabiliy indicator, as detected with substrate cleavage to a fluorescent probe in living cells.","CCTE_Deisenroth_AIME_384WELL_CTox_Active  is designed to make measurements of a protease substrate [Gly-Phe-AFCoumarin], a type of viabiliy indicator. The non-flourescent substrate is enzymatically converted to a fluorescent probe in living cells. Changes in the signal are indicative of cytotoxicity. ",single,inducible reporter,mRNA induction,regulation of estrogen receptor activity,Fluorescence,Fluorescence intensity,multimode microplate reader,protease substrate,Gly-Phe-AFCoumarin,chemical,fluorogenic probe,17,CCTE_Deisenroth_AIME_384WELL,"CCTE_Deisenroth_AIME_384WELL (AIME metabolism assay) is a cell-based, single-readout assay that uses VM7Luc4E2, a human mammary gland/breast cell line, with measurements taken at 24 hour after chemical dosing in a 384-well plate.",24.0,9606.0,human,mammary gland/breast,cell line,,VM7Luc4E2,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.2,Selected assays,671.0,55.0,616.0
1148,2490,2468,CCTE_Deisenroth_AIME_384WELL_LUC_Inactive,1,1,"CCTE_Deisenroth_AIME_384WELL_LUC_Inactive is a component of the CCTE_Deisenroth_AIME_384WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates reporter induction in metabolism negative mode. Using a type of inducible reporter in VM7Luc cells, gain-of-signal activity can be used to understand changes in the reporter gene as they relate to xenobiotic metabolism and the gene ESR1. This assay endpoint, CCTE_Deisenroth_AIME_384WELL_LUC_Inactive, was analyzed in the positive analysis fitting direction relative to 17beta-estradiol as the positive control in the ERTA assay. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the nuclear receptor intended target family, where the subfamily is steroidal.",reporter gene,percent_activity,0,17beta-estradiol,gain,protein,transcription factor,nuclear receptor,steroidal,0,0,1,769,4464,685,CCTE_Deisenroth_AIME_384WELL_LUC_Inactive,"CCTE_Deisenroth_AIME_384WELL_LUC_Inactive is one of four assay components measured or calculated from the CCTE_Deisenroth_AIME_384WELL assay. It is designed to make measurements of luciferase induction, a form of inducible reporter, as detected with bioluminescence signals by luciferase-coupled ATP quantitation technology.",CCTE_Deisenroth_AIME_384WELL_LUC_Inactive was designed to measure changes to bioluminescence signals produced from an enzymatic reaction involving the key substrate [Bright-Glo]. Changes are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372].,single,inducible reporter,mRNA induction,regulation of estrogen receptor activity,Luminescense,Luminescence intensity,multimode microplate reader,inducer,ERE linked luciferase reporter enzyme,rna,mRNA,17,CCTE_Deisenroth_AIME_384WELL,"CCTE_Deisenroth_AIME_384WELL (AIME metabolism assay) is a cell-based, single-readout assay that uses VM7Luc4E2, a human mammary gland/breast cell line, with measurements taken at 24 hour after chemical dosing in a 384-well plate.",24.0,9606.0,human,mammary gland/breast,cell line,,VM7Luc4E2,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.2,Selected assays,699.0,40.0,659.0
1149,2491,2469,CCTE_Deisenroth_AIME_384WELL_CTox_Inactive,1,1,"CCTE_Deisenroth_AIME_384WELL_CTox_Inactive is a component of the CCTE_Deisenroth_AIME_384WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively. This endpoint evaluates cytotoxicity in metabolism negative mode. Using a type of flourescent probe in VM7Luc cells, loss-of-signal activity can be used to understand loss of viability. This assay endpoint, CCTE_Deisenroth_AIME_384WELL_CTox_Inactive, was analyzed with bidirectional fitting in the ERTA assay.",viability,log2_fold_induction,0,,loss,protein,protein-unspecified,protease,,0,0,1,769,3197,685,CCTE_Deisenroth_AIME_384WELL_CTox_Inactive,"CCTE_Deisenroth_AIME_384WELL_CTox_Inactive is one of four assay components measured or calculated from the CCTE_Deisenroth_AIME_384WELL assay. It is designed to make measurements of a protease substrate, a type of viabiliy indicator, as detected with substrate cleavage to a fluorescent probe in living cells.","CCTE_Deisenroth_AIME_384WELL_CTox_Inactive  is designed to make measurements of a protease substrate [Gly-Phe-AFCoumarin], a type of viabiliy indicator. The non-flourescent substrate is enzymatically converted to a fluorescent probe in living cells. Changes in the signal are indicative of cytotoxicity. ",single,inducible reporter,mRNA induction,regulation of estrogen receptor activity,Fluorescence,Fluorescence intensity,multimode microplate reader,protease substrate,Gly-Phe-AFCoumarin,chemical,fluorogenic probe,17,CCTE_Deisenroth_AIME_384WELL,"CCTE_Deisenroth_AIME_384WELL (AIME metabolism assay) is a cell-based, single-readout assay that uses VM7Luc4E2, a human mammary gland/breast cell line, with measurements taken at 24 hour after chemical dosing in a 384-well plate.",24.0,9606.0,human,mammary gland/breast,cell line,,VM7Luc4E2,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.2,Selected assays,686.0,89.0,597.0
1150,2492,2470,CCTE_Deisenroth_AIME_384WELL_LUC_Shift,1,1,"CCTE_Deisenroth_AIME_384WELL_LUC_Shift is a component of the CCTE_Deisenroth_AIME_384WELL assay that measures the effect of retroftting the VM7Luc ERTA assay with the Alginate Immobolization of Metabolic Enzymes (AIME) metabolism method. AIME is optimized to impart phase I hepatic metabolism using phenobarbital/beta-naphthoflavone induced hepatic S9 from male Sprague Dawley rats. Parent chemicals are incubated for 2 hours in the AIME assay prior to transfer to the VM7Luc ERTA assay plate. The AIME metabolism assay is run simultaneously in negative (inactive) and positive (active) modes to evaluate the activity of parent and metabolites, respectively.                                                                                                                                                                                                                                                                                      This endpoint evaluates the shift in metabolism-dependent changes between positive (active) and negative (inactive) assay modes. The metabolic curve shift response is defined as the pairwise difference between the positive (AEID 2488) and negative (AEID 2490) normalized response values at each concentration for a given chemical across replicate experiments. The pairwise differences form the basis for a concentration-response curve. Standard curve fit analysis identfiied chemicals where the calculated shift was greater than the shift-derived baseline cutoff. A positive hit designation in this endpoint indicates a significant shift trend in the positive direction for bioactivation. ",reporter gene,percent_activity,0,17beta-estradiol,bidirectional,protein,transcription factor,nuclear receptor,steroidal,0,0,1,768,0,685,CCTE_Deisenroth_AIME_384WELL_LUC_Shift,CCTE_Deisenroth_AIME_384WELL_LUC_Shift is one of two analysis components calculated from the CCTE_Deisenroth_AIME_384WELL assay. It is designed to evaluate the shift in metabolism-dependent changes of the inducible luciferase reporter between positive (active) and negative (inactive) assay modes.,CCTE_Deisenroth_AIME_384WELL_LUC_Shift was designed to measure the shift in bioluminescence signals produced from an enzymatic reaction involving the key substrate [Bright-Glo]between metabolism positive (active) and negative (inactive) assay modes. Shifts are indicative of changes in transcriptional gene expression due to agonist activity regulated by the human estrogen receptor 1 [GeneSymbol:ESR1 | GeneID:2099 | Uniprot_SwissProt_Accession:P03372]. Positive shifts are indicative of bioactivation.,single,inducible reporter,mRNA induction,regulation of estrogen receptor activity,Luminescense,Luminescence intensity,multimode microplate reader,inducer,ERE linked luciferase reporter enzyme,rna,mRNA,17,CCTE_Deisenroth_AIME_384WELL,"CCTE_Deisenroth_AIME_384WELL (AIME metabolism assay) is a cell-based, single-readout assay that uses VM7Luc4E2, a human mammary gland/breast cell line, with measurements taken at 24 hour after chemical dosing in a 384-well plate.",24.0,9606.0,human,mammary gland/breast,cell line,,VM7Luc4E2,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.2,Selected assays,685.0,46.0,639.0
1151,2494,2471,CCTE_Shafer_MEA_dev_firing_rate_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_firing_rate_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_firing_rate_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: activity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_firing_rate_mean,"CCTE_Shafer_MEA_dev_firing_rate_mean is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the frequency of spikes (action potential firings) as the total number of spikes divided by the length of the recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The firing rate is averaged across the active electrodes to report a well-mean value. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",Mean firing rate is a measure of general activity in the network. Changes in electrical activity are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,330.0,66.0,264.0
1152,2496,2472,CCTE_Shafer_MEA_dev_burst_rate,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_burst_rate was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_burst_rate, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: activity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_burst_rate,"CCTE_Shafer_MEA_dev_burst_rate is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the frequency of single-electrode bursts (temporally-clustered groups of action potential firing) as the total number of bursts divided by the length of the recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The mean bursting rate is averaged across the active electrodes to report a well-mean value. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The mean bursting rate is a measure of general activity in the network. Changes in mean burst rate are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,323.0,64.0,259.0
1153,2498,2473,CCTE_Shafer_MEA_dev_active_electrodes_number,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_active_electrodes_number was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_active_electrodes_number, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: activity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_active_electrodes_number,"CCTE_Shafer_MEA_dev_active_electrodes_number is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the number of electrodes in a well with a mean firing rate of at least 5 spikes (action potential firings) per minute during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The number of active electrodes is a measure of general activity in the network. Changes in the number of active electrodes are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,317.0,112.0,205.0
1154,2500,2474,CCTE_Shafer_MEA_dev_bursting_electrodes_number,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_bursting_electrodes_number was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_bursting_electrodes_number, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: activity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_bursting_electrodes_number,"CCTE_Shafer_MEA_dev_bursting_electrodes_number is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the number of electrodes in a well with a burst rate of at least 1 burst (temporally-clustered group of action potential firing) every 2 minutes during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The number of actively bursting electrodes is a measure of general activity in a network. Changes in the number of actively bursting electrodes are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,324.0,116.0,208.0
1155,2502,2475,CCTE_Shafer_MEA_dev_per_burst_interspike_interval,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_per_burst_interspike_interval was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_per_burst_interspike_interval, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: bursting activity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_per_burst_interspike_interval,"CCTE_Shafer_MEA_dev_per_burst_interspike_interval is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the average time interval between spikes (action potential firings) within a single-electrode burst (temporally-clustered group of spikes) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The mean inter-spike interval within bursts is averaged across the actively bursting electrodes to report a well-mean value. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The inter-spike interval within bursts is a measure of bursting activity in the network. Changes in the inter-spike interval within bursts are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,324.0,60.0,264.0
1156,2504,2476,CCTE_Shafer_MEA_dev_per_burst_spike_percent,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_per_burst_spike_percent was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_per_burst_spike_percent, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: bursting activity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_per_burst_spike_percent,"CCTE_Shafer_MEA_dev_per_burst_spike_percent is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the percentage of spikes (action potential firings) in a single-electrode burst (temporally-clustered group of spikes) as the total number spikes in bursts divided by the total number of spikes during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The percent of spikes in bursts is averaged across the actively bursting electrodes to report a well-mean value. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The percent of spikes in bursts is a measure of bursting activity in a network. Changes in the percent of spikes in bursts are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,320.0,102.0,218.0
1157,2506,2477,CCTE_Shafer_MEA_dev_burst_duration_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_burst_duration_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_burst_duration_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: bursting activity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_burst_duration_mean,"CCTE_Shafer_MEA_dev_burst_duration_mean is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the average time interval from the first spike (action potential firing) to the last spike in a singe-electrode burst (temporally-clustered group of spikes) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The mean burst duration is averaged across the actively bursting electrodes to report a well-mean value. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The mean burst duration is a measure of bursting activity in a network. Changes in the mean burst duration are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,257.0,43.0,214.0
1158,2508,2478,CCTE_Shafer_MEA_dev_interburst_interval_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_interburst_interval_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_interburst_interval_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: bursting activity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_interburst_interval_mean,"CCTE_Shafer_MEA_dev_interburst_interval_mean is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the average time interval between consecutive single-electrode bursts (temporally-clustered groups of action potential firing) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The mean inter-burst interval is averaged across the actively bursting electrodes to report a well-mean value. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The mean inter-burst interval is a measure of bursting activity in a network. Changes in the mean inter-burst interval are indicative of effects on the spontaneous neural activity.,single,functional reporter,electrical activity,spontaneous neural activity ,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,330.0,69.0,261.0
1159,2510,2479,CCTE_Shafer_MEA_dev_network_spike_number,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_network_spike_number was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_network_spike_number, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_network_spike_number,"CCTE_Shafer_MEA_dev_network_spike_number is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the number of network spikes (temporally-clustered groups of action potential firing across multiple electrodes) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The number of network spikes is a measure of the network connectivity. Changes in the number of network spikes are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,330.0,71.0,259.0
1160,2512,2480,CCTE_Shafer_MEA_dev_network_spike_peak,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_network_spike_peak was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_network_spike_peak, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_network_spike_peak,"CCTE_Shafer_MEA_dev_network_spike_peak is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the average number of electrodes participating at the peak of a network spike (the peak of a temporally-clustered group of action potential firing across multiple electrodes) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The network spike peak is a measure of the network connectivity. Changes in the network spike peak are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,321.0,123.0,198.0
1161,2514,2481,CCTE_Shafer_MEA_dev_spike_duration_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_spike_duration_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_spike_duration_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_spike_duration_mean,"CCTE_Shafer_MEA_dev_spike_duration_mean is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the average duration of network spikes (temporally-clustered groups of action potential firing across multiple electrodes) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The mean network spike duration is a measure of the network connectivity. Changes in the mean network spike duration are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,336.0,118.0,218.0
1162,2516,2482,CCTE_Shafer_MEA_dev_network_spike_duration_std,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_network_spike_duration_std was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_network_spike_duration_std, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_network_spike_duration_std,"CCTE_Shafer_MEA_dev_network_spike_duration_std is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the standard deviation of the duration of network spikes (temporally-clustered groups of action potential firing across multiple electrodes) during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The standard deviation of network spike duration is a measure of network connectivity. Changes in the standard deviation of network spike duration are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,325.0,75.0,250.0
1163,2518,2483,CCTE_Shafer_MEA_dev_inter_network_spike_interval_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_inter_network_spike_interval_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_inter_network_spike_interval_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_inter_network_spike_interval_mean,"CCTE_Shafer_MEA_dev_inter_network_spike_interval_mean is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the average time interval between network spikes (temporally-clustered groups of actional potential firing across multiple electrodes) as the average time between peaks of consecutive network spikes during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The inter-network spike interval is a measure of the network connectivity. Changes in the inter-network spike interval are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,275.0,34.0,241.0
1164,2520,2484,CCTE_Shafer_MEA_dev_per_network_spike_spike_number_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_per_network_spike_spike_number_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_per_network_spike_spike_number_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_per_network_spike_spike_number_mean,"CCTE_Shafer_MEA_dev_per_network_spike_spike_number_mean is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the average number of spikes (action potential firings) in a network spike (temporally-clustered group of spikes across multiple electrodes) as the number of spikes that occur within a 0.05 s time window at the peak of a network spike divided by the total number of network spikes during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The mean number of spikes in network spikes is a measure of the network connectivity. Changes in the mean number of network spikes are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,346.0,115.0,231.0
1165,2522,2485,CCTE_Shafer_MEA_dev_per_network_spike_spike_percent,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_per_network_spike_spike_percent was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_per_network_spike_spike_percent, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_per_network_spike_spike_percent,"CCTE_Shafer_MEA_dev_per_network_spike_spike_percent is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the percent of spikes (action potential firings) in a network spike (temporally-clustered group of spikes across multiple electrodes) as the number of spikes that occur within a 0.05 s time window at the peak of a network spike divided by the total number of spikes during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.",The percent of spikes in network spikes is a measure of the network connectivity. Changes in the percent of spikes in network spikes are indicative of changes in coordinated neural network activity.,single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,327.0,101.0,226.0
1166,2524,2486,CCTE_Shafer_MEA_dev_correlation_coefficient_mean,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_correlation_coefficient_mean was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_correlation_coefficient_mean, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_correlation_coefficient_mean,"CCTE_Shafer_MEA_dev_correlation_coefficient_mean is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It measures the correlation coefficent of spikes (action potential firings) between every pair of electrodes in a well during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. The pairwise correlations are averaged across active electrodes to report a well-mean value. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.","Electrical activity is captured from neurons cultured over electrodes. Increases in correlation coefficient indicate that the activity of individual neurons in the network is more synchronous, reflecting increased coordination of activity.",single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,323.0,104.0,219.0
1167,2526,2487,CCTE_Shafer_MEA_dev_mutual_information_norm,1,1,"Data from the assay component CCTE_Shafer_MEA_dev_mutual_information_norm was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Shafer_MEA_dev_mutual_information_norm, was analyzed in the negative analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand electrical activity.",electrical activity,percent_activity,0,,bidirectional,extracellular,action potential,neurodevelopment,neural network function: network connectivity,0,0,1,396,1683,573,CCTE_Shafer_MEA_dev_mutual_information_norm,"CCTE_Shafer_MEA_dev_mutual_information_norm is 1 of 19 assay components of the CCTE_Shafer_MEA_dev assay. It is a measure of shared information between electrodes during a recording in a microelectrode array (MEA) using Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector. To collapse across multiple recordings made on days post-plating 5, 7, 9 and 12, the trapezoidal area-under-the-curve of the component is calculated.","Normalized Mutual Information is a normalized measure of complexity and synchrony in a network that is robust to changes in network size. It is a scalar (rather than pairwise) measure of mutual information in a multivariate network (See Ball et al., Neural Networks. 2017. 95, 29-43 for further information).",single,functional reporter,electrical activity,functional neural network activity,microelectrode array (MEA),"extracellular measurements of action potential spikes and groups of spikes, or bursts",Axion Biosystems Maestro 768 channel amplifier with the AxIS adaptive spike detector ,,,cellular,electrical activity,20,CCTE_Shafer_MEA_dev,"CCTE_Shafer_MEA_dev assay is conducted using Axion Biosystems 48 well microelectrode array (MEA) plates and Maestro recording system. Each well of the MEA plate contains a grid of 16 microelectrodes embedded in the culture surface. Electrically active cells, such as neurons, can be cultured over the electrodes, and electrical activity in these cells can be recorded extracellularly. The spontaneous firing of neurons is captured from each electrode on a microsecond timescale providing both temporally and spatially precise data. Because the recordings do not impact the health of the cells, multiple recordings can be made from the same neural network over time in culture. The CCTE_Shafer_MEA_dev assay uses primary cultures of rat cortical neurons. Recordings are made on days post-plating 5, 7, 9 and 12. As these cultures mature over time, neural networks develop functional activity and form cohesive networks in which electrical activity can be highly coordinated. ",0.25,10116.0,rat,cortical,primary cell,,primary cortical cell culture,adherent,microplate: 48-well plate,cell-based,cell-based format,multiplexed,"DMSO, water, or ethanol",0.2,Selected assays,319.0,93.0,226.0
1174,2545,2500,UKN5_HCS_SBAD2_neurite_outgrowth,1,1,"The assay endpoint UKN5_HCS_SBAD2_neurite_outgrowth was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neurite outgrowth.",developmental,percent_activity,0,Narciclasine,bidirectional,cellular,cellular,neurodevelopment,neurite outgrowth,0,0,1,72,702,691,UKN5_HCS_SBAD2_neurite_outgrowth,"UKN5_HCS_SBAD2_neurite_outgrowth is an assay component measured from the UKN5_HCS_SBAD2 assay. It is designed to make measurements of neurite outgrowth, a form of morphology reporter, as detected with Fluorescence intensity signals by HCS Fluorescent Imaging.",Changes in the neurite area are indicative of neurodevelopment.,multiplexed,morphology reporter,neurite outgrowth,neurodevelopment,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain;stain,calcein-AM; Hoechst 33339,cellular,neurite area,27,UKN5_HCS_SBAD2,"UKN5_HCS_SBAD2 is a cell-based, multiplexed-readout assay screening  for neurite outgrowth and cell viability that uses SBAD2 (peripheral neurons differentiated from iPSC), a human peripheral nervous system cell line, with measurements taken at 3 hours after chemical dosing in a microplate: 96-well plate. UKN5, also referred to as PeriTox, is an assay that uses human iPSC line SBAD2 as a model of peripheral neurons. Following 24 hr chemical exposures in multi-well plates, neurite area is evaluated as a marker of neurite outgrowth using high-content imaging of cells stained with calcein-AM. Cell viability is assessed using stain Hoechst H-33342.",3.0,9606.0,human,peripheral nervous system,cell line,,SBAD2 (peripheral neurons differentiated from iPSC),adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,56.0,12.0,44.0
1322,2697,2650,UKN2_HCS_IMR90_neural_migration,1,1,"The assay endpoint UKN2_HCS_IMR90_neural_migration was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neural crest cell migration.",developmental,percent_activity,0,Cytochalasin D,bidirectional,cellular,cellular,neurodevelopment,neural crest cell migration,0,0,1,71,2005,840,UKN2_HCS_IMR90_neural_migration,"UKN2_HCS_IMR90_neural_migration is an assay component measured from the UKN2_HCS_IMR90 assay. It is designed to make measurements of neural crest cell migration, a form of morphology reporter, as detected with Fluorescence intensity signals by HCS Fluorescent Imaging.",Changes in the number of migrated cells are indicative of neurodevelopment.,multiplexed,morphology reporter,neural crest cell migration,neurodevelopment,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain;stain,calcein-AM; Hoechst 33341,cellular,number of migrated cells,27,UKN2_HCS_IMR90,"UKN2_HCS_IMR90 is a cell-based, multiplexed-readout assay screening  for neural crest cell migration and cell viability that uses IMR90 (neural crest cells differentiated from iPSC), a human embryo cell line, with measurements taken at 3 hours after chemical dosing in a microplate: 96-well plate. UKN2, also known as cMINC, is an assay that uses IMR90 cells (neural crest cells differentiated from iPSC) as a model of neural crest cell migration. 24 hr after cell seeding, cell migration was initiated and proceeded for 24 hr. Then, chemical was applied, and after 24 hr of exposure migration and viability were assessed using high-content imaging of cells stained with calcein-AM and Hoechst H-33342.",3.0,9606.0,human,embryo,cell line,,IMR90 (neural crest cells differentiated from iPSC),adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,63.0,11.0,52.0
1324,2701,2652,UKN4_HCS_LUHMES_neurite_outgrowth,1,1,"The assay endpoint UKN4_HCS_LUHMES_neurite_outgrowth was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, gain or loss-of-signal activity can be used to understand developmental effects. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the neurodevelopment intended target family, where the subfamily is neurite outgrowth.",developmental,percent_activity,0,Narciclasine,bidirectional,cellular,cellular,neurodevelopment,neurite outgrowth,0,0,1,76,2666,841,UKN4_HCS_LUHMES_neurite_outgrowth,"UKN4_HCS_LUHMES_neurite_outgrowth is an assay component measured from the UKN4_HCS_LHUMES assay. It is designed to make measurements of neurite outgrowth, a form of morphology reporter, as detected with Fluorescence intensity signals by HCS Fluorescent Imaging.",Changes in the neurite area are indicative of neurodevelopment.,multiplexed,morphology reporter,neurite outgrowth,neurodevelopment,Fluorescence,Fluorescence intensity,HCS Fluorescent Imaging,stain;stain,calcein-AM; Hoechst 33343,cellular,neurite area,27,UKN4_HCS_LUHMES,"UKN4_HCS_LUHMES is a cell-based, multiplexed-readout assay screening  for neurite outgrowth and cell viability that uses LUHMES, a human central nervous system cell line, with measurements taken at 3 hours after chemical dosing in a microplate: 96-well plate. UKN4, also referred to as NeuriTox, is an assay that uses LUHMES neuronal precursors as a model of dopaminergic neuronal differentiation. Following a 2-day differentiation period, cells are exposed to chemicals for 24 hr and neurite area is evaluated as a marker of neurite outgrowth using high-content imaging of cells stained with calcein AM. Cell viability is assessed using stain Hoechst H-33342.",3.0,9606.0,human,central nervous system,cell line,,LUHMES,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,54.0,24.0,30.0
1329,2767,2685,TAMU_PeakParms_SingleDonor1434_Chronotropy,1,1,"Data from the assay component TAMU_PeakParms_SingleDonor1434_Chronotropy was analyzed into 1 assay endpoint. This assay endpoint, TAMU_PeakParms_SingleDonor1434_Chronotropy_Negative, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, gain or loss-of-signal activity can be used to understand changes in the cardiac function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cardiomyocyte function intended target family, where the subfamily is lowered beat rate.",cardiac function,percent_activity,0,,bidirectional,extracellular,action potential ,cardiomyocyte function,lowered beat rate,0,0,1,95,323,845,TAMU_PeakParms_SingleDonor1434_Chronotropy,"TAMU_PeakParms_SingleDonor1434_Chronotopy is a phenotype derived from the peak.freq.avg parameter and uses an EC05 as its POD (5% increase in beat rate, compared to controls).  Peak.Freq.Avg measures the average peak frequency, in beats per second, uisng Fluorescence intensity as a functional reporter from Calcium (Ca+2) flux assay technology. Before modeling, data is preprocessed to remove data points where there is a cessation of beating (where peak.freq.avg equals 0) to ensure the capture of the upwards response that isn't confounded by the drop in beat rate at higher concentrations and to ensure the drop in beat rate is captured before asystole, which is captured elsewhere.","Changes in the calcium flux readouts is used to quantify changes in peak frequency, which can be an indication of elevated or lowered beat rate.",single,functional reporter,beating,cardiac function,Fluorescence,Fluorescence intensity,Calcium (Ca+2) flux assay,stain,Ca+2 dye reagent,calcium influx rate,"average peak frequency, in beats per second",29,TAMU_PeakParms,"TAMU_PeakParms is a cell-based, multiplexed-readout assay that uses iPSC-derived cardiomyocytes with measurements taken at 1.5 hours after chemical dosing in a microplate: 384-well plate.",1.5,9606.0,human,heart,cell-based,iPSC-derived cardiomyocytes,,adherent,microplate: 384-well plate,cell-based,physicochemical format,multiplexed,DMSO,0.5,Selected assays,74.0,22.0,52.0
1330,2771,2687,IUF_NPC1b_proliferation_BrdU_72hr,1,1,"Data from the IUF_NPC1b_proliferation_BrdU component was analyzed at the endpoint IUF_NPC1b_proliferation_BrdU in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of growth reporter, gain or loss-of-signal activity can be used to understand cell proliferation effects.",cell proliferation,percent_activity,0,media without growth factors,bidirectional,dna,dna-unspecified,cell cycle,proliferation,1,0,1,124,5652,846,IUF_NPC1b_proliferation_BrdU_72hr,IUF_NPC1b_proliferation_BrdU_72hr is one of 4 assay components measured from the IUF_NPC1 assay. It is designed to measure cell proliferation as assessed by the incorporation of Bromodeoxyuridine (BrdU) in the last 16 h of a 72 h compound exposure using a luminescence-based cell proliferation ELISA.,Changes to chemiluminescence signals based on BrdU incorporation during DNA synthesis in proliferating cells are correlated to proliferation of the system.,multiplexed,growth reporter,dna content,cell proliferation,Chemiluminescence,luminescence intensity,Luminescence-based cell proliferation ELISA,antibody,BrdU antibody,cellular,BrdU labeled DNA,30,IUF_NPC1,"IUF_NPC1 is a cell-based, multiplexed assay that uses hNPC, a human primary neural progenitor cells, with measurements taken at 72 hours after chemical dosing in a 96-well plate. Human neural progenitor cells (hNPC) are generated from human fetal brain cortex at gestational week (GW) 16-19. Grown in suspension culture and under proliferative conditions (proliferation media and growth factors), these cells represent neural progenitor cell proliferation. In the NPC1 assay, hNPC's are exposed to the test compound for 72h. Cell proliferation is assessed as an increase in sphere area using automated phase contrast imaging and as incorporation of Bromodeoxyuridine (BrdU) during DNA synthesis using a luminescence-based cell proliferation ELISA. In parallel, the cell viability is assessed using an alamar blue viability assay and the cytotoxicity using a lactate dehydrogenase dependent membrane integrity assay.",72.0,9606.0,human,brain,primary cell,neural progenitor cells,hNPC,suspension,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,110.0,21.0,89.0
1334,2777,2699,CCTE_Mundy_HCI_Cortical_NOG_BPCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_NOG_BPCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_NOG_BPCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,152,601,850,CCTE_Mundy_HCI_Cortical_NOG_BPCount,CCTE_Mundy_HCI_Cortical_NOG_BPCount is one of four components of the CCTE_Mundy_HCI_Cortical_NOG assay.  It measures neurite outgrowth related to the number of branch points using High Content Imaging of fluorescently labelled markers.,Changes in the number of branch points are indicative of neurodevelopment.,single,morphology reporter,neurite outgrowth,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,number of branch points,31,CCTE_Mundy_HCI_Cortical_NOG,"CCTE_Mundy_HCI_Cortical_NOG is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,132.0,32.0,100.0
1335,2778,2698,CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,152,601,850,CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount,CCTE_Mundy_HCI_Cortical_NOG_NeuriteCount is one of four components of the CCTE_Mundy_HCI_Cortical_NOG assay.  It measures neurite outgrowth related to the number of neurites  using High Content Imaging of fluorescently labelled markers.,Changes in the number of neurites  are indicative of neurodevelopment.,single,morphology reporter,neurite outgrowth,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,number of neurites,31,CCTE_Mundy_HCI_Cortical_NOG,"CCTE_Mundy_HCI_Cortical_NOG is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,139.0,29.0,110.0
1336,2779,2697,CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,180,676,850,CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength,CCTE_Mundy_HCI_Cortical_NOG_NeuriteLength is one of four components of the CCTE_Mundy_HCI_Cortical_NOG assay.  It measures neurite outgrowth related to the neurite length using High Content Imaging of fluorescently labelled markers.,Changes in the neurite length are indicative of neurodevelopment.,single,morphology reporter,neurite outgrowth,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,neurite length,31,CCTE_Mundy_HCI_Cortical_NOG,"CCTE_Mundy_HCI_Cortical_NOG is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,158.0,38.0,120.0
1337,2780,2696,CCTE_Mundy_HCI_Cortical_NOG_NeuronCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_NOG_NeuronCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_NOG_NeuronCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,180,674,850,CCTE_Mundy_HCI_Cortical_NOG_NeuronCount,CCTE_Mundy_HCI_Cortical_NOG_NeuronCount is one of four components of the CCTE_Mundy_HCI_Cortical_NOG assay.  It measures cell viability related to the number of neurons using High Content Imaging of fluorescently labelled markers.,Changes in the number of neurons are indicative of neurodevelopment.,single,morphology reporter,cell viability,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,number of neurons,31,CCTE_Mundy_HCI_Cortical_NOG,"CCTE_Mundy_HCI_Cortical_NOG is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,149.0,27.0,122.0
1338,2781,2707,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,151,264,852,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_BPCount is one of eight components of the CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur assay. It measures synaptogenesis and neurite maturation related to number of branch points using High Content Imaging of fluorescently labelled markers.,Changes in the number of branch points are indicative of neurodevelopment.,single,morphology reporter,synaptogenesis and neurite maturation,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,MAP2 antibody,cellular,number of branch points,31,CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur,"CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 288.33 hours after chemical dosing in a microplate: 96-well plate.",288.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,113.0,33.0,80.0
1339,2782,2702,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339,852,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_CellBodySpotCount is one of eight components of the CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur assay. It measures synaptogenesis and neurite maturation related to number of cell body-associated synapses (synaptophysin puncta) per neuron using High Content Imaging of fluorescently labelled markers.,Changes in the number of cell body-associated synapses (synaptophysin puncta) per neuron are indicative of neurodevelopment.,single,morphology reporter,synaptogenesis and neurite maturation,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,Synaptophysin antibody,cellular,number of cell body-associated synapses (synaptophysin puncta) per neuron,31,CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur,"CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 288.33 hours after chemical dosing in a microplate: 96-well plate.",288.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,160.0,16.0,144.0
1340,2783,2706,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,151,264,852,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteCount is one of eight components of the CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur assay. It measures synaptogenesis and neurite maturation related to number of neurites  using High Content Imaging of fluorescently labelled markers.,Changes in the number of neurites  are indicative of neurodevelopment.,single,morphology reporter,synaptogenesis and neurite maturation,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,MAP2 antibody,cellular,number of neurites,31,CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur,"CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 288.33 hours after chemical dosing in a microplate: 96-well plate.",288.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,136.0,17.0,119.0
1341,2784,2705,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339,852,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteLength is one of eight components of the CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur assay. It measures synaptogenesis and neurite maturation related to neurite length using High Content Imaging of fluorescently labelled markers.,Changes in the neurite length are indicative of neurodevelopment.,single,morphology reporter,synaptogenesis and neurite maturation,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,MAP2 antibody,cellular,neurite length,31,CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur,"CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 288.33 hours after chemical dosing in a microplate: 96-well plate.",288.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,148.0,49.0,99.0
1342,2785,2704,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339,852,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuriteLength,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuriteLength is one of eight components of the CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur assay. It measures synaptogenesis and neurite maturation related to number of neurite-associated synapses (synaptophysin puncta) per unit length of neurite using High Content Imaging of fluorescently labelled markers.,Changes in the number of neurite-associated synapses (synaptophysin puncta) per unit length of neurite are indicative of neurodevelopment.,single,morphology reporter,synaptogenesis and neurite maturation,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,Synaptophysin antibody,cellular,number of neurite-associated synapses (synaptophysin puncta) per unit length of neurite,31,CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur,"CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 288.33 hours after chemical dosing in a microplate: 96-well plate.",288.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,149.0,14.0,135.0
1343,2786,2703,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339,852,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuriteSpotCountPerNeuron is one of eight components of the CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur assay. It measures synaptogenesis and neurite maturation related to number of neurite-associated synapses (synaptophysin puncta) per neuron using High Content Imaging of fluorescently labelled markers.,Changes in the number of neurite-associated synapses (synaptophysin puncta) per neuron are indicative of neurodevelopment.,single,morphology reporter,synaptogenesis and neurite maturation,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,Synaptophysin antibody,cellular,number of neurite-associated synapses (synaptophysin puncta) per neuron,31,CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur,"CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 288.33 hours after chemical dosing in a microplate: 96-well plate.",288.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,148.0,51.0,97.0
1344,2787,2701,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339,852,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_NeuronCount is one of eight components of the CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur assay. It measures cell viability related to number of neurons using High Content Imaging of fluorescently labelled markers.,Changes in the number of neurons are indicative of neurodevelopment.,single,morphology reporter,cell viability,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,MAP2 antibody,cellular,number of neurons,31,CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur,"CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 288.33 hours after chemical dosing in a microplate: 96-well plate.",288.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,136.0,34.0,102.0
1345,2788,2708,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount,1,1,"Data from the assay component CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount was analyzed at the endpoint CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,sodium orthovanadate (10uM),loss,cellular,cellular,neurodevelopment,synaptogenesis and neurite maturation,0,0,1,179,339,852,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount,CCTE_Mundy_HCI_Cortical_Synap&Neur_Matur_SynapseCount is one of eight components of the CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur assay. It measures synaptogenesis and neurite maturation related to number of synpases per neuron using High Content Imaging of fluorescently labelled markers.,Changes in the number of synpases per neuron are indicative of neurodevelopment.,single,morphology reporter,synaptogenesis and neurite maturation,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,Synaptophysin antibody,cellular,number of synpases per neuron,31,CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur,"CCTE_Mundy_HCI_Cortical_Synap&Neurite_Matur is a multiplexed, cell-based-readout assay that uses rat primary cortical cells with measurements taken at 288.33 hours after chemical dosing in a microplate: 96-well plate.",288.33,10116.0,rat,cortical,primary cell,rat primary cortical cells,,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,145.0,42.0,103.0
1346,2789,2695,CCTE_Mundy_HCI_hN2_NOG_BPCount,1,1,"Data from the assay component CCTE_Mundy_HCI_hN2_NOG_BPCount was analyzed at the endpoint CCTE_Mundy_HCI_hN2_NOG_BPCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects. This assay component endpoint is considered less reliable by experts on the assay due to low occurrence of branch points in the hN2 cells. Use data with caution.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,83,108,849,CCTE_Mundy_HCI_hN2_NOG_BPCount,CCTE_Mundy_HCI_hN2_NOG_BPCount is one of four components of the CCTE_Mundy_HCI_hN2_NOG assay. It measures neurite outgrowth related to number of branch points using High Content Imaging of fluorescently labelled markers. This assay component is considered less reliable by experts on the assay due to low occurrence of branch points in the hN2 cells. Use data with caution.,Changes in the number of branch points are indicative of neurodevelopment.,single,morphology reporter,neurite outgrowth,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,number of branch points,31,CCTE_Mundy_HCI_hN2_NOG,"CCTE_Mundy_HCI_hN2_NOG is a multiplexed, cell-based-readout assay that uses immature neurons derived from hNP1 neuroprogenitor cells with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,9606.0,human,neural,secondary cell,immature neurons derived from hNP1 neuroprogenitor cells,hN2,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,53.0,14.0,39.0
1347,2790,2694,CCTE_Mundy_HCI_hN2_NOG_NeuriteCount,1,1,"Data from the assay component CCTE_Mundy_HCI_hN2_NOG_NeuriteCount was analyzed at the endpoint CCTE_Mundy_HCI_hN2_NOG_NeuriteCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,83,108,849,CCTE_Mundy_HCI_hN2_NOG_NeuriteCount,CCTE_Mundy_HCI_hN2_NOG_NeuriteCount is one of four components of the CCTE_Mundy_HCI_hN2_NOG assay. It measures neurite outgrowth related to number of neurites  using High Content Imaging of fluorescently labelled markers.,Changes in the number of neurites  are indicative of neurodevelopment.,single,morphology reporter,neurite outgrowth,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,number of neurites,31,CCTE_Mundy_HCI_hN2_NOG,"CCTE_Mundy_HCI_hN2_NOG is a multiplexed, cell-based-readout assay that uses immature neurons derived from hNP1 neuroprogenitor cells with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,9606.0,human,neural,secondary cell,immature neurons derived from hNP1 neuroprogenitor cells,hN2,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,64.0,11.0,53.0
1348,2791,2693,CCTE_Mundy_HCI_hN2_NOG_NeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_hN2_NOG_NeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_hN2_NOG_NeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,85,117,849,CCTE_Mundy_HCI_hN2_NOG_NeuriteLength,CCTE_Mundy_HCI_hN2_NOG_NeuriteLength is one of four components of the CCTE_Mundy_HCI_hN2_NOG assay. It measures neurite outgrowth related to neurite length using High Content Imaging of fluorescently labelled markers.,Changes in the neurite length are indicative of neurodevelopment.,single,morphology reporter,neurite outgrowth,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,neurite length,31,CCTE_Mundy_HCI_hN2_NOG,"CCTE_Mundy_HCI_hN2_NOG is a multiplexed, cell-based-readout assay that uses immature neurons derived from hNP1 neuroprogenitor cells with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,9606.0,human,neural,secondary cell,immature neurons derived from hNP1 neuroprogenitor cells,hN2,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,65.0,16.0,49.0
1349,2792,2692,CCTE_Mundy_HCI_hN2_NOG_NeuronCount,1,1,"Data from the assay component CCTE_Mundy_HCI_hN2_NOG_NeuronCount was analyzed at the endpoint CCTE_Mundy_HCI_hN2_NOG_NeuronCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss -of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,85,117,849,CCTE_Mundy_HCI_hN2_NOG_NeuronCount,CCTE_Mundy_HCI_hN2_NOG_NeuronCount is one of four components of the CCTE_Mundy_HCI_hN2_NOG assay. It measures cell viability related to number of neurons using High Content Imaging of fluorescently labelled markers.,Changes in the number of neurons are indicative of neurodevelopment.,single,morphology reporter,cell viability,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,number of neurons,31,CCTE_Mundy_HCI_hN2_NOG,"CCTE_Mundy_HCI_hN2_NOG is a multiplexed, cell-based-readout assay that uses immature neurons derived from hNP1 neuroprogenitor cells with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,9606.0,human,neural,secondary cell,immature neurons derived from hNP1 neuroprogenitor cells,hN2,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,52.0,16.0,36.0
1350,2793,2691,CCTE_Mundy_HCI_hNP1_Casp3_7,1,1,"Data from the assay component CCTE_Mundy_HCI_hNP1_Casp3_7 was analyzed at the endpoint CCTE_Mundy_HCI_hNP1_Casp3_7_gain in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain -of-signal activity can be used to understand viability effects.",viability,percent_activity,0,staurosporine (0.1 uM),gain,cellular,cellular,cell cycle,apoptosis,0,0,1,229,1219,848,CCTE_Mundy_HCI_hNP1_Casp3_7,CCTE_Mundy_HCI_hNP1_Casp3_7 is one component of the CCTE_Mundy_HCI_hNP1_Casp3_7 assay. It measures apoptosis related to caspase activation using Luminescent Reporter.,Changes in the caspase activation are indicative of cell death.,single,viability reporter,apoptosis,cell death,Fluorescence,fluorescence intensity,Luminescent Reporter,luciferase assay,Caspase-Glo 3/7 detection reagent,protein,caspase activation,31,CCTE_Mundy_HCI_hNP1_Casp3_7,"CCTE_Mundy_HCI_hNP1_Casp3_7 is a multiplexed, cell-based-readout assay that uses neural stem cells derived from a neuroepithelial cell lineage of WA09 embryonic cells with measurements taken at 26.5 hours after chemical dosing in a microplate: 96-well plate.",26.5,9606.0,human,neural,primary cell,neural stem cells derived from a neuroepithelial cell lineage of WA09 embryonic cells,hNP1,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,211.0,21.0,190.0
1351,2794,2700,CCTE_Mundy_HCI_hNP1_CellTiter,1,1,"Data from the assay component CCTE_Mundy_HCI_hNP1_CellTiter was analyzed at the endpoint CCTE_Mundy_HCI_hNP1_CellTiter in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss -of-signal activity can be used to understand viability effects.",viability,percent_activity,0,staurosporine (0.1 uM),loss,cellular,cell count,cell cycle,cell count,0,0,1,202,1087,851,CCTE_Mundy_HCI_hNP1_CellTiter,CCTE_Mundy_HCI_hNP1_CellTiter is one component of the CCTE_Mundy_HCI_hNP1_CellTiter assay. It measures cell viability related to ATP content using Luminescent Reporter.,Changes in the ATP content are indicative of cell viability.,single,viability reporter,cell viability,cell viability,Fluorescence,fluorescence intensity,Luminescent Reporter,luciferase assay,CellTiter-Glo assay buffer,cellular,ATP content,31,CCTE_Mundy_HCI_hNP1_CellTiter,"CCTE_Mundy_HCI_hNP1_CellTiter is a multiplexed, cell-based-readout assay that uses neural stem cells derived from a neuroepithelial cell lineage of WA09 embryonic cells with measurements taken at 26.5 hours after chemical dosing in a microplate: 96-well plate.",26.5,9606.0,human,neural,primary cell,neural stem cells derived from a neuroepithelial cell lineage of WA09 embryonic cells,hNP1,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,184.0,20.0,164.0
1352,2797,2710,CCTE_Mundy_HCI_hNP1_Pro_ResponderAvgInten,1,1,"Data from the assay component CCTE_Mundy_HCI_hNP1_Pro_ResponderAvgInten was analyzed at the endpoint CCTE_Mundy_HCI_hNP1_Pro_ResponderAvgInten in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of growth reporter, loss -of-signal activity can be used to understand viability effects.",viability,percent_activity,0,aphidicolin (10uM),loss,cellular,cellular,cell cycle,proliferation,0,0,1,230,1059,853,CCTE_Mundy_HCI_hNP1_Pro_ResponderAvgInten,CCTE_Mundy_HCI_hNP1_Pro_ResponderAvgInten is one of three components of the CCTE_Mundy_HCI_hNP1_Pro assay. It measures proliferation related to percentage of BrdU positive cells using High Content Imaging of fluorescently labelled markers.,Changes in the percentage of BrdU positive cells are indicative of cell proliferation.,single,growth reporter,proliferation,cell proliferation,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,Brdu antibody,cellular,percentage of BrdU positive cells,31,CCTE_Mundy_HCI_hNP1_Pro,"CCTE_Mundy_HCI_hNP1_Pro is a multiplexed, cell-based-readout assay that uses neural stem cells derived from a neuroepithelial cell lineage of WA09 embryonic cells with measurements taken at 26.25 hours after chemical dosing in a microplate: 96-well plate.",26.25,9606.0,human,neural,primary cell,neural stem cells derived from a neuroepithelial cell lineage of WA09 embryonic cells,hNP1,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.1,Selected assays,187.0,24.0,163.0
1354,2809,1068,BSK_BT_Bcell_Proliferation,1,1,"Data from the assay component BSK_BT_Bcell_Proliferation  was analyzed at the endpoint, BSK_BT_Bcell_Proliferation, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  viability reporter, gain or loss-of-signal activity can be used to understand cellular changes in viability. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell cycle' intended target family, where the subfamily is 'proliferation'.",viability,log10_fold_induction,0,colchicine,bidirectional,cellular,cellular,cell cycle,proliferation,0,0,1,577,0,433,BSK_BT_Bcell_Proliferation,"BSK_BT_Bcell_Proliferation is an assay component measured in the BSK_BT assay. It measures protein content, a form of viability reporter, as detected with absorbance signals by Sulforhodamine staining technology.","B cell proliferation is a critical event driving both adaptive immunity (antibody production) as well as  auto-immune diseases where B cells are key disease players (Lupus, MS, RA etc). Inhibition of B cell proliferation is considered an immune supressive effect.",single,viability reporter,protein content,cell proliferation,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_BT,"BSK_BT is a cell-based, multiplexed-readout assay that uses Bcellandperipheralbloodmononuclearcells, a human vascular primarycellco-culture, with measurements taken at 24 hours after chemical dosing in a microplate:96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,B and peripheral blood mononuclear cells,suspension,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,543.0,133.0,410.0
1356,2813,1070,BSK_BT_sIgG,1,1,"Data from the assay component BSK_BT_sIgG was analyzed at the endpoint, BSK_BT_sIgG, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'immunoglobulin' intended target family, where the subfamily is 'IgG'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,immunoglobulin,IgG,0,0,1,577,0,433,BSK_BT_sIgG,BSK_BT_sIgG is an assay component measured in the BSK_BT assay. It measures secreted IgG related to regulation of gene expression using ELISA technology.,Secreted IgG (sIgG) is produced by B cells and is the main type of antibody found in blood and extracellular fluid that mediates the immune response against pathogens. sIgG is categorized as an immunomodulatory-related activity in the BT system modeling T cell depdendent B cell activation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,secreted IgG,protein,protein-specified,4,BSK_BT,"BSK_BT is a cell-based, multiplexed-readout assay that uses Bcellandperipheralbloodmononuclearcells, a human vascular primarycellco-culture, with measurements taken at 24 hours after chemical dosing in a microplate:96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,B and peripheral blood mononuclear cells,suspension,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,527.0,182.0,345.0
1357,2815,1071,BSK_BT_xIL17A,1,1,"Data from the assay component BSK_BT_xIL17A was analyzed at the endpoint, BSK_BT_xIL17A, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,577,0,433,BSK_BT_xIL17A,BSK_BT_xIL17A is an assay component measured in the BSK_BT assay. It measures secreted IL-17A related to regulation of gene expression using LumineX xMAP technology.,Interleukin 17A (IL-17A) is a proinflammatory cytokine produced by T cells that induces cytokine production and mediates monocyte and neutrophil recruitment to sites of inflammation.  Secreted IL-17A (sIL-17A) is categorized as an immunomodulatory-related activity in the BT system modeling T cell depdendent B cell activation.,single,cytokine quantitation reporter,cytokine-specific antibody bead-based method,regulation of gene expression,Fluorescence,Fluorescence intensity,LumineX xMAP,antibody,secreted IL-17A,protein,protein-specified,4,BSK_BT,"BSK_BT is a cell-based, multiplexed-readout assay that uses Bcellandperipheralbloodmononuclearcells, a human vascular primarycellco-culture, with measurements taken at 24 hours after chemical dosing in a microplate:96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,B and peripheral blood mononuclear cells,suspension,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,543.0,109.0,434.0
1358,2817,1072,BSK_BT_xIL17F,1,1,"Data from the assay component BSK_BT_xIL17F was analyzed at the endpoint, BSK_BT_xIL17F, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,577,0,433,BSK_BT_xIL17F,BSK_BT_xIL17F is an assay component measured in the BSK_BT assay. It measures secreted IL-17F related to regulation of gene expression using LumineX xMAP technology.,"Interleukin 17F (IL-17F) is a proinflammatory cytokine produced by T cells that induces cytokine, chemokine and adhesion molecule production and mediates neutrophil recruitment to sites of inflammation.  Secreted IL-17F (sIL-17F) is categorized as an immunomodulatory-related activity in the BT system modeling T cell depdendent B cell activation.",single,cytokine quantitation reporter,cytokine-specific antibody bead-based method,regulation of gene expression,Fluorescence,Fluorescence intensity,LumineX xMAP,antibody,secreted IL-17F,protein,protein-specified,4,BSK_BT,"BSK_BT is a cell-based, multiplexed-readout assay that uses Bcellandperipheralbloodmononuclearcells, a human vascular primarycellco-culture, with measurements taken at 24 hours after chemical dosing in a microplate:96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,B and peripheral blood mononuclear cells,suspension,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,531.0,143.0,388.0
1359,2819,1073,BSK_BT_xIL2,1,1,"Data from the assay component BSK_BT_xIL2 was analyzed at the endpoint, BSK_BT_xIL2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,577,0,433,BSK_BT_xIL2,BSK_BT_xIL2 is an assay component measured in the BSK_BT assay. It measures secreted IL-2 related to regulation of gene expression using LumineX xMAP technology.,Interleukin 2 (IL-2) is a secreted proinflammatory cytokine produced by T cells that regulates lymphocyte proliferation and promotes T cell differentiation.  Secreted IL-2 (IL-2) is categorized as an immunomodulatory-related activity in the BT system modeling T cell depdendent B cell activation.,single,cytokine quantitation reporter,cytokine-specific antibody bead-based method,regulation of gene expression,Fluorescence,Fluorescence intensity,LumineX xMAP,antibody,secreted IL-2,protein,protein-specified,4,BSK_BT,"BSK_BT is a cell-based, multiplexed-readout assay that uses Bcellandperipheralbloodmononuclearcells, a human vascular primarycellco-culture, with measurements taken at 24 hours after chemical dosing in a microplate:96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,B and peripheral blood mononuclear cells,suspension,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,548.0,118.0,430.0
1360,2821,1074,BSK_BT_xIL6,1,1,"Data from the assay component BSK_BT_xIL6 was analyzed at the endpoint, BSK_BT_xIL6, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,577,0,433,BSK_BT_xIL6,BSK_BT_xIL6 is an assay component measured in the BSK_BT assay. It measures secreted IL-6 related to regulation of gene expression using LumineX xMAP technology.,Interleukin 6 (IL-6) is a secreted proinflammatory cytokine and acute phase reactant.  Secreted IL-6 (sIL-6) is categorized as an immunomodulatory-related activity in the BT system modeling T cell depdendent B cell activation.,single,cytokine quantitation reporter,cytokine-specific antibody bead-based method,regulation of gene expression,Fluorescence,Fluorescence intensity,LumineX xMAP,antibody,secreted IL-6,protein,protein-specified,4,BSK_BT,"BSK_BT is a cell-based, multiplexed-readout assay that uses Bcellandperipheralbloodmononuclearcells, a human vascular primarycellco-culture, with measurements taken at 24 hours after chemical dosing in a microplate:96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,B and peripheral blood mononuclear cells,suspension,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,528.0,117.0,411.0
1361,2823,1075,BSK_BT_xTNFa,1,1,"Data from the assay component BSK_BT_xTNFa was analyzed at the endpoint, BSK_BT_xTNFa, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  cytokine quantitation reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,577,0,433,BSK_BT_xTNFa,BSK_BT_xTNFa is an assay component of the BSK_BT assay. It measures secreted TNF-alpha related to regulation of gene expression using LumineX xMAP technology.,Tumor necrosis factor alpha (TNF-alpha) is a secreted proinflammatory cytokine involved in Th1 inflammation. Secreted TNF-alpha is categorized as an inflammation-related activity in the BT system modeling T cell dependent B cell activation.,single,cytokine quantitation reporter,cytokine-specific antibody bead-based method,regulation of gene protein expression,Fluorescence,Fluorescence intensity,LumineX xMAP,antibody,secreted TNF-alpha,protein,protein-specified,4,BSK_BT,"BSK_BT is a cell-based, multiplexed-readout assay that uses Bcellandperipheralbloodmononuclearcells, a human vascular primarycellco-culture, with measurements taken at 24 hours after chemical dosing in a microplate:96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,B and peripheral blood mononuclear cells,suspension,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,533.0,127.0,406.0
1362,2825,1081,BSK_MyoF_ACTA1,1,1,"Data from the assay component BSK_MyoF_ACTA1 was analyzed at the endpoint, BSK_MyoF_ACTA1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'actin'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,actin,0,0,1,577,0,435,BSK_MyoF_ACTA1,BSK_MyoF_ACTA1 is an assay component measured in the BSK_MyoF assay. It measures a-SMA antibody related to regulation of gene expression using ELISA technology.,"alpha-Smooth muscle actin (a-SMA) is a protein involved in muscle contraction, cell motility, structure and integrity and is a marker for activated myofibroblast phenotype.  a-SMA is categorized as a tissue remodeling-related activity in the MyoF system modeling pulmonary myofibroblast development.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,a-SMA antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,542.0,133.0,409.0
1363,2827,1082,BSK_MyoF_bFGF,1,1,"Data from the assay component BSK_MyoF_bFGF was analyzed at the endpoint, BSK_MyoF_bFGF, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'growth factor' intended target family, where the subfamily is 'basic fibroblast growth factor '.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,growth factor,basic fibroblast growth factor ,0,0,1,577,0,435,BSK_MyoF_bFGF,BSK_MyoF_bFGF is an assay component measured in the BSK_MyoF assay. It measures bFGF antibody related to regulation of gene expression using ELISA technology.,"Basic fibroblast growth factor (bFGF) is a pro-fibrotic growth factor that drives fibroblast proliferation, migration and fibronectin synthesis.  bFGF is categorized as a tissue remodeling-related activity in the MyoF system modeling pulmonary myofibroblast development.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,bFGF antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,553.0,69.0,484.0
1364,2829,1083,BSK_MyoF_VCAM1,1,1,"Data from the assay component BSK_MyoF_VCAM1 was analyzed at the endpoint, BSK_MyoF_VCAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,577,0,435,BSK_MyoF_VCAM1,BSK_MyoF_VCAM1 is an assay component measured in the BSK_MyoF assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.,Vascular Cell Adhesion Molecule 1 (VCAM-1/CD106) is a cell adhesion molecule that mediates adhesion of monocytes and T cells to endothelial cells.  VCAM-1 is categorized as an inflammation-related activity in the MyoF system modeling pulmonary myofibroblast development.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,VCAM-1 antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,533.0,124.0,409.0
1365,2831,1084,BSK_MyoF_CollagenI,1,1,"Data from the assay component BSK_MyoF_CollagenI was analyzed at the endpoint, BSK_MyoF_CollagenI, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'collagen'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,collagen,0,0,1,577,0,435,BSK_MyoF_CollagenI,BSK_MyoF_CollagenI is an assay component measured in the BSK_MyoF assay. It measures Collagen I antibody related to regulation of gene expression using ELISA technology.,"Collagen I is involved in tissue remodeling and fibrosis, and is the most  common fibrillar collagen that is found in skin, bone, tendons and other connective tissues.  Collagen I is categorized a tissue remodeling-related activity in the MyoF system modeling pulmonary myofibroblast development.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Collagen I antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,539.0,104.0,435.0
1366,2833,1085,BSK_MyoF_CollagenIII,1,1,"Data from the assay component BSK_MyoF_CollagenIII was analyzed at the endpoint, BSK_MyoF_CollagenIII, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'collagen'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,collagen,0,0,1,577,0,435,BSK_MyoF_CollagenIII,BSK_MyoF_CollagenIII is an assay component measured in the BSK_MyoF assay. It measures Collagen III antibody related to regulation of gene expression using ELISA technology.,"Collagen III is an extracellular matrix protein and fibrillar collagen found in extensible connective tissues (skin, lung and vascular system) and is involved in cell adhesion, cell migration, tissue remodeling.  Collagen III is categorized a tissue remodeling-related activity in the MyoF system modeling pulmonary myofibroblast development.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Collagen III antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,533.0,124.0,409.0
1367,2835,1086,BSK_MyoF_CollagenIV,1,1,"Data from the assay component BSK_MyoF_CollagenIV was analyzed at the endpoint, BSK_MyoF_CollagenIV, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'collagen'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,collagen,0,0,1,577,0,435,BSK_MyoF_CollagenIV,BSK_MyoF_CollagenIV is an assay component measured in the BSK_MyoF assay. It measures Collagen IV antibody related to regulation of gene expression using ELISA technology.,Collagen IV is the major structural component of the  basal lamina.  Collagen IV is categorized a tissue remodeling-related activity in the MyoF system modeling pulmonary myofibroblast development.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Collagen IV antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,537.0,76.0,461.0
1368,2837,1087,BSK_MyoF_IL8,1,1,"Data from the assay component BSK_MyoF_IL8 was analyzed at the endpoint, BSK_MyoF_IL8, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,577,0,435,BSK_MyoF_IL8,BSK_MyoF_IL8 is an assay component measured in the BSK_MyoF assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.,Interleukin 8 (IL-8/CXCL8) is a chemokine that mediates neutrophil recruitment into acute inflammatory sites.  IL-8 is categorized as an inflammation-related activity in the MyoF system modeling pulmonary myofibroblast development.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-8 antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,547.0,75.0,472.0
1369,2839,1088,BSK_MyoF_Decorin,1,1,"Data from the assay component BSK_MyoF_Decorin was analyzed at the endpoint, BSK_MyoF_Decorin, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'decorin'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,decorin,0,0,1,577,0,435,BSK_MyoF_Decorin,BSK_MyoF_Decorin is an assay component measured in the BSK_MyoF assay. It measures Decorin antibody related to regulation of gene expression using ELISA technology.,Decorin is a proteoglycan that is a component of connective tissue and is involved in collagen and matrix assembly.  Decorin is categorized as a tissue remodeling-related activity in the MyoF system modeling pulmonary myofibroblast development.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Decorin antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,550.0,63.0,487.0
1370,2841,1089,BSK_MyoF_MMP1,1,1,"Data from the assay component BSK_MyoF_MMP1 was analyzed at the endpoint, BSK_MyoF_MMP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,577,0,435,BSK_MyoF_MMP1,BSK_MyoF_MMP1 is an assay component measured in the BSK_MyoF assay. It measures PAI-1 antibody related to regulation of gene expression using ELISA technology.,"Matrix metalloproteinase-1 (MMP-1) is an interstitial collagenase that degrades collagens I, II and III and is involved in the process of tissue remodeling.  MMP-1 is categorized as a tissue remodeling-related activity in the MyoF system modeling pulmonary myofibroblast development.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,PAI-1 antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,537.0,97.0,440.0
1371,2843,1090,BSK_MyoF_PAI1,1,1,"Data from the assay component BSK_MyoF_PAI1 was analyzed at the endpoint, BSK_MyoF_PAI1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'plasmogen activator inhibitor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,577,0,435,BSK_MyoF_PAI1,BSK_MyoF_PAI1 is an assay component measured in the BSK_MyoF assay. It measures PAI-1 antibody related to regulation of gene expression using ELISA technology.,Plasminogen activator inhibitor-1 (PAI-I) is a serine proteinase inhibitor and inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA) and is involved in tissue remodeling and fibrinolysis.  PAI-I is categorized as a tissue remodeling-related activity in the MyoF system modeling pulmonary myofibroblast development.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,PAI-1 antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,523.0,101.0,422.0
1372,2845,1091,BSK_MyoF_SRB,1,1,"Data from the assay component BSK_MyoF_SRB was analyzed at the endpoint, BSK_MyoF_SRB, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell morphology' intended target family, where the subfamily is 'cell conformation'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,577,0,435,BSK_MyoF_SRB,BSK_MyoF_SRB is an assay component measured in the BSK_MyoF assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,"SRB in the MyoF system is a measure of the total protein content of lung fibroblasts.  Cell viability of adherent cells is measured by Sulforhodamine B (SRB) staining, a method that determines cell density by measuring total protein content of test wells.",single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,554.0,103.0,451.0
1373,2847,1092,BSK_MyoF_TIMP1,1,1,"Data from the assay component BSK_MyoF_TIMP1 was analyzed at the endpoint, BSK_MyoF_TIMP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,577,0,435,BSK_MyoF_TIMP1,BSK_MyoF_TIMP1 is an assay component measured in the BSK_MyoF assay. It measures TIMP-1 antibody related to regulation of  gene expression using ELISA technology.,"TIMP-1 is a tissue inhibitor of matrix metalloprotease-7 (MMP-7) and other MMPs, and is involved in tissue remodeling, angiogenesis and fibrosis.  TIMP-1 is categorized as a tissue remodeling-related activity in the MyoF system modeling pulmonary myofibroblast development.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,TIMP-1 antibody,protein,protein-specified,4,BSK_MyoF,"BSK_MyoF is a cell-based, multiplexed-readout assay that uses lungfibroblasts, a human vascular primarycell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,lung fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,546.0,79.0,467.0
1374,2849,2719,BSK_BF4T_MCP1,1,1,"Data from the assay component BSK_BF4T_MCP1 was analyzed at the endpoint, BSK_BF4T_MCP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,164,0,857,BSK_BF4T_MCP1,BSK_BF4T_MCP1 is an assay component measured in the BSK_BF4T assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.,Monocyte chemoattractant protein-1 (MCP-1/CCL2) is a chemoattractant cytokine (chemokine) that regulates the recruitment of monocytes and T cells into sites of inflammation.  MCP-1 is categorized as an inflammation-related activity in the BF4T system modeling Th2 airway inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MCP-1 antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,157.0,26.0,131.0
1375,2851,2720,BSK_BF4T_Eotaxin3,1,1,"Data from the assay component BSK_BF4T_Eotaxin3 was analyzed at the endpoint, BSK_BF4T_Eotaxin3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,164,0,857,BSK_BF4T_Eotaxin3,BSK_BF4T_Eotaxin3 is an assay component measured in the BSK_BF4T assay. It measures Eotaxin-3 antibody related to regulation of gene expression using ELISA technology.,Eotaxin-3/CCL26 is a chemokine that mediates recruitment of eosinophils and basophils into tissue sites.  Eotaxin-3 is categorized as an inflammation-related activity in the BF4T system modeling Th2 airway inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Eotaxin-3 antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,155.0,22.0,133.0
1376,2853,2721,BSK_BF4T_VCAM1,1,1,"Data from the assay component BSK_BF4T_VCAM1 was analyzed at the endpoint, BSK_BF4T_VCAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,164,0,857,BSK_BF4T_VCAM1,BSK_BF4T_VCAM1 is an assay component measured in the BSK_BF4T assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.,Vascular Cell Adhesion Molecule 1 (VCAM-1/CD106) is a cell adhesion molecule that mediates adhesion of monocytes and T cells to endothelial cells.  VCAM-1 is categorized as an inflammation-related activity in the BF4T system modeling Th2 airway inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,VCAM-1 antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,157.0,18.0,139.0
1377,2855,2722,BSK_BF4T_ICAM1,1,1,"Data from the assay component BSK_BF4T_ICAM1 was analyzed at the endpoint, BSK_BF4T_ICAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,164,0,857,BSK_BF4T_ICAM1,BSK_BF4T_ICAM1 is an assay component measured in the BSK_BF4T assay. It measures ICAM-1 antibody related to regulation of gene expression using ELISA technology.,Intercellular Adhesion Molecule 1 (ICAM-1/CD54) is a cell adhesion molecule that mediates leukocyte-endothelial cell adhesion and leukocyte recruitment.  ICAM-1 is categorized as an inflammation-related activity in the BF4T system modeling Th2 airway inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,ICAM-1 antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,160.0,17.0,143.0
1379,2859,2724,BSK_BF4T_IL8,1,1,"Data from the assay component BSK_BF4T_IL8 was analyzed at the endpoint, BSK_BF4T_IL8, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,164,0,857,BSK_BF4T_IL8,BSK_BF4T_IL8 is an assay component measured in the BSK_BF4T assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.,Interleukin 8 (IL-8/CXCL8) is a chemokine that mediates neutrophil recruitment into acute inflammatory sites.  IL-8 is categorized as an inflammation-related activity in the BF4T system modeling Th2 airway inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-8 antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,159.0,17.0,142.0
1380,2861,2725,BSK_BF4T_IL1a,1,1,"Data from the assay component BSK_BF4T_IL1a was analyzed at the endpoint, BSK_BF4T_IL1a, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,164,0,857,BSK_BF4T_IL1a,BSK_BF4T_IL1a is an assay component measured in the BSK_BF4T assay. It measures IL-1a antibody related to regulation of gene expression using ELISA technology.,Interleukin 1 alpha (IL-1a) is a secreted proinflammatory cytokine involved in endothelial cell activation and neutrophil recruitment.  Secreted IL-1? (sIL-1?)is categorized as an inflammation-related activity in the BF4T system modeling Th2 airway inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-1a antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,164.0,19.0,145.0
1381,2863,2726,BSK_BF4T_Keratin818,1,1,"Data from the assay component BSK_BF4T_Keratin818 was analyzed at the endpoint, BSK_BF4T_Keratin818, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'keratin'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,keratin,0,0,1,164,0,857,BSK_BF4T_Keratin818,BSK_BF4T_Keratin818 is an assay component measured in the BSK_BF4T assay. It measures Keratin 8/18 antibody related to regulation of gene expression using ELISA technology.,"Keratin 8/18 is an intermediate filament  heterodimer of fibrous structural poteins involved in Epithelial cell death, EMT, COPD, Lung Inflammation.  Keratin 8/18 is categorized as a tissue remodeling-related activity in the BF4T system modeling Th2 airway inflammation.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Keratin 8/18 antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,164.0,16.0,148.0
1383,2867,2728,BSK_BF4T_MMP3,1,1,"Data from the assay component BSK_BF4T_MMP3 was analyzed at the endpoint, BSK_BF4T_MMP3, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,164,0,857,BSK_BF4T_MMP3,BSK_BF4T_MMP3 is an assay component measured in the BSK_BF4T assay. It measures MMP-3 antibody related to regulation of gene expression using ELISA technology.,"Matrix metalloproteinase-3 (MMP-3) is an enzyme involved in tissue remodeling that can activate other MMPs (MMP-1, MMP-7 and MMP-9) and degrade collagens (II, III, IV, IX and X), proteoglycans, fibronectin, laminin and elastin.  MMP-3 is categorized as a tissue remodeling-related activity in the BF4T system modeling Th2 airway inflammation.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MMP-3 antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,159.0,24.0,135.0
1384,2869,2729,BSK_BF4T_MMP9,1,1,"Data from the assay component BSK_BF4T_MMP9 was analyzed at the endpoint, BSK_BF4T_MMP9, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,164,0,857,BSK_BF4T_MMP9,BSK_BF4T_MMP9 is an assay component measured in the BSK_BF4T assay. It measures MMP-9 antibody related to regulation of gene expression using ELISA technology.,Matrix metalloproteinase-9 (MMP-9) is a gelatinase B that degrades collagen IV and gelatin and is involved in airway matrix remodeling.  MMP-9 is categorized as a tissue remodeling-related activity in the BF4T system modeling Th2 airway inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MMP-9 antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,161.0,21.0,140.0
1385,2871,2730,BSK_BF4T_PAI1,1,1,"Data from the assay component BSK_BF4T_PAI1 was analyzed at the endpoint, BSK_BF4T_PAI1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'plasmogen activator inhibitor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,164,0,857,BSK_BF4T_PAI1,BSK_BF4T_PAI1 is an assay component measured in the BSK_BF4T assay. It measures PAI-1 antibody related to regulation of gene expression using ELISA technology.,Plasminogen activator inhibitor-1 (PAI-I) is a serine proteinase inhibitor and inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA) and is involved in tissue remodeling and fibrinolysis.  PAI-I is categorized as a tissue remodeling-related activity in the BF4T system modeling Th2 airway inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,PAI-1 antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,161.0,16.0,145.0
1386,2873,2731,BSK_BF4T_SRB,1,1,"Data from the assay component BSK_BF4T_SRB  was analyzed at the endpoint, BSK_BF4T_SRB, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  viability reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell morphology' intended target family, where the subfamily is 'cell conformation'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,164,0,857,BSK_BF4T_SRB,BSK_BF4T_SRB is an assay component measured in the BSK_BF4T assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,"SRB in the BF4T system is a measure of the total protein content of bronchial epithelial cells and dermal fibroblasts.  Cell viability of adherent cells is measured by Sulforhodamine B (SRB) staining, a method that determines cell density by measuring total protein content of test wells.",single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,161.0,12.0,149.0
1387,2875,2732,BSK_BF4T_tPA,1,1,"Data from the assay component BSK_BF4T_tPA was analyzed at the endpoint, BSK_BF4T_tPA, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'serine protease'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,serine protease,0,0,1,164,0,857,BSK_BF4T_tPA,BSK_BF4T_tPA is an assay component measured in the BSK_BF4T assay. It measures tPA antibody related to regulation of gene expression using ELISA technology.,"Tissue plasminogen activator (tPA) is a serine protease that catalyzes the cleavage of plasminogen to plasmin and regulates clot degradation.  tPA is involved in fibrinolyis, cell migration and tissue remodeling.  tPA is categorized as a tissue remodeling-related activity in the BF4T system modeling Th2 airway inflammation.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,tPA antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,155.0,19.0,136.0
1388,2877,2733,BSK_BF4T_uPA,1,1,"Data from the assay component BSK_BF4TA was analyzed at the endpoint, BSK_BF4TA, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'serine protease'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,serine protease,0,0,1,164,0,857,BSK_BF4T_uPA,BSK_BF4TA is an assay component measured in the BSK_BF4T assay. It measures uPA antibody related to regulation of gene expression using ELISA technology.,Urokinse plasminogen activator (uPA) is a serine protease with thrombolytic activity.  Triggers fibrinolysis and extracellular matrix degradation.  uPA is categorized as a tissue remodeling-related activity in the BF4T system modeling Th2 airway inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,uPA antibody,protein,protein-specified,4,BSK_BF4T,"BSK_BF4T is a cell-based, multiplexed-readout assay that uses bronchial epithelial cells and dermal fibroblasts, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,bronchial epithelial cells and dermal fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,161.0,16.0,145.0
1389,2879,2734,BSK_BE3C_ICAM1,1,1,"Data from the assay component BSK_BE3C_ICAM1 was analyzed at the endpoint, BSK_BE3C_ICAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,238,0,9,BSK_BE3C_ICAM1,BSK_BE3C_ICAM1 is an assay component measured in the BSK_BE3C assay. It measures ICAM-1 antibody related to regulation of gene expression using ELISA technology.,Intercellular Adhesion Molecule 1 (ICAM-1/CD54) is a cell adhesion molecule that mediates leukocyte-endothelial cell adhesion and leukocyte recruitment.  ICAM-1 is categorized as an inflammation-related activity in the BE3C system modeling Th1 lung inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,ICAM-1 antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,235.0,24.0,211.0
1390,2881,2735,BSK_BE3C_ITAC,1,1,"Data from the assay component BSK_BE3C_ITAC was analyzed at the endpoint, BSK_BE3C_ITAC, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,238,0,9,BSK_BE3C_ITAC,BSK_BE3C_ITAC is an assay component measured in the BSK_BE3C assay. It measures I-TAC antibody related to regulation of gene expression using ELISA technology.,Interferon inducible T Cell Alpha Chemoattractant (I-TAC/CXCL11) is a chemokine that mediates T cell and monocyte chemotaxis.   I-TAC is categorized as an inflammation-related activity in the BE3C system modeling Th1 lung inflammation. ,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,I-TAC antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,232.0,30.0,202.0
1391,2883,2736,BSK_BE3C_IL8,1,1,"Data from the assay component BSK_BE3C_IL8 was analyzed at the endpoint, BSK_BE3C_IL8, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,238,0,9,BSK_BE3C_IL8,BSK_BE3C_IL8 is an assay component measured in the BSK_BE3C assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.,Interleukin 8 (IL-8/CXCL8) is a chemokine that mediates neutrophil recruitment into acute inflammatory sites.  IL-8 is categorized as an inflammation-related activity in the BE3C system modeling Th1 lung inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-8 antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,226.0,29.0,197.0
1392,2885,2737,BSK_BE3C_EGFR,1,1,"Data from the assay component BSK_BE3C_EGFR was analyzed at the endpoint, BSK_BE3C_EGFR, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'kinase' intended target family, where the subfamily is 'receptor tyrosine kinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,receptor,kinase,receptor tyrosine kinase,0,0,1,238,0,9,BSK_BE3C_EGFR,BSK_BE3C_EGFR is an assay component measured in the BSK_BE3C assay. It measures EGFR antibody related to regulation of gene expression using ELISA technology.,"Epidermal growth factor receptor (EGFR) is a cell surface receptor for epidermal growth factor involved in cell proliferation, cell differentiation, tissue remodeling and tumor growth.  EGFR is categorized as a tissue remodeling-related activity in the BE3C system modeling Th1 lung inflammation.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,EGFR antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,233.0,22.0,211.0
1393,2887,2738,BSK_BE3C_Keratin818,1,1,"Data from the assay component BSK_BE3C_Keratin818 was analyzed at the endpoint, BSK_BE3C_Keratin818, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'keratin'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,keratin,0,0,1,238,0,9,BSK_BE3C_Keratin818,BSK_BE3C_Keratin818 is an assay component measured in the BSK_BE3C assay. It measures Keratin 8/18 antibody related to regulation of gene expression using ELISA technology.,"Keratin 8/18 is an intermediate filament  heterodimer of fibrous structural poteins involved in Epithelial cell death, EMT, COPD, Lung Inflammation.  Keratin 8/18 is categorized as a tissue remodeling-related activity in the BE3C system modeling Th1 lung inflammation.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Keratin 8/18 antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,234.0,21.0,213.0
1394,2889,2739,BSK_BE3C_MMP9,1,1,"Data from the assay component BSK_BE3C_MMP9 was analyzed at the endpoint, BSK_BE3C_MMP9, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,238,0,9,BSK_BE3C_MMP9,BSK_BE3C_MMP9 is an assay component measured in the BSK_BE3C assay. It measures MMP-9 antibody related to regulation of gene expression using ELISA technology.,Matrix metalloproteinase-9 (MMP-9) is a gelatinase B that degrades collagen IV and gelatin and is involved in airway matrix remodeling.  MMP-9 is categorized as a tissue remodeling-related activity in the BE3C system modeling Th1 lung inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MMP-9 antibody,protein,protein-specified,4,BSK_BE3C,"BSK_BE3C is a cell-based, multiplexed-readout assay that uses bronchial epithelial cell, a human lung primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,lung,primary cell,,bronchial epithelial cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,228.0,38.0,190.0
1396,2893,2741,BSK_hDFCGF_MCP1,1,1,"Data from the assay component BSK_hDFCGF_MCP1 was analyzed at the endpoint, BSK_hDFCGF_MCP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,238,0,11,BSK_hDFCGF_MCP1,BSK_hDFCGF_MCP1 is an assay component measured in the BSK_hDFCGF assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.,Monocyte chemoattractant protein-1 (MCP-1/CCL2) is a chemoattractant cytokine (chemokine) that regulates the recruitment of monocytes and T cells into sites of inflammation.  MCP-1 is categorized as an inflammation-related activity in the HDF3CGF system modeling Th1 inflammation involved in wound healing and matrix remodeling of the skin.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MCP-1 antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,227.0,37.0,190.0
1397,2895,2742,BSK_hDFCGF_ICAM1,1,1,"Data from the assay component BSK_hDFCGF_ICAM1 was analyzed at the endpoint, BSK_hDFCGF_ICAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,238,0,11,BSK_hDFCGF_ICAM1,BSK_hDFCGF_ICAM1 is an assay component measured in the BSK_hDFCGF assay. It measures ICAM-1 antibody related to regulation of gene expression using ELISA technology.,Intercellular Adhesion Molecule 1 (ICAM-1/CD54) is a cell adhesion molecule that mediates leukocyte-endothelial cell adhesion and leukocyte recruitment.  ICAM-1 is categorized as an inflammation-related activity in the HDF3CGF system modeling Th1 inflammation involved in wound healing and matrix remodeling of the skin.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,ICAM-1 antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,230.0,34.0,196.0
1398,2897,2743,BSK_hDFCGF_CollagenI,1,1,"Data from the assay component BSK_hDFCGF_CollagenI was analyzed at the endpoint, BSK_hDFCGF_CollagenI, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'collagen'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,collagen,0,0,1,238,0,11,BSK_hDFCGF_CollagenI,BSK_hDFCGF_CollagenI is an assay component measured in the BSK_hDFCGF assay. It measures Collagen I antibody related to regulation of gene protein expression using ELISA technology.,"Collagen I is involved in tissue remodeling and fibrosis, and is the most common fibrillar collagen that is found in skin, bone, tendons and other connective tissues.  Collagen I is categorized as a tissue remodeling-related activity in the HDF3CGF system modeling Th1 inflammation involved in wound healing and matrix remodeling of the skin.",single,binding reporter,immunoassay: elisa,regulation of gene protein expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Collagen I antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,233.0,24.0,209.0
1399,2899,2744,BSK_hDFCGF_ITAC,1,1,"Data from the assay component BSK_hDFCGF_ITAC was analyzed at the endpoint, BSK_hDFCGF_ITAC, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,238,0,11,BSK_hDFCGF_ITAC,BSK_hDFCGF_ITAC is an assay component measured in the BSK_hDFCGF assay. It measures I-TAC antibody related to regulation of gene expression using ELISA technology.,Interferon inducible T Cell Alpha Chemoattractant (I-TAC/CXCL11) is a chemokine that mediates T cell and monocyte chemotaxis.   I-TAC is categorized as an inflammation-related activity in the HDF3CGF system modeling Th1 inflammation involved in wound healing and matrix remodeling of the skin,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,I-TAC antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,233.0,62.0,171.0
1400,2901,2745,BSK_hDFCGF_TIMP2,1,1,"Data from the assay component BSK_hDFCGF_TIMP2 was analyzed at the endpoint, BSK_hDFCGF_TIMP2, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'protease' intended target family, where the subfamily is 'matrix metalloproteinase'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,protease,matrix metalloproteinase,0,0,1,238,0,11,BSK_hDFCGF_TIMP2,BSK_hDFCGF_TIMP2 is an assay component measured in the BSK_hDFCGF assay. It measures TIMP-2 antibody related to regulation of gene expression using ELISA technology.,"TIMP-2 is a tissue inhibitor of matrix metalloproteases and is involved in tissue remodeling, angiogenesis and fibrosis.  TIMP-2 is categorized as a tissue remodeling-related activity in the HDF3CGF system modeling Th1 inflammation involved in wound healing and matrix remodeling of the skin.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,TIMP-2 antibody,protein,protein-specified,4,BSK_hDFCGF,"BSK_hDFCGF is a cell-based, multiplexed-readout assay that uses foreskin fibroblast, a human skin primary cell, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell,,foreskin fibroblast,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,226.0,38.0,188.0
1401,2903,2746,BSK_KF3CT_IL8,1,1,"Data from the assay component BSK_KF3CT_IL8 was analyzed at the endpoint, BSK_KF3CT_IL8, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,238,0,12,BSK_KF3CT_IL8,BSK_KF3CT_IL8 is an assay component measured in the BSK_KF3CT assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.,Interleukin 8 (IL-8/CXCL8) is a chemokine that mediates neutrophil recruitment into acute inflammatory sites.  IL-8 is categorized as an inflammation-related activity in the KF3CT system modeling Th1 cutaneous inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-8 antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,229.0,24.0,205.0
1402,2905,2747,BSK_KF3CT_MIG,1,1,"Data from the assay component BSK_KF3CT_MIG was analyzed at the endpoint, BSK_KF3CT_MIG, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,238,0,12,BSK_KF3CT_MIG,BSK_KF3CT_MIG is an assay component measured in the BSK_KF3CT assay. It measures MIG antibody related to regulation of gene expression using ELISA technology.,Monokine induced by gamma interferon (MIG/CXCL9) is a chemokine that mediates T cell recruitment.  MIG is categorized as an inflammation-related activity in the KF3CT system modeling Th1 cutaneous inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MIG antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,234.0,24.0,210.0
1403,2907,2748,BSK_KF3CT_PAI1,1,1,"Data from the assay component BSK_KF3CT_PAI1 was analyzed at the endpoint, BSK_KF3CT_PAI1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'plasmogen activator inhibitor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,plasmogen activator inhibitor,0,0,1,238,0,12,BSK_KF3CT_PAI1,BSK_KF3CT_PAI1 is an assay component measured in the BSK_KF3CT assay. It measures PAI-1 antibody related to regulation of gene expression using ELISA technology.,Plasminogen activator inhibitor-1 (PAI-I) is a serine proteinase inhibitor and inhibitor of tissue plasminogen activator (tPA) and urokinase (uPA) and is involved in tissue remodeling and fibrinolysis.  PAI-I is categorized as a tissue remodeling-related activity in the KF3CT system modeling Th1 cutaneous inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,PAI-1 antibody,protein,protein-specified,4,BSK_KF3CT,"BSK_KF3CT is a cell-based, multiplexed-readout assay that uses keratinocytes and foreskin fibroblasts, a human skin primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,skin,primary cell co-culture,,keratinocytes and foreskin fibroblasts,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,231.0,31.0,200.0
1404,2909,2749,BSK_IMphg_MCP1,1,1,"Data from the assay component BSK_IMphg_MCP1 was analyzed at the endpoint, BSK_IMphg_MCP1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'chemotactic factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,chemotactic factor,0,0,1,164,0,856,BSK_IMphg_MCP1,BSK_IMphg_MCP1 is an assay component measured in the BSK_IMphg assay. It measures MCP-1 antibody related to regulation of gene expression using ELISA technology.,Monocyte chemoattractant protein-1 (MCP-1/CCL2) is a chemoattractant cytokine (chemokine) that regulates the recruitment of monocytes and T cells into sites of inflammation.  MCP-1 is categorized as an inflammation-related activity in the lMphg system modeling macrophage-driven Th1 vascular inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MCP-1 antibody,protein,protein-specified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,160.0,16.0,144.0
1405,2911,2750,BSK_IMphg_MIP1a,1,1,"Data from the assay component BSK_IMphg_MIP1a was analyzed at the endpoint, BSK_IMphg_MIP1a, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,164,0,856,BSK_IMphg_MIP1a,BSK_IMphg_MIP1a is an assay component measured in the BSK_IMphg assay. It measures MIP-1a antibody related to regulation of gene expression using ELISA technology.,Macrophage inflammatory protein 1 alpha (MIP-1a/CCL3) is a pro-inflammatory chemokine that mediates leukocyte recruitment to sites of inflammation. MIP-1a is categorized as an inflammation-related activity in the lMphg system modeling macrophage-driven Th1 vascular inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,MIP-1a antibody,protein,protein-specified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,159.0,19.0,140.0
1406,2913,2751,BSK_IMphg_VCAM1,1,1,"Data from the assay component BSK_IMphg_VCAM1 was analyzed at the endpoint, BSK_IMphg_VCAM1, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'Immunoglobulin CAM'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,Immunoglobulin CAM,0,0,1,164,0,856,BSK_IMphg_VCAM1,BSK_IMphg_VCAM1 is an assay component measured in the BSK_IMphg assay. It measures VCAM-1 antibody related to regulation of gene expression using ELISA technology.,Vascular Cell Adhesion Molecule 1 (VCAM-1/CD106) is a cell adhesion molecule that mediates adhesion of monocytes and T cells to endothelial cells.  VCAM-1 is categorized as an inflammation-related activity in the lMphg system modeling macrophage-driven Th1 vascular inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,VCAM-1 antibody,protein,protein-specified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,161.0,26.0,135.0
1407,2915,2752,BSK_IMphg_CD40,1,1,"Data from the assay component BSK_IMphg_CD40 was analyzed at the endpoint, BSK_IMphg_CD40, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,164,0,856,BSK_IMphg_CD40,BSK_IMphg_CD40 is an assay component measured in the BSK_IMphg assay. It measures CD40 antibody related to regulation of gene expression using ELISA technology.,"CD40 is a cell surface adhesion receptor and costimulatory receptor for T cell activation that is expressed on antigen presenting cells, endothelial cells, smooth muscle cells, fibroblasts and epithelial cells.  CD40 is categorized as an immunomodulatory-related activity in the lMphg system modeling macrophage-driven Th1 vascular inflammation.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,CD40 antibody,protein,protein-specified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,161.0,29.0,132.0
1408,2917,2753,BSK_IMphg_ESelectin,1,1,"Data from the assay component BSK_IMphg_ESelectin was analyzed at the endpoint, BSK_IMphg_ESelectin, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell adhesion molecules' intended target family, where the subfamily is 'selectins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cell adhesion molecules,selectins,0,0,1,164,0,856,BSK_IMphg_ESelectin,BSK_IMphg_ESelectin is an assay component measured in the BSK_IMphg assay. It measures E-selectin antibody related to regulation of gene expression using ELISA technology.,E-Selectin/CD62E is a cell adhesion molecule expressed only on endothelial cells that mediates leukocyte-endothelial cell interactions.  E-Selectin is categorized as an inflammation-related activity in the lMphg system modeling macrophage-driven Th1 vascular inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,E-selectin antibody,protein,protein-specified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,160.0,28.0,132.0
1409,2919,2754,BSK_IMphg_CD69,1,1,"Data from the assay component BSK_IMphg_CD69 was analyzed at the endpoint, BSK_IMphg_CD69, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,164,0,856,BSK_IMphg_CD69,BSK_IMphg_CD69 is an assay component measured in the BSK_IMphg assay. It measures CD69 antibody related to regulation of gene expression using ELISA technology.,CD69 is a cell surface activation antigen that is induced early during immune activation and is involved in macrophage activation.  CD69 is categorized as an immunomodulatory-related activity in the lMphg system modeling macrophage-driven Th1 vascular inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,CD69 antibody,protein,protein-specified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,162.0,27.0,135.0
1410,2921,2755,BSK_IMphg_IL8,1,1,"Data from the assay component BSK_IMphg_IL8 was analyzed at the endpoint, BSK_IMphg_IL8, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,164,0,856,BSK_IMphg_IL8,BSK_IMphg_IL8 is an assay component measured in the BSK_IMphg assay. It measures IL-8 antibody related to regulation of gene expression using ELISA technology.,Interleukin 8 (IL-8/CXCL8) is a chemokine that mediates neutrophil recruitment into acute inflammatory sites.  IL-8 is categorized as an inflammation-related activity in the lMphg system modeling macrophage-driven Th1 vascular inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-8 antibody,protein,protein-specified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,161.0,30.0,131.0
1411,2923,2756,BSK_IMphg_IL1a,1,1,"Data from the assay component BSK_IMphg_IL1a was analyzed at the endpoint, BSK_IMphg_IL1a, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,164,0,856,BSK_IMphg_IL1a,BSK_IMphg_IL1a is an assay component measured in the BSK_IMphg assay. It measures IL-1a antibody related to regulation of gene expression using ELISA technology.,Interleukin 1alpha (IL-1a) is a secreted proinflammatory cytokine involved in endothelial cell activation and neutrophil recruitment.  Secreted IL-1a (sIL-1a) is categorized as an inflammation-related activity in the lMphg system modeling macrophage-driven Th1 vascular inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-1a antibody,protein,protein-specified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,162.0,12.0,150.0
1412,2925,2757,BSK_IMphg_MCSF,1,1,"Data from the assay component BSK_IMphg_MCSF was analyzed at the endpoint, BSK_IMphg_MCSF, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'colony stimulating factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,colony stimulating factor,0,0,1,164,0,856,BSK_IMphg_MCSF,BSK_IMphg_MCSF is an assay component measured in the BSK_IMphg assay. It measures M-CSF antibody related to regulation of gene expression using ELISA technology.,Macrophage colony-stimulating factor (M-CSF) is a secreted and cell surface cytokine that mediates macrophage differentiation.  M-CSF is categorized as an immunomodulatory-related activity in the lMphg system modeling macrophage-driven Th1 vascular inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,M-CSF antibody,protein,protein-specified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,160.0,11.0,149.0
1413,2927,2758,BSK_IMphg_IL10,1,1,"Data from the assay component BSK_IMphg_IL10 was analyzed at the endpoint, BSK_IMphg_IL10, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'interleukins'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,interleukins,0,0,1,164,0,856,BSK_IMphg_IL10,BSK_IMphg_IL10 is an assay component measured in the BSK_IMphg assay. It measures IL-10 antibody related to regulation of gene expression using ELISA technology.,Interleukin 10 (IL-10) is a secreted anti-inflammatory cytokine.  Secreted IL-10 (sIL-10) is categorized as an immunomodulatory-related activity in the lMphg system modeling macrophage-driven Th1 vascular inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,IL-10 antibody,protein,protein-specified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,160.0,41.0,119.0
1414,2929,2759,BSK_IMphg_SRB,1,1,"Data from the assay component BSK_IMphg_SRB  was analyzed at the endpoint, BSK_IMphg_SRB, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  viability reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell morphology' intended target family, where the subfamily is 'cell conformation'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,164,0,856,BSK_IMphg_SRB,BSK_IMphg_SRB is an assay component measured in the BSK_IMphg assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,"SRB in the lMphg system is a measure of the total protein content of venular endothelial cells and macrophages.  Cell viability of adherent cells is measured by Sulforhodamine B (SRB) staining, a method that determines cell density by measuring total protein content of test wells.",single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,160.0,16.0,144.0
1415,2931,2760,BSK_IMphg_SRB.Mphg,1,1,"Data from the assay component BSK_IMphg_SRB.Mphg  was analyzed at the endpoint, BSK_IMphg_SRB.Mphg, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of  viability reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cell morphology' intended target family, where the subfamily is 'cell conformation'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-unspecified,cell morphology,cell conformation,0,0,1,164,0,856,BSK_IMphg_SRB.Mphg,BSK_IMphg_SRB.Mphg is an assay component measured in the BSK_IMphg assay. It measures 0.1% sulforhodamine related to cell death using Sulforhodamine staining technology.,"SRB-Mphg in the lMphg system is a measure of the total protein content of macrophages alone.  Cell viability of adherent cells is measured by Sulforhodamine B (SRB) staining, a method that determines cell density by measuring total protein content of test wells.",single,viability reporter,protein content,cell death,Spectrophotometry,Absorbance,Sulforhodamine staining,stain,0.1% sulforhodamine,protein,protein-unspecified,4,BSK_IMphg,"BSK_IMphg is a cell-based, multiplexed-readout assay that uses venular endothelial cells and macrophages, a human vascular primary cell, with measurements taken at 24 hours after chemical dosing in a microplate:96-wellplate.",24.0,9606.0,human,vascular,primary cell,,venular endothelial cells and macrophages,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,158.0,23.0,135.0
1416,2933,2761,BSK_LPS_Thrombomodulin,1,1,"Data from the assay component BSK_LPS_Thrombodulin was analyzed at the endpoint, BSK_LPS_Thrombomodulin, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'gpcr' intended target family, where the subfamily is 'rhodopsin-like receptor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,gpcr,rhodopsin-like receptor,0,0,1,238,0,13,BSK_LPS_Thrombomodulin,BSK_LPS_Thrombomodulin is an assay component measured in the BSK_LPS assay. It measures Thrombomodulin antibody related to regulation of gene expression using ELISA technology.,"Thrombomodulin/CD141 is a cell surface receptor for complement factor 3b with anti-coagulant, anti-inflammatory and cytoprotective activities during the process of fibrinolysis, coagulation and thrombosis.  Thrombomodulin is categorized as a hemostasis-related activity in the LPS system modeling monocyte-driven Th1 vascular inflammation.",single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,Thrombomodulin antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,234.0,29.0,205.0
1417,2935,2762,BSK_LPS_CD69,1,1,"Data from the assay component BSK_LPS_CD69 was analyzed at the endpoint, BSK_LPS_CD69, in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of binding reporter, gain or loss-of-signal activity can be used to understand protein changes. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the 'cytokine' intended target family, where the subfamily is 'inflammatory factor'.",signaling,log10_fold_induction,0,colchicine,bidirectional,protein,protein-specified,cytokine,inflammatory factor,0,0,1,238,0,13,BSK_LPS_CD69,BSK_LPS_CD69 is an assay component measured in the BSK_LPS assay. It measures CD69 antibody related to regulation of gene expression using ELISA technology.,CD69 is a cell  surface activation antigen.  CD69 is categorized as an immunomodulatory-related activity in the LPS system modeling monocyte-driven Th1 vascular inflammation.,single,binding reporter,immunoassay: elisa,regulation of gene expression,Fluorescence,Fluorescence intensity,ELISA,antibody,CD69 antibody,protein,protein-specified,4,BSK_LPS,"BSK_LPS is a cell-based, multiplexed-readout assay that uses umbilical vein endothelium and peripheral blood mononuclear cells, a human vascular primary cell co-culture, with measurements taken at 24 hours after chemical dosing in a 96-well plate.",24.0,9606.0,human,vascular,primary cell co-culture,,umbilical vein endothelium and peripheral blood mononuclear cells,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,232.0,41.0,191.0
1425,2952,2770,IUF_NPC5_oligodendrocyte_differentiation_120hr,1,1,"Data from the IUF_NPC5_oligodendrocyte_differentiation_120hr component was analyzed at the endpoint IUF_NPC5_oligodendrocyte_differentiation_120hr in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of differentiation reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,BMP7,loss,cellular,cellular,neurodevelopment,neural progenitor differentiation,1,0,1,124,2009,858,IUF_NPC5_oligodendrocyte_differentiation_120hr,IUF_NPC5_oligodendrocyte_differentiation_120hr is one of 12 assay components measured from the IUF_NPC2-5 assay. Oligodendrocyte differentiation at 120 hr is determined as the number of all O4-positive cells in percent of the number of  Hoechst-positive nuclei in the total neurosphere migration area (see IUF_NPC2a_ glia_migration_120hr) after 120 hr of migration/differentiation. Oligodendrocytes are automatically identified using a convolutional neural network (CNN) that was trained using manually annotated images of differentiated oligodendrocytes.,Changes in the oligodendrocyte differentiation are indicative of neurodevelopment.,multiplexed,differentiation reporter,oligodendrocyte differentiation,neurodevelopment,Fluorescence microscopy,cell identification,High content image analysis,antibody,O4 antibody,cellular,oligodendrocyte differentiation at 120hr,30,IUF_NPC2-5,"IUF_NPC2-5 is a cell-based, multiplexed assay that uses hNPC, a human primary neural progenitor cells, with measurements taken at 72 or 120 hours after chemical dosing in a 96-well plate. Human neural progenitor cells (hNPC) are generated from human fetal brain cortex at gestational week (GW) 16-19. In the neural progenitor cell migration and differentiation assay (NPC2-5), hNPCs grown as spheres are plated on an extracellular matrix and migrate and differentiate out of the sphere core. The processes radial glia migration, neuronal and oligodendrocyte migration as well as neuronal differentiation, neuronal morphology and oligodendrocyte differentiation are studied using automated phase contrast imaging and automated fluorescence imaging in combination with high content image analysis. In parallel, the cell viability is assessed using an alamar blue viability assay and the cytotoxicity using a lactate dehydrogenase dependent membrane integrity assay.",72.0,9606.0,human,brain,primary cell,neural progenitor cells,hNPC,suspension,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO,0.1,Selected assays,109.0,22.0,87.0
1444,3067,2836,CCTE_Mundy_HCI_iCellGluta_NOG_BPCount,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGluta_NOG_BPCount was analyzed at the endpoint CCTE_Mundy_HCI_iCellGluta_NOG_BPCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects. This assay endpoint is considered less reliable by experts on the assay due to low occurrence of branch points in the iCell GlutaNeurons. Use data with caution.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,140,974,867,CCTE_Mundy_HCI_iCellGluta_NOG_BPCount,CCTE_Mundy_HCI_iCellGluta_NOG_BPCount is one of four components of the CCTE_Mundy_HCI_iCellGluta_NOG assay. It measures neurite outgrowth related to number of branch points using High Content Imaging of fluorescently labelled markers. This assay component is considered less reliable by experts on the assay due to low occurrence of branch points in the iCell GlutaNeurons. Use data with caution.,Changes in the number of branch points are indicative of neurodevelopment.,single,morphology reporter,neurite outgrowth,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,number of branch points,31,CCTE_Mundy_HCI_iCellGluta_NOG,"CCTE_Mundy_HCI_iCellGluta_NOG is a multiplexed, cell-based-readout assay that uses iCell GlutaNeurons from FUJIFILM Cellular Dynamics, Inc. (FCDI), human glutamatergic enriched neurons derived from induced pluripotent stem (iPS) cells, with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,9606.0,human,neural,secondary cell,human glutamatergic enriched neurons derived from induced pluripotent stem (iPS) cells,iCell GlutaNeurons,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.15,Selected assays,127.0,12.0,115.0
1446,3069,2838,CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteLength,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteLength was analyzed at the endpoint CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteLength in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of morphology reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,neurite outgrowth (initiation),0,0,1,140,974,867,CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteLength,CCTE_Mundy_HCI_iCellGluta_NOG_NeuriteLength is one of four components of the CCTE_Mundy_HCI_iCellGluta_NOG assay. It measures neurite outgrowth related to neurite length using High Content Imaging of fluorescently labelled markers.,Changes in the neurite length are indicative of neurodevelopment.,single,morphology reporter,neurite outgrowth,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,neurite length,31,CCTE_Mundy_HCI_iCellGluta_NOG,"CCTE_Mundy_HCI_iCellGluta_NOG is a multiplexed, cell-based-readout assay that uses iCell GlutaNeurons from FUJIFILM Cellular Dynamics, Inc. (FCDI), human glutamatergic enriched neurons derived from induced pluripotent stem (iPS) cells, with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,9606.0,human,neural,secondary cell,human glutamatergic enriched neurons derived from induced pluripotent stem (iPS) cells,iCell GlutaNeurons,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.15,Selected assays,124.0,23.0,101.0
1447,3070,2839,CCTE_Mundy_HCI_iCellGluta_NOG_NeuronCount,1,1,"Data from the assay component CCTE_Mundy_HCI_iCellGluta_NOG_NeuronCount was analyzed at the endpoint CCTE_Mundy_HCI_iCellGluta_NOG_NeuronCount in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of viability reporter, loss-of-signal activity can be used to understand developmental effects.",developmental,percent_activity,0,Rac 1 inhibitor (10uM),loss,cellular,cellular,neurodevelopment,cytotoxicity,0,0,1,140,974,867,CCTE_Mundy_HCI_iCellGluta_NOG_NeuronCount,CCTE_Mundy_HCI_iCellGluta_NOG_NeuronCount is one of four components of the CCTE_Mundy_HCI_iCellGluta_NOG assay. It measures cell viability related to number of neurons using High Content Imaging of fluorescently labelled markers.,Changes in the number of neurons are indicative of neurodevelopment.,single,viability reporter,cell viability,neurodevelopment,Fluorescence,fluorescence intensity,HCS Fluorescent Imaging,antibody,TUBB3 antibody,cellular,number of neurons,31,CCTE_Mundy_HCI_iCellGluta_NOG,"CCTE_Mundy_HCI_iCellGluta_NOG is a multiplexed, cell-based-readout assay that uses iCell GlutaNeurons from FUJIFILM Cellular Dynamics, Inc. (FCDI), human glutamatergic enriched neurons derived from induced pluripotent stem (iPS) cells, with measurements taken at 50.33 hours after chemical dosing in a microplate: 96-well plate.",50.33,9606.0,human,neural,secondary cell,human glutamatergic enriched neurons derived from induced pluripotent stem (iPS) cells,iCell GlutaNeurons,adherent,microplate: 96-well plate,cell-based,cell-based format,multiplexed,DMSO or water,0.15,Selected assays,135.0,11.0,124.0
1449,3074,2842,CCTE_Deisenroth_5AR_NBTE_donor,1,1,"Data from the assay component CCTE_Deisenroth_5AR NBTE_donor was analyzed into 1 assay endpoint. This assay endpoint,  CCTE_Deisenroth_5AR NBTE_donor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity can be used to understand changes in the donor luminescence as related to 5alpha-reductase catalytic function. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves an artifact detection function.",enzymatic activity,log2_fold_induction,0,"Dutasteride, Finasteride",bidirectional,protein,protein-specified,background measurement,artifact luminescence,0,0,1,229,1512,869,CCTE_Deisenroth_5AR_NBTE_donor,"CCTE_Deisenroth_5AR NBTE_donor is one of four assay components measured from the CCTE_Deisenroth_5AR NBTE assay. It is designed to make measurements of donor luminescence, as detected by bioluminescence intensity emission signals using spectrometry technology.","The technology is based on the concept of Bioluminescence Resonance Energy Transfer BRET. Target proteins fused to NanoLuc luciferase generate luminescence signal in the presence of furimazine substrate. BRET occurs when custom fluorescent tracers, bound to the target protein, resonate luminescent energy from the luciferase enzyme to the tracer molecule to yield a lower-energy fluorescent emission signal.",single,inducible reporter,donor luminescence emission,regulation of  5alpha-reductase enzyme activity,Luminescence,Luminescence Intensity,multimode microplate reader,substrate,luciferase substrate: furimazine,chemical,protein-specified,17,CCTE_Deisenroth_5AR_NBTE,"CCTE_Deisenroth_5AR NBTE (5alpha-reductase NanoBRET Target Engagement Assay) is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 5 hours after chemical dosing in a 384 well plate. This assay includes a primary and secondary screen as well as an autofluorscence screen.",5.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.3,Selected assays,211.0,50.0,161.0
1450,3076,2843,CCTE_Deisenroth_5AR_NBTE_acceptor,1,1,"Data from the assay component CCTE_Deisenroth_5AR NBTE_acceptor was analyzed into 1 assay endpoint. This assay endpoint,  CCTE_Deisenroth_5AR NBTE_acceptor, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity can be used to understand changes in the acceptor fluorescence as related to 5alpha-reductase catalytic function. Furthermore, this assay endpoint can be referred to as a secondary readout, because this assay has produced multiple assay endpoints where this one serves an artifact detection function.",enzymatic activity,log2_fold_induction,0,"Dutasteride, Finasteride",bidirectional,protein,protein-specified,background measurement,artifact fluorescence,0,0,1,229,1512,869,CCTE_Deisenroth_5AR_NBTE_acceptor,"CCTE_Deisenroth_5AR NBTE_acceptor is one of four assay components measured from the CCTE_Deisenroth_5AR NBTE assay. It is designed to make measurements of resonant fluorescence generated by bioluminescent energy transfer to a target fluorophore, as detected by fluorescence intensity emission signals using spectrometry technology.","The technology is based on the concept of Bioluminescence Resonance Energy Transfer BRET. Target proteins fused to NanoLuc luciferase generate luminescence signal in the presence of furimazine substrate. BRET occurs when custom fluorescent tracers, bound to the target protein, resonate luminescent energy from the luciferase enzyme to the tracer molecule to yield a lower-energy fluorescent emission signal.",single,inducible reporter,acceptor fluorescence emission,regulation of  5alpha-reductase enzyme activity,Fluorescence,Fluorescence Intensity,multimode microplate reader,substrate,tracer fluorogenic probe: MC547-NanoBRET 590 SE,chemical,protein-specified,17,CCTE_Deisenroth_5AR_NBTE,"CCTE_Deisenroth_5AR NBTE (5alpha-reductase NanoBRET Target Engagement Assay) is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 5 hours after chemical dosing in a 384 well plate. This assay includes a primary and secondary screen as well as an autofluorscence screen.",5.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.3,Selected assays,211.0,46.0,165.0
1451,3078,2844,CCTE_Deisenroth_5AR_NBTE_ratio,1,1,"Data from the assay component CCTE_Deisenroth_5AR NBTE_ratio was analyzed into 1 assay endpoint. This assay endpoint, CCTE_Deisenroth_5AR NBTE_ratio, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline of activity. Using a type of inducible reporter, gain or loss-of-signal activity can be used to understand changes in 5alpha-reductase catalytic function. Furthermore, this assay endpoint can be referred to as a primary readout. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the misc protein intended target family, where the subfamily is 5-alpha reductase.",enzymatic activity,fold_induction,0,"Dutasteride, Finasteride",bidirectional,protein,enzyme,misc protein,5-alpha reductase,0,0,1,229,1512,869,CCTE_Deisenroth_5AR_NBTE_ratio,CCTE_Deisenroth_5AR NBTE_ratio is one of four assay components calculated from the CCTE_Deisenroth_5AR NBTE assay. It is designed to measure the ratio of target acceptor fluorophore resonance to donor bioluminescent signals.,The ratio of acceptor signal fluorescence to donor signal luminescence yields a normalized quantitative value in milliBRET Units mBU that can be used to evaluate direct disruption of small molecule target protein interactions of 5 alpha reductase.,single,ratiometric,ratio,regulation of  5alpha-reductase enzyme activity,Bioluminescence Resonance Energy Transfer,Bioluminescence Resonance Energy Transfer Ratio,multimode microplate reader,ratio,acceptor/donor,protein,enzyme,17,CCTE_Deisenroth_5AR_NBTE,"CCTE_Deisenroth_5AR NBTE (5alpha-reductase NanoBRET Target Engagement Assay) is a cell-based, single-readout assay that uses HEK293T, a human kidney cell line, with measurements taken at 5 hours after chemical dosing in a 384 well plate. This assay includes a primary and secondary screen as well as an autofluorscence screen.",5.0,9606.0,human,kidney,cell line,,HEK293T,adherent,microplate: 384-well plate,cell-based,cell-based format,single,DMSO,0.3,Selected assays,205.0,92.0,113.0
1452,3086,2848,TAMU_PeakParms_SingleDonor1434_Asystole,1,1,"Data from the assay component TAMU_PeakParms_SingleDonor1434_Asystole was analyzed into 1 assay endpoint. This assay endpoint, TAMU_PeakParms_SingleDonor1434_Asystole, was analyzed in the positive analysis fitting direction relative to DMSO as the negative control and baseline of activity. Using a type of functional reporter, loss-of-signal activity can be used to understand changes in the cardiac function. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the cardiomyocyte function intended target family, where the subfamily is cessation of beating.",cardiac function,percent_activity,0,,loss,extracellular,action potential ,cardiomyocyte function,cessation of beating,0,0,1,95,397,845,TAMU_PeakParms_SingleDonor1434_Asystole,"TAMU_PeakParms_SingleDonor1434_Chronotopy is a phenotype derived from the peak.freq.avg parameter and uses an EC95 as its POD (95% decrease in beat rate, compared to controls). Peak.Freq.Avg measures the average peak frequency, in beats per second, uisng Fluorescence intensity as a functional reporter from Calcium (Ca+2) flux assay technology. There is no preprocessing performed on the data used to model this phenotype.","Changes in the calcium flux readouts is used to quantify changes in peak frequency, which can be an indication of the cessation of beating",single,functional reporter,beating,cardiac function,Fluorescence,Fluorescence intensity,Calcium (Ca+2) flux assay,stain,Ca+2 dye reagent,calcium influx rate,"average peak frequency, in beats per second",29,TAMU_PeakParms,"TAMU_PeakParms is a cell-based, multiplexed-readout assay that uses iPSC-derived cardiomyocytes with measurements taken at 1.5 hours after chemical dosing in a microplate: 384-well plate.",1.5,9606.0,human,heart,cell-based,iPSC-derived cardiomyocytes,,adherent,microplate: 384-well plate,cell-based,physicochemical format,multiplexed,DMSO,0.5,Selected assays,78.0,10.0,68.0
1459,3094,2855,CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox17,1,1,"Data from the assay component CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox17 was analyzed into 2 assay endpoint. This assay endpoint, CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox17, was analyzed with bidirectional fitting relative to DMSO as the negative control and baseline activity. Using a type of inducible reporter, gain or loss-of-signal activity can be used to understand changes in gene expression. Furthermore, this assay endpoint can be referred to as a primary readout, because this assay has produced multiple assay endpoints where this one serves as a measure of endoderm differentiation. To generalize the intended target to other relatable targets, this assay endpoint is annotated to the transcription factor intended target family, where the subfamily is SRY-related HMG-box.",gene expression,percent_activity,0,SB431542,bidirectional,protein,transcription factor,transcription factor,SRY-related HMG-box,0,0,1,68,576,875,CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox17,CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox17 is one of 4 assay components calculated from the CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo assay and it measures an increase in the percentage of cells in an endoderm state. It is designed to make measurements of inducible reporter a form of fluorescent protein induction as detected with optical fluorescence microscopy. Percentage Sox17+ cells are determined by calculating the number of Sox17+ cells divided by cell count. A cell is Sox17+ if the cell Sox17 mean intensity is 5x BMAD above the pluripotent control median cell Sox17 mean. The assay endpoints were analyzed with bidirectional fitting relative to 0.2% DMSO control in the CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo assay.,CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo_Sox17 was designed to measure changes in cellular Sox17 expression. Changes are indicative of changes in Sox17 gene expression due to perturbations in endoderm differentiation.,single,inducible reporter,fluorescent protein induction,regulation of gene expression,microscopy,optical microscopy: fluorescence microscopy,microscopy,,,protein,transcription factor,17,CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo,"CCTE_Deisenroth_DEVTOX_RUES2-GLR_Endo assay is a cell-based, multiplex-readout assay that uses RUES2-GLR, a human pluripotent cell line, with measurements taken at 48 hours after chemical dosing in a 384-well microplate",48.0,9606.0,human,pluripotent cell line,cell-based,,RUES2-GLR,adherent,microplate: 384-well plate,cell-based,cell-based format,multiplexed,DMSO,0.2,Selected assays,60.0,31.0,29.0
